December 29, 2011 1-התשע"ב טבתב 'ג
12/2011 ג'/תשע"ב
December 29, 2011 התשע"ב טבתב 'ג
יומן הפטנטים והמדגמים
PATENTS AND DESIGNS JOURNAL
Page/עמוד Patents פטנטים
Applications filed 4 ות שהוגשובקש Applications accepted 149 בקשות שקובלו
Patents granted 416 פטנטים שניתנו Patents renewed 416 פטנטים שחודשו
Patents not in force 416 פטנטים שתוקפם פקע
Patents renewed for 20 years 419 פטנטים שחודשו לעשרים שנה Country codes 465 קודים למדינות
Indices of applications accepted 455 מפתחות לבקשות שהתקבלו
Designs מדגמים
Designs registered 437 מדגמים שנרשמו
Designs canceled 453 מדגמים שבוטלו
December 29, 2011 2-התשע"ב טבתב 'ג
ידיעות כלליות
מכתבים, מסמכים, וכו' בענייני פטנטים ומדגמים יש לשלוח אל: ירושלים.מלחה, 5רשם הפטנטים והמדגמים, גנים טכנולוגיים ירושלים, בנין
אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הרשות בבנק הדואר מס' . יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה 0-24145-2
שולמה.
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to: The Patent Authority, Jerusalem Technology Park, Building5, Malcha., Jerusalem.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Authority, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office
together with the application for the action for which the fee has been paid.
זכות היוצרים בתקצירים אלה שמורה למדינת ישראל, אין להעתיק מתקצירים אלה אלא
ברשות לשכת הפטנטים.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
December 29, 2011 3-התשע"ב טבתב 'ג
PATENTS פטנטים-, תשכ"זלחוק הפטנטים 16הודעה לפי סעיף
1967
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
להלן רשימת בקשות חדשות הממלאות אחר )א( לתקנות 32הדרישות שנקבעו בתקנה
:1968-הפטנטים, תשכ"ח
In the following there are listed new
applications complying with the provisions
of rule 32(a) of the Patent Regulations, 5728-
1968:
Particulars of the applications are given in פרטי הבקשות מובאים לפי סדר זה:
the following order:
ותאריך הגשתה וארבעה –מספר הבקשה הסמנים הראשונים של הסיווג הבינלאומי
Number and date of application and the first
four symbols of the International
Classification.
Title of invention (as proposed by applicant) שם האמצאה )כפי שהוצע ע"י המבקש(
Applicant המבקש
:Convention country- Priority right –מדינת האיגוד דין קדימה:
Number and date of תאריך ומספר
Foreign application בקשת החוץ
International Application Number מספר בקשה בינלאומית
International Publication Number מספר פרסום בינלאומי
December 29, 2011 4-התשע"ב טבתב 'ג
(2011.01 )F41H 768<;; 01//4/0/22
יחידה אנרגטית המבוססת על גשר מוליך למחצה
ENERGETIC UNIT BASED ON
SEMICONDUCTOR BRIDGE
RAFAEL ADVANCED DEFENSE רפאל מערכות לחימה מתקדמות בע"מ
SYSTEMS LTD.
(2011.01 )F41H 768=;: 1///4/0/22
ANTIBALLISTIC ARTICLE AND בליסטי ושיטה לייצורו–מוצר אנטי
METHOD OF PRODUCING SAME .ISRAEL MILITARY INDUSTRIES LTD התעשייה הצבאית לישראל בע"מ
(2011.01 )H01L 76:5>; 20//1/0/2/
מתקנים לריכוז והולכת אנרגיה סולארית ע"י סטימולציה של פליטה לומינסנטית
STIMULATED EMISSION
LUMINESCENT LIGHT-GUIDE SOLAR
CONCENTRATORS .MORGAN SOLAR INC מורגן סולאר בע"מ
12/03/2009 2,658193 CA 04//2/0/2/ 42/07624/ US PCT/CA/2010/000363 WO/2010/102408
(2011.01 )C07C 76:5>= 27//1/0/2/
ALCOHOL AS SANDALWOOD ODORANT אלכוהול בניחוח אלגום
FIRMENICH SA 24/03/2009 PCT/IB2009/051223 IB PCT/IB/2010/051199
December 29, 2011 5-התשע"ב טבתב 'ג
WO/2010/109391
(2011.01 )H01H 76:5>> 26//1/0/2/
( בעל MEMSמבנה מיקרו אלקטרו מכני )הממברנה גמישה ואמצעי הפעלה
אלקטרוניים משופרים
MEMS STRUCTURE WITH A
FLEXIBLE MEMBRANE AND
IMPROVED ELECTRIC ACTUATION
MEANS DELFMEMS 20/03/2009 09370007.8 EP PCT/EP/2010/001701 WO/2010/105827
(2011.01 )C07D 76:655 26//1/0/2/
שיפור סינטזה כימית של דיאזאינדולים על ידי ציקליזציה של חיחיבאבין
IMPROVED CHEMICAL SYNTHESIS
OF DIAZAINDOLES BY CHICHIBABIN
CYCLIZATION SANOFI 19/03/2009 61/161440 US 23/20/0//7 /736753 FR PCT/US/2010/027755 WO/2010/107969
(2011.01 )A61B 76:656 20//1/0/2/
מכשיר ושיטה לשילוב קריותרפיה עם ברכיתרפיה
COMBINED CRYOTHERAPY AND
BRACHYTHERAPY DEVICE AND
METHOD ICECURE MEDICAL LTD אייסקיור מדיקל בע"מ
12/03/2009 61/159497 US PCT/US/2010/027142 WO/2010/105158
(2011.01 )C07D 76:658 23//1/0/2/
December 29, 2011 6-התשע"ב טבתב 'ג
–[אוקט1.2.3ביציקלו]–אזא–N–[(6נגזרות הטרובנזאמיד, –מתיל[–אריל–איל(–1
הכנתן, ושימוש רפואי שלהן
N-[(6-AZA-bicyclo[3.2.1]OCT-5-YL]-
ARYL-METHYL]-
HETEROBENZAMIDE DERIVATIVES,
PREPARATION THEREOF, AND
THERAPEUTIC USE OF SAME SANOFI 16/03/2009 09/01220 FR PCT/FR/2010/050448 WO/2010/106270
(2011.01 )C07D 76:659 23//1/0/2/
–1–[ הקס1.1.2אזאביצקלו]–N–[(2נגזרות הטרובנזאמיד, הכנתן, –מתיל[–אריל–אין(
ויישום שלהן ברפואה
DERIVATIVES OF N-[(2-AZA-
BICYCLO[2.1.1]HEX-1-YL)-ARYL-
METHYL]-HETEROBENZAMIDE,
PREPARATION THEREOF AND
APPLICATION OF SAME IN
THERAPEUTICS SANOFI 16/03/2009 09/01219 FR 22//2/0//7 /7//262/ FR PCT/FR/2010/050447 WO/2010/106269
(2011.01 )C07D 76:65: /2//3/0/2/
NEMATOCIDAL SULFONAMIDES סולפונאמידים קוטלי תולעים
E.I. DU PONT DE NEMOURS AND
COMPANY 04/05/2009 61/175206 US PCT/US/2010/033471 WO/2010/129500
(2011.01 )A61K 76:65< /6//2/0/2/
תולדות בנזודיאזפין לטיפול בנאופלסמה ההמטופואטית ולויקמי
BENZODIAZEPINE DERIVATIVE FOR
THE TREATMENTOF
HEMATOPOIETIC NEOPLASM AND
LUEKEMIA ELI LILLY AND COMPANY
December 29, 2011 7-התשע"ב טבתב 'ג
14/04/2009 61/169094 US PCT/US/2010/030315 WO/2010/120614
(2011.01 )A61K 76:65= /6//2/0/2/
אמאטוקסין –מטרה מצוידי–חלקים קושרי לטיפול בסרטן
AMATOXIN-ARMED TARGET-
BINDING MOIETIES FOR THE
TREATMENT OF CANCER FAULSTICH, HEINZ 08/04/2009 61/167690 US PCT/EP/2010/002206 WO/2010/115630
(2011.01 )C07D 76:65> 06//2/0/2/
ISOXAZOLE-PYRIDAZINE פירידאזין–תולדות איזוקסאזול
DERIVATIVES F. HOFFMANN-LA ROCHE AG 05/05/2009 09159412.7 EP PCT/EP/2010/055669 WO/2010/127968
(2011.01 )A21D 76:668 01//2/0/2/
טריות של מאפה בצק –תהליך נגד אי שטוח
ANTISTALING PROCESS FOR FLAT
BREAD
NOVOZYMES NORTH AMERICA, INC. 24/04/2009 61/172515 US PCT/US/2010/032233 WO/2010/124206
(2011.01 )F17C 76:669 00//2/0/2/
METHOD AND DEVICE FOR GASSING שיטה ומכשיר לאספקת גז
LINDE AG 13/03/2009 102009013133.7 DE
December 29, 2011 8-התשע"ב טבתב 'ג
PCT/EP/2010/000397 WO/2010/102693
(2011.01 )C12N 76:66; 24//1/0/2/
מערכת לייצור חלבון כריסוספוריום לוקנוונס
CHRYSOSPORIUM LUCKNOWENSE
PROTEIN PRODUCTION SYSTEM
DYADIC NEDERLAND B.V. 16/03/2009 09003750 EP PCT/NL/2010/000045 WO/2010/107303
(2011.01 )A61K 76:66> 20//1/0/2/
SUBSTITTED FUSED PYRIMIDINE תרכובות פירימידין דחוסות ומותמרות
COMPOUNDS
ADVINUS THERAPEUTICS PRIVATE
LIMITED 13/03/2009 0571/CHE/2009 IN PCT/IN/2010/000145 WO/2010/103547
(2011.01 )C07D 76:675 /3//2/0/2/
הידרוקסיתיאנוקווינולונים ותרכובות ומייםזיה–קשורות כגורמים אנטי
HYDROXYTHIENOQUINOLONES
AND RELATED COMPOUNDS AS
ANTI-INFECTIVE AGENTS
ACHILLION PHARMACEUTICALS,
INC 03/04/2009 61/166371 US PCT/US/2010/029938 WO/2010/115184
(2011.01 )H04W 76:676 25//1/0/2/
December 29, 2011 9-התשע"ב טבתב 'ג
שיטה ומערכת לבקרת כח שידור אות (SRSהתייחסות צלילי )
METHOD AND APPARATUS FOR
POWER CONTROL OF SOUNDING
REFERENCE SIGNAL (SRS)
TRANSMISSION
INTERDIGITAL PATENT HOLDINGS,
INC. 17/03/2009 61/160979 US PCT/US/2010/027617 WO/2010/107880
(2011.01 )A61K 76:677 07//1/0/2/
FAST-ACTING INSULIN הרכב אינסולין הפועל במהירות
FORMULATION ADOCIA 27/03/2009 61/202692 US 05//1/0//7 /7//2256 FR PCT/IB/2010/000711 WO/2010/122385
(2011.01 )A61K 76:678 04//1/0/2/
גורם, חלקיקים, תכשירים –תצמידי פולימר ושיטות קשורות לשימוש
POLYMER-AGENT CONJUGATES,
PARTICLES, COMPOSITIONS, AND
RELATED METHODS OF USE CERULEAN PHARMA INC. 30/03/2009 61/164734 US 1///1/0//7 42/242500 US 1///1/0//7 42/24250/ US 1///1/0//7 42/242503 US 1///1/0//7 42/242506 US 1///1/0//7 42/242512 US 0//22/0//7 42/040771 US 0//22/0//7 42/040772 US PCT/US/2010/028770 WO/2010/117668
(2011.01 )C10G 76:679 21//1/0//7
December 29, 2011 10-התשע"ב טבתב 'ג
מיצוי של פחמימנים מחומרים המכילים פחמימנים ו/או עיבוד של חומרים
המכילים פחמימנים
EXTRACTION OF HYDROCARBONS
FROM HYDROCARBON-
CONTAINING MATERIALS AND/OR
PROCESSING OF HYDROCARBON-
CONTAINING MATERIALS GREEN SOURCE ENERGY LLC PCT/US/2009/037112 WO/2010/104516
(2011.01 )A61K 76:67; 02//1/0/2/
משחה תרופתית נגד חיידקים ותהליך לייצורה
A MEDICINAL ANTIBACTERIAL
CREAM AND A PROCESS TO MAKE IT
VANANGAMUDI, SULUR,
SUBRAMANIAM 25/03/2009 701/MUM/2009 IN PCT/IB/2010/051280 WO/2010/109417
(2011.01 )C07C 76:67= 07//1/0/2/
METHOD FOR PRODUCING שיטה לייצור תרכובת אלכוהולית
ALCOHOL COMPOUND
SUMITOMO CHEMICAL COMPANY,
LIMITED
31/03/2009 2009-
084832 JP
PCT/JP/2010/056109 WO/2010/114137
(2011.01 )A61K 76:686 00//1/0/2/
METHODS OF TREATMENT USING שיטות לטיפול תוך שימוש בריפוי משולב
COMBINATION THERAPY AMBIT BIOSCIENCES CORPORATION 23/03/2009 61/202647 US 07//2/0//7 42/2516/1 US /2/20/0//7 42/044767 US PCT/US/2010/028129
December 29, 2011 11-התשע"ב טבתב 'ג
WO/2010/111172
(2011.01 )H04N 76:688 25//1/0/2/
התקן ושיטות להפצת וידאו לפי ביקושAPPARATUS AND METHODS FOR
SYNDICATION OF ON-DEMAND
VIDEO ACTIVEVIDEO NETWORKS INC 17/03/2009 61/160880 US PCT/US/2010/027724 WO/2010/107954
(2011.01 )G01C 76:689 20//0/0/2/
CARRIER MODULATING תאוצה מאפנן נשא–מד
ACCELEROMETER RAYTHEON COMPANY 04/05/2009 12/435098 US PCT/US/2010/024183 WO/2010/129079
(2011.01 )F16K 76:68: /6//1/0/2/
REGULATING VALVE DEVICE התקן שסתום מווסת
FUJIKIN INCORPORATED
17/03/2009 2009-
064546 JP
PCT/JP/2010/053749 WO/2010/106935
(2011.01 )H01Q 76:68; 01//0/0/2/
בעלת פס VHF/UHFערוצית –משושה דו רחב
VHF/UHF BROADBAND DUAL
CHANNEL ANTENNA
THALES 13/03/2009 0901187 FR PCT/EP/2010/052302
December 29, 2011 12-התשע"ב טבתב 'ג
WO/2010/102901
(2011.01 )A61K 76:68= 26//1/0/2/
לטיפול בפקקת ורידית 5026AVEמנה של בחולים עם אי ספיקת כליות חמורה
A DOSE OF AVE5026 FOR THE
TREATMENT OF VENOUS
THROMBOEMBOLISM IN PATIENTS
WITH SEVERE RENAL IMPAIRMENT SANOFI 19/03/2009 09290202.2 FR PCT/IB/2010/051186 WO/2010/106519
(2011.01 )C07D 76:68> 26//1/0/2/
, תכשירים HSP90נגזרות אינדזול מעכבות המכילים אותן ושימוש שלהן
HSP90 INHIBITING INDAZOLE
DERIVATIVES, COMPOSITIONS
CONTAINING SAME AND USE
THEREOF SANOFI 19/03/2009 0901274 FR 27//2/0/2/ 2/3/122 FR PCT/FR/2010/050483 WO/2010/106290
(2011.01 )F24J 76:695 27//1/0/2/
אור עבור קולט משטח המחזיר קרני אנרגיה סולרית
REFLECTIVE SURFACE FOR SOLAR
ENERGY COLLECTOR
SKYLINE SOLAR INC. 20/03/2009 61/162125 US PCT/US/2010/028047 WO/2010/108141
(2011.01 )C12N 6:6967 27//1/0//7
December 29, 2011 13-התשע"ב טבתב 'ג
טראוסטוציטרידים, תכשירים של חומצות שומן ושיטות להכנה ושימושים בהם
THRAUSTOCHYTRIDS, FATTY ACID
COMPOSITIONS, AND METHODS OF
MAKING AND USES THEREOF
MARTEK BIOSCIENCES
CORPORATION PCT/US/2009/001720 WO/2010/107415
(2011.01 )C09K 76:697 24//1/0/2/
נוזלי קידוח בעלי ביצועים גבוהים עם מיקרון כגורם –חלקיקים בגודל תת
הכבידה
HIGH PERFORMANCE DRILLING
FLUIDS WITH SUBMICRON-SIZE
PARTICLES AS THE WEIGHTING
AGENT
HALLIBURTON ENERGY SERVICES
INC 23/03/2009 12/409240 US PCT/GB/2010/000469 WO/2010/109163
(2011.01 )A01N 76:698 03//1/0/2/
PROCESS FOR THE PREPARATION תהליך להכנת אלוגליפטין
OF ALOGLIPTIN MAPI PHARMA LTD מאפי פארמה בע"מ
26/03/2009 61/163481 US PCT/IL/2010/000260 WO/2010/109468
(2011.01 )C01G 76:699 22//7/0/22
METHOD OF RECOVERING שיטה למיצוי מתכות קבוצה פלטינה
PLATINUM GROUP METAL BORIS GOLDIN
December 29, 2011 14-התשע"ב טבתב 'ג
(2011.01 )B24B 76:69; 12/20/0//7
–כלי ממרט לשימוש כפד החלקה כימי צבמכני מיי
ABRASIVE TOOL USE AS A
CHEMICAL MECHANICAL
PLANARIZATION PAD
CONDITIONER Saint-Gobain ABRASIFS 24/03/2009 61/162893 US 02//6/0//7 42/01376/ US PCT/US/2009/069961 WO/2010/110834
(2011.01 )C07D 76:69< 27//1/0/2/
COMPOUNDS תרכובות
MEDICAL RESEARCH COUNCIL
TECHNOLOGY 19/03/2009 0904746.5 GB 0///1/0//7 42/240/02 US 22//5/0//7 /72001691 GB 06//2/0/2/ 2//222692 GB PCT/GB/2010/000498 WO/2010/106333
(2011.01 )G06T 76:69= 07//4/0//7
CONTENT PROTECTION MESSAGE חילוץ מודעות מתכנים מוגנים
EXTRACTION NDS LIMITED PCT/IB/2009/052784 WO/2011/001204
(2011.01 )A61M 76:69> 26//1/0/2/
December 29, 2011 15-התשע"ב טבתב 'ג
מתאם למשאף עבור מערכת דיפרקצית לייזר ושיטה למדידת התפלגות של גדלי
חלקיקים
INHALER ADAPTOR FOR A LASER
DIFFRACTION APPARATUS AND
METHOD FOR MEASURING
PARTICLE SIZE DISTRIBUTION MANNKIND CORPORATION 18/03/2009 61/161379 US PCT/US/2010/027880 WO/2010/108046
(2011.01 )C04B 76:6:5 26//1/0//7
לוח או טבלה המוצרים מצבור אבן ילים דבק אורגני ממוצא צמחיוהמכ
BOARD OR SLAB FORMED BY
STONE AGGLOMERATE
CONTAINING AN ORGANIC BINDER
OF VEGETABLE ORIGIN COSENTINO, S.A. PCT/ES/2009/000153 WO/2010/106196
(2011.01 )F42B 76:6:6 01//2/0/2/
שיטה לבקרת טורפדו, טורפדו עבורה וקטע אנטנה של טורפדו כזה
METHOD FOR CONTROLLING A
TORPEDO, TORPEDO THEREFOR AND
ANTENNA SECTION OF SUCH A
TORPEDO ATLAS ELEKTRONIK GMBH 02/05/2009 102009019790.7 DE PCT/EP/2010/055475 WO/2010/127953
(2011.01 )C07D 76:6:8 23//1/0/2/
תרכובות נגזרות אמיד, תכשירים המכילים אותן ושימושים בהן
AMIDE DERIVATIVE COMPOUNDS,
COMPOSITIONS COMPRISING THE
SAME AND USES THERE OF
DAIICHI SANKYO COMPANY,
LIMITED
17/03/2009 2009-
065029 JP
December 29, 2011 16-התשע"ב טבתב 'ג
PCT/JP/2010/054291 WO/2010/106988
(2011.01 )A61K 76:6:9 02/2//0//7
PHOTODYNAMIC DISINFECTION ושימושים בהםתכשירי חיטוי פוטודינמי,
COMPOSITIONS AND USES THEREOF ONDINE INTERNATIONAL LTD. 16/03/2009 61/160435 US PCT/US/2009/061442 WO/2010/107454
(2011.01 )A23L 76:6:: 24//1/0/2/
תכשיר תזונתי המכיל כורכומינואידים ושיטות ייצור
NUTRITIONAL COMPOSITION
COMPRISING CURCUMINOIDS AND
METHODS OF MANUFACTURE ABBOTT LABORATORIES 26/03/2009 61/163688 US 04//1/0//7 42/241461 US PCT/US/2010/027477 WO/2010/111070
(2011.01 )A01N 76:6:; 27//1/0/2/
נוקליאוזיד מותמר ואנלוגים של נוקליאוטיד
SUBSTITUTED NUCLEOSIDE AND
NUCLEOTIDE ANALOGS
ALIOS BIOPHARMA INC. 20/03/2009 61/162198 US 2///5/0//7 42/002623 US 22//6/0//7 42/012247 US PCT/US/2010/028046 WO/2010/108140
(2011.01 )C25D 76:6:< 12//1/0/2/
December 29, 2011 17-התשע"ב טבתב 'ג
הרכב לציפוי מתכתי המכיל גורם הסתרה מיקרוני–לל חופשי תתעבור מילוי של ח
COMPOSITION FOR METAL PLATING
COMPRISING SUPPRESSING AGENT
FOR VOID FREE SUBMICRON
FEATURE FILLING BASF SE 07/04/2009 09157540.7 EP 1//2//0//7 42/034106 US PCT/EP/2010/054281 WO/2010/115796
(2011.01 )C07D 76:6:= /2//2/0/2/
[ 4,3,1][B–1,2תולדות אימידאזו ] תיאדיאזול
IMIDAZO [2,1-B] [1,3,4]
THIADIAZOLE DERIVATIVES
CENTRO NACIONAL DE
INVESTIGACIONES ONCOLOGICAS
(CNIO) 02/04/2009 09380069.6 EP PCT/GB/2010/000674 WO/2010/112874
(2011.01 )B32B 76:6:> 26//1/0/2/
THIN FILM COATING AND METHOD שכבת ציפוי דקה ושיטה לייצורה
OF MAKING THE SAME AGC GLASS EUROPE 18/03/2009 61/161186 US /2//6/0//7 42/0120/7 US PCT/US/2010/027806 WO/2010/107998
(2011.01 )H01L 76:6;5 01//1/0/2/
SLIP CHIP DEVICE AND METHODS התקן להחלקת שבב ושיטות
THE UNIVERSITY OF CHICAGO 24/03/2009 61/162922 US 26/22/0//7 42/040153 US 00//1/0/2/ 42/12/650 US PCT/US/2010/028316
December 29, 2011 18-התשע"ב טבתב 'ג
WO/2010/111265
(2011.01 )C07D 76:6;6 02//2/0/2/
ALKYNYL-PYRIDINES-5 פירידינים–אלקיניל–5
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH 21/04/2009 09158327.8 EP PCT/EP/2010/055293 WO/2010/122069
(2011.01 )B01J 76:6;7 27//1/0/2/
שיטות יעילות לפעולה עם נוזלים בלחץ גבוה
EFFICIENT METHODS FOR
OPERATION WITH HIGH PRESSURE
LIQUIDS ENERGY RECOVERY, INC. 20/03/2009 61/161977 US PCT/US/2010/027918 WO/2010/108070
(2011.01 )B05D 76:6;8 02//1/0/2/
רצועה מצופה ע"י שיחול עבור אריזות קשיחות
EXTRUSION-COATED STRIP FOR RIGID
PACKAGINGS
HYDRO ALUMINIUM DEUTSCHLAND
GMBH 26/03/2009 102009003683.0 DE PCT/EP/2010/053833 WO/2010/108953
(2011.01 )C12Q 76:6;9 23//1/0/2/
תהליך להגברת אותות המבוסס על זיהוי מוליקולרי
ABSCRIPTION BASED MOLECULAR
DETECTION
RIBOMED BIOTECHNOLOGIES, INC. 15/03/2009 61/160335 US
December 29, 2011 19-התשע"ב טבתב 'ג
PCT/US/2010/027367 WO/2010/107716
(2011.01 )C07K 76:6;: 26//1/0/2/
שיטה להכנת פוליפפטיד קוניוגאנט פעיל פיזיולוגית באתר ספציפי
METHOD FOR PREPARING A SITE-
SPECIFIC PHYSIOLOGICALLY
ACTIVE POLYPEPTIDE CONJUGATE HANMI HOLDINGS CO., LTD.
20/03/2009 10-2009-
0023953 KR
PCT/KR/2010/001674 WO/2010/107256
(2011.01 )A61K 76:6;; 02//1/0/2/
טן השד העושה שימוש משטר טיפול לסר בנראטיניב
TREATMENT REGIMEN UTILIZING
NERATINIB FOR BREAST CANCER
WYETH LLC 06/04/2009 61/166796 US PCT/US/2010/028448 WO/2010/117633
(2011.01 )C07K 76:6;= 01//2/0/2/
תכשירים ושיטות להגברת גדילת שרירCOMPSITIONS COMPOSITIONS AND
METHODS FOR INCREASING
MUSCLE GROWTH NOVARTIS AG 27/04/2009 61/173004 US 27//0/0/2/ 42/1/4215 US PCT/EP/2010/055458 WO/2010/125003
(2011.01 )C07D 76:6;> 06//2/0/2/
December 29, 2011 20-התשע"ב טבתב 'ג
פירידין כמאפנני –תולדות איזוקסאזולGABA
ISOXAZOLE -PYRIDINE
DERIVATIVES AS GABA
MODULATORS F. HOFFMANN-LA ROCHE AG 07/05/2009 09159631.2 EP PCT/EP/2010/055701 WO/2010/127978
(2011.01 )A01N 76:6<5 01//2/0/2/
אלכוהול אלקוקסילאטים כחומר מסייע לתכשירים אגרוכמיקליים
ALCOHOL ALKOXYLATES AS
ADJUVANTS FOR AGROCHEMICAL
FORMULATIONS SYNGENTA LIMITED 23/04/2009 0907003.8 GB PCT/GB/2010/000821 WO/2010/122313
(2011.01 )F27B 76:6<6 24//1/0/2/
A PYROLYTIC REACTOR כור פירוליטי
T.D.E. RECOVERY TECHNOLOGIES טי.די.אי. טכנולוגיות מיחזור בע"מ
LTD 17/03/2009 61/160842 US PCT/IL/2010/000217 WO/2010/106538
(2011.01 )F23K 76:6<7 24//1/0/2/
FEEDING APPARATUS AND METHOD מכשיר הזנה ושיטה לכור פירוליטי
FOR A PYROLYTIC REACTOR
T.D.E. RECOVERY TECHNOLOGIES טי.די.אי. טכנולוגיות מיחזור בע"מ
LTD 17/03/2009 61/160842 US PCT/IL/2010/000218 WO/2010/106539
December 29, 2011 21-התשע"ב טבתב 'ג
(2011.01 )C08J 76:6<8 24//1/0/2/
תהליך נקי סביבתית לשימוש במוצרי פירוליזה
ENVIRONMENTALLY CLEAN
PROCESS FOR UTILIZING
PYROLYSIS PRODUCTS
T.D.E. RECOVERY TECHNOLOGIES טי.די.אי. טכנולוגיות מיחזור בע"מ
LTD 17/03/2009 61/160842 US PCT/IL/2010/000219 WO/2010/106540
(2011.01 )C07D 76:6<9 00//1/0/2/
קטון אפוקסי טריפפטיד קריסטלי מעכבי פרוטאז
CRYSTALLINE TRIPEPTIDE EPOXY
KETONE PROTEASE INHIBITORS
ONYX THERAPEUTICS, INC. 20/03/2009 61/162196 US 00//3/0//7 42/26/342 US PCT/US/2010/028126 WO/2010/108172
(2011.01 )C07D 76:6<: 01//1/0/2/
נגזרות של תיאנופירימידינדיאון 1TRPAכמאפנני
THIENOPYRIMIDINEDIONE
DERIVATIVES AS TRPA1
MODULATORS GLENMARK PHARMACEUTICALS S.A. 23/03/2009 665/MUM/2009 IN 02//2/0//7 42/252133 US 01//7/0//7 0021/MUM/2009 IN 23/2//0//7 42/032772 US 24/20/0//7 07/4/MUM/2009 IN 20//2/0/2/ 42/07225/ US PCT/IB/2010/000930 WO/2010/109334
(2011.01 )B62B 76:6<; /7//1/0/2/
CART עגלה
December 29, 2011 22-התשע"ב טבתב 'ג
FINE, AMOS 16/03/2009 12/382410 US PCT/IB/2010/051009 WO/2010/106464
(2011.01 )C07D 76:6<< 00//1/0/2/
נגזרות של פורופירימידינדיאון 1TRPAכמאפנני
FUROPYRIMIDINEDIONE DERIVATIVES
AS TRPA1 MODULATORS
GLENMARK PHARMACEUTICALS S.A. 23/03/2009 665/MUM/2009 IN 02//2/0//7 42/252133 US 01//7/0//7 0021/MUM/2009 IN 23/2//0//7 42/032772 US 24/20/0//7 07/4/MUM/2009 IN 20//2/0/2/ 42/07225/ US PCT/IB/2010/000840 WO/2010/109329
(2011.01 )C07D 76:6<= 25//1/0/2/
נגזרות מאוחות של פירימידינדיאון 1TRPAכמאפנני
FUSED PYRIMIDINEDIONE
DERIVATIVES AS TRPA1 MODULATORS
GLENMARK PHARMACEUTICALS S.A. 23/03/2009 665/MUM/2009 IN 02//2/0//7 42/252133 US 01//7/0//7 0022/MUM/2009 IN 01//7/0//7 0020/MUM/2009 IN 23/2//0//7 42/032722 US 0//2//0//7 42/031041 US 23/20/0//7 0672/MUM/2009 IN 23/20/0//7 0670/MUM/2009 IN 20//2/0/2/ 42/072241 US /2//0/0/2/ 42/1//022 US PCT/IB/2010/000553 WO/2010/109287
(2011.01 )C07D 76:6<> 00//1/0/2/
December 29, 2011 23-התשע"ב טבתב 'ג
פירימידינדיאון –נגזרות של איזותיאזולו 1TRPAכמאפנני
ISOTHIAZOLO-PYRIMIDINEDIONE
DERIVATIVES AS TRPA1
MODULATORS GLENMARK PHARMACEUTICALS S.A. 23/03/2009 665/MUM/2009 IN 02//2/0//7 42/252133 US PCT/IB/2010/000834 WO/2010/109328
(2011.01 )A61L 76:6=5 00//2/0/2/
BIOCOMPATIBLE COMPOSITE AND מרוכב מתאים לשימוש בגוף ושימוש שלו
ITS USE VIVOXID OY 23/04/2009 09158597.6 EP PCT/EP/2010/055335 WO/2010/122098
(2011.01 )C03C 76:6=6 0///2/0/2/
תכשירי סיבי זכוכית הניתנים לספיגה חוזרת ומתאימים לשימוש בגוף ושימושים
שלהם
RESORBABLE AND BIOCOMPATIBLE
FIBRE GLASS COMPOSITIONS AND
THEIR USES
VIVOXID OY 23/04/2009 09158608.1 EP PCT/EP/2010/055192 WO/2010/122019
(2011.01 )C12Q 76:6=7 25//1/0/2/
IMPROVED DETECTION OF GENE גילוי משופר של ביטוי גנים
EXPRESSION MDxHEALTH S.A. 17/03/2009 61/160935 US PCT/EP/2010/001674 WO/2010/105815
December 29, 2011 24-התשע"ב טבתב 'ג
(2011.01 )C07C 76:6=8 26//1/0/2/
–2–בנזיל–V7–(Rתהליך להכנת )–S–)בנזילאוקסיקרבונילאמינו(
ופיונאמידמתוקסיפר
PROCESS FOR PREPARING (R)-7V-
BENZYL-2-
(BENZYLOXYCARBONYLAMINO)-S-
METHOXYPROPIONAMIDE PLIVA HRVATSKA D.O.O. 18/03/2009 61/161181 US 05//2/0//7 42/2507/1 US PCT/US/2010/027800 WO/2010/107993
(2011.01 )F01N 76:6=9 06//1/0/2/
EXHAUST GEOMETRY FOR פליטה גיאומטרית של קבוצת חלקיקים
PARTICLE GROUPING RUZAL MICHAL ערן שר
30/03/2009 61/164477 US PCT/IL/2010/000269 WO/2010/113156
(2011.01 )C07C 76:6=> 1///1/0/2/
שיטה לייצור תרכובת אלכוהולית וזרז עבורה
METHOD FOR PRODUCING
ALCOHOL COMPOUND AND
CATALYST THEREFOR
SUMITOMO CHEMICAL COMPANY,
LIMITED
31/03/2009 2009-
084833 JP
PCT/JP/2010/056130 WO/2010/114151
(2011.01 )A23L 76:6>5 01//1/0/2/
טעם טבעי המגביר את התיבול הבסיסי והליך להכנתו
A NATURAL TASTE ENHANCING
SAVOURY BASE AND A PROCESS FOR ITS
PREPARATION NESTEC S.A. 25/03/2009 PCT/EP2009/053530 EP
December 29, 2011 25-התשע"ב טבתב 'ג
PCT/EP/2010/053735 WO/2010/108901
(2011.01 )B65D 76:6>6 04//1/0/2/
IMPROVED CONTAINERS מיכלים משופרים
GARMOND PTY. LIMITED 03/04/2009 2009901455 AU PCT/AU/2010/000340 WO/2010/111729
(2011.01 )C23C 76:6>7 02//1/0/2/
תהליך לסינטור ננו חלקיקים בטמפרטורה נמוכה
PROCESS FOR SINTERING
NANOPARTICLES AT LOW
TEMPERATURES
יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים בע"מ
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD. 24/03/2009 61/162744 US PCT/IL/2010/000249 WO/2010/109465
(2011.01 )F16D 76:6>8 /4//2/0/2/
מכשיר מכאני לשידור כח עם סףMECHANICAL DEVICE FOR THE
TRANSMISSION OF A FORCE WITH A
THRESHOLD MESSIER-BUGATTI-DOWTY 06/04/2009 09/01683 FR PCT/EP/2010/054538 WO/2010/115895
(2011.01 )A61K 76:6>9 24//1/0/2/
NOVEL ANTI-INFLAMMATORY דלקתיים–גורמים חדשים אנטי
AGENTS
December 29, 2011 26-התשע"ב טבתב 'ג
RESVERLOGIX CORP 18/03/2009 61/161089 US PCT/IB/2010/000826 WO/2010/106436
(2011.01 )A61K 76:6>: 24//1/0/2/
עם מינונים עולים NASH–שיטה לטיפול ב של חומצה אורסודיאוקסיכולית
METHOD OF TREATING
NONALCOHOLIC STEATOHEPATITIS
WITH ELEVATED DOSES OF
URSODEOXYCHOLIC ACID AXCAN PHARMA INC 17/03/2009 61/160955 US PCT/IB/2010/000551 WO/2010/106420
(2011.01 )A61K 76:6>; 03//1/0/2/
טרום מוות של גורמים זיהוי מהיר זיהומיים
RAPID ANTEMORTEM DETECTION
OF INFECTIOUS AGENTS
THE RESEARCH FOUNDATION OF
STATE UNIVERSITY OF NEW YORK 25/03/2009 61/211264 US 03//1/0//7 42/022043 US PCT/US/2010/028698 WO/2010/111514
(2011.01 )C07D 76:6>> 02//2/0/2/
ציקלופנטאזולנים כמעכבי –טריאזא–תיה3PI–קינאזות לטיפול בסרטן
THIA-TRIAZA-
CYCLOPENTAZULENES AS PI3-
KINASES INHIBITORS FOR THE
TREATMENT OF CANCER
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH 22/04/2009 09158493.8 EP PCT/EP/2010/055295 WO/2010/122071
December 29, 2011 27-התשע"ב טבתב 'ג
(2011.01 )A61K 76:755 02//1/0/2/
DRUG FUSIONS AND CONJUGATES מיזוגי ותצמידי תרופות
GLAXO GROUP LIMITED 27/03/2009 61/163917 US PCT/EP/2010/053806 WO/2010/108937
(2011.01 )E01F 76:756 27//1/0/2/
IMPROVED ROAD BARRIER מחסום כביש משופר
INDUSTRIAL GALVANIZERS
CORPORATION PTY LTD 19/03/2009 2009901186 AU 25//2/0//7 0//77/2436 AU 22//4/0//7 0//77/0475 AU 21/22/0//7 0//77/3343 AU PCT/AU/2010/000321 WO/2010/105307
(2011.01 )A01N 76:757 03//1/0/2/
C FUSED RING INHIBITORS OF–מעכבים טבעתיים מאוחים של צהבת
HEPATITIS C PRESIDIO PHARMACEUTICALS, INC. 27/03/2009 61/164342 US 06//2/0//7 42/022661 US PCT/US/2010/028730 WO/2010/111534
(2011.01 )A61B 76:758 27//0/0/2/
שיטה להתקן להעברת פריט זוכר צורה לאתר ניתוח
METHOD AND APPARATUS FOR
DELIVERING A SHAPE MEMORY
ARTICLE TO A SURGICAL SITE
CORE ESSENCE ORTHOPAEDICS,
LLC
December 29, 2011 28-התשע"ב טבתב 'ג
19/03/2009 61/161604 US PCT/US/2010/024728 WO/2010/107549
(2011.01 )G01R 76:759 1///1/0/2/
–תפעול אוטומטי של מכשיר בדיקה רב נקודתי
AUTOMATED MULTI-POINT PROBE
MANIPULATION
CAPRES A/S 31/03/2009 09388007.8 EP PCT/EP/2010/054180 WO/2010/115771
(2011.01 )A61K 76:75: 03//1/0/2/
עיניות למתן תרופות –מערכות תוךבשחרור ממושך ושיטות לטיפול במחלות
עיניים
INTRAOCULAR SUSTAINED
RELEASE DRUG DELIVERY
SYSTEMS AND METHODS FOR
TREATING OCULAR CONDITIONS ALLERGAN, INC. 25/03/2009 12/411250 US PCT/US/2010/028584 WO/2010/111449
(2011.01 )C07D 76:75; 27//2/0/2/
SOLID FORMS OF AN AZOCYCLIC צורות מוצקות של אמיד אזוציקלי
AMIDE
E.I. DU PONT DE NEMOURS AND
COMPANY 22/04/2009 61/171573 US /6//1/0/2/ 42/122320 US PCT/US/2010/031546 WO/2010/123791
(2011.01 )H04W 76:75< 03//2/0/2/
December 29, 2011 29-התשע"ב טבתב 'ג
שיטה וציוד לטיפול בתיחול בקשת תזמוןMETHOD AND USER EQUIPMENT
FOR HANDLING A SCHEDULING
REQUEST TRIGGER
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL) 05/05/2009 61/175668 US PCT/SE/2010/050063 WO/2010/128927
(2011.01 )C07K 76:75= 25//1/0/2/
נוגדנים הנקשרים לפלאק טרשת עורקים כלילית, שיטות להכנתם ושימושם בהם
ANTIBODIES BINDING
ATHEROSCLEROTIC CORONARY
PLAQUE, PROCESSES FOR THE
PREPARATION OF THE SAME AND
USES THEREOF BRACCO IMAGING S.P.A. 19/03/2009 09155614.2 EP PCT/EP/2010/053430 WO/2010/106088
(2011.01 )C07C 76:75> 20//1/0/2/
–טרו–לייצור תולדות קארבוקסילישיטה יוד ארומטייות
PROCESS FOR THE PREPARATION
OF TRIIODINATED CARBOXYLIC
AROMATIC DERIVATIVES BRACCO IMAGING S.P.A. 20/03/2009 09155695.1 EP PCT/EP/2010/053186 WO/2010/105983
(2011.01 )A61M 76:765 04//1/0/2/
התקן לשחרור תרופה עם מקל בוכנה משופר
DRUG DELIVERY DEVICE WITH AN
IMPROVED PISTON ROD
SANOFI-AVENTIS DEUTSCHLAND
GMBH 30/03/2009 09004570.9 EP PCT/EP/2010/053968 WO/2010/112409
December 29, 2011 30-התשע"ב טבתב 'ג
(2011.01 )A61M 76:766 12//1/0/2/
מתן מינון להתקן לשחרור תרופה ושיטות לייצור מתג המינון
DOSE BUTTON FOR A DRUG
DELIVERY DEVICE AND METHOD
FOR MANUFACTURING A DOSE
BUTTON
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004674.9 EP 24//2/0//7 42/24766/ US PCT/EP/2010/054352 WO/2010/112565
(2011.01 )A61M 76:767 12//1/0/2/
FIXING MEANS אמצעי קיבוע
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004673.1 EP 24//2/0//7 42/247655 US PCT/EP/2010/054351 WO/2010/115822
(2011.01 )A61M 76:768 12//1/0/2/
אי בעל מנגנון ושימוש בחומר התקן רפו בעל חיכוך נמוך בתוך ההתקן הרפואי
MEDICAL DEVICE HAVING A
MECHANISM AND USE OF A LOW-
FRICTION SYNTHETIC MATERIAL
WITHIN A MEDICAL DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004672.3 EP 24//2/0//7 42/247650 US PCT/EP/2010/054349 WO/2010/112563
December 29, 2011 31-התשע"ב טבתב 'ג
(2011.01 )B29C 76:769 12//1/0/2/
שיטות לייצור חלק העשוי מחומר מרוכב להתקן לשחרור תרופה ושימוש בחלק זה
להתקן לשחרור תרופה
METHOD FOR MANUFACTURING A
COMPOSITE WORK PIECE FOR A
DRUG DELIVERY DEVICE AND
COMPOSITE WORK PIECE FOR A
DRUG DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004671.5 EP 24//2/0//7 42/247652 US PCT/EP/2010/054348 WO/2010/112562
(2011.01 )A61M 76:76: 12//1/0/2/
PEN CAP מכסה עט
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004670.7 EP 24//2/0//7 42/247647 US PCT/EP/2010/054347 WO/2010/115821
(2011.01 )G09F 76:76; 12//1/0/2/
שיטות ליצירת גוף של התקן לשחרור תרופה בשימוש בחומר דביק והתקן
לשחרור תרופה
METHOD FOR MANUFACTURING A
DRUG DELIVERY DEVICE BODY
USING AN ADHESIVE AND DRUG
DELIVERY DEVICE BODY
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004669.9 EP 24//2/0//7 42/247645 US PCT/EP/2010/054346 WO/2010/115820
(2011.01 )A61M 76:76< 12//1/0/2/
December 29, 2011 32-התשע"ב טבתב 'ג
התקן רפואי בעל מנגנון עם קפיץ ושימוש בקפיץ גלי או בטבעת אוטמת גלית בהתקן
הרפואי
MEDICAL DEVICE HAVING A
MECHANISM WITH A SPRING AND
USE OF A WAVE SPRING OR WAVE
WASHER WITHIN A MEDICAL
DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004668.1 EP 24//2/0//7 42/247643 US PCT/EP/2010/054345 WO/2010/112561
(2011.01 )A61M 76:76= 12//1/0/2/
סידור הרכבה ומיכלול צימוד להתקן לשחרור תרופה
MOUNTING ARRANGEMENT AND
COUPLING ASSEMBLY FOR A DRUG
DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004667.3 EP 24//2/0//7 42/247642 US PCT/EP/2010/054344 WO/2010/115819
(2011.01 )A61M 76:76> 12//1/0/2/
DRUG DELIVERY DEVICE התקן לשחרור תרופה
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004666.5 EP 24//2/0//7 42/247636 US PCT/EP/2010/054343 WO/2010/115818
(2011.01 )A61M 76:775 12//1/0/2/
DRUG DELIVERY DEVICE התקן לשחרור תרופה
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004665.7 EP
December 29, 2011 33-התשע"ב טבתב 'ג
24//2/0//7 42/247630 US PCT/EP/2010/054342 WO/2010/115817
(2011.01 )F16F 76:776 12//1/0/2/
מרכיב קפיצי להתקן לשחרור תרופה, שימוש בו והתקן לשחרור תרופה
SPRING ELEMENT FOR A DRUG
DELIVERY DEVICE, USE THEREOF
AND DRUG DELIVERY DEVICE
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004663.2 EP 22//2/0//7 42/24676/ US PCT/EP/2010/054339 WO/2010/112559
(2011.01 )A61M 76:777 12//1/0/2/
DRUG DELIVERY DEVICE התקן לשחרור תרופה
SANOFI-AVENTIS DEUTSCHLAND
GMBH 31/03/2009 09004661.6 EP 22//2/0//7 42/246756 US PCT/EP/2010/054336 WO/2010/112557
(2011.01 )C07D 76:77; 27//1/0/2/
נגזרות אמיד כליגנדים לקולטן ניורופפטיד 5Y
AMIDE DERIVATIVES AS
NEUROPEPTIDE Y5 RECEPTOR
LIGANDS H. LUNDBECK A/S 20/03/2009 61/161802 US PCT/US/2010/027892 WO/2010/108052
December 29, 2011 34-התשע"ב טבתב 'ג
(2011.01 )C07D 76:77< 04//1/0/2/
טריאזיניל בנזאימידזול –1,3,5–פירימידין וסולפונאמידים ושימושים שלהם בטיפול
בסרטן
PYRIMIDINYL AND 1,3,5-TRIAZINYL
BENZIMIDAZOLE SULFONAMIDES
AND THEIR USE IN CANCER
THERAPY PATHWAY THERAPEUTICS, INC. 27/03/2009 61/164359 US /5//5/0//7 42/001465 US 1///7/0//7 42/025232 US PCT/NZ/2010/000060 WO/2010/110685
(2011.01 )C12N 76:77= 04//1/0/2/
בעזרת שימוש בתאי הרג דיכוי גידול ביניים טבעיים שמקורם בשליה אנושית
ותרכובות אימונומודולטוריות
TUMOR SUPPRESSION USING
HUMAN PLACENTA-DERIVED
INTERMEDIATE NATURAL KILLER
CELLS AND IMMUNOMODULATORY
COMPOUNDS ANTHROGENESIS CORPORATION 25/03/2009 61/163449 US PCT/US/2010/028885 WO/2010/111631
(2011.01 )C07D 76:77> 06/2//0/2/
CARBINOL COMPOUND HAVING תרכובת קרבינול עם מקשר הטרוציקלי
HETEROCYCLIC LINKER KOWA COMPANY, LTD. 29/04/2009 61/173690 US PCT/JP/2010/003039 WO/2010/125811
(2011.01 )A61K 76:785 /5//2/0/2/
פורמולצית פראציפקסול למתן פומי CR/IR פעם ביום
ONCE-DAILY ORAL IR/CR
PRAMIPEXOLE FORMULATION
PURDUE PHARMA
December 29, 2011 35-התשע"ב טבתב 'ג
09/04/2009 61/167980 US PCT/CA/2010/000482 WO/2010/115267
(2011.01 )B25B 76:786 27//1/0/2/
התקן לקביעה של חפץ מעובד על יועדים מנשא ושיטה לעיבוד חפצים המ
לעיבוד
DEVIE FOR FIXING WORKPIECES ON A
WORKPIECE CARRIER AND METHOD
FOR MACHINING WORKPIECES
MTU AERO ENGINES GMBH 20/03/2009 102009013726.2 DE PCT/DE/2010/000308 WO/2010/105612
(2011.01 )C07K 76:789 /2//2/0/2/
METHOD FOR PURIFYING רקומביננטי FSHשיטה לטיהור
RECOMBINANT FSH BIOGENERIX AG 01/04/2009 09157133.1 EP PCT/EP/2010/002111 WO/2010/115586
(2011.01 )C07D 76:78: 03//1/0/2/
PYRAZOLE COMPOUND תרכובת פיראזול
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
26/03/2009 2009-
077078 JP
PCT/JP/2010/055257 WO/2010/110378
(2011.01 )H01R 76:78; 00//2/0/2/
ELECTRICALLY CONDUCTIVE מחזיקי מיסבים מוליכים חשמלית
BEARING RETAINERS
December 29, 2011 36-התשע"ב טבתב 'ג
RAYTHEON COMPANY 25/03/2009 12/411168 US PCT/US/2010/021745 WO/2010/110933
(2011.01 )A61N 76:78< 01//1/0/2/
אנליזה של נתוני פיזור לאחור בזמן אמת רפואי HIFUליצירת אות ליקוי בהתקן
ANALYSIS OF REAL TIME
BACKSCATTER DATA FOR FAULT
SIGNAL GENERATION IN A
MEDICAL HIFU DEVICE
MEDICIS TECHNOLOGIES
CORPORATION 23/03/2009 61/162641 US PCT/US/2010/028254 WO/2010/111233
(2011.01 )F01C 76:78= 03//1/0/2/
מנוע בעל העברת מיקום הפכית, (IDARוסיבוביות אסימטרית )
INVERSE DISPLACEMENT
ASYMMETRIC ROTARY (IDAR)
ENGINE LUMENIUM LLC 25/03/2009 61/211192 US PCT/US/2010/028754 WO/2010/111557
(2011.01 )C12N 76:78> 03//1/0/2/
–אן JEJUNI.Cהמציגה סלמונלת המעיים גליקן או נגזרות מתאימות
SALMONELLA ENTERICA
PRESENTING C.JEJUNI N-GLYCAN
OR DERIVATIVES THEREOF
EIDGENOSSISCHE TECHNISCHE
HOCHSCHULE ZURICH 27/03/2009 09004445.4 EP PCT/EP/2010/001884 WO/2010/108682
December 29, 2011 37-התשע"ב טבתב 'ג
(2011.01 )F41G 76:795 07//1/0/2/
ASSIGNING WEAPONS TO THREATS הקצאת כלי נשק לסכנות
BAE SYSTEMS PLC 31/03/2009 0905563.3 GB 12//1/0//7 /703/7639/ EP PCT/GB/2010/050530 WO/2010/112907
(2011.01 )F16L 76:796 /7//1/0/2/
לחיבור צינור לצינור עם CIPPטכנולוגית מחסום מסטירן
CURED IN PLACE PIPE LINER WITH
STYRENE BARRIER
LUBRIZOL ADVANCED MATERIALS,
INC. 24/03/2009 61/162725 US PCT/US/2010/026580 WO/2010/111025
(2011.01 )A61F 76:798 26//1/0/2/
APPARATUS AND METHOD FOR מכשיר ושיטה ליצירת חתך מעגלי
MAKING A CIRCULAR INCISION V.R, HEXIS LTD קסיס בע"מוי.אר. ה
23/03/2009 12/408841 US PCT/IL/2010/000225 WO/2010/109447
(2011.01 )G11B 76:799 12//1/0/2/
מכשיר ושיטה אינטראקטיביות לבקשות תתוכן במדיה דיגיטלי
APPARATUS AND METHOD FOR
INTERACTIVE DIGITAL MEDIA
CONTENT REQUESTS AKOO INTERNATIONAL, INC. 31/03/2009 12/415096 US PCT/US/2010/029306 WO/2010/117828
December 29, 2011 38-התשע"ב טבתב 'ג
(2011.01 )A61K 76:79: 26//1/0/2/
USE OF NKP46 FOR PREVENTING למניעת סוכרת 46NKP–שימוש ב
DIABETES
יישום חברה לפיתוח המחקר של האוניברסיטה העברית בירושלים בע"מ
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD 19/03/2009 61/202629 US /7/22/0//7 42/03712/ US PCT/IL/2010/000228 WO/2010/106542
(2011.01 )C07D 76:79= 04//0/0/2/
תהליך להפרדת אננטיומרים של טריאזין–5,3,1–דיהידרו–6,3נגזרות של
PROCESS FOR SEPARATING
ENANTIOMERS OF 3,6-DIHYDRO-1,3,5-
TRIAZINE DERIVATIVES MERCK PATENT GMBH 25/03/2009 102009014898.1 DE PCT/EP/2010/001219 WO/2010/108583
(2011.01 )C07D 76:79> 1///2/0/2/
–בתא 11מעכבים ציקליים של 1הידרוקסיסטירואיד דהידרוגנאז
CYCLIC INHIBITORS OF 11BETA-
HYDROXYSTEROID DEHYDROGENASE 1
VITAE PHARMACEUTICALS, INC. 30/04/2009 PCT/US09/002653 US 01//5/0//7 PCT/US09/004261 US PCT/US/2010/033157 WO/2010/127237
(2011.01 )F28D 76:7:5 20//1/0/2/
December 29, 2011 39-התשע"ב טבתב 'ג
יריעה מעבירה חום עבור ממיר חם משובי סיבובי
HEAT TRANSFER SHEET FOR
ROTARY REGENERATIVE HEAT
EXCHANGER ALSTOM TECHNOLOGY LTD. 08/05/2009 12/437914 US PCT/US/2010/027076 WO/2010/129092
(2011.01 )C07D 76:7:6 02//1/0/2/
–3–פוריניל–2אטרופאיזומרים של תולדות קווינאזולינון ושיטות לשימוש בהן–טוליל
ATROPISOMERS OF2-PURINYL-3-
TOLYL-QUINAZOLINONE
DERIVATIVES AND METHODS OF
USE GILEAD CALISTOGA LLC 24/03/2009 61/162980 US /3//6/0//7 42/01233/ US PCT/US/2010/028554 WO/2010/111432
(2011.01 )C25B 76:7:7 26//3/0/2/
CATHODE FOR ELECTROLYTIC קטודה עבור תהליכים אלקטרוליטיים
PROCESSES INDUSTRIE DE NORA S.P.A 19/05/2009 MI2009A000880 IT PCT/EP/2010/056797 WO/2010/133583
(2011.01 )C12Q 76:7:8 /5//2/0/2/
שיטות לחיזוי סיכון לסרטן ע"י שימוש ממאירה–בביטוי גני ברקמה טרום
METHODS OF PREDICTING CANCER
RISK USING GENE EXPRESSION IN
PREMALIGNANT TISSUE GENOMIC HEALTH, INC. 07/04/2009 61/167503 US 26//7/0//7 42/0215/6 US PCT/US/2010/030285 WO/2010/118166
December 29, 2011 40-התשע"ב טבתב 'ג
(2011.01 )G10L 76:7:9 /1//0/0/22
מפענח אודיו ושיטה פענוח המשתמשת בערבוב יעיל
AUDIO DECODER AND DECODING
METHOD USING EFFICIENT
DOWNMIXING
DOLBY LABORATORIES LICENSING
CORPORATION 18/02/2010 61/305871 US 07//4/0/2/ 42/137541 US PCT/US/2011/023533 WO/2011/102967
(2011.01 )G02B 76:7:: 00//2/0/2/
אמת של השפעות עיוות קיזוז אופטי בזמן מסלול במדמים בעלי זמן –נגרמות
אינטגרציה ארוך
REAL-TIME OPTICAL
COMPENSATION OF ORBIT-
INDUCED DISTORTION EFFECTS IN
LONG INTEGRATION TIME IMAGERS RAYTHEON COMPANY 26/03/2009 12/412118 US PCT/US/2010/021748 WO/2010/110934
(2011.01 )A61B 76:7:; 03//1/0/2/
התקן תפירה כירורגי, שיטה וכלים שמשתמשים בהם אתו
SURGICAL SUTURING DEVICE,
METHOD AND TOOLS USED
THEREWITH ALPHA SCIENTIFIC CORPORATION 02/04/2009 12/384326 US PCT/US/2010/000891 WO/2010/114591
(2011.01 )C07D 76:7:= /1//1/0/2/
תרכובות הטרוציקליות כמעכבי אוטוטקסין
HETEROCYCLIC COMPOUNDS AS
AUTOTAXIN INHIBITORS
December 29, 2011 41-התשע"ב טבתב 'ג
MERCK PATENT GMBH 02/04/2009 09004858.8 EP PCT/EP/2010/001324 WO/2010/112116
(2011.01 )C07D 76:7:> /7//1/0/2/
AUTOTAXIN INHIBITORS מעכבי אוטוטקסין
MERCK PATENT GMBH 02/04/2009 09004866.1 EP PCT/EP/2010/001457 WO/2010/112124
(2011.01 )C07D 76:7;5 /1//1/0/2/
נגזרות של פיפרידין ופיפראזין כמעכבי אוטוטקסין
PIPERIDINE AND PIPERAZINE
DERIVATIVES AS AUTOTAXIN
INHIBITORS MERCK PATENT GMBH 02/04/2009 09004856.2 EP PCT/EP/2010/001323 WO/2010/115491
(2011.01 )C07D 76:7;6 27//1/0/2/
מאפנני הרגולטור למוליכותהטרנסממברני של סיסטיק פיברוזה,
תכשירים המכילים אותם ושימושים בהם
MODULATORS OF CYSTIC FIBROSIS
TRANSMEMBRANE CONDUCTANCE
REGULATOR, COMPOSITIONS
CONTAINING THE SAME AND USES
THEREOF
VERTEX PHARMACEUTICALS
INCORPORATED 20/03/2009 61/162130 US PCT/US/2010/028062 WO/2010/108155
December 29, 2011 42-התשע"ב טבתב 'ג
(2011.01 )C07D 76:7;7 27//1/0/2/
שיטה לייצור מאפנני הרגולטור למוליכות הטרנסממברני של סיסטוק פיברוזה,
מוצרים שלהם ושימושים בהם
PROCESS FOR PRODUCING A
CYSTIC FIBROSIS
TRANSMEMBRANE CONDUCTANCE
MODULATOR, PRODUCTS THEREOF
AND USES OF THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED 20/03/2009 61/162148 US 06//7/0//7 42/0241/1 US /3/2//0//7 42/026343 US PCT/US/2010/028069 WO/2010/108162
(2011.01 )C07D 76:7;9 06//1/0/2/
HIV LIPOPEPTIDE INHIBITORS OF HIV-1–1ליפופפטידים מעכבי
YEDA RESEARCH AND ידע חברה למחקר ופיתוח בע"מ
DEVELOPMENT CO. LTD. 01/04/2009 61/165536 US PCT/IL/2010/000271 WO/2010/113157
(2011.01 )C07K 76:7>6 01//1/0/2/
NOVEL ANTI-a5?1 ANTIBODIES AND חדשים ושימושים בהם a5?1נוגדנים אנטי
USES THEREOF GENENTECH, INC. 25/03/2009 61/163241 US PCT/US/2010/028291 WO/2012/111254
(2011.01 )A61K 76:7>7 00//1/0/2/
תרכובות ושיטות לאפנון תגובה חיסוניתCOMPOUNDS AND METHODS FOR
MODULATING AN IMMUNE
RESPONSE
THE WALTER AND ELIZA HALL
INSTITUTE OF MEDICAL RESEARCH
December 29, 2011 43-התשע"ב טבתב 'ג
23/03/2009 61/162616 US PCT/AU/2010/000325 WO/2010/108215
(2011.01 )G06F 76:7>8 /2//2/0/2/
מתן גישה לפריט נתונים באמצעות גרפי גישה
PROVIDING ACCESS TO A DATA
ITEM USING ACCESS GRAPHS
MICROSOFT CORPORATION 01/04/2009 12/416164 US PCT/US/2010/029712 WO/2010/115059
(2011.01 )A63F 76:7>9 04//2/0/2/
מערכות ושיטות ליישום מודל מעקב ללכידת תנועה
SYSTEMS AND METHODS FOR
APPLYING MODEL TRACKING TO
MOTION CAPTURE MICROSOFT CORPORATION 01/05/2009 61/174950 US 24//4/0//7 20/26351/ US PCT/US/2010/032366 WO/2010/126816
(2011.01 )C12Q 76:7>; 24//0/0/2/
לאפיון האיזור הלא מתורגם PCRשיטות 2FMR–ו 1FMRשל הגנים 5'
PCR METHODS FOR
CHARACTERIZING THE 5'
UNTRANSLATED REGION OF THE
FMR1 AND FMR2 GENES ASURAGEN, INC. 24/03/2009 61/162977 US PCT/US/2010/000426 WO/2010/110835
(2011.01 )C07D 76:7>< 24//2/0/2/
December 29, 2011 44-התשע"ב טבתב 'ג
אימידאזופיראזינים לשימוש כמעכבי קינאז
IMIDAZOPYRAZINES FOR USE AS
KINASE INHIBITORS
CENTRO NACIONAL DE
INVESTIGACIONES ONCOLOGICAS
(CNIO) 16/04/2009 09380079.5 EP PCT/GB/2010/000773 WO/2010/119264
(2011.01 )C07D 76:7>= 02//1/0/2/
–(R3,R4])–7מלחי רוקחות שימושיים של
–פירולידין–הידרוקסימתיל–4–הידרוקסי–3–2,3פירולו]–דיהידרו–5,3–אילמתיל[–1Dאון–4–[פירימידין
USEFUL PHARMACEUTICAL SALTS
OF 7[(3R,4R)-3-HYDROXY-4-
HYDROXYMETHYL-PYRROLIDIN-1-
YLMETHYL]-3,5-DIHYDRO-
PYRROLO[3,2-D]PYRIMIDIN-4-ONE
BIOCRYST PHARMACEUTICALS ,
INC. 24/03/2009 61/162805 US PCT/US/2010/028490 WO/2010/111381
(2011.01 )A01N 76:7>> 01//1/0/2/
[דקאנים 5,4]–אזאספירו–8–דיאוקסא–4,1המותמרים משמשים כקוטלי פטריות
ותהליך להכנתם
SUBSTITUTED 1,4-DIOXA-8-
AZASPIRO[4,5]DECANES USEFUL AS
FUNGICIDES AND A PROCESS FOR
THE PREPARATION THEREOF
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH 27/03/2009 612/DEL/2009 IN PCT/IB/2010/000648 WO/2010/109299
(2011.01 )H04N 76:855 25//1/0/2/
מערכת ושיטה לדחיסת וידאו המבוססות על מדידות זמן המתנה או היזון חוזר אחר
SYSTEM AND METHOD FOR
COMPRESSING VIDEO BASED ON
LATENCY MEASUREMENTS AND
OTHER FEEDBACK
December 29, 2011 45-התשע"ב טבתב 'ג
ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/62 US PCT/US/2010/027692 WO/2010/111092
(2011.01 )A63F 76:856 25//1/0/2/
מערכת ושיטה עבור מיתוג מכונה מואץSYSTEM AND METHOD FOR
ACCELERATED MACHINE
SWITCHING ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/55 US PCT/US/2010/027730 WO/2010/111102
(2011.01 )H04N 76:857 25//1/0/2/
מערכת ושיטה לדחיסת וידאו ע"י שימוש בהיזון חוזר הכולל נתונים הקשורים
לה מוצלחת של תוכן וידאולקב
SYSTEM AND METHOD FOR VIDEO
COMPRESSION USING FEEDBACK
INCLUDING DATA RELATED TO THE
SUCCESSFUL RECEIPT OF VIDEO
CONTENT ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/74 US PCT/US/2010/027712 WO/2010/111095
(2011.01 )H04B 76:858 25//1/0/2/
מערכת ושיטה להצפנת וידאו ע"י שימוש בקטע נבחר ותבנית רוטצית קטע
SYSTEM AND METHOD FOR
ENCODING VIDEO USING A
SELECTED TILE AND TILE
ROTATION PATTERN ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/54 US PCT/US/2010/027718
December 29, 2011 46-התשע"ב טבתב 'ג
WO/2010/111097
(2011.01 )H04N 76:859 25//1/0/2/
ן שגיאה מערכת ושיטה לשימוש בתיקו מתמשך בדחיסת וידאו
SYSTEM AND METHOD FOR
UTILIZING FORWARD ERROR
CORRECTION WITH VIDEO
COMPRESSION ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/40 US PCT/US/2010/027727 WO/2010/111101
(2011.01 )G06K 76:85: 25//1/0/2/
מערכת ושיטה לדחיסת וידאו מרובה זרמים
SYSTEM AND METHOD FOR MULTI-
STREAM VIDEO COMPRESSION
ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/22 US PCT/US/2010/027725 WO/2010/111100
(2011.01 )G06K 76:85; 25//1/0/2/
מערכת ושיטה לדחיסת וידאו מרובה זרמים ע"י שימוש בפורמטי הצפנה
מרובים
SYSTEM AND METHOD FOR MULTI-
STREAM VIDEO COMPRESSION
USING MULTIPLE ENCODING
FORMATS ONLIVE, INC. 23/03/2009 61/210888 US /5//6/0//7 20/316/70 US PCT/US/2010/027723 WO/2010/111099
December 29, 2011 47-התשע"ב טבתב 'ג
(2011.01 )G06K 76:85< 25//1/0/2/
TEMPORARY DECODER APPARATUS ערכת ושיטה לפענוח זמנימ
AND METHOD ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/64 US PCT/US/2010/027720 WO/2010/111098
(2011.01 )H04N 76:85= 25//1/0/2/
מערכת ושיטה לבחירת פורמט הצפנה לוידאו המבוססות על היזון חוזר של
נתונים
SYSTEM AND METHOD FOR
SELECTING A VIDEO ENCODING
FORMAT BASED ON FEEDBACK
DATA ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/7/ US PCT/US/2010/027699 WO/2010/111093
(2011.01 )H04N 76:85> 25//1/0/2/
מערכת ושיטה לדחיסת פרימים בוידאו או חלקים מהם המבוססות על היזון חוזר של
מידע ממכשיר לקוח
SYSTEM AND METHOD FOR
COMPRESSING VIDEO FRAMES OR
PORTIONS THEREOF BASED ON
FEEDBACK INFORMATION FROM A
CLIENT DEVICE ONLIVE, INC. 23/03/2009 61/210,888 US /5//6/0//7 20/3165/32 US PCT/US/2010/027716 WO/2010/111096
(2011.01 )C07D 76:865 /7//2/0/2/
ORGANIC COMPOUNDS AND THEIR תרכובות אורגניות ושימושן
USES NOVARTIS AG
December 29, 2011 48-התשע"ב טבתב 'ג
10/04/2009 61/168,408 US 04//3/0//7 42/2625/16 US PCT/IB/2010/000784 WO/2010/116248
(2011.01 )C07K 76:869 00//1/0/2/
HUMANIZED ANTIBODIES AGAINST נוגדנים אנושיים כנגד לייט ושימושהם
LIGHT AND USES THEREOF
TEVA BIOPHARMACEUTICALS USA,
INC. 24/03/2009 61/202,661 US PCT/US/2010/028144 WO/2010/111180
(2011.01 )C07D 76:86: 04//1/0/2/
SOLID STATE FORMS OF מבנים גבישיים של מלחי סיטאגליפטין
SITAGLIPTIN SALTS
TEVA PHARMACEUTICAL טבע תעשיות פרמצבטיות בע"מ
INDUSTRIES LTD. 30/03/2009 61/164,563 US 0///2/0//7 42/25/5475 US 1///2/0//7 42/2525/51 US /2//4/0//7 42/2605550 US 22//4/0//7 42/2645/12 US /7//0/0/2/ 42/1/05404 US 23//0/0/2/ 42/1/25423 US /2//1/0/2/ 42/1/75/02 US 2///1/0/2/ 42/1205154 US 26//1/0/2/ 42/1235227 US PCT/US/2010/029098 WO/2010/117738
(2011.01 )A61K 76:86; 01//1/0/2/
פעילים TAT HIVפוליפפטידים נגזרים מ אימונית, לטיפול בסרטן
TREATMENT OF CANCER WITH
IMMUNOSTIMULATORY HIV TAT
DERIVATIVE POLYPEPTIDES NANIRX INC.
December 29, 2011 49-התשע"ב טבתב 'ג
23/03/2009 61/162605 US 27//0/0/2/ 42/1/4056 US /1//1/0/2/ 42/12/002 US PCT/US/2010/028347 WO/2010/111292
(2011.01 )F24J 76:86< 2///2/0/2/
התקן תמיכה, מערכת ושיטה עבור מסגרת של מראה סולארית
STRUT, SYSTEM AND METHOD FOR
A SOLAR MIRROR FRAME
WERNER EXTRUSION SOLUTIONS
LLC 16/04/2009 61/212854 US PCT/US/2010/001062 WO/2010/120349
(2011.01 )H02M 76:86= 07//2/0/2/
מערכות ושיטות של חיבורי דיודה במעגלים חשמליים בטרנזיסטורים
TRANSISTOR JUNCTION DIODE
CIRCUITRY SYSTEMS AND
METHODS ENTROPIC COMMUNICATIONS, INC. 01/05/2009 61/174813 US 02//4/0//7 20/27/125 US PCT/US/2010/032917 WO/2010/127078
(2011.01 )H04B 76:86> 04//1/0/2/
הסדר לניהול תקשורת אלחוטית בין מכשירים
AN ARRANGEMENT FOR MANAGING
WIRELESS COMMUNICATION
BETWEEN DEVICES XPED HOLDINGS PTY LTD 26/03/2009 2009901298 AU PCT/AU/2010/000358 WO/2010/108235
December 29, 2011 50-התשע"ב טבתב 'ג
(2011.01 )B42D 76:875 01//1/0/2/
מכשיר ושיטה לאימות אוטומטי של תמונות בגרסת פולריזאציה
DEVICE AND METHOD FOR
AUTOMATED VERIFICATION OF
POLARIZATION-VARIANT IMAGES LATENT IMAGE TECHNOLOGY LTD. LATENT IMAGE TECHNOLOGY LTD.
07/04/2009 12/419360 US PCT/IB/2010/051250 WO/2010/116279
(2011.01 )G01N 76:876 12//1/0/2/
שיטה לגילוי חומר בדגימה ביולוגיתMETHOD FOR DETECTING
SUBSTANCE IN BIOLOGICAL
SAMPLE VIRUS IKAGAKU KENKYUSHO INC
31/03/2009 2009-
087839 JP
PCT/JP/2010/055887 WO/2010/114031
(2011.01 )G01N 76:877 12//1/0/2/
בדגימה SITH–1שיטה לגילוי נוגדן נגד ביולוגית
METHOD FOR DETECTING
ANTIBODY AGAINST SITH-1 IN
BIOLOGICAL SAMPLE VIRUS IKAGAKU KENKYUSHO INC
31/03/2009 2009-
087816 JP
PCT/JP/2010/055884 WO/2010/114029
(2011.01 )G09G 76:879 02//1/0/2/
סכימת מניע בעל וולטאג' נמוך למאפננים אינטרפרומטריים
LOW VOLTAGE DRIVER SCHEME
FOR INTERFEROMETRIC
MODULATORS
QUALCOMM MEMS TECHNOLOGIES,
INC. 27/03/2009 12/413336 US
December 29, 2011 51-התשע"ב טבתב 'ג
0///2/0/2/ 20/47/172 US PCT/US/2010/028552 WO/2010/111431
(2011.01 )A61K 76:87: /2//2/0/2/
LYOPHILIZATION CAKES OF נתחי ליופיליזציה של מעכבי פרוטיאזום
PROTEASOME INHIBITORS CEPHALON. INC. 03/04/2009 61/166529 US /5//2/0//7 /71/307296 EP 00/20/0//7 42/066733 US PCT/US/2010/029597 WO/2010/114982
(2011.01 )A01N 76:87; 04//1/0/2/
תכשיר כימי המשפר את היבול לבקרת מזיקים ושיטה לבקרת מזיקים
AGROCHEMICAL COMPOSITION FOR
PEST CONTROL AND PEST CONTROL
METHOD ISHIHARA SANGYO KAISHA LTD.
31/03/2009 2009-
084618 JP
PCT/JP/2010/055314 WO/2010/113775
(2011.01 )C25D 76:87< 03//1/0/2/
–התקן ושיטה לניהול ריאקציה אלקטרושטח של מצע מוליך –כימית על פני
למחצה
DEVICE AND METHOD TO CONDUCT
AN ELECTROCHEMICAL REACTION
ON A SURFACE OF A SEMI-
CONDUCTOR SUBSTRATE ALCHIMER 27/03/2009 0901518 FR PCT/EP/2010/053955 WO/2010/108996
December 29, 2011 52-התשע"ב טבתב 'ג
(2011.01 )C12N 76:87= 07//1/0/2/
שיטה להשריית מוות תאי בתאי גזע פלוריפוטנטיים ובתאים שעברו התמיינות
מלבד קרדיומיוציטים
METHOD FOR INDUCING CELL
DEATH IN PLURIPOTENT STEM
CELLS AND DIFFERENTIATED
CELLS OTHER THAN CARDIAC
MYOCYTES KEIO UNIVERSITY
30/03/2009 2009-
083553 JP
PCT/JP/2010/056108 WO/2010/114136
(2011.01 )A01B 76:87> 01//1/0/2/
זרעים ושיטות להנחת תכשירים לציפויחומרים פעילי שטח לאדמה על קרקע
דוחת מים
SEED COATING COMPOSITIONS AND
METHODS FOR APPLYING SOIL
SURFACTANTS TO WATER-
REPELLENT SOIL BRIGHAM YOUNG UNIVERSITY 23/03/2009 61/210868 US PCT/US/2010/028371 WO/2010/111309
(2011.01 )A61K 76:885 01//1/0/2/
פוליפפטידים ותכשירים מחסנים המכילים פוליפפטידים גראם חיוביים ושיטות
לשימוש
POLYPEPTIDES AND IMMUNIZING
COMPOSITIONS CONTAINING GRAM
POSITIVE POLYPEPTIDES AND
METHODS OF USE EPITOPIX, LLC 23/03/2009 61/210772 US PCT/US/2010/028326 WO/2010/111273
(2011.01 )H01B 76:886 01//1/0/2/
סרטי תחמוצת מתכת דיאלקטרי ושיטות להכנתם
DIELECTRIC METAL OXIDE FILMS
AND PROCESSES FOR PRODUCING
THE SAME
December 29, 2011 53-התשע"ב טבתב 'ג
SBA MATERIALS, INC. 23/03/2009 61/162549 US PCT/US/2010/028374 WO/2010/111311
(2011.01 )A61L 76:88: 00//1/0/2/
CARTILAGE REPAIR תיקון סחוס
GENZYME CORPORATION 23/03/2009 61/162447 US PCT/US/2010/028086 WO/2010/111161
(2011.01 )C07D 76:88; /4//2/0/2/
און –(2H) 3–אנאלוגים של איזוקסאזול כחומרים טיפוליים
ISOXAZOL-3(2H)-ONE ANALOGS AS
THERAPEUTIC AGENTS
ASTRAZENECA AB 07/04/2009 61/167224 US 01//2/0//7 42/252734 US PCT/SE/2010/050375 WO/2010/117323
(2011.01 )C07K 76:88< 04//1/0/2/
פפטידים שעברו ציטרוליניזציה לאבחון וצפי של דלקת מפרקים שיגרונית
CITRULLINATED PEPTIDES FOR
DIAGNOSING AND PROGNOSING
RHEUMATOID ARTHRITIS PROMETHEUS LABORATORIES INC. 30/03/2009 61/164840 US 25//7/0//7 42/021274 US 04/2//0//7 42/033/36 US PCT/US/2010/028946 WO/2010/117694
(2011.01 )C07K 76:88= 02//1/0/2/
December 29, 2011 54-התשע"ב טבתב 'ג
PROTEIN (1CAPהחלבון )
ASSOCIATED–CYCLASE ADENYLYL לאימונומודולציה ושימושיו כמטרה
ADENYLYL CYCLASE-ASSOCIATED
PROTEIN (CAP1) AND USES
THEREOF AS A TARGET FOR
IMMUNO-MODULATION PROTAB LTD פרוטאב בע"מ
30/03/2009 61/164489 US PCT/IL/2010/000231 WO/2010/113148
(2011.01 )F24J 76:88> /1//7/0/2/
מרכזת פרבולית עם חלקי סיבוב עקמומים פרבולית
PARABOLIC CONCENTRATOR WITH
PARABOLICALLY CURVED ROTATING
SECTORS FARINA, GIUSEPPE 09/09/2009 RM2009A000457 IT PCT/IT/2010/000384 WO/2011/030364
(2011.01 )C12M 76:896 /7//1/0/2/
כור פוטוסינטטי לתרבות מיקרואורגניזמים ושיטה לתרבות מיקרואורגניזמים
A PHOTOSYNTHETIC REACTOR FOR
CULTURE OF MICROORGANISMS
AND METHOD FOR CULTURE OF
MICROORGANISMS MICROPHYT 25/03/2009 09/51917 FR PCT/FR/2010/050395 WO/2010/109108
(2011.01 )C07J 76:897 12//1/0/2/
תולדות אמיד חדשות של תרכובות [פיראזול עם פעילות C–2,3סטרואידל ]
גלוקוקורטיקואיד
NOVEL AMIDE DERIVATIVES OF
STEROIDAL[3,2-C]PYRAZOLE
COMPOUNDS WITH
GLUCOCOTRICOID ACTIVITY ASTRAZENECA AB 03/04/2009 61/166324 US PCT/SE/2010/050354 WO/2010/114471
December 29, 2011 55-התשע"ב טבתב 'ג
(2011.01 )B29C 76:898 01//1/0/2/
שכבה לייצור חפצים מחומרים מורכבים, שיטת ייצור של אותה שכבה ושיטת ייצור של החפצים
מהחומרים המורכבים תוך שימוש באותה שכבה
FILM FOR PRODUCTION OF COMPOSITE
MATERIAL ARTEFACTS, PRODUCTION
METHOD OF SAID FILM AND
PRODUCTION METHOD OF COMPOSITE
MATERIAL ARTEFACTS USING SAID
FILM A. PERUZZA S.R.L. 23/03/2009 TV2009A000056 IT PCT/EP/2010/053768 WO/2010/108916
(2011.01 )B61F 76:899 /7//1/0/2/
VEHICLE HAVING ROLLING רכב בעל מנטרל טלטול
COMPENSATION
BOMBARDIER TRANSPORTATION
GMBH 30/03/2009 102009014866.3 DE PCT/EP/2010/052978 WO/2010/112306
(2011.01 )G06T :89:76 /2//2/0/2/
מערכות ושיטות לזיהוי חריגות במידעSYSTEMS AND METHODS FOR
DETECTING ANOMALIES FROM
DATA I-CETANA PTY LTD 01/04/2009 2009901406 AU /2/20/0//7 0//77/3715 AU PCT/AU/2010/000379 WO/2010/111748
(2011.01 )A61P 76:89; 20//3/0/2/
December 29, 2011 56-התשע"ב טבתב 'ג
תכשירים ושיטות לעיכוב ביטוי של גנים של קולטן גלוקוקורטיקואיד
COMPOSITIONS AND METHODS FOR
INHIBITING EXPRESSION OF
GLUCOCORTICOID RECEPTOR (GCR)
GENES F. HOFFMANN-LA ROCHE AG 15/05/2009 09160411.6 EP PCT/EP/2010/056527 WO/2010/130771
(2011.01 )B01D 76:89< /2//0/0/2/
GAS STREAM PROCESSING עיבוד זרם גז
ALSTOM TECHNOLOGY LTD. 27/03/2009 61/164185 US 1//2//0//7 20/4/7/54 US PCT/US/2010/022710 WO/2010/110939
(2011.01 )A61K 76:89= /2//2/0/2/
חומצה דיקרבוקסילית חדשה הקשורה דים לחומצת אמינו ומטרימי תרופות פפטי
של אופיאוידים ושימושים בהם
NOVEL DICARBOXYLIC ACID
LINKED AMINO ACID AND PEPTIDE
PRODRUGS OF OPIOIDS AND USES
THEREOF SHIRE LLC 02/04/2009 61/211831 US 00//5/0//7 42/005524 US PCT/GB/2010/050584 WO/2010/112942
(2011.01 )A61K 76:89> 02//1/0/2/
תרכובות מאפננות הפריה ותהליך ליישומם
FERTILIZATION MODULATION
COMPOUNDS AND PROCESS FOR
IMPLEMENTING THEM UNIVERSITE JOSEPH FOURIER 24/03/2009 09305261.1 EP PCT/EP/2010/053815 WO/2010/108942
December 29, 2011 57-התשע"ב טבתב 'ג
(2011.01 )F25B 76:8:5 03//1/0/2/
SUPERSONIC COOLING SYSTEM מערכת קירור סופרסונית
CAITIN, INC. 25/03/2009 61/163438 US 03//5/0//7 42/006335 US PCT/US/2010/028761 WO/2010/111560
(2011.01 )G01N 76:8:6 04//1/0/2/
שיטת הדמיה על ממשק דק במצב מוצק בין שני זורמים
METHOD FOR IMAGING ON THIN
SOLID-STATE INTERFACE BETWEEN
TWO FLUIDS TRUSTEES OF BOSTON UNIVERSITY 26/03/2009 61/211260 US PCT/US/2010/028845 WO/2010/111602
(2011.01 )C07C 76:8:7 24//2/0/2/
MESYLATEסינתזה של
PENTAMETHYLCYCLOHEXANE–
1,3,3,5,5–AMINO–1
SYNTHESIS OF 1-AMINO-1,3,3,5,5-
PENTAMETHYLCYCLOHEXANE
MESYLATE
MERZ PHARMA GMBH & CO. KGaA 17/04/2009 09005471.9 EP 25//2/0//7 42/022/23 US PCT/EP/2010/002361 WO/2010/118889
(2011.01 )A61K 76:8:9 24//2/0/2/
נוסחה לייצוב חלבונים, נקייה מחומרים לא פעילים שמקורם ביונקים
FORMULATION FOR STABILIZING
PROTEINS, WHICH IS FREE OF
MAMMALIAN EXCIPIENTS MERZ PHARMA GMBH & CO. KGaA
December 29, 2011 58-התשע"ב טבתב 'ג
17/04/2009 09005470.1 EP 25//2/0//7 42/020730 US PCT/EP/2010/002360 WO/2010/118888
(2011.01 )A61M 76:8:: 04//1/0/2/
שיפורים להתקן, חפץ ושיטה להקטנה כאב במהלך תהליכי
דיקור עור
IMPROVEMENTS TO APPARATUS,
ARTICLE AND METHOD FOR REDUCING
PAIN DURING SKIN PUNCTURING
PROCESURES BING INNOVATIONS, LLC 27/03/2009 61/163945 US 07/22/0//7 PCT/US2009/066033 US PCT/US/2010/028858 WO/2010/111611
(2011.01 )F41A 76:8:; 22//2/0/2/
A MOBILE MISSILE LAUNCH SYSTEM מערכת שיגור טילים ניידת ושיטה לכך
AND METHOD THEREOF
DIRECTOR GENERAL, DEFENCE
RESEARCH & DEVELOPMENT
ORGANISATION 30/03/2009 00648/DEL/2009 IN 12//1/0//7 //462/DEL/2009 IN 12//1/0//7 //463/DEL/2009 IN /4//2/0//7 //5/1/DEL/2009 IN PCT/IN/2010/000018 WO/2010/113171
(2011.01 )C07C 76:8:< 03//1/0/2/
–Y–שיטה לייצור נגזרת חומצת ביציקלו אמינו
A METHOD FOR PRODUCING
BICYCLIC Y-MINO ACID
DERIVATIVES
DAIICHI SANKYO COMPANY,
LIMITED
26/03/2009 2009-
075792 JP
December 29, 2011 59-התשע"ב טבתב 'ג
PCT/JP/2010/055202 WO/2010/110361
(2011.01 )C07C 76:8:= 03//1/0/2/
יות ושיטות תרכובות חומצות קארבוקסיל לייצורן
CARBOXYLIC ACID COMPOUNDS
AND PROCESSES FOR PRODUCING
THE SAME JAPAN TOBACCO INC.
26/03/2009 2009-
077601 JP
/0//2/0//7 42/022520 US PCT/JP/2010/055160 WO/2010/110352
(2011.01 )C07D 76:8:> 03//1/0/2/
COMPOUND CONTAINED IN A BLUE תרכובת הנמצאת בוורד כחול
ROSE SUNTORY HOLDINGS LIMITED
27/03/2009 2009-
080524 JP
20//3/0//7 0//7-223500 JP 02//5/0//7 0//7-251/74 JP PCT/JP/2010/055262 WO/2010/110382
(2011.01 )C08L 76:8;6 04//1/0/2/
PROCESS FOR PRODUCING PLASTIC שיטה לייצור בקבוקים מפלסטיק
BOTTLES ADEKA CORPORATION
27/03/2009 2009-
078851 JP
PCT/JP/2010/055366 WO/2010/110422
December 29, 2011 60-התשע"ב טבתב 'ג
(2011.01 )A61K 76:8;7 24//2/0/2/
פורמולציות נוזליות של מלחים –4,2)–2]–1של
דימתילפנילסולפניל(פניל[פיפרזין
LIQUID FORMULATIONS OF SALTS OF 1-[2-(2,4-
DIMETHYLPHENYLSULFANYL)PHENYL]PIPERAZINE
H. LUNDBECK A/S 24/04/2009 PA200900531 DK PCT/DK/2010/050084 WO/2010/121621
(2011.01 )A61K 76:8;8 /4//2/0/2/
EGFR–די חומרי אנטיי–טיפול משולב על 1R–IGF–ומעכבים ספציפיים ל
COMBINATION THERAPY USING AN
ANTI-EGFR AGENT(S) AND IGF-1R
SPECIFIC INHIBITORS MERCK SHARP & DOHME CORP 16/04/2009 61/169768 US PCT/US/2010/030022 WO/2010/120592
(2011.01 )D04H 76:8;9 03//1/0/2/
APPARATUS FOR COMPACTING A התקן לדחיסת רשת סיבית
FIBROUS WEB TRUTZSCHLER NONWOVENS GMBH 08/04/2009 102009016996.2 DE 22//2/0//7 2/0//7/2550797 DE PCT/DE/2010/000337 WO/2010/115400
(2011.01 )H04N 76:8;: 26//1/0/2/
שיטה ומערכת מסתגלות לחילוץ דמות בהירה מדמות תרמית
ADAPTIVE METHOD AND SYSTEM
FOR EXTRACTING A BRIGHT IMAGE
FROM A THERMAL IMAGE
ITT MANUFACTURING
ENTERPRISES, INC. 25/03/2009 12/410714 US PCT/US/2010/027791
December 29, 2011 61-התשע"ב טבתב 'ג
WO/2010/111110
(2011.01 )H04L 76:8;; /2//2/0/2/
נסיגה המשתמשת בבחירת תחום גישה יוע התקן ניידמסיים בס
FALL BACK USING MOBILE DEVICE
ASSISTED TERMINATING ACCESS
DOMAIN SELECTION QUALCOMM INCORPORATED 01/04/2009 61/165717 US 04//1/0/2/ 20/5106/4 US PCT/US/2010/029692 WO/2010/115045
(2011.01 )G02B 76:8;< 25//1/0/2/
מראה המשקפת אור השמש בעלת ציפוי מגן ושיטה להכנתה
SOLAR REFLECTING MIRROR
HAVING A PROTECTIVE COATING
AND METHOD OF MAKING SAME PPG INDUSTRIES OHIO, INC. 27/03/2009 61/164047 US 27//0/0/2/ 20/5/7/23 US 27//0/0/2/ 20/5/7/72 US PCT/US/2010/027556 WO/2010/111075
(2011.01 )A61K 76:8;= 03//1/0/2/
THERAPEUTIC USES OF שימושים רפואיים של נגזרות קונאזולין
QUINAZOLINEDIONE DERIVATIVES SANOFI 27/03/2009 0901460 FR PCT/FR/2010/050549 WO/2010/109148
(2011.01 )A61K 76:8;> 12//1/0/2/
December 29, 2011 62-התשע"ב טבתב 'ג
INHIBITION OF BIOFILM דיכוי יצורי ביופילם
ORGANISMS NOVABIOTICS LTD 01/03/2009 61/165396 US /2//1/0//7 /7/323292 GB PCT/GB/2010/000631 WO/2010/112848
(2011.01 )B62D 76:8<5 27//1/0/2/
י, במיוחד רכב רכב בעל היגוי מפרק משוריין
VEHICLE HAVING ARTICULATED
VEHICLE STEERING, IN PARTICULAR
ARMORED VEHICLE SKOFF, GERHARD 26/03/2009 102009014401.3 DE PCT/EP/2010/001735 WO/2010/108629
(2011.01 )C01B 76:8<6 03//1/0/2/
METHOD AND DEVICE FOR זרחתית–שיטה ומתקן לייצור חומצה רב
PRODUCING POLYPHOSPHORIC ACID PRAYON TECHNOLOGIES 26/03/2009 BE2009/0186 BE PCT/EP/2010/053947 WO/2010/108991
(2011.01 )C12Q 76:8<7 24//2/0/2/
שיטות וכלים לניבוי היעילות של אנתראציקלינים בסרטן
METHODS AND TOOLS FOR PREDICTING
THE EFFICIENCY OF ANTHRACYCLINES
IN CANCER UNIVERSITE LIBRE DE BRUXELLES 17/04/2009 PCT/EP2009/054606 EP PCT/EP/2010/055067 WO/2010/119133
December 29, 2011 63-התשע"ב טבתב 'ג
(2011.01 )C12N 76:8<; 02//1/0/2/
שיטות ומיקרואורגניזימים לייצור של דיקארבוקסיליות 4Cחומצות
METHODS AND MICROORGANISMS
FOR PRODUCTION OF C4-
DICARBOXYLIC ACIDS DSM IP ASSETS B.V. 24/03/2009 61/163019 US PCT/US/2010/028429 WO/2010/111344
(2011.01 )C12Q 76:8<< 03//1/0/2/
METHOD OF GENOTYPING שיטה לגנוטיפיזציה
MERCK SERONO S.A. 27/03/2009 09156487.2 EP 12//1/0//7 42/243222 US PCT/EP/2010/053871 WO/2010/127906
(2011.01 )C08C 76:8=5 /0//0/0/2/
לברומינציה של תרכובות תהליך –אורגניות בלתי רוויות עם הפחתה של חד
כלורידים בעלי אמוניום או פוספוניום רביעוני
PROCESS FOR BROMINATING
UNSATURATED ORGANIC
COMPOUNDS WITH REMOVAL OF
QUATERNARY AMMONIUM OR
QUATERNARY PHOSPHONIUM
MONOCHLORIDES DOW GLOBAL TECHNOLOGIES LLC 31/03/2009 61/165402 US PCT/US/2010/022802 WO/2010/114637
(2011.01 )B65D 76:8=6 04//7/0/22
A WATER DISPENSER WITH A מתקן מים עם מיכל מים הניתן להסתה
TILTED CONTAINER NEVIOT NATURE GALILEE LTD
December 29, 2011 64-התשע"ב טבתב 'ג
(2011.01 )B01J 76:8=7 1///1/0/2/
שיטות ומערכות ליצור מימן בשימוש לסיליצידי נטרן ג'ל וחומרי מסיליקט נתרן
HYDROGEN GENERATION SYSTEMS
AND METHODS UTILIZING SODIUM
SILICIDE AND SODIUM SILICA GEL
MATERIALS SIGNA CHEMISTRY, INC. 30/03/2009 61/164888 US /7//4/0//7 42/263357 US PCT/US/2010/029257 WO/2010/114849
(2011.01 )G06K 76:8=8 12//1/0//7
מאיר מנחה או טבעתי וסורק אופטיANNULAR LIGHT GUIDE
ILLUMINATOR AND OPTICAL
SCANNER SICPA HOLDING SA PCT/IB/2009/005137 WO/2010/112950
(2011.01 )H04N 76:8=9 20//2/0/2/
שיטות והתקנים להנחת תוכן על זרם וידאו משותף
METHODS AND APPARATUS FOR
OVERLAYING CONTENT ONTO A
COMMON VIDEO STREAM ECHOSTAR TECHNOLOGIES L.L.C. 13/04/2009 12/422398 US PCT/US/2010/030752 WO/2010/120693
(2011.01 )G06F 76:8=< 00//1/0/2/
APPLICATION SHARING יישום שיתוף
December 29, 2011 65-התשע"ב טבתב 'ג
SOCIAL COMMUNICATIONS
COMPANY 03/04/2009 12/418270 US PCT/US/2010/028088 WO/2010/114724
(2011.01 )C07D 76:8== 00//2/0/2/
–פלואורו–2–כלורו–3)–4תהליך להכנת –N)–1]–6–מתוקסי–7–אנילינו(
–4–פיפרידינ–מתילקרבמוילמתיל( יל[קווינזולין
PROCESS FOR THE PREPARATION
OF 4-(3-CHLORO-2-FLUORO-
ANILINO)-7-METHOXY-6-[1-(N-
METHYLCARBAMOYLMETHYL)-
PIPERIDIN-4-YL]QUINAZOLINE ASTRAZENECA AB 23/04/2009 61/171994 US PCT/GB/2010/050653 WO/2010/122340
(2011.01 )A61K 76:8=> 25//1/0/2/
PNEUMOCOCCAL VACCINE AND מושיוחיסון פנאומקוקאלי ושי
USES THEREOF
COLEY PHARMACEUTICAL GROUP,
INC. 30/04/2009 61/174068 US 12//6/0//7 42/016121 US PCT/IB/2010/051150 WO/2010/125480
(2011.01 )C02F 76:8>5 07//1/0/2/
מטהר מי שתייה מסוג זרימה מתמשכת מופעל ידנית המשתמש בקרינה
סולארית מרוכזת
A MANUALLY OPERATED
CONTINUOUS FLOW TYPE DRINKING
WATER DISINFECTOR USING
CONCENTRATED SOLAR RADIATION
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH 27/03/2009 615/DEL/2009 IN PCT/IN/2010/000323 WO/2010/119457
December 29, 2011 66-התשע"ב טבתב 'ג
(2011.01 )C01C 76:8>6 07//1/0/2/
–תהליך להכנה בו זמנית של אשלגן–סולפט, מגנזיום–סולפט, אמוניוםמגנזיום אוקסיד ממלח הידרוקסיד ו/או
קיינייט מעורב ואמוניה
PROCESS FOR SIMULTANEOUS
PRODUCTION OF POTASSIUM
SULPHATE, AMMONIUM SULFATE,
MAGNESIUM HYDROXIDE AND/OR
MAGNESIUM OXIDE FROM KAINITE
MIXED SALT AND AMMONIA
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH 27/03/2009 618/DEL/2009 IN PCT/IN/2010/000194 WO/2010/109492
(2011.01 )C12Q 76:8>7 06//1/0/2/
שיטות לקביעת מהלך קליני וטיפול בטרשת נפוצה
METHODS OF PREDICTING
CLINICAL COURSE AND TREATING
MULTIPLE SCLEROSIS
מחקרים ,תשתית ושירותים -תל השומר רפואיים בע"מ
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD. 30/03/2009 61/202703 US PCT/IB/2010/051344 WO/2010/113096
(2011.01 )A61K 76:8>8 07//1/0/2/
THERAPY FOR PROMOTING CELL טיפול להגברת גדילת תאים
GROWTH MOLEAC PTE. LTD 27/03/2009 61/164352 US PCT/SG/2010/000122 WO/2010/110755
(2011.01 )G03H 76:8>9 12//1/0/2/
December 29, 2011 67-התשע"ב טבתב 'ג
–שיטה ומערכת להדמיית עצם באור לא קוהרנטי
METHOD AND SYSTEM FOR
IMAGING AND OBJECT USING
INCOHERENT LIGHT
אוניברסיטת בן גוריון בנגב הרשות למחקר ופיתוח
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY 01/04/2009 61/202763 US PCT/IB/2010/051401 WO/2010/113123
(2011.01 )C07C 76:8>> /2//2/0/2/
שיטות וחומרי ביניים להכנת גורמים רוקחיים
METHODS AND INTERMEDIATES
FOR PREPARING PHARMACEUTICAL
AGENTS GILEAD SCIENCES, INC. 03/04/2009 61/166498 US PCT/US/2010/029633 WO/2010/115000
(2011.01 )C07K 76:957 12//1/0/2/
ותצמידים חיסוניים 5FCRH–נוגדנים אנטי ושיטות לשימוש
ANTI-FCRH5 ANTIBODIES AND
IMMUNOCONJUGATES AND
METHODS OF USE GENENTECH, INC. 01/04/2009 61/211695 US /0//2/0//7 42/244025 US /2/20/0//7 42/044750 US PCT/US/2010/029516 WO/2010/120561
(2011.01 )H04N 76:958 /1//2/0//7
שיטה לעיבוד קובץ דיגיטלי, בעיקר הדמות, וידיאו ו/או מסוג אודיו
METHOD FOR PROCESSING A
DIGITAL FILE NOTABLY OF THE
IMAGE, VIDEO AND/OR AUDIO TYPE
I-CES (INNOVATIVE COMPRESSION
ENGINEERING SOLUTIONS)
December 29, 2011 68-התשע"ב טבתב 'ג
PCT/IB/2009/005550 WO/2010/112957
(2011.01 )C07K 76:959 12//1/0/2/
ותצמידים חיסוניים 5FCRH–נוגדנים אנטי ת לשימושושיטו
ANTI-FCRH5 ANTIBODIES AND
IMMUNOCONJUGATES AND
METHODS OF USE GENENTECH, INC. 01/04/2009 61/211754 US /0//2/0//7 42/244022 US PCT/US/2010/029521 WO/2010/114940
(2011.01 )A61C 76:95: 02//4/0/2/
O-RING INSERYION TOOL AND מכשיר החדרה טבעתי ושיטה
METHOD ZEST IP HOLDINGS LLC 24/06/2009 61/220086 US PCT/US/2010/039830 WO/2010/151676
(2011.01 )B01D 76:95< 12//1/0/2/
חמצני עם –תהליך ללכידת פחמן דו ביצועים משופרים
PROCESS FOR CO2 CAPTURE WITH
IMPROVED STRIPPER
PERFORMANCE ALSTOM TECHNOLOGY LTD. 31/03/2009 61/164944 US 04//1/0/2/ 20/510742 US PCT/US/2010/029420 WO/2010/120527
(2011.01 )F16D 76:95= /4//2/0/2/
December 29, 2011 69-התשע"ב טבתב 'ג
מכשיר כח הילוכים בררני ותושבת הכוללת יישום שלו
A SELECTIVE FORCE
TRANSMISSION DEVICE AND AN
UNDERCARRIAGE CONSISTING OF
AN APPLICATION THEREOF MESSIER-BUGATTI-DOWTY 06/04/2009 0901684 FR PCT/EP/2010/054536 WO/2010/115893
(2011.01 )G06F 76:969 01//2/0/2/
אופטימיזצית ביצוע של תוכנית להדמיית יםנתונ
DATA VISUALIZATION PLATFORM
PERFORMANCE OPTIMIZATION
MICROSOFT CORPORATION 30/04/2009 12/433288 US PCT/US/2010/032307 WO/2010/126802
(2011.01 )G06F 76:96: 01//2/0/2/
תמיכה למיזוג מהיר עבור מסמכים במערכות מסורתיות
FAST MERGE SUPPORT FOR LEGACY
DOCUMENTS
MICROSOFT CORPORATION 30/04/2009 12/432817 US PCT/US/2010/032309 WO/2010/126804
(2011.01 )G06F 76:96; 1///2/0/2/
תזמון עבודה משותפת במחברת אלקטרונית
SHARED JOB SCHEDULING IN
ELECTRONIC NOTEBOOK
MICROSOFT CORPORATION 01/05/2009 12/433907 US PCT/US/2010/033235 WO/2010/127286
December 29, 2011 70-התשע"ב טבתב 'ג
(2011.01 )G06F 76:96< 1///2/0/2/
CROSS-CHANNEL COAUTHORING עקביות בכתיבה משותפת בין ערוצים
CONSISTENCY MICROSOFT CORPORATION 01/05/2009 12/433929 US PCT/US/2010/033241 WO/2010/127291
(2011.01 )G06F 76:96= 2///3/0/2/
HIERARCHICALLY-ORGANIZED גלריות בקרה מאורגנות באופן היררכי
CONTROL GALLERIES MICROSOFT CORPORATION 12/05/2009 12/464584 US PCT/US/2010/034277 WO/2010/132376
(2011.01 )A63B 76:96> 07//1/0/2/
MONITORING OF PHYSICAL ניטור אירועי אימון פיזיים
TRAINING EVENTS
INFOMOTION SPORTS
TECHNOLOGIES, INC. 27/03/2009 61/164277 US /5/2//0//7 42/027304 US PCT/US/2010/029068 WO/2010/111705
(2011.01 )B64C 76:975 21//2/0/2/
כלי רכב אווירי ושיטה להפעלת כלי רכב אווירי
AIR VEHICLE METHOD FOR
OPERATING AN AIR VEHICLE
ISRAEL AEROSPACE INDUSTRIES התעשייה האוירית לישראל בע"מ
LTD. 16/04/2009 198124 IL PCT/IL/2010/000298 WO/2010/119442
December 29, 2011 71-התשע"ב טבתב 'ג
(2011.01 )C08J 76:976 12//1/0/2/
NON-DEWETTING POROUS ות שאינן נרטבותממברנות נקבובי
MEMBRANES SOLVAY SOLEXIS S.P.A 06/04/2009 61/166879 US PCT/US/2010/029344 WO/2010/117845
(2011.01 )G02B 76:977 /0//1/0/2/
הדמיה עם תצוגה פעילה מערכת המסופקת עם עינית
ACTIVE DISPLAY IMAGING SYSTEM
PROVIDED WITH AN EYECUP
THALES 27/03/2009 0901502 FR PCT/EP/2010/052627 WO/2010/108764
(2011.01 )A61K 76:985 04//1/0/2/
METHODS AND COMPOSITIONS FOR שיטות ותכשירים לחיסון נגד וירוס
ACADEMIA SINICA 27/03/2009 61/164385 US 06//1/0//7 42/242165 US 06//1/0//7 42/242166 US 06//1/0//7 42/242167 US 20//1/0/2/ 42/121454 US PCT/US/2010/028968 WO/2010/111687
(2011.01 )C07D 76:988 /0//2/0/2/
ACRYLAMIDE COMPOUNDS AND תרכובות אקרילמיד והשימוש בהן
THE USE THEREOF SHIONOGI & CO. LTD. 02/04/2009 61/166206 US
December 29, 2011 72-התשע"ב טבתב 'ג
PCT/JP/2010/056404 WO/2010/114181
(2011.01 )E01F 76:989 23//1/0/2/
מעקה בטיחות, עמוד תמיכה עם מכלול ניתוק ושיטות לחיבורים ולשימוש בהם
GUARDRAIL ASSEMBLY,
BREAKAWAY SUPPORT POST FOR A
GUARDRAIL AND METHODS FOR
THE ASSEMBLY AND USE THEREOF ENERGY ABSORTION SYSTEMS, INC. 31/03/2009 61/211522 US 02//6/0//7 42/014065 US /0/20/0//7 20/407162 US PCT/US/2010/027331 WO/2010/114693
(2011.01 )A23L 76:98: /4//2/0/2/
שיטה להענקת חדירות לממברנות של תאים ביולוגיים על ידי שדה חשמלי פועם
METHOD FOR RENDERING THE
MEMBRANES OF BIOLOGICAL
CELLS PERVIOUS BY USING A
PULSED ELECTRIC FIELD
COMMISSARIAT A L'ENERGIE
ATOMIQUE ET AUX ENERGIES
ALTERNATIVES 07/04/2009 0952262 FR PCT/EP/2010/054511 WO/2010/115875
(2011.01 )G06K 76:98; /4//2/0/2/
זיהוי ווידאו על ידי שימוש בסימני חומר גבישי נוזלי פולימרי
IDENTIFICATION AND AUTHENTICATION
USING POLYMERIC LIQUID CRYSTAL
MATERIAL MARKINGS SICPA HOLDING SA 02/04/2009 PCT/EP2009/002434 EP /0//2/0//7 20/16212/ US PCT/EP/2010/054515 WO/2010/115879
December 29, 2011 73-התשע"ב טבתב 'ג
(2011.01 )H04L 8=76:9 12//1/0/2/
שיטות והתקן לייצור ושימוש באיתותים יחוסיים במערכת תקשורת
METHODS AND APPARATUS FOR
GENERATION AND USE OF
REFERENCE SIGNALS IN A
COMMUNICATIONS SYSTEM QUALCOMM INCORPORATED 31/03/2009 61/165456 US 1///1/0/2/ 20/53/334 US PCT/US/2010/029437 WO/2010/120530
(2011.01 )C12N 76:98> /2//2/0/2/
נוגדן מונוקלונול שיכול לקשור לאפיטופ 1ADרציף מסוים שנמצא באיזור –בלתי
גלקוחלבון, וקטע GBשל ציטומגלווירוס אנטיגן–מקשר
MONOCLONAL ANTIBODY
CAPABLE OF BINDING TO SPECIFIC
DISCONTINUOUS EPITOPE
OCCURRING IN AD1 REGION OF
HUMAN CYTOMEGALOVIRUS GB
GLYCOPROEIN, AND ANTIGEN-
BINDING FRAGMENT THEREOF EVEC INCORPORATED
01/04/2009 2009-
089442 JP
PCT/JP/2010/056037 WO/2010/114106
(2011.01 )A61F 76:995 04//1/0/2/
מערכות ושיטות להגנה על פצע וטיפול בהפרשות
SYSTEMS AND METHODS FOR
WOUND PROTECTION AND
EXUDATE MANAGEMENT AALNEX, INC. 01/04/2009 12/416826 US PCT/US/2010/028785 WO/2010/120470
December 29, 2011 74-התשע"ב טבתב 'ג
(2011.01 )G01N 76:996 01//2/0/2/
אמצעים ושיטות להגדרת כמות הפוליפפטיד נוירוטוקסין ואת פעילות
שבו PROTEOYTIC–החומר המזרז וה
MEANS AND METHODS FOR THE
DETERMINATION OF THE AMOUNT
OF NEUROTOXIN POLYPEPTIDE AND
OF ITS CATALYTIC AND
PROTEOLYTIC ACTIVITIES MERZ PHARMA GMBH & CO. KGaA 27/04/2009 09158788.1 EP 05//2/0//7 42/02243/ US PCT/EP/2010/055432 WO/2010/124998
(2011.01 )F01K 76:997 26//0/0/2/
עד להמרת אנרגיה תרמית התקן המיו סביבתית לאנרגיה מועילה
INSTALLATION DESIGNED TO
CONVERT ENVIRONMENTAL
THERMAL ENERGY INTO USEFUL
ENERGY COHEN, YOAV 08/04/2009 09157592.8 EP PCT/EP/2010/052027 WO/2010/115654
(2011.01 )H01L 76:998 01//1/0/2/
INFRARED DETECTOR אדום–גלאי אינפרא
UD HOLDINGS, LLC 12/04/2009 61/168601 US PCT/US/2010/028293 WO/2010/120447
(2011.01 )C07D 76:999 22//1/0/2/
והשימוש R7X2Pאנטגוניסטים חדשים ל בהם
NOVEL P2X7R ANTAGONISTS AND
THEIR USE
AFFECTIS PHARMACEUTICALS AG 14/04/2009 09005324.0 EP PCT/EP/2010/053097
December 29, 2011 75-התשע"ב טבתב 'ג
WO/2010/118921
(2011.01 )G01R 76:99: 12//1/0/2/
,A COMMUNICATIONS PROCESS תהליך, התקן ומערכת לתקשורת
DEVICE AND SYSTEM FREESTYLE TECHNOLOGY PTY LTD 31/03/2009 2009901397 AU PCT/AU/2010/000367 WO/2010/111738
(2011.01) C12N 76:99= 27//4/0//7
בידוד של תאי גזע מזנכימאליים שמקורם בדם תבורי אנושי
ISOLATION OF HUMAN UMBILICAL
CORD BLOOD-DERIVED
MESENCHYMAL STEM CELLS
THE BOARD OF REGENTS OF THE
UNIVERSITY OF TEXAS SYSTEM 31/03/2009 61/165193 US PCT/US/2009/047981 WO/2010/114572
(2011.01 )A61K 76:99> /2//2/0/2/
L–אורניטין פניל אצטט ושיטות להכנתו L-ORNITHINE PHENYL ACETATE
AND METHODS OF MAKING
THEREOF OCERA THERAPEUTICS, INC. 03/04/2009 61/166676 US PCT/US/2010/029708 WO/2010/115055
(2011.01 )A61K 76:9:6 /2//2/0/2/
PHARMACEUTICAL COMPOSITION חותתכשיר רוק
K.U. LEUVEN RESEARCH &
DEVELOPMENT
December 29, 2011 76-התשע"ב טבתב 'ג
03/04/2009 09157303.0 EP PCT/EP/2010/054418 WO/2010/115843
(2011.01 )B23K 76:9:7 04//1/0/2/
ל נתיב לייזר חופף, שיטה רכיב בע ליצור רכיב כזה
COMPONENT HAVING AN
OVERLAPPING LASER TRACK;
METHOD FOR PRODUCING SUCH A
COMPONENT CERAMTEC GMBH, 31/03/2009 102009015087.0 DE PCT/EP/2010/053972 WO/2010/112412
(2011.01 )A61K 76:9:8 01//2/0/2/
הרכב לתרסיס תת לשוני המכיל דיהידרוארטמסינין
SUBLINGUAL SPRAY FORMULATION
COMPRISING DIHYDROARTEMESININ
LONDONPHARMA LTD 23/04/2009 0906971.7 GB 01//2/0//7 PCT/GB09/050415 GB PCT/GB/2010/050672 WO/2010/122356
(2011.01 )A61K 76:9:9 01//2/0/2/
תכשיר רוקחות תת לשוני המכיל שמן ניטראלי
SUBLINGUAL PHARMACEUTICAL
COMPOSITION COMPRISING A NEUTRAL
OIL LONDONPHARMA LTD 23/04/2009 0906977.4 GB 01//2/0//7 PCT/GB09/050416 GB PCT/GB/2010/050671 WO/2010/122355
December 29, 2011 77-התשע"ב טבתב 'ג
(2011.01 )A61K 76:9:: /3//2/0/2/
METHODS AND MATERIALS FOR שיטות וחומרים למתן מולקולות
DELIVERING MOLECULES
MAYO FOUNDATION FOR MEDICAL
EDUCATION AND RESEARCH 06/04/2009 61/166929 US PCT/US/2010/029985 WO/2010/117957
(2011.01 )C08G 76:9:; 03//1/0/2/
תהליך לייצור תמיסה של מלחי דיחומצה/דיאמין
PROCESS FOR THE MANUFACTURE
OF A SOLUTION OF SALTS OF
DIACIDS/ DIAMINE (S) RHODIA OPERATIONS 09/04/2009 0952333 FR PCT/EP/2010/053946 WO/2010/115727
(2011.01 )F41A 76:9:< 21//3/0/2/
מערכת מסילה משולבת ושיטה ליצורה ושימוש בה
INTEGRATED RAIL SYSTEM AND
METHOD FOR MAKING AND USING
SAME THE OTIS PATENT TRUST 15/05/2009 12/466857 US PCT/US/2010/034673 WO/2010/132643
(2011.01 )F41A 76:9:= 21//3/0/2/
מערכת מסילה משולבת ושיטה ליצורה ושימוש בה
INTERGATED RAIL SYSTEM AND
METHOD FOR MAKING AND USING
SAME THE OTIS PATENT TRUST 15/05/2009 12/466905 US PCT/US/2010/034681 WO/2010/132649
December 29, 2011 78-התשע"ב טבתב 'ג
(2011.01 )B64F 76:9:> 27//2/0/2/
צלצל עיגון המיועד במיוחד עבור מטוס ומערכת עיגון הכוללת צלצל אחד כזה
ANCHORING HARPOON INTENDED
IN PARTICULAR FOR AN AIRCRAFT
AND ANCHORING SYSTEM
INCLUDING ONE SUCH HARPOON DCNS 03/04/2009 0952177 FR PCT/FR/2010/050076 WO/2010/112717
(2011.01 )A61K 76:9;5 /4//2/0/2/
COMPOSITIONS AND METHODS FOR תכשירים ושיטות לטיפול בלייפת ותינית
TREATMENT OF AORTIC FIBROSIS VECTUS BIOSYSTEMS PTY LIMITED 02/04/2009 2009901425 AU PCT/AU/2010/000391 WO/2010/111753
(2011.01 )C08G 76:9;6 12//1/0/2/
מדללים עבור תרחיפים מימיים של חלקיקי מינרלים ומשחות כורכן
הידראוליות
THINNERS FOR AQUEOUS
SUSPENSIONS OF MINERAL
PARTICLES AND HYDRAULIC
BINDER PASTES CHRYSO 02/04/2009 0952132 FR PCT/FR/2010/050614 WO/2010/112775
(2011.01 )C12Q 76:9;7 /0//2/0/2/
שיטה להגברת ריבוי תחלים עבור ברקוד של חומצות מיועדות
MULTI-PRIMER AMPLIFICATION
METHOD FOR BARCODING OF
TARGET NUCLEIC ACIDS FLUIDIGM CORPORATION
December 29, 2011 79-התשע"ב טבתב 'ג
02/04/2009 61/166105 US /0//2/0//7 42/244262 US 22//4/0//7 42/264105 US 26//0/0/2/ 42/1/37/5 US PCT/US/2010/029854 WO/2010/115154
(2011.01 )A61K 76:9;8 12//1/0/2/
סלולריזציה של –סלולריזציה ורה–דה איברים ורקמות
DECELLULARIZATION AND
RECELLULARIZATION OF ORGANS
AND TISSUES
REGENTS OF THE UNIVERSITY OF
MINNESOTA, 31/03/2009 61/211613 US PCT/US/2010/029463 WO/2010/120539
(2011.01 )B64F 76:9;9 /2//2/0/2/
צלצל עיגון, לדוגמא עבור מטוס, ומערכת עיגון הכוללת צלצל אחד כזה
ANCHORING HARPOON, FOR
EXAMPLE FOR AN AIRCRAFT, AND
ANCHORING SYSTEM INCLUDING
ONE SUCH HARPOON DCNS 03/04/2009 0952175 FR PCT/FR/2010/050625 WO/2010/112780
(2011.01 )A61L 76:9;: 02//1/0/2/
מכשיר, מערכת ושיטה למניעת זיהום ביולוגי לחומרים במהלך אחסון ע"י
שימוש באנרגיה חשמלית פועמת
AN APPARTUS, SYSTEM AND
METHOD FOR PREVENTING
BIOLOGICAL CONTAMINATION TO
MATERIALS DURING STORAGE
USING PULSED ELECTRICAL
ENERGY
רמות ליד אוניברסיטת תל אביב בע"מYISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM LTD.
December 29, 2011 80-התשע"ב טבתב 'ג
30/03/2009 61/164502 US PCT/IL/2010/000251 WO/2010/113150
(2011.01 )G01N 76:9;; /4//2/0/2/
METHOD FOR ASSAYING INOSITOL שיטה לבדיקת אינוסיטול הקסאפוספט
HEXAPHOSPHATE (IHP) ERYTECH PHARMA 03/04/2009 0952208 FR PCT/EP/2010/054516 WO/2010/115880
(2011.01 )C07K 76:9;< /4//2/0/2/
גורמים טיפוליים לטיפול במחלות הקשורות עם התרבות מהירה בלתי רצויה
םשל תאי
THERAPEUTIC AGENTS FOR THE
TREATMENT OF DISEASES
ASSOCIATED WITH UNDESIRED
CELL PROLIFERATION
FUNDACIO PRIVADA INSTITUT
D'INVESTIGACIO ONCOLOGICA DE
VALL HEBRON 03/04/2009 P200900928 ES PCT/EP/2010/054499 WO/2010/115868
(2011.01 )B64F 76:9;= 22//2/0/2/
צלצל עיגון המיועד במיוחד עבור מטוס ומערכת עיגון הכוללת צלצל אחד כזה
ANCHORING HARPOON INTENDED
IN PARTICULAR FOR AN AIRCRAFT
AND ANCHORING SYSTEM
INCLUDING ONE SUCH HARPOON DCNS 03/04/2009 0952183 FR PCT/FR/2010/050030 WO/2010/112716
December 29, 2011 81-התשע"ב טבתב 'ג
(2011.01 )C08J 76:9;> 00//1/0/2/
OXYGEN SCAVENGING FILMS שכבות טיהור באמצעות חמצן
MULTISORB TECHNOLOGIES, INC. 01/04/2009 12/416685 US PCT/US/2010/028102 WO/2010/120435
(2011.01 )C08G 76:9<5 12//1/0/2/
חומרים שמקנים פלסטיות עבור תרחיפים ומשחות מימיים של חלקיקי מינרלים
כורכן הידראוליות
PLASTICIZERS FOR AQUEOUS
SUSPENSIONS OF MINERAL
PARTICLES AND HYDRAULIC
BINDER PASTES CHRYSO 02/04/2009 0952132 FR PCT/FR/2010/050614 WO/2010/112775
(2011.01 )F24F 76:9<6 /4//2/0/2/
מערכת מיזוג אויר המונעת על ידי חום שיורי
WASTE HEAT AIR CONDITIONING
SYSTEM
LINUM SYSTEMS LTD לינום סיסטמס בע"מ 01/04/2009 61/165533 US PCT/IL/2010/000272 WO/2010/113158
(2011.01 )C07D 76:9<7 1///2/0/2/
SALT OF ABT-263 AND SOLID-STATE וצורותיו במצב מוצק ABT–263מלח של
FORMS THEREOF ABBOTT LABORATORIES 30/04/2009 61/174274 US PCT/US/2010/033072 WO/2010/127190
December 29, 2011 82-התשע"ב טבתב 'ג
(2011.01 )A61K 76:9<8 1///2/0/2/
פורמולציה ליפידית של מקדם לאפופטוזהLIPID FORMULATION OF APOPTOSIS
PROMOTER
ABBOTT LABORATORIES 30/04/2009 61/174245 US PCT/US/2010/033074 WO/2010/127192
(2011.01 )A61K 76:9<9 1///2/0/2/
פורמולציה ליפידית מיוצבת של מקדם אפופטוזה
STABILIZED LIPID FORMULATION
OF APOPTOSIS PROMOTER
ABBOTT LABORATORIES 30/04/2009 61/174299 US 00/20/0//7 42/067032 US PCT/US/2010/033075 WO/2010/127193
(2011.01 )A61B 76:9<: /2//2/0/2/
APPARATUS AND METHOD FOR FAT מנגנון ושיטה להסרת שומן
REMOVAL
THE GENERAL HOSPITAL
CORPORATION 01/04/2009 61/165844 US PCT/US/2010/029607 WO/2010/114987
(2011.01 )H04N 76:9<; /2//2/0//7
CONTENT SUB-ITEM SUBSTITUTION פריט של תוכן–החלפת תת
NDS LIMITED PCT/IB/2009/051370 WO/2010/112978
December 29, 2011 83-התשע"ב טבתב 'ג
(2011.01 )A61B 76:9<< 1///1/0/2/
שימוש בשינויים בקצב הלב להתאמת שינויים בשדה מגנטי לרגישות
ה תואמתפיזיולוגית ושיט
USE OF THE HEART RATE
VARIABILITY CHANGE TO CORRELATE
MAGNETIC FIELD CHANGES WITH
PHYSIOLOGICAL SENSITIVITY AND
METHOD THEREFOR PLANK, ELISABETH 02/04/2009 102009002134.5 DE PCT/EP/2010/054191 WO/2010/112503
(2011.01 )B09C 76:9<> 1///1/0//7
שיטה להתאוששות של שטחים מפוררים על ידי שימוש בזני צמחים מותאמים
גנטית
METHOD FOR THE RECOVERY OF
DEGRADED AREAS USING
GENETICALLY MODIFIED PLANT
SPECIES JUAN PEDRO NAVARRO AVINO PCT/ES/2009/070080 WO/2010/112622
(2011.01 )C07K 76:9=5 23//2/0/2/
שליטה בגליקוזילציה של חלבון ותרכובות ושיטות הקשורות לכך
CONTROL OF PROTEIN
GLYCOSYLATION AND
COMPOSITIONS AND METHODS
RELATING THERETO PFIZER INC. 20/04/2009 61/170897 US PCT/IB/2010/051650 WO/2010/122460
(2011.01 )A61K 76:9=6 /5//2/0/2/
December 29, 2011 84-התשע"ב טבתב 'ג
IMPROVED GLUCOCORTICOID ואיד משופרטיפול גלוקוקורטק
THERAPY DUOCORT PHARMA AB 07/04/2009 PA200900470 DK PCT/EP/2010/002178 WO/2010/115615
(2011.01 )C07K 76:9=7 1///1/0/2/
דנים מונוקלוניים הכנה של נוג אדאר מבודדדים–אגוניסט אנטי
PREPARATION OF ISOLATED AGONIST
ANTI-EDAR MONOCLONAL ANTIBODIES
UNIVERSITE DE LAUSANNE 30/03/2009 PCT/IB2009/005118 IB PCT/IB/2010/051385 WO/2010/113117
(2011.01 )A61K 76:9=8 /0//2/0/2/
–N–[6–(1–טריפלואורו–6,4,2תכשיר של –2–פירימידין–קרבוניל(–4–פיפרידין–מתיל
בנזאמיד–יל[
COMPOSITION OF 2,4,6-TRIFLUORO-
N-[6-(1-METHYL-PIPERIDIN-4-
CARBONYL)-PYRIDIN-2-YL]-
BENZAMIDE COLUCID PHARMACEUTICALS, INC. 02/04/2009 61/166097 US PCT/US/2010/029810 WO/2010/115125
(2011.01 )G02F 76:9=9 12//1/0//7
שיטה ומערכת הכרעת מקדמים אופטיים שני–לינאריים מסדר–בלתי
METHOD AND SYSTEM FOR
DETERMINING SECOND-ORDER
NONLINEAR OPTICAL
COEFFICIENTS SELEX SISTEMI INTEGRATI S.P.A PCT/IT/2009/000131 WO/2010/113190
December 29, 2011 85-התשע"ב טבתב 'ג
(2011.01 )F24J 76:9=: 12//1/0/2/
העברת מומנט הפיתול בין מודולי אבוס מאסף
TORQUE TRANSFER BETWEEN
TROUGH COLLECTOR MODULES
ABENGOA SOLAR INC. 01/04/2009 12/416536 US PCT/US/2010/029481 WO/2010/120545
(2011.01 )A61K 76:9=; /0//2/0/2/
COMPOSITIONS OF תכשירים של מעכבי קולינאסטרייס
CHOLINESTERASE INHIBITORS COLUCID PHARMACEUTICALS, INC. 02/04/2009 61/166143 US PCT/US/2010/029809 WO/2010/115124
(2011.01 )A61K 76:9=> /0//2/0/2/
SYSTEMS AND METHODS FOR מערכות ושיטות לייצור מימן
GENERATING NITROGEN ST. RENATUS, LLC 03/04/2009 61/166680 US PCT/US/2010/001002 WO/2010/114622
(2011.01 )C07D 76:9>5 /2//4/0/2/
AMINO PYRIMIDINE ANTICANCER תרכובות אמינו פירימידין אנטי סרטניות
COMPOUNDS OSI PHARMACEUTICALS, LLC 01/06/2009 61/182898 US 04//2/0/2/ 42/076127 US PCT/US/2010/036808 WO/2010/141406
December 29, 2011 86-התשע"ב טבתב 'ג
(2011.01 )A61K 76:9>6 /7//4/0//7
הרכב תאי גזע משתית עצמיים וחיצונים ממקור שומני לטיפול בפסיטולות
AUTOLOGOUS AND ALLOGENIC
ADIPOSE-DERIVED STROMAL STEM
CELL COMPOSITION FOR TREATING
FISTULAS ANTEROGEN CO, LTD
28/04/2009 10-2009-
0036942 KR
PCT/KR/2009/003078 WO/2010/126194
(2011.01 )A61F 76:9>8 /2//2/0/2/
GRAFTסוג פתיחת פתחים בתומכן מ
STENT STENT GRAFT FENESTRATION
קרן מחקרים רפואיים פיתוח תשתית ושירותי בריאות ע"י המרכז הרפואי תל
אביב
SERVICES FUND OF THE TEL AVIV
MEDICAL CENTER THE MEDICAL
RESEARCH, INFRASTRUCTURE AND
HEALTH 02/04/2009 61/165946 US PCT/IB/2010/051438 WO/2010/113138
(2011.01 )A61K 76:9>9 06//0/0/2/
שיטה לבקרת ריבוי והתמיינות של קראטינוציטים
A METHOD OF REGULATING
PROLIFERTATION AND
DIFFERENTIATION OF
KERATINOCYES
ים רפואיים פתוח תשתית קרן מחקרושרותי בריאות ליד המרכז הרפואי תל
אביב
THE MEDICAL RESEARCH AND
INFRASTRUCTURE FUND OF THE
TEL-AVIV SOURASKY MEDICAL
CENTER 01/04/2009 61/202760 US PCT/IL/2010/000167 WO/2010/113146
December 29, 2011 87-התשע"ב טבתב 'ג
(2011.01 )C12N 76:9>: 02//1/0/2/
תירכובות ושיטות להגברת תכולת שומן באצות
COMPOSITIONS AND METHODS FOR
INCREASING OIL CONTENT IN
ALGAE ROSETTA GREEN LTD רוסטה גרין בע"מ
02/04/2009 61/165912 US PCT/IL/2010/000247 WO/2010/113149
(2011.01 )C07D 76:9>< 07//1/0/2/
תולדות אוקסאדיאזול ותכשירי רוקחות המכילים אותן
OXADIAZILE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM MERCK SERONO S.A. 03/04/2009 09157301.4 EP 24//2/0//7 42/247551 US PCT/EP/2010/054100 WO/2010/115751
(2011.01 )C07D 76:9>= 07//1/0/2/
תולדות אוקסאדיאזול ותכשירי רוקחות מכילים אותןה
OXADIAZOLE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM MERCK SERONO SA, 03/04/2009 09157301.4 EP 24//2/0//7 42/247551 US PCT/EP/2010/054103 WO/2010/112461
(2011.01 )E04D 76:9>> 20//3/0/2/
CONNECTOR ASSEMBLIES FOR מערכת חיבור עבור לוחות מחוברים
CONNECTING PANELS
December 29, 2011 88-התשע"ב טבתב 'ג
SABIC INNOVATIVE PLASTICS IP
B.V. 13/05/2009 61/177693 US PCT/US/2010/034485 WO/2010/132529
(2011.01 )E05F 76::57 0///2/0//7
PNEUMATIC DOOR ASSIST SYSTEM מערכת עזר עם מנעול לדלת פניאומטית
WITH LOCK
INTERNATIONAL TRUCK
INTELLECTUAL PROPERTY
COMPANY, LLC. PCT/US/2009/041073 WO/2010/123486
(2011.01 )C07K 76::58 24//2/0/2/
פפטידים לשימוש בטיפול בעור ו/או בשיער והשימוש בהם בתכשירים
קוסמטיים או של רוקחות
PEPTIDES USED IN THE TREATMENT
AND/OR CARE OF THE SKIN AND/OR
HAIR AND THEIR USE IN COSMETIC
OR PHARMACEUTICAL
COMPOSITIONS LIPOTEC S.A. 20/04/2009 61/170891 US 25//2/0/22 0//7/2/20 ES PCT/EP/2010/002348 WO/2010/118880
(2011.01 )A61K 76::59 2///1/0/2/
המודיאליזה ופתרונות להפרדה של הצפק המכיל אחת או יותר של קריאטין
HEMODIALYSIS AND PERITONEAL
DIALYSIS SOLUTIONS COMPRISING
ONE OR MORE CREATINE
COMPOUNDS CREARENE LTD 06/04/2009 09005038.6 EP PCT/CH/2010/000065 WO/2010/115291
December 29, 2011 89-התשע"ב טבתב 'ג
(2011.01 )A23L 76::5: /5//2/0/2/
WHOLEGRAIN INSTANT PASTA פסטה אינסטנט מדגנים מלאים
NESTEC S.A. 17/04/2009 09158132.2 EP PCT/EP/2010/054562 WO/2010/118974
(2011.01 )A61P 76::5; 26//3/0/2/
PROTEASE INHIBITORS מעכבי פרוטאז
ORION CORPORATION 18/05/2009 758/KOL/2009 IN PCT/FI/2010/000031 WO/2010/133748
(2011.01 )A41B 76::5= 22/20/0//7
FUNCTIONAL UNDERPANTS FOR תחתונים פונקציונליים לגברים
MEN BAEK, GYEONG-SU,
13/04/2009 10-2009-
0031932 KR
PCT/KR/2009/007459 WO/2010/120030
(2011.01 )B23B 76::5> /3//2/0/2/
ישיר עבור כלי חתיכה–קירור בלתיINDIRECT COOLING OF A CUTTING
TOOL
CREARE INCORPORATED 06/04/2009 12/418688 US PCT/US/2010/029950 WO/2011/005340
December 29, 2011 90-התשע"ב טבתב 'ג
(2011.01 )C09D 76::65 /5//2/0/2/
PIEZOCHROMIC SECURITY ELEMENT אלמנט ביטחון פיאזוכרומי
SICPA HOLDING SA 07/04/2009 PCT/IB2009/005198 IB PCT/EP/2010/054597 WO/2010/115928
(2011.01 )G01J 76::66 20//0/0/2/
קונפורמי IRמשושות למערכי גלאי –ננו קוהקנטי בעל פס רחב
NANO-ANTENNA FOR WIDEBAND
COHERENT CONFORMAL IR
DETECTOR ARRAYS RAYTHEON COMPANY 30/04/2009 12/433576 US PCT/US/2010/024169 WO/2010/126641
(2011.01 )C07D 76::67 /4//2/0/2/
און –(H1)4–אלקילסינון–1נגזרות מותמרות, הכנתן ויישום רפואי שלהן
SUBSTITUTED 1-ALKYLCINNOLIN-
4(1H)-ONE DERIVATIVES,
PREPARATION THEREOF AND
THERAPEUTIC APPLICATION OF
SAME SANOFI 07/04/2009 0901696 FR PCT/FR/2010/050657 WO/2010/116084
(2011.01 )E04H 76::68 /5//2/0/2/
והתקן להפעלת מנקה בריכות עם שיטה מחולל כלור משולב
METHOD AND APPARATUS FOR
OPRATION OF POOL CLEANER WITH
INTEGRAL CHLORINE GENERATOR AQUATRON, INC. 08/04/2009 12/384806 US
December 29, 2011 91-התשע"ב טבתב 'ג
PCT/US/2010/001071 WO/2010/117469
(2011.01 )G06K 76::6: /4//2/0/2/
מערכת הדמייה הכוללת ייצוב ופיצוי לתנועת המצלמה במרחב
VIDEO MOTION COMPENSATION
AND STABILIZATION GIMBALED
IMAGING SYSTEM
NEXTVISION STABILIZED SYSTEMS נקסט ויז'ן מערכות מיוצבות בע"מ
LTD 07/04/2009 61/167226 US PCT/IL/2010/000280 WO/2010/116366
(2011.01 )C07C 76::6; 23//2/0/2/
פלואורו –תחליבים המורכבים מפר פחמנים
EMULSIONS OF
PERFLUOROCARBONS
OXYGEN BIOTHERAPEUTICS, INC. 15/04/2009 61/212689 US 07//2/0//7 42/022770 US 27/2//0//7 42/057137 US 21/22/0//7 42/062272 US PCT/US/2010/031320 WO/2010/121082
(2011.01 )C07D 76::6< /5//2/0/2/
–יל(–3–[הקס3.1.0ביציקלו]–אזא–3)–6 פירימידינים–פניל–2
6-(3-AZA-BICYCLO[3.1.0]HEX-3-YL)-2-
PHENYL-PYRIMIDINES
ACTELION PHARMACEUTICALS LTD. 08/04/2009 PCT/IB09/051486 IB PCT/IB/2010/051499 WO/2010/116328
(2011.01 )G06F 76::6= /3//2/0/2/
December 29, 2011 92-התשע"ב טבתב 'ג
REMOTE ANALYSIS AND אנליזה ותיקון מרחוק של תנאי יבול
CORRECTION OF CROP CONDITION SMARTFIELD, INC. 06/04/2009 61/166819 US /4//2/0//7 42/244606 US PCT/US/2010/029947 WO/2010/117944
(2011.01 )C07D 76::6> 07//2/0/2/
תהליך להכנת תרכובות איזוקסאזולין מותמרות וחומרים מקדימים שלהן
PROCESS FOR PREPARING
SUBSTITUTED ISOXAZOLINE
COMPOUNDS AND THEIR
PRECURSORS BASF SE 30/04/2009 09159246.9 EP PCT/EP/2010/055773 WO/2010/125130
(2011.01 )B63B 76::75 23//2/0/2/
מערכת להעברת נוזלים בין שני כלים המוצבים זה לצד זה
SYSTEM FOR TRANSFERRING
FLUIDS BETWEEN TWO VESSELS
PLACED SIDE BY SIDE TECHNIP FRANCE, 09/04/2009 0952368 FR PCT/FR/2010/050731 WO/2010/116113
(2011.01 )C07D 76::76 04//3/0/2/
–5H–דיהידרו–7,6תולדות של אמידים של חומצה –3–[אימידאזולa–2,1אימידאזו]
קרבוקסילית
DERIVATIVES OF 6,7-DIHYDRO-5H-
IMIDAZO[1,2-a]IMIDAZOLE-3-
CARBOXYLIC ACID AMIDES
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH 02/06/2009 61/183098 US PCT/US/2010/036094 WO/2010/141273
December 29, 2011 93-התשע"ב טבתב 'ג
(2011.01 )C07D 76::77 /2//2/0/2/
COPPER BROMIDE HUMIDITY כרטיס זיהוי ללחות המכיל נחושת ברומית
INDICATING CARD MULTISORB TECHNOLOGIES, INC. 06/04/2009 12/419116 US PCT/US/2010/029567 WO/2010/117865
(2011.01 )G06Q 76::78 /5//2/0/2/
SYSTEM AND METHOD FOR HYBRID מערכת ושיטה לנתיב הנחיה מוכלא
COURSE INSTRUCTION LEARNIG TREE INTERNATIONAL 07/04/2009 61/167364 US PCT/US/2010/030257 WO/2010/118145
(2011.01 )A61K 76::79 21//2/0/2/
METHOD FOR ON-DEMAND שיטה למתן אמצעי מניעה לפי דרישה
CONTRACEPTION LABORATOIRE HRA-PHARMA 14/04/2009 61/169149 US PCT/EP/2010/054812 WO/2010/119029
(2011.01 )C07K 76::7: 20//2/0/2/
רצפי חומצות אמיניות משופרים המכוונים פפטידים המכילים אותם ופולי R6–ILנגד
–לטיפול במחלות והפרעות הקשורות לR6–IL
IMPROVED AMINO ACID
SEQUENCES DIRECTED AGAINST IL-
6R AND POLYPEPTIDES
COMPRISING THE SAME FOR THE
TREATMENT OF IL-6R RELATED
DISEASES AND DISORDERS ABLYNX NV
December 29, 2011 94-התשע"ב טבתב 'ג
10/04/2009 61/168410 US PCT/EP/2010/054764 WO/2010/115998
(2011.01 )F24J 76::7; /4//2/0/2/
SOLAR MIRROR PANLES AND THEIR לוחות מראות סולרים וייצורם
MANUFACTURE WIZARD POWER PTY LTD 06/04/2009 2009901467 AU PCT/AU/2010/000390 WO/2010/115237
(2011.01 )C07D 76::86 07//1/0/2/
תרכובות ציקליות מותמרות בקבוצת פניל, תכשירים המכילים אותן ושימושים
בהן
CYCLIC COMPOUNDS HAVING A
SUBSTITUTED PHENYL GROUP,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
DAIICHI SANKYO COMPANY,
LIMITED
06/04/2009 2009-
091671 JP
PCT/JP/2010/055547 WO/2010/116915
(2011.01 )B32B 76::87 /6//2/0/2/
התאמת פני השטח ממברנות אוסמוזה הפוכה באמצעות פולימרים דנדריטיים
הידרופיליים
SURFACE MODIFICATION OF
REVERSE OSMOSIS MEMBRANES BY
HYDROPHILIC DENDRITIC
POLYMERS MICHIGAN MOLECULAR INSTITUTE 08/04/2009 61/212206 US PCT/US/2010/001058 WO/2010/117460
December 29, 2011 95-התשע"ב טבתב 'ג
(2011.01 )C09D 76::88 /7//2/0/2/
CLEAR MAGNETIC INTAGLIO PRINTING דיו הדפסת חריטה מגנטית שקופה
INK SICPA HOLDING SA 09/04/2009 PCT/IB2009/005227 IB PCT/EP/2010/054716 WO/2010/115986
(2011.01 )H02J 76::8: /5//2/0/2/
WIRELESS POWER TRANSMISSION מערכת העברת כוח אלחוטי ושיטה
SYSTEM AND METHOD RAYTHEON COMPANY 10/04/2009 12/421789 US PCT/US/2010/030153 WO/2010/118075
(2011.01 )C07K 76::8< 0///2/0/2/
-RECOMBINANT HUMAN ALPHA1 אנטיטרפזין רקומביננטי אנושי–1אלפא
ANTITRYPSIN CRUCELL HOLLAND B.V. 23/04/2009 61/214492 US 01//2/0//7 /723642/92 EP PCT/EP/2010/055177 WO/2010/127939
(2011.01 )C07K 76::8= 27//2/0/2/
–חלבוני איחוי נוגדנים עם אתרי קישור לFCRN שעברו שינוי
ANTIBODY FUSION PROTEINS WITH
MODIFIED FCRN BINDING SITES
MERCK PATENT GMBH 22/04/2009 61/171650 US PCT/EP/2010/002377 WO/2010/121766
December 29, 2011 96-התשע"ב טבתב 'ג
(2011.01 )B29C 76::8> 22//2/0/2/
POWDER IN-MOLD COATING BY עת איבוק בתוך תבניתצבי
COMPRESSING ITEMS
ORLITE INDUSTRIES (MILLENIUM ( בע"מ2000אורלייט תעשיות )מילניום
2000) LTD. 17/04/2009 61/170280 US PCT/IB/2010/051631 WO/2010/119414
(2011.01 )F03B 76::95 /5//2/0/2/
ENERGY RELEASE BUOYANT מפעיל צף משחרר אנרגיה
ACTUATOR CETO IP PTY LTD 07/04/2009 2009901502 AU PCT/AU/2010/000398 WO/2010/115241
(2011.01 )B64C 76::96 /4//2/0/2/
מערכת, יחדיה מעופפת ושיטה להעלאת מטענים
SYSTEM, FLOATING UNIT AND
EMTHOD FOR ELEVATING
PAYLOADS SHY COHEN שי כהן
06/04/2009 61/166820 US PCT/IL/2010/000273 WO/2010/116362
(2011.01 )H04H 76::98 00//2/0//7
AUDIENCE MEASUREMENT SYSTEM מערכת למדידת קהל צופים
NDS LIMITED PCT/IB/2009/051657 WO/2010/122373
December 29, 2011 97-התשע"ב טבתב 'ג
(2011.01 )A23L 76::9; 12//1/0/2/
תהליך להסרת קוטלי מזיקים מתמציות אונתי ותמציות המתקבלות –גינקגו דו
באמצעות תהליך זה
PROCESS FOR REMOVING PESTICIDES
FROM GINKGO BILOBA EXTRACTS,
AND EXTRACTS OBTAINABLE BY SAID
PROCESS INDENA S.P.A. 06/04/2009 MI2009A000548 IT PCT/EP/2010/002046 WO/2010/115566
(2011.01 )H01L 76::9< /5//2/0/2/
שיקוע משופר של שכבה דקה של סיליקון טאיעבור יישומי מכשיר פוטווול
IMPROVED SILICON THIN FILM
DEPOSITION FOR PHOTOVOLTAIC
DEVICE APPLICATIONS ASAHI GLASS COMPANY LIMITED 07/04/2009 61/167349 US PCT/US/2010/030199 WO/2010/118105
(2011.01 )H04W 76::9= 2///3/0/2/
MULTIMODAL CONVERSATION מערך מגוון להשהיית הודעות ושליפתן
PARK AND RETRIEVAL MICROSOFT CORPORATION 13/05/2009 12/465421 US PCT/US/2010/034280 WO/2010/132379
(2011.01 )C07K 76::9> /4//2/0/2/
שבטי ממקור אנושי בררני עבור –נוגדן חד 01( של סרוטייפ LPSליפופוליסאכרידים )
IATS שלAERUGINOSA
PSEUDOMONAS
PSEUDOMONAS AERUGINOSA
ANTIBODY SPECIFIC FOR
LIPOPOLYSACCARIDES (LPS) OF
SEROTYPE IATS 01 OF
PSEUDOMONAS AERUGINOSA
December 29, 2011 98-התשע"ב טבתב 'ג
KENTA BIOTECH AG 09/04/2009 09005245.7 EP PCT/EP/2010/002158 WO/2010/115606
(2011.01 )C07D 76:::5 22//2/0/2/
יל –2–תהליך להכנת אסטר של ביפניל ומצה קרבמיתח
PROCESS FOR THE PREPARATION
OF A BIPHENYL-2-YLCARBAMIC
ACID ESTER GLAXO GROUP LIMITED 14/04/2009 61/169046 US PCT/EP/2010/054893 WO/2010/119064
(2011.01 )C07D 76:::6 22//2/0/2/
7מאפנני נגזרת אינדולית של אלפא NACHR
INDOLE DERIVATIVE MODULATORS
OF THE ALPHA 7 NACHR
PROXIMAGEN LIMITED 16/04/2009 61/169742 US PCT/EP/2010/054910 WO/2010/119078
(2011.01 )C07D 76:::7 /7//0/0/2/
)פניל –2–בנזואיל–5–אמינו–4קרבוניטרילים מותמרים –3–אמינו(תיאופן
)פניל –2–בנזואיל–5–אמינו–4–וקרבוקסאמידים מותמרים –3–אמינו(תיאופן
כמכעבי פילמור טובולין
SUBSTITUTED 4-AMINO-5-BENZOYL-
2-(PHENYLAMINO)THIOPHENE-3-
CARBONITRILES AND SUBSTITUTED
4-AMINO-5-BENZOYL-2-
(PHENYLAMINO)THIOPHENE-3-
CARBOXAMIDES AS TUBULIN
POLYMERIZATION INHIBITORS TELIK, INC. 16/04/2009 61/169785 US PCT/US/2010/023561 WO/2010/120400
December 29, 2011 99-התשע"ב טבתב 'ג
(2011.01 )C07D 76:::8 00//2/0/2/
תהליכים להכנת תרכובות מורפינאן ומורפינון
PROCESSES FOR THE PREPARATION
OF MORPHINANE AND
MORPHINONE COMPOUNDS BROCK UNIVERSITY 24/04/2009 61/172521 US PCT/CA/2010/000587 WO/2010/121369
(2011.01 )C07D 76:::9 24//2/0/2/
תרכובות דיאמיד בעלות פעילות אנטגוניסטית לקולטן מוסקריני ופעילות
אדרנרגי–?2אגוניסטית לקולטן
DIAMIDE COMPOUNDS HAVING
MUSCARINIC RECEPTOR
ANTAGONIST AND ?2 ADRENERGIC
RECEPTOR AGONIST ACTIVITY THERAVANCE, INC. 23/04/2009 61/172039 US PCT/US/2010/031356 WO/2010/123766
(2011.01 )F16K 76:::: /6//4/0/2/
VALVE שסתום
MOKVELD VALVES B.V. 09/06/2009 102009026838.3 DE PCT/EP/2010/058005 WO/2010/142677
(2011.01 )A61K 76:::; 23//2/0/2/
שיטה ותכשיר לטיפול ניוון כתמיMETHOD AND COMPOSITION FOR
TREATING MACULAR
DEGENERATION SUCAMPO AG 15/04/2009 61/169512 US 20//2/0/2/ 20/53633/ US
December 29, 2011 100-התשע"ב טבתב 'ג
PCT/JP/2010/057108 WO/2010/119986
(2011.01 )C07D 76:::< 21//2/0/2/
CONDENSED PYRROLOPYRIDINE תולדת פירולופירידין דחוסה
DERIVATIVE ASTELLAS PHARMA INC.
14/04/2009 2009-
097974 JP
PCT/JP/2010/056619 WO/2010/119875
(2011.01 )B21D 76:::= 24//1/0/2/
METHOD OF MANUFACTURING A שיטה לייצור כלי מתכתי
METAL VESSEL THE COCA COLA COMPANY 06/04/2009 12/418758 US PCT/US/2010/027410 WO/2010/117564
(2011.01 )C07D 76:::> /3//2/0/2/
–תולדות אינדול ושיטות לטיפול אנטי ויראלי
INDOLE DERIVATIVES AND
METHODS FOR ANTIVIRAL
TREATMENT PTC THERAPEUTICS, INC 06/04/2009 61/166893 US PCT/US/2010/029923 WO/2010/117932
(2011.01 )G06F 76::;5 /0//2/0/2/
HYPERLINK TO COMPUTER קישור היפרטקסט לתוכן תוצרת מחשב
GENERATED CONTENT BCInnovation
December 29, 2011 101-התשע"ב טבתב 'ג
05/04/2009 61/166757 US PCT/IB/2010/051450 WO/2010/116311
(2011.01 )C07K 76::;7 /5//2/0/2/
PROCESS FOR ISOLATING תהליך להפרדת פפטיד ריפויי
THERAPEUTIC PEPTIDE CORDEN PHARMA COLORADO, INC. 10/04/2009 61/168259 US PCT/EP/2010/054577 WO/2010/115916
(2011.01 )G06F 76::;8 /2//2/0/2/
UNIFIED INPUT AND DISPLAY מערכת ושיטה לתצוגה מאוחדת קלט
SYSTEM AND METHOD RADION ENGINEERING CO. LTD רדיון חברה להנדסה בע"מ
05/04/2009 61/166747 US PCT/IB/2010/051439 WO/2010/116308
(2011.01 )F04C 76::;9 /5//2/0/2/
COMPRESSOR HAVING CAPACITY מדחס הכולל מכלול ויסות קיבולת
MODULATION ASSEMBLY
EMERSON CLIMATE
TECHNOLOGIES, INC. 07/04/2009 61/167309 US /4//2/0/2/ 20/53270/ US PCT/US/2010/030248 WO/2010/118140
(2011.01 )B01J 76::;= 04//6/0/2/
December 29, 2011 102-התשע"ב טבתב 'ג
שיטה למניעת סתימת מערכת כור –תעלות לתגובה רציפה ומיקרו
לביצוע השיטה
METHOD FOR PREVENTING PLUGGING OF
A CONTINUOUS-REACTION CHANNEL-
SYSTEM AND MICRO-REACTOR FOR
CARRYING OUT THE METHOD LONZA AG 28/08/2009 PCT/EP2009/061143 EP 22//7/0//7 /7/2250496 EP 01//1/0/2/ 2/23506395 EP PCT/EP/2010/062476 WO/2011/023761
(2011.01 )H04L 76::;> 23//2/0/2/
שיתוף תוכן אודיו/וידאו עם משתמש נבחר
SHARING OF AUDIO/VISUAL
CONTENT WITH A SELECTED USER
SLING MEDIA, INC. 15/04/2009 12/424249 US PCT/US/2010/031150 WO/2010/120972
(2011.01 )B01J 76::<5 20//3/0/2/
-CONTINUOUS REACTION MICRO כור לתגובה רציפה–מיקרו
REACTOR LONZA AG 12/05/2009 PCT/EP2009/055739 EP PCT/EP/2010/056594 WO/2010/130808
(2011.01 )A01H 76::<6 /7//2/0/2/
SNFI PLANT SNFI-RELATED PROTEIN–גן קינאז חלבון צמח קשור ל
KINASE GENE DOW AGROSCIENCES LLC 10/04/2009 61/168532 US PCT/US/2010/030563 WO/2010/118338
December 29, 2011 103-התשע"ב טבתב 'ג
(2011.01 )B01J 76::<7 20//3/0/2/
METHOD OF MANUFACTURING A שיטה לייצור כור ומערכך כורים
REACTOR AND SET OF REACTORS LONZA AG 12/05/2009 PCT/EP2009/055740 EP PCT/EP/2010/056597 WO/2010/130811
(2011.01 )A47J 76::<8 /4/2//0/22
ספוג לרחיצת כלים הנושא סימון "חלבי", "בשרי" או "פרווה"
SCOURING SPONGE WITH SYMBOL
OF "MEET", "MILK" AND "PARVE"
MAYA ARAD מאיה ארד
(2011.01 )B62H 76::<9 /4/2//0/22
A TWO-WHEELED VEHICLE מייצב לכלי רכב דו גלגלי
STABILIZER ELIYAHU MASHIAH אליהו משיח
(2011.01 )G06F 76::<: /4/2//0/22
מערכת רב שכבתית למיפוי, ניתוח וקבלת החלטות של ארגונים, פונקציות פעילויות
ורשתות
SYSTEM FOR MULTI-LAYER
ORGANIZATIONAL, FUNCTIONAL,
ACTIVITIES AND NETWORK
MAPPING, ANALYZING AND
DECISION MAKING
T.E. COMMERCIALIZE ת.ע. ייזום וישום חידושים בע"מ
INNOVATIONS LTD
December 29, 2011 104-התשע"ב טבתב 'ג
(2011.01 )G06F 76::<; /4/2//0/22
וידוא למנוע שיטה ומערכת לאימות ו דליפת מידע במחשוב ענן
A METHOD AND A SYSTEM FOR
AUTHENTICATION AND
PREVENTING DATA BREACHES IN
CLOUP COMPUTING CONCEALIUM I.T. SECURITY LTD קונסליום אבטחת טכנולוגיות מידע בע"מ
07/10/2010 61/390877 US
(2011.01 )H04N 76::<< /1//4/0//7
שיטה ומערכת לבקרת שימוש במכשיר אלקטרוני
METHOD AND SYSTEM FOR
CONTROLLING THE USE OF AN
ELECTRONIC DEVICE
VAZQUEZ DEL MERCADO HABIF,
DAVID 08/04/2009 09157658 EP PCT/MX/2009/000051 WO/2010/117252
(2011.01 )A47J 76::<= /6//2/0/2/
מתקן להכנת משקה בעל סגירה מיכנית עם אמצעי כוח שאינו מרובה
BEVERAGE PREPARATION DEVICE
HAVING A CLOSING MECHANISM
WITH FORCE DEMULTIPLYING
MEANS NESTEC S.A. 09/04/2009 09157751.0 EP PCT/EP/2010/054621 WO/2010/115946
December 29, 2011 105-התשע"ב טבתב 'ג
(2011.01 )C07D 76::=5 04//3/0/2/
המעכבות תרכובות פירימידין ביציקליות K3PI 110בררניות עבורP דלתא, ושיטות
לשימוש
BICYCLIC PYRIMIDINE PI3K
INHIBITOR COMPOUNDS SELECTIVE
FOR P110 DELTA, AND METHODS OF
USE GENENTECH, INC. 27/05/2009 61/181452 US 25/20/0//7 42/0654/5 US PCT/US/2010/036199 WO/2010/138589
(2011.01 )A61K 76::=6 21//2/0/2/
תאי גזע מסנכימלים מהונדסים ושיטה לשימוש בהם לטיפול בגידולים
ENGINEERED MESENCHYMAL STEM
CELLS AND METHOD OF USING
SAME TO TREAT TUMORS APCETH GMBH & CO. KG 13/04/2009 61/168787 US PCT/EP/2010/054844 WO/2010/119039
(2011.01 )A01N 76::=8 /7//2/0/2/
שיטות למניעת ו/או טיפול בהפרעות באחסון ליזוזומלי
METHODS FOR PREVENTING
AND/OR TREATING LYSOSOMAL
STORAGE DISORDERS AMICUS THERAPEUTICS, INC. 09/04/2009 61/168109 US PCT/US/2010/030472 WO/2010/118283
(2011.01 )A01N 76::=9 /7//2/0/2/
שיטות למניעת ו/או טיפול בהפרעות ניווניות של מערכת העצבים המרכזית
METHODS FOR PREVENTING
AND/OR TREATING DEGENERATIVE
DISORDERS OF THE CENTRAL
NERVOUS SYSTEM AMICUS THERAPEUTICS, INC. 09/04/2009 61/168101 US
December 29, 2011 106-התשע"ב טבתב 'ג
PCT/US/2010/030470 WO/2010/118282
(2011.01 )C10G 76::=: /0//5/0//7
התקן ושיטה לפירוק בחום של פסולת פלסטיק
APPARATUS FOR THERMOLYSIS
WASTE PLASTICS AND METHOD
FOR THERMOLYSIS WASTE
CLARITER POLAND SPOLKA Z
ORGANICZONA
ODPOWIEDZIALNOSCIA 08/04/2009 P-387742 PL PCT/IB/2009/052879 WO/2010/116211
(2011.01 )H04W 76::=; /4//2/0/2/
שיטות ומכשירים עבור השקטת ערוץ פס וגיות גישת רדיוטלוויזיה דרך טכנול
METHODS AND APPARATUS FOR
TELEVISION BAND (TVBD)
CHANNEL QUIETING ACROSS
DIVERSE RADIO ACCESS
TECHNOLOGIESS
INTERDIGITAL PATENT HOLDINGS,
INC. 06/04/2009 61/167050 US 27//2/0/2/ 42/074137 US PCT/US/2010/030063 WO/2010/117998
(2011.01 )G06F 76::=< 05/2//0//7
–מערכת לאחסון מסה המשתמשת בתת מערכת אחסון מסייעת במצב מוצק
A MASS-STORAGE SYSTEM
UTILIZING AUXILIARY SOLID-
STATE STORAGE SUBSYSTEM KAMINARIO TECHNOLOGIES LTD. 10/04/2009 61/168346 US PCT/IL/2009/001004 WO/2010/116349
December 29, 2011 107-התשע"ב טבתב 'ג
(2011.01 )E06B 76::>5 /5//2/0//7
חוצץ לרווח חלונות זכוכית בחלונות זכוכיות מרובי זכוכיות, חלון מרובה
ושיטה לייצור חלון מרובה זכוכיות
SPACER FOR SPACING GLASS PANES
IN A MULTIPLE GLASS PANE, A
MULTIPLE GLASS PANE, AND A
METHOD FOR PRODUCING A
MULTIPLE GLASS PANE PROWERB ST. GALLEN AG PCT/EP/2009/054153 WO/2010/115456
(2011.01 )A61K 76::>6 01//2/0/2/
חיסון נגד שחפת למניעת התעוררות חוזרת
A TUBERCULOSIS TB VACCINE TO
PREVENT REACTIVATION
STATENS SERUM INSTITUT 24/04/2009 PA200900539 DK PCT/DK/2010/000054 WO/2010/121618
(2011.01 )C07C 76::>7 21//2/0/2/
תכשירים ושיטות לטיפול בדלקתCOMPOSITIONS AND METHODS FOR
THE TREATMENT OF
INFLAMMATION C.T. RESOLVE SARL 13/04/2009 61/168739 US /2//3/0//7 42/2526/4 US PCT/US/2010/030813 WO/2010/120719
(2011.01 )A61K 76::>8 22//2/0/2/
תכשירים לחיסון נגד סטפילוקוקוס AUREUS
COMPOSITIONS FOR IMMUNISING
AGAINST STAPHYLOCOCCUS
AUREUS
December 29, 2011 108-התשע"ב טבתב 'ג
NOVARTIS AG 14/04/2009 61/212705 US 22//6/0//7 42/012/57 US PCT/IB/2010/000998 WO/2010/119343
(2011.01 )A23L 76::>9 21//2/0/2/
אמולסיות תזונתיות בעלות כמות סיבים גבוהה
HIGH FIBER NUTRITIONAL
EMULSIONS
ABBOTT LABORATORIES 14/04/2009 61/169022 US PCT/US/2010/030834 WO/2010/120734
(2011.01 )A23L 76::>: 21//2/0/2/
אמולסיות תזונתיות בעלות כמות סיבים גבוהה לבקרת רמת גלוקוז בדם
HIGH FIBER NUTRITIONAL
EMULSIONS FOR BLOOD GLUCOSE
CONTROL ABBOTT LABORATORIES 14/04/2009 61/169030 US PCT/US/2010/030837 WO/2010/120736
(2011.01 )A23L 76::>; 21//2/0/2/
אמולסיות תזונתיות בעלות כמות סיבים גבוה עם גליצרין
HIGH FIBER NUTRITIONAL
EMULSION WITH GLYCERIN
ABBOTT LABORATORIES 14/04/2009 61/169027 US PCT/US/2010/030884 WO/2010/120772
(2011.01 )H04M 76::>= 12//1/0/2/
December 29, 2011 109-התשע"ב טבתב 'ג
שיטה ומערכת להשגת מידע על רשת ( של רשת תקשורת RANגישה רדיו )
סלולרית
METHOD AND SYSTEM FOR
OBTAINING RADIO ACCESS
NETWORK (RAN) INFORMATION OF
CELLULAR TELECOMMUNICATIONS
NETWORKS INTUCELL LTD אינטיוסל בע"מ
07/04/2009 198100 IL PCT/IB/2010/051400 WO/2010/116292
(2011.01 )A61M 76:;55 05//2/0/2/
שיטה והתקן לווידןא אוטומטי של אינטובציה תוך קנה הנשימתית
METHOD AND APPARATUS FOR
AUTOMATIC VERIFICATION OF
ENDOTRACHEAL INTUBATION TUBEEYE MEDICAL LTD 28/04/2009 61/173324 US PCT/IB/2010/051833 WO/2010/125520
(2011.01 )C07C 76:;56 /6//2/0/2/
נגזרות של רזורצינול שעברו סולפוריזציה, הכנתן ושימושים קוסמטיים בהן
SULPHURATED DERIVATIVES OF
RESORCINOL, PREPARATION OF
SAME AND COSMETIC USES
THEREOF
PIERRE FABRE DERMO-
COSMETIQUE 08/04/2009 0952289 FR PCT/EP/2010/054619 WO/2010/115945
(2011.01 )C12N 76:;57 /7//2/0/2/
שיטה לתרבות אוכלוסית תאים במדיום בלי נסיוב
METHOD FOR THE CULTIVATION OF
CELL POPULATION IN A SERUM
FREE MEDIUM CELLCA GMBH 09/04/2009 09005211.9 EP PCT/EP/2010/002217
December 29, 2011 110-התשע"ב טבתב 'ג
WO/2010/115634
(2011.01 )A61K 76:;58 /5//2/0/2/
פרמקוקינטיקה שלדי חלבון אנושי עםבנסיוב מבוקר, תכשירים המכילים אותם
ושימושים בהם
HUMAN PROTEIN SCAFFOLD WITH
CONTROLLED SERUM
PHARMACOKINETICS,
COMPOSITIONS COMPRISING THE
SAME AND USES THEREOF
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA 08/04/2009 61/167844 US PCT/US/2010/030291 WO/2010/118169
(2011.01 )A01N 76:;59 /7//2/0/2/
תכשירים המכילים אמינואלקיל גלוקוסאמיניד פוספאט לשימוש בטיפול
ה–רפרפוזי–ה–בבצקת הקשורה לאיסכמי
COMPOSITIONS COMPRISING
AMINOALKYL GLUCOSAMINIDE
PHOSPHATE FOR USE IN TREATING
EDEMA RELATED TO ISCHEMIA-
REPEFUSION
THE UNIVERSITY OF NORTH
CAROLINA AT CHAPEL HILL 09/04/2009 61/168089 US PCT/US/2010/030556 WO/2010/118334
(2011.01 )H04N 76:;5; /6//2/0/2/
SYSTEM AND METHOD FOR IMAGE מערכת ושיטה לעיבוד תמונה
COMPRESSION WATCHITOO, INC. 08/04/2009 61/167536 US PCT/US/2010/030425 WO/2010/118254
December 29, 2011 111-התשע"ב טבתב 'ג
(2011.01 )C22C 76:;5< /6//2/0//7
סגסוגת מבוססת נחושת שניתנת לעיבוד ושיטה לייצורה
MACHINABLE COPPER-BASED
ALLOY AND METHOD FOR
PRODUCING THE SAME
SWISSMETAL-UMS
SCHWEIZERISCHE METALL WERKE
AG PCT/EP/2009/054250 WO/2010/115462
(2011.01 )A61K 76:;5= /6//2/0/2/
DRUG DELIVERY COMPOSITION תכשיר לשחרור תרופה
ALKERMES PHARMA IRELAND
LIMITED 09/04/2009 61/168040 US PCT/US/2010/030387 WO/2010/118228
(2011.01 )C07D 76:;5> /5//2/0/2/
נגזרות קינאזולינדיאון, הכנתן ושימושים רפואיים מגוונים שלהן
QUINAZOLINEDIONE DERIVATIVES,
PREPARATION THEREOF AND
VARIOUS THERAPEUTIC USES
THEREOF SANOFI 09/04/2009 0901760 FR PCT/FR/2010/050664 WO/2010/116088
(2011.01 )A61K 76:;65 /5//2/0/2/
יישומים רפואיים של נגזרות קינאזולינדיאון בתחום הלב וכלי הדם
THERAPEUTIC APPLICATIONS IN
THE CARDIOVASCULAR FIELD OF
QUINAZOLINEDIONE DERIVATIVES SANOFI 09/04/2009 09/01755 FR PCT/FR/2010/050672
December 29, 2011 112-התשע"ב טבתב 'ג
WO/2010/116090
(2011.01 )A01N 76:;67 21//2/0/2/
כנה מערכות למתן אנזימים ושיטות לה ושימוש
ENZYME DELIVERY SYSTEMS AND
METHODS OF PREPARATIONS AND
USE CUREMARK LLC 13/04/2009 12/386051 US PCT/US/2010/030895 WO/2010/120781
(2011.01 )H01S 76:;68 21//2/0/2/
–התקני ספיגה הניתנים לרוויה מבוססי גרפן ושיטות
GRAPHENE-BASED SATURABLE
ABSORBER DEVICES AND METHODS
NATIONAL UNIVERSITY OF
SINGAPORE 13/04/2009 61/168661 US PCT/SG/2010/000148 WO/2010/120246
(2011.01 )B29C 76:;69 00//2/0/2/
COMPRESSED SHEET יריעה דחוסה
DSM IP ASSETS B.V. 23/04/2009 09158621.4 EP PCT/EP/2010/055337 WO/2010/122099
(2011.01 )C07D 76:;6: /3//3/0/2/
–1 750תרכובות ציאנואתילהטרוציקלילקרבוקסאמיד
מותמרות
SUBSTITUTED 1-
CYANOETHYLHETEROCYCLYLCARBOXAMIDE
COMPOUNDS 750
ASTRAZENECA AB
December 29, 2011 113-התשע"ב טבתב 'ג
07/05/2009 61/176279 US 2///4/0//7 42/263407 US PCT/GB/2010/050736 WO/2010/128324
(2011.01 )C07D 76:;6; 01//2/0/2/
[ הפטנים המשמשים 0.1.4אזאביציקלו[–3 כאנטגוניסטים לאורקסין
3-AZABICYCLO [4.1.0] HEPTANES
USED AS OREXIN ANTAGONISTS
GLAXO GROUP LIMITED 24/04/2009 0907112.7 GB 25//4/0//7 /72/26195 GB 00/20/0//7 /70025094 GB PCT/EP/2010/055449 WO/2010/122151
(2011.01 )C12Q 76:;6= 22//2/0/2/
PREDICTIVE MODELS AND METHOD ושיטה להערכת גיל מודלים מנבאים
FOR ASSESSING AGE CARDIODX, INC 14/04/2009 61/169241 US PCT/US/2010/031076 WO/2010/120914
(2011.01 )G11C 76:;=< 22/2//0/22
REAL-TIME RECORDING SYSTEM מערכת הקלטה בזמן אמת
ISRAEL AEROSPACE INDUSTRIES התעשייה האוירית לישראל בע"מ
LTD.
(2011.01 )A61B 76:;>= 22/2//0/22
LARYNGOSCOPE HANDLE ידית לרינגוסקוף
December 29, 2011 114-התשע"ב טבתב 'ג
.TRUPHATEK INTERNATIONAL LTD תרופאטק אינטרנשיונל בע"מ
(2011.01 )A61M 76:;>> 22/2//0/22
התקן לשחזור תרופה נוזלית לשימוש עם ובקבוקון תרופה IVשקית
LIQUID DRUG RECONSTITUTION
ASSEMBLAGE FOR USE WITH IV
BAG AND DRUG VIAL .MEDIMOP MEDICAL PROJECTS LTD מדימופ פרוייקטים רפואיים בע"מ
(2011.01 )F28F 76:<55 22/2//0/22
COOLING SYSTEM AND METHOD מערכת ושיטה לקירור
.ELTA SYSTEMS LTD אלתא מערכות בע"מ
(2011.01 )G02B 76:<6: 22/2//0/22
אמצעי ביתי להפקת מדבקות לנטיקולריות אישיות
MEANS FOR PRODUCING HOME
MADE IENTICULAR STICKERS
ITZHAK BAR YONA יצחק בר יונה
(2011.01 )C25B 76:<75 22/2//0/22
DEHUMIDIFIER AND METHOD OF מייבש אוויר ושיטת שימושו
USE THEREOF .AGAM ENERGY SYSTEMS LTD אג"מ מערכות אנרגיה בע"מ
December 29, 2011 115-התשע"ב טבתב 'ג
(2011.01 )G08B 76:<89 22/2//0/22
RAISABLE BED מיטה מתרוממת
AMINACH BEDDING & FURNITURE עמינח תעשיות רהיטים ומזרונות
MANUFACTURING LTD
(2011.01 )D21H 76:<8: 22/2//0/22
תהליך הדפסה על בדים רטובים לא ארוגים ומוצרים כתוצאה מכך
IN-LINE PRINTING PROCESS ON WET
NON-WOVEN FABRIC AND
PRODUCTS THEREOF .N.R. SPUNTECH INDUSTRIES LTD נ.ר. ספאנטק תעשיות בע"מ
19/10/2010 61/394407 US
(2011.01 )G06F 76:<8; 22/2//0/22
מערכת למתן אתראות התעוררות לנוסעים בתחבורה ציבורית
A SYSTEM FOR PROVIDING WAKE-
UP ALERTS TO PASSENGERS OF
PUBLIC TRANSPORTATION GRATZYA CHECHIK גרציה צ'צ'יק
(2011.01 )G06Q 76:<98 01/2//0/22
December 29, 2011 116-התשע"ב טבתב 'ג
מערכת אוטומטית לבדיקת הימצאות דואר בתיבת הדואר ושליחת התראה
צלום תוכן התיבההכוללת
AUTOMATIC SYSTEM MONITORING
EXISTENCE OF MAIL IN A MAIL BOX
AND SENDING ALERT INCLUDING A
PICTURE OF THE BOX'S CONTENT AVI PARASH אבי פרש
(2011.01 )G01L 76:<99 01/2//0/22
גילוי ותיקון של סחיפת נקודת האפס במדידות של כוח מגע
ZERO-DRIFT DETECTION AND
CORRECTION IN CONTACT FORCE
MEASUREMENTS BIOSENSE WEBSTER (ISRAEL) LTD 03/11/2010 12/938458 US
(2011.01 )A61B 76:<9; 01/2//0/22
הצגת מגע בין צנתר לרקמה ע"י עיוות של מפה
VISUALIZATION OF CATHETER-
TISSUE CONTACT BY MAP
DISTORTION BIOSENSE WEBSTER (ISRAEL) LTD 04/11/2010 12/939259 US
(2011.01 )A61K 76:<=7 01/2//0/22
METHOD FOR TREATING A שיטה לטיפול במחלת חניכיים
PERIODONTAL DISEASE
DEXCEL PHARMA TECHNOLOGIES דקסל פארמה טכנולוגיות בע"מ
LTD. 25/10/2010 61/406288 US
December 29, 2011 117-התשע"ב טבתב 'ג
(2011.01 )C07D 76:<== 06//2/0//4
תהליך להכנת נגזרת פוליציקלית של קרבאמוילפירידון בעלת פעילות מעכבת
של נגיף האיידס
PROCESS FOR THE PREPARATION
OF POLYCYCLIC
CARBAMOYLPYRIDONE
DERIVATIVE HAVING HIV
INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD.
28/04/2005 2005-
131161 JP
05/2//0//3 0//3-120/54 JP PCT/US/2006/016604 WO/2006/116764
(2011.01 )B65D 76:=7: 01/2//0/22
SELABLE STORAGE CONTAINER מיכל איחסון הניתן לאיטום
THE STANLEY WORKS ISRAEL LTD דה סטנלי וורקס ישראל בע"מ 15/12/2010 12/969352 US
(2011.01 )A23L 76:=89 /6//1/0//4
( HMFוסף חיזוק נוזלי לחלב אנושי )ת ולתרכובות הזנה לתינוקות
LIQUID HUMAN MILLC FORTIFIER
(HMF) COMPOSITION FOR ADDING
TO HUMAN MILK OR INFANT
NUTRITIONAL FORMULA ABBOTT LABORATORIES 09/03/2005 60/660087 US PCT/US/2006/008354 WO/2006/099013
(2011.01 )C07K 76:=:7 2///1/0//4
December 29, 2011 118-התשע"ב טבתב 'ג
ספציפי ללאוקמיה CD 43אפיטופ אקוטית וללימפומה לימפובלסטית
ושימוש בו
ACUTE LEUKEMIA AND
LYMPHOBLASTIC LYMPHOMA-
SPECIFIC CD43 EPITOPE AND USE
THEREOF DINONA INC. 11/05/2005 60/679910 US
02//6/0//3 2/-0//3-//557/4 KR
0//20/0//3 22/120204 US PCT/KR/2006/000870 WO/2006/121240
(2011.01 )A61F 76:=;8 20//2/0//4
יב להפעלת צנתר השתלה דרך כלי רכ דם של שסתומי לב תותבים
CATHETER FOR THE TRANSVASCULAR
IMPLANTATION OF PROSTHETIC
HEART VALVES JENAVALVE TECHNOLOGY, INC. 20/01/2005 102005003632.5 DE PCT/DE/2006/000056 WO/2006/076890
(2011.01 )G07B 76:=<8 01/2//0/22
שיטה להערכת עלות הבעלות הכוללת לדרישה
A METHOD FOR ESTIMATING THE
TOTAL COST OF OWNERSHIP (TCO)
FOR A REQUIREMENT MY SINGLE POINT LTD מיי סינגל פוינט בע"מ
(2011.01 )A61B 76:=<< 02/2//0/22
ROUTING OF PACING SIGNALS ניתוב של אותות קיצוב
BIOSENSE WEBSTER (ISRAEL) LTD 28/10/2010 12/914199 US
December 29, 2011 119-התשע"ב טבתב 'ג
(2011.01 )H04J 76:==5 02/2//0/22
SIMULTANEOUS ABLATION BY זמנית–אבלציה ע"י אלקטרודות רבות בו
MULTIPLE ELECTRODES BIOSENSE WEBSTER (ISRAEL) LTD 08/11/2010 12/941165 US
(2011.01 )H04J 76:==6 02/2//0/22
MULTICHANNEL ABLATION WITH ערוצית עם הפרדת תדרים–אבלציה רב
FREQUENCY DIFFERENTIATION BIOSENSE WEBSTER (ISRAEL) LTD 08/11/2010 12/941165 US 00/22/0/2/ 20/7320// US
(2011.01 )A23L 76:==7 02/2//0/22
אריזת מזון קפוא להכנת מוצר מזון מוגמר והכנתו
A FROZEN FOOD PACKAGE FOR
PREPARING A FINISHED FOOD
PRODUCT AND ITS PREPARATION SUNFROST LTD סנפרוסט בע"מ
(2011.01 )H01R 76:==: 02/2//0/22
A ROTABLE ELECTRIC CONNECTOR ני בעל יכולת סיבוביתמחבר אלקטרו
ALON ALMOULI אלון אלמולי 21/10/2010 GB1017782.2 UA
December 29, 2011 120-התשע"ב טבתב 'ג
(2011.01 )G06F 76:==; 02/2//0/22
מטית לניהול כותבי פלטפורמה אוטו תכנים לצרכי שיווק אינטרנטי והסברה
A CROWD-SOURCE BASED SYSTEM
AND METHOD OF SUPERVISING
AND DISPATCHING ON-LINE
CONTENT PRODUCTING FOR
ADVOCACY AND SEARCH ENGINE
OPTIMIZATION YECHEZKEL ZVI GREEN יחזקאל צבי גרין
25/10/2010 61406339 US
(2011.01 )C07D 76:=>5 12//6/0//2
PEPTIDOMIMETIC PROTEASE מעכבים של פרוטאז פפטידומימטיים
INHIBITORS
VERTEX PHARMACEUTICALS
INCORPORATED 31/08/2000 60/229398 US 02//1/0//2 4//055422 US PCT/US/2001/026008 WO/2002/018369
(2011.01 )C07D 76:=>6 12//6/0//2
PEPTIDOMIMETIC PROTEASE מעכבים של פרוטאז פפטידומימטיים
INHIBITORS
VERTEX PHARMACEUTICALS
INCORPORATED 31/08/2000 60/229398 US 02//1/0//2 4//055422 US PCT/US/2001/026008 WO/2002/018369
(2011.01 )C07D 76:=>7 12//6/0//2
December 29, 2011 121-התשע"ב טבתב 'ג
PEPTIDOMIMETIC PROTEASE טייםמעכבים פרוטאז פפטידומימ
INHIBITORS
VERTEX PHARMACEUTICALS
INCORPORATED 31/08/2000 60/229398 US 02//1/0//2 4//055422 US PCT/US/2001/026008 WO/2002/018369
(2011.01 )A61K 76:=>; 23//5/0//3
COMPOUNDS AND METHODS FOR תרכובות ושיטות לטיפול בסרטן
TREATMENT OF CANCER
THE TEXAS A&M UNIVERSITY
SYSTEM 16/07/2004 60/588596 US PCT/US/2005/025192 WO/2006/020048
(2011.01 )A61K 76:=>< 26//1/0//3
–4תכשיר רוקחי שיווי משקל המכיל הידרוקסי טאמוקסיפן ושיטה להכנתו
PHARMACEUTICAL COMPOSITION
AT THE EQUILIBRIUM STATE
COMPRISING 4-HYDROXY
TAMOXIFEN AND METHOD FOR
MAKING IT
LABORATOIRES BESINS
INTERNATIONAL 22/03/2004 04290762.6 EP 00//1/0//2 2//6/331/ US PCT/EP/2005/003455 WO/2005/092310
(2011.01 )C07D 76:>6< 03//0/0//2
P38 INHIBITORS AND METHODS OF ושיטות לשימוש בהם 38Pמדכאי
USE THEREOF ARRAY BIOPHARMA, INC 03/03/2003 10/378164 US 23/2//0//1 2//466627 US
December 29, 2011 122-התשע"ב טבתב 'ג
PCT/US/2004/005693 WO/2004/078116
(2011.01 )C02F 76:>6= 1///2/0/2/
התקן לטיהור ושיטה לסילוק קסנוביוטיים ממים
PURIFYING DEVICE AND METHOD FOR
ELIMINATION OF XENOBIOTICS IN
WATER LOIRA 30/04/2009 PCT/FR2009/050800 FR PCT/IB/2010/000982 WO/2010/125450
(2011.01 )C07K 76:>6> 07//2/0/2/
ANTI CXCR4 ANTIBODIES FOR THE לטיפול בנגיף האיידס 4CXCRנוגדנים נגד
TREATMENT OF HIV PIERRE FABRE MEDICAMENT 29/04/2009 09159076.0 EP 07//2/0//7 42/25146/ US PCT/EP/2010/055863 WO/2010/125162
(2011.01 )G02C 76:>75 03/2//0/22
התקן ושיטות לפליטת אור חכמה ולבניית פולט אור חכם
APPARATUS AND METHOD FOR
SMART LIGHT EMISSION AND
SMART LIGHT EMITTER
CONSTRUCTION
ISRAEL AEROSPACE INDUSTRIES התעשייה האוירית לישראל בע"מ
LTD.
(2011.01 )A61K 76:>77 01//4/0//7
December 29, 2011 123-התשע"ב טבתב 'ג
משותפים –תכשיר תוך ורידי עם גבישיםלסליצילית מסיסים במים של חומצה אצטי
ותיאנין
INTRAVENOUS FORMULATION
WITH WATER-SOLUBLE
COCRYSTALS OF
ACETYLSALICYLIC ACID AND
THEANINE
SOLUPRIN PHARMACEUTICALS,
INC. 08/05/2009 12/437735 US PCT/US/2009/048275 WO/2010/128977
(2011.01 )H01L 76:>78 04//6/0//2
OPTICAL ELEMENT AND EXPOSURE רכיב אופטי והתקן חשיפה
APPARATUS NIKON CORPORATION
26/08/2003 2003-
302122 JP
05//6/0//1 0//1-1/1210 JP 05//6/0//1 0//1-1/0327 JP 04//7/0//1 0//1-114240 JP 26//0/0//2 0//2-/22626 JP 26//0/0//2 0//2-/20235 JP 27//0/0//2 0//2-/20530 JP 0///0/0//2 0//2-/22007 JP PCT/JP/2004/012296 WO/2005/020298
(2011.01 )C07K 76:>79 05//2/0/2/
LPS–תכשיר אימונוגלובולין מועשר נגד לטיפול ו/או מניעה של הפרעה פתולוגית
ANTI-LPS ENRICHED
IMMUNOGLOBULIN PREPARATIONS
FOR THE TREATMENT AND/OR
PROPHYLAXIS OF A PATHOLOGIC
DISORDER IMMURON LIMITED 27/04/2009 61/172922 US PCT/IL/2010/000339 WO/2010/125565
December 29, 2011 124-התשע"ב טבתב 'ג
(2011.01 )A61K 76:>7: 05//2/0/2/
תכשירי נוזל שעבר שינוי אלקטרוקינטי ושימוש בו לטיפול בהתנגדות לאינסולין
בסכרת
ELECTROKINETICALLY-ALTERED
FLUID COMPOSITIONS AND USE
THEREOF FOR TREATING INSULIN
RESISTANCE AND DIABETES
MELLITUS REVALESIO CORPORATION 27/04/2009 61/173134 US PCT/US/2010/032620 WO/2010/126908
(2011.01 )B02C 76:>7; 02//3/0/2/
HARD DRIVE DESTRUCTION מערכת השמדת כונן קשיח
SYSTEM SCOTT ANTHONY WOZNY 23/05/2009 61/180841 US PCT/US/2010/035881 WO/2010/138427
(2011.01 )A01H 76:>7< 22//0/0//3
חי וזרעי עגבניות המכילות אלל עמיד צמ לנגיף ושיטות להכנתם
TOMATO PLANTS AND SEEDS
COMPRISING A VIRUS RESISTANT
ALLELE AND METHODS OF
PRODUCING THE SAME SEMINIS VEGETABLE SEEDS, INC. 12/02/2004 10/777984 US PCT/US/2005/004547 WO/2005/079342
(2011.01 )A61K 76:>7= 1///2/0/2/
נוגדנן בעל איזור משתנה כפול ושימושיוDUAL VARIABLE DOMAIN
IMMUNIGLOBULINS AND USES
THEREOF ABBOTT LABORATORIES 01/05/2009 61/174711 US PCT/US/2010/033231
December 29, 2011 125-התשע"ב טבתב 'ג
WO/2010/127284
(2011.01 )C07D 76:>7> /2/2//0//4
פירזולופירימידינים חדשים כמעכבים לקינאזים תלויי ציקלין
NOVEL PYRAZOLOPYRIMIDINES AS
CYCLIN DEPENDENT KINASE
INHIBITORS SCHERING CORPORATION 06/10/2005 11/245401 US PCT/US/2006/038939 WO/2007/044449
(2011.01 )C07D 76:>85 1///2/0/2/
צורה גבישית של תרכובת בנזופיראן ייצורהטריציקלית ושיטה ל
NOVEL CRYSTAL FORM OF
TRICYCLIC BENZOPYRAN
COMPOUND AND PRODUCTION
METHOD THEREOF
NISSAN CHEMICAL INDUSTRIES
LTD.
30/04/2009 2009-
111281 JP
PCT/JP/2010/057698 WO/2010/126138
(2011.01 )A01G 76:>86 03/2//0/22
LABYRINTH WITH MEMBRANE מבוך עם ממברנה
AMIRIM PRODUCTS DEVELOPMENT אמירים פיתוח מוצרים ופטנטים בע"מ
& PATENTS LTD 25/10/2010 1017985.1 GB
(2011.01 )A61K 76:>87 23//2/0/2/
December 29, 2011 126-התשע"ב טבתב 'ג
COMPOSITIONS AND METHODS FOR תרכובות ושיטות לטיפול בכוויות
TREATING BURNS MINDCAKE, LLC 23/04/2009 12/429169 US PCT/US/2010/031315 WO/2010/123759
(2011.01 )C07D 76:>88 21/2//0//2
חומצות קרבוקסיליות ואצילסופונאמידים HCVמקרוציקליים כמעכבי שכפול
MACROCYCLIC CARBOXYLIC ACIDS
AND ACYLSULFONAMIDES AS
INHIBITORS OF HCV REPLICATION INTERMUNE, INC. 14/10/2003 60/511541 US 00//7/0//2 4//42024/ US PCT/US/2004/033970 WO/2005/037214
(2011.01 )C07D 76:>89 21/2//0//2
חומצות קרבוקסיליות ואצילסופונאמידים HCVכבי שכפול מקרוציקליים כמע
MACROCYCLIC CARBOXYLIC ACIDS
AND ACYLSULFONAMIDES AS
INHIBITORS OF HCV REPLICATION INTERMUNE, INC. 14/10/2003 60/511541 US 00//7/0//2 4//42024/ US PCT/US/2004/033970 WO/2005/037214
(2011.01 )C01C 76:>8: 06//2/0/2/
COMBINED PLANT מפעל משולב
YOSUKE IIDA, 05/05/2009 200910149706.3 JP PCT/JP/2010/057918 WO/2010/128682
December 29, 2011 127-התשע"ב טבתב 'ג
(2011.01 )C08B 76:>8; /5//3/0/2/
–(2,1)–תכשירים ושיטות להכנת אלפא אוליגודקסטראנים–(6,1)–מסועף אלפא
COMPOSITIONS AND METHODS FOR
MAKING ALPHA-(1,2)-BRANCHED
ALPHA-(1,6) OLIGODEXTRANS
TATE & LYLE INGREDIENTS
FRANCE SAS 07/05/2009 61/176242 US PCT/US/2010/033984 WO/2010/129839
(2011.01 )A61K 76:>8< /2//3/0/2/
FGF21 MUTANTS AND USES ושימושים שלהם 21FGFמוטנטים של
THEREOF AMGEN INC. 05/05/2009 61/175736 US /7/20/0//7 42/063226 US PCT/US/2010/033478 WO/2010/129503
(2011.01 )B21D 76:>8= /6/22/0//4
שיטה להפקת אלמנטים של לוח סלולר מסרטי משטח מתכת ושורת הפקה
METHOD FOR MANUFACTURING OF
CELLULAR BOARD, CELLULAR
BOARD, METHOD FOR PRODUCING
CELLULAR BOARD ELEMENT OF
STEEL PLATE STRIP, AND
PRODUCTION LINE OY SHIPPAX LTD 08/11/2005 20051131 FI 05/20/0//3 0//32105 FI /5//0/0//4 0//4/225 FI /6//3/0//4 0//4/221 FI /4//5/0//4 0//4/437 FI 0///7/0//4 0//4/616 FI PCT/FI/2006/000359 WO/2007/054608
December 29, 2011 128-התשע"ב טבתב 'ג
(2011.01 )A61K 76:>99 22//1/0//1
שימוש בתכשיר רוקחי המכיל טסטוסטרון להכנת תרופה לטיפול או מניעה בסיכון
של התפתחות מחלה דיכאונית
USE OF A TESTOSTERONE
COMPRISING PHARMACEUTICAL
COMPOSITION IN THE
PREPARATION OF MEDICAMENT
FOR TREATING OR PREVENTING
THE RISK OF DEVELOPING A
DEPRESSIVE DISORDER UNIMED PHARMACEUTICALS, LLC 15/03/2002 10/098232 US 02//3/0//0 2//231246 US PCT/US/2003/007910 WO/2004/091631
(2011.01 )G07B 76:>;5 04/2//0/22
CASH SLIDING SLIDING ASSISTANT מתקן עזר להחלקת מזומן
HALM SHELEMEY חיים שלומי
(2011.01 )C09G 76:>;> 22//1/0//3
מכנית עם –כרית נקבובית למריקה כימית ברכיבנקבוביות מלאות
CMP POROUS PAD WITH
COMPONENT-FILLED PORES
CABOT MICROELECTRONICS
CORPORATION 23/03/2004 10/807064 US PCT/US/2005/008527 WO/2005/100497
(2011.01 )E03C 76:><5 04/2//0/22
ADJUSTABLE SINK כיור מתכון
GAD TAVORI גד תבורי
December 29, 2011 129-התשע"ב טבתב 'ג
(2011.01 )B62J 76:><6 05/2//0/22
MOTORCYCLE STABILITY התקן יציבות לאופנוע
OREN YAKOBIAN ארן יעקביאן
(2011.01 )B41L 76:><7 05/2//0/22
DIGITAL PRINTING METHOD AND שיטה והתקן להדפסה דיגיטאלית
APPARATUS MICHAL IVRI מיכל עברי
(2011.01 )A61K 76:><= /2/2//0//5
הכנת סטנסופורפין עם דרגת טיהור גבוהה בקנה מידה גדול
HIGH-PURITY LARGE SCALE
PREPARATION OF STANNSOPORFIN
INFACARE PHARMACEUTICAL
CORPORATION 04/10/2006 60/849641 US 06//0/0//5 4//7/24/2 US PCT/US/2007/021485 WO/2008/045377
(2011.01 )C07D 76:>>< 2///4/0//2
December 29, 2011 130-התשע"ב טבתב 'ג
צת תרכובות מאוחות המכילות קבו–אוראידו המעכבות קולטן וינלואיד תת
( של הקולטן, לטיפול 1VR) 1סוג ידי פעילות של –בהפרעות הנגרמות על
קולטן וינלואיד ותהליך להכנתן
FUSED COMPOUNDS CONTAINING
AN UREIDO GROUP THAT INHIBIT
VANILLOID RECEPTOR SUBTYPE 1
(VR1) RECEPTOR ,FOR TREATING
DISORDERS CAUSED BY VANILLOID
RECEPTOR ACTIVITY AND PROCESS
FOR THEIR PREPARATION ABBOTT LABORATORIES 12/06/2003 10/459925 US /7//4/0//2 2//642/46 US PCT/US/2004/018590 WO/2004/111009
(2011.01 )G06F 76;575 05/2//0/22
IMPROVED DATA ENTRY SYSTEMS שיטות משופרות להכנסת נתונים
BENJAMIN FIROOZ GHASSABIAN בנימין פירוז גסביאן
(2011.01 )C12N 76;598 03//0/0/2/
נבט אוכלוסיות מבודדות של תאי כיליתיים ושיטות לבידוד ושימוש בהם
ISOLATED POPULATIONS OF RENAL
STEM CELLS AND METHODS OF
ISOLATING AND USING GAME
תל השומר מחקרים, תשתית ושירותים רפואיים בע"מ
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD. 26/02/2009 61/202425 US 04//0/0//7 42/0/0204 US PCT/IL/2010/000158 WO/2010/097793
(2011.01 )G06F 76;59: 1//2//0/22
IMPROVED DATA SYSTEMS שיטות משופרות להכנסת נתונים
BENJAMIN FIROOZ GHASSABIAN ירוז גסביאןבנימין פ
December 29, 2011 131-התשע"ב טבתב 'ג
(2011.01 )C07D 76;59; 2///4/0//2
תרכובות מאוחות המכילות קבוצת –אוראידו המעכבות קולטן וינלואיד תת
ול ( של הקולטן, לטיפ1VR) 1סוג ידי פעילות של –בהפרעות הנגרמות על
קולטן וינלואיד ותהליך להכנתן
FUSED COMPOUNDS CONTAINING
AN UREIDO GROUP THAT INHIBIT
VANILLOID RECEPTOR SUBTYPE 1
(VR1) RECEPTOR ,FOR TREATING
DISORDERS CAUSED BY VANILLOID
RECEPTOR ACTIVITY AND PROCESS
FOR THEIR PREPARATION ABBOTT LABORATORIES 12/06/2003 10/459925 US /7//4/0//2 2//642/46 US PCT/US/2004/018590 WO/2004/111009
(2011.01 )B65D 76;5:: 12/2//0/22
STRONG AND ENLARGEABLE BAG חזק הניתן להגדלה סל
HARTAL GUY הרטל גיא
(2011.01 )G06F 76;5:; 12/2//0/22
COMBINED DATABASE SYSTEM מערכת ושיטה לשילוב בסיסי נתונים
AND METHOD .VERINT SYSTEMS LTD ורינט מערכות בע"מ
(2011.01 )G06T 76;5:= 12/2//0/22
December 29, 2011 132-התשע"ב טבתב 'ג
מערכת ושיטה לניתוח קשרים על ידי עיבוד תמונה
SYSTEM AND METHOD FOR LINK
ANALYSIS BASED ON IMAGE
PROCESSING .VERINT SYSTEMS LTD ורינט מערכות בע"מ
(2011.01 )G06F 76;5:> 12/2//0/22
מטרות על ידי מערכת ושיטה לאפיון ניתוח רשתות חברתיות
SYSTEM AND METHOD FOR TARGET
PROFILING USING SOCIAL
NETWORK ANALYSIS .VERINT SYSTEMS LTD ורינט מערכות בע"מ
(2011.01 )G10L 76;5;= /7//4/0//1
מערכת לקידור אודיו המשתמש כמאפיינים של סיגנל מפוענח כדי לתאם
מרכיבים ספקטראליים מסונתזים
AUDIO CODING SYSTEM USING
CHARACTERISTICS OF A DECODED
SIGNAL TO ADAPT SYNTHESIZED
SPECTRAL COMPONENTS
DOLBY LABORATORIES LICENSING
CORPORATION PCT/US/2003/018065 WO/2003/107329
(2011.01 )G10L 76;5;> /7//4/0//1
מערכת לקידור אודיו המתשמש כמאפיינים של סיגנל מפוענח כדי לתאם
מרכיבים ספקטרואליים
AUDIO CODING SYSTEM USING
CHARACTERISTICS OF A DECODED
SIGNAL TO ADAPT SYNTHESIZED
SPECTRAL COMPONENTS
DOLBY LABORATORIES LICENSING
CORPORATION 17/07/2002 10/174493 US /4//7/0//0 2//016/25 US
December 29, 2011 133-התשע"ב טבתב 'ג
PCT/US/2003/018065 WO/2003/107329
(2011.01 )A61M 76;5<5 03//4/0//2
DISPENSING DEVICE מתקן מינון
PFIZER LIMITED 02/07/2003 0315509.0 GB PCT/GB/2004/002748 WO/2005/002654
(2011.01 )B60L 76;5<> /2/22/0/22
ELECTRICAL POWER FOR VEHICLES עבור כלי רכב מנוע כח חשמלי
JOSEF JEFFRIES יוסף ארווין ג'פריס
(2011.01 )C07D 76;5=> 03//4/0//2
אמינומתיל –9תרופות מתרכובות –קדם טטראציקליניות
PRODRUGS OF 9-AMINOMETHYL
TETRACYCLINE COMPOUNDS
PARATEK PHARMACEUTICALS, INC. 09/07/2003 60/486017 US 03/22/0//1 4//303065 US 24/20/0//1 4//31/201 US 05//2/0//2 4//34423/ US PCT/US/2004/020305 WO/2005/009944
(2011.01 )H04L 76;5>5 /2/22/0/22
LOGICAL BRIDGING SYSTEM AND מערכת גישור לוגית ושיטה
METHOD .MARVELL ISRAEL (M.I.S.L) LTD מארוול ישראל )אמ.איי.אס.אל( בע"מ
14/02/2007 60/889809 US
December 29, 2011 134-התשע"ב טבתב 'ג
/2//3/0//5 4//724/43 US
(2011.01 )B60S 76;5>8 /2/22/0/22
VEHICULAR DISPOSABLE פעמי לרכב–כיסוי הגנתי חד
PROTECTIVE COVER SHLOMO VANUNU שלמה ואנונו
(2011.01 )A61K 76;5>: 21//7/0//3
חלבוני איחוי ותכשירי רוקחות המכילים אותם
FUSION PROTEINS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME GENZYME CORPORATION 13/09/2004 60/608887 US /2//1/0//3 4//4360/7 US PCT/US/2005/032320 WO/2006/031689
(2011.01 )G02C 76;5>; /0/22/0/22
MULTI FUNCTIONAL GLASSES משקפיים רב תכליתיים
ROSHDI ASSI רושדי עאסי
(2011.01 )A61B 76;658 /0/22/0/22
CATHETER WITH OPTICAL צנתר עם חישת מגע אופטית
CONTACT SENSING BIOSENSE WEBSTER (ISRAEL) LTD
December 29, 2011 135-התשע"ב טבתב 'ג
16/11/2010 12/946910 US
(2011.01 )A61K 76;659 07/22/0//3
COATED DRUG DELIVERY שחרור פורמולציות מתרופה מצופה
FORMULATIONS
WESTERN UNIVERSITY OF HEALTH
SCIENCES 30/11/2004 10/999831 US PCT/US/2005/042958 WO/2006/060325
(2011.01 )A61M 76;66; /3/22/0//2
POWDER INHALER משאף לאבקה
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH 08/11/2003 10352277.8 DE PCT/EP/2004/012535 WO/2005/044353
(2011.01 )H04W 76;66< /3//5/0//3
שיטה והתקן לריבוב מוגבר בהעברת אות ללויין
METHOD AND APPARATUS FOR
ENHANCED UPLINK MULTIPLEXING
INTERDIGITAL TECHNOLOGY
CORPORATION 19/07/2004 60/588960 US 03//2/0//3 22/221541 US PCT/US/2005/023891 WO/2006/019562
(2011.01 )E02B 76;67< /1/22/0/22
FLOATING OIL RIG PROTECTION הגנה להתקנות ימיות ותשתיות
December 29, 2011 136-התשע"ב טבתב 'ג
AGRO SHIPPING LTD בע"מ אגרו ספנות
(2011.01 )G08B 76;67> /1/22/0/22
שיטה ומערכת לאישור הפעלת רכבA METHOD AND SYSTEM FOR
AUTHORIZING VEHICLES
OPERATION ERM ELECTRONIC SYSTEMS LTD אר אם מערכות אלקטרוניות בע"מאי
(2011.01 )A61B 76;689 /1/22/0/22
POLYGRAPH פוליגרף
ZEEV DANIELI שאול בר לב 31/10/2011 000000 US
(2011.01 )H04L 76;68> 23//3/0//7
שיכוך הפרעה מרחבי לתקשורת אלחוטיתSPATIAL INTERFERENCE
MITIGATION FOR WIRELESS
COMMUNICATION QUALCOMM INCORPORATED 15/05/2008 61/053564 US 03/22/0//6 42/225630 US 22//3/0//7 20/241501 US PCT/US/2009/044204 WO/2009/140633
(2011.01 )A61M 76;6:= /4/22/0/22
December 29, 2011 137-התשע"ב טבתב 'ג
אוטומטי אלקטרוני ומחסניות התקן מזרק לשימוש איתו
ELECTRONIC AUTOINJECTOR
APPARATUS AND CASSETTES FOR
USE THEREWITH .MEDIMOP MEDICAL PROJECTS LTD מדימופ פרוייקטים רפואיים בע"מ
(2011.01 )G06Q 76;6;6 /4/22/0/22
אינטראקציות מבוטחות על ידי מבטח אוטומטי
AUTOMATED INSURER INSURED
INTERACTIONS
DAVIDSHIELD L.I.A. (2000) LTD ( בע"מ2000דודשילד אל.אי.איי. ) 18/11/2010 12/949367 US
(2011.01 )A61B 76;6;9 /4/22/0/22
AN ORAL CONDOM קונדום אוראלי
ALON ZHABOKRITSKY אלון ז'בוקריצקי
(2011.01 )G08B 76;6;: /4/22/0/22
מערכת להתזת חומר דביק לעיכוב פורצים
AN ADHESIVE SPRAY SYSTEM THAT
HINDERS INTRUDERS
OFER HAI עופר חי
(2011.01 )G06F 76;6<5 /5/22/0/22
December 29, 2011 138-התשע"ב טבתב 'ג
IMPROVED DATA ENTRY SYSTEMS שיטות משופרות להכנסת נתונים
BENJAMIN FIROOZ GHASSABIAN בנימין פירוז גסביאן
(2011.01 )B41J 76;6=6 /5/22/0/22
MOBILE PRINTER מדפסת ניידת
YEHEZKEL AHARON BORNSTEIN יחזקאל אהרון בורנשטין
(2011.01 )A01N 76;6>: 1///4/0//3
יות של חומרים תערובות סינרגיסטאנתרנילאמידיים מדבירי מזיקים חסרי
חוליות
SYNERGISTIC MIXTURES OF
ANTHRANILAMIDE INVERTEBRATE
PEST CONTROL AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY 01/07/2004 60/584601 US 07//1/0//3 4//444/51 US PCT/US/2005/023813 WO/2006/007595
(2011.01 )A01N 76;6>; 1///4/0//3
תערובות סינרגיסטיות של חומרים אנתרנילאמידיים מדבירי מזיקים חסרי
חוליות
SYNERGISTIC MIXTURES OF
ANTHRANILAMIDE INVERTEBRATE
PEST CONTROL AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY 01/07/2004 60/584601 US 07//1/0//3 4//444/51 US PCT/US/2005/023813 WO/2006/007595
December 29, 2011 139-התשע"ב טבתב 'ג
(2011.01 )A01N 76;6>< 1///4/0//3
ת סינרגיסטיות של חומרים תערובואנתרנילאמידיים מדבירי מזיקים חסרי
חוליות
SYNERGISTIC MIXTURES OF
ANTHRANILAMIDE INVERTEBRATE
PEST CONTROL AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY 01/07/2004 60/584601 US 07//1/0//3 4//444/51 US PCT/US/2005/023813 WO/2006/007595
(2011.01 )A01N 76;6>= 1///4/0//3
תערובות סינרגיסטיות של חומרים אנתרנילאמידיים מדבירי מזיקים חסרי
חוליות
SYNERGISTIC MIXTURES OF
ANTHRANILAMIDE INVERTEBRATE
PEST CONTROL AGENTS
E.I. DU PONT DE NEMOURS AND
COMPANY 01/07/2004 60/584601 US 07//1/0//3 4//444/51 US PCT/US/2005/023813 WO/2006/007595
(2011.01 )H04M 76;776 /6/22/0/22
מערכת ושיטה לקורלציה של כלי רכב ונהגים
SYSTEM AND METHOD FOR
CORRELATION OF VEHICLES AND
DRIVERS MIZRACHI GIL גיל מזרחי
08/11/2010 12/941360 US
(2011.01 )C07C 76;785 27/22/0//0
December 29, 2011 140-התשע"ב טבתב 'ג
פרופיוניות ותכשירי –אריל–2חומצות רוקחות המכילים אותן
2-ARYL-PROPIONIC ACIDS AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM DOMPE S.P.A. 20/11/2001 MI2001A002434 IT PCT/EP/2002/012939 WO/2003/043625
(2011.01 )B25H 76;788 /7/22/0/22
מערכת המשלבת יחדיו אחד על פני השני חלקים גליליים מרובים
A SYSTEM FOR INTERLOCKING A
PLURALITY OF STACKABLE
CYLINDRICAL SECTIONS YUVAL COHEN יובל כהן
(2011.01 )C07D 76;79< 25//5/0//4
אריל –טטראהידרובנזאזפינים מותמריוהטרואריל והשימוש בהם כדי למנוע
קליטה מחודשת של נוראפינפרין, דופאמין וסרוטונין
ARYL-AND HETEROARYL-
SUBSTITUTED
TETRAHYDROBENZAZEPINES AND
USE THEREOF TO BLOCK REUPTAKE
OF NOREPINEPHRINE, DOPAMINE
AND SEROTONIN BRISTOL-MYERS SQUIBB COMPANY 15/07/2005 60/700057 US PCT/US/2006/027574 WO/2007/011820
(2011.01 )A61P 76;79> 20/2//0//2
מאליאט של תרכובת אמינו –מלח די קרוטונילית, תהליך להכנתו והשימוש בו
A DIMALEATE SALT OF AN AMINO
CROTONYL COMPOUND, A PROCESS
FOR PREPARING THE SALT AND
USES THEREOF
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH 17/10/2003 10349113.9 DE
December 29, 2011 141-התשע"ב טבתב 'ג
PCT/EP/2004/011378 WO/2005/037824
(2011.01 )E01F 76;7<< 2//22/0/22
מתקן להסתרה ושיטות שימוש
OBSTRUCTING DEVICE AND
METHODS OF USE
YIFAT HAFNER יפעת הפנר
(2011.01 )H04W 76;87; 22//5/0//3
EFFICIENT SIGNALING OVER איתות יעיל מעבר ערוץ גישה
ACCESS CHANNEL QUALCOMM INCORPORATED 21/07/2004 60/590113 US 00/20/0//2 22//0/235 US PCT/US/2005/024614 WO/2006/019710
(2011.01 )A01C 76;89; 21//1/0//5
קרקעית עם התקן –מערכת להזרקה תת נתינה משופר
SUBSURFACE SOIL INJECTION
APPARATUS WITH IMPROVED
DELIVERY DEVICE
ARYSTA LIFESCIENCE NORTH
AMERICA, LLC. 27/03/2006 11/389054 US PCT/US/2007/063839 WO/2007/117833
(2011.01 )A01H 76;8<7 /3//4/0//0
December 29, 2011 142-התשע"ב טבתב 'ג
ות ושיט 15985MONאירוע גנטי בכותנה לאבחונו בהם
COTTON EVENT MON15985 AND
METHODS FOR DETECTION
THEREOF MONSANTO TECHNOLOGY LLC 11/06/2001 60/297406 US PCT/US/2002/017853 WO/2002/100163
(2011.01 )H04L 76;8<= 23/2//0//2
פרוטוקול מהיר לשליטה לגישה למדיה וקשר ישיר
HIGH SPEED MEDIA ACCESS
CONTROL AND DIRECT LINK
PROTOCOL QUALCOMM INCORPORATED 15/10/2003 60/511904 US 23/2//0//1 4//32253/ US 02/2//0//1 4//321017 US /2/20/0//1 4//304134 US /2/20/0//1 4//304125 US 01/20/0//1 4//310572 US 26//0/0//2 4//323741 US /0//4/0//2 4//354323 US /6//5/0//2 4//364622 US 22//6/0//2 4//4//74/ US 21/2//0//2 2//742122 US PCT/US/2004/034259 WO/2005/039105
(2011.01 )C07K 76;8=6 02//6/0//5
נוגדנים אנושיים מונוקלונליים לפוליפפטיד LIGHT–אנטגוניסטים מוכווני
אנושי
ANTAGONISTIC HUMAN LIGHT-
SPECIFIC HUMAN MONOCLONAL
ANTIBODIES
LA JOLLA INSTITUTE FOR ALLERGY
AND IMMUNOLOGY 28/08/2006 60/840774 US 03//2/0//5 4//675653 US PCT/US/2007/018832 WO/2008/027338
December 29, 2011 143-התשע"ב טבתב 'ג
(2011.01 )A61K 76;956 27//5/0//4
SUSTAINED RELEASE OF שחרור מושהה של נוגדי זיהומים
ANTIINFECTIVES TRANSAVE, INC. 19/07/2005 11/185448 US PCT/US/2006/027859 WO/2007/011940
(2011.01 )C07C 76;958 /6//2/0//2
METHODS FOR TREATMENT OF שיטות לטיפול במחלת פרקינסון
PARKINSON'S DISEASE NEWRON PHARMACEUTICALS S.P.A. 11/04/2003 60/462205 US PCT/IB/2004/001408 WO/2004/089353
(2011.01 )C07F 76;99> 23//5/0//2
PROCESS FOR THE PREPARATION תהליך להכנת נגזרות של טטרזול
OF TETRAZOLE DERIVATIVES NOVARTIS AG 15/07/2003 0316546.1 GB PCT/EP/2004/007980 WO/2005/014602
(2011.01 )C07D 76;9:9 26/22/0//2
ושיטות MEKמעכבים הטרוציקליים של שימוש בהם
HETEROCYCLIC INHIBITORS OF
MEK AND METHODS OF USE
THEREOF ARRAY BIOPHARMA INC. 19/11/2003 60/523270 US PCT/US/2004/039060 WO/2005/051301
December 29, 2011 144-התשע"ב טבתב 'ג
(2011.01 )C07D 76;9:: 26/22/0//2
ושיטות MEKשל מעכבים הטרוציקליים שימוש בהם
HETEROCYCLIC INHIBITORS OF
MEK AND METHODS OF USE
THEREOF ARRAY BIOPHARMA INC. 19/11/2003 60/523270 US PCT/US/2004/039060 WO/2005/051301
(2011.01 )C07F 76;9:> 0///0/0//5
תרכובת ושיטת הכנת חומר נפץ ראשוני נטול עופרת
LEAD-FREE PRIMARY EXPLOSIVE
COMPOSITION AND METHOD OF
PREPARATION
PACIFIC SCIENTIFIC ENERGETIC
MATERIALS COMPANY 16/05/2006 60/800816 US PCT/US/2007/004846 WO/2008/048351
(2011.01 )C22B 76;9;: 23//1/0//4
שיטה להכנת מתכת ראשונית עמידה בפני חם
METHOD OF PREPARING PRIMARY
REFRACTORY METAL
H.C. STARCK INC. 22/03/2005 11/085876 US PCT/US/2006/009174 WO/2006/101850
(2011.01 )G06K 76;:5: /2//3/0//6
כלוב בעל יכולת להידוק עצמי ומקיף מכשיר רזוננס מגנטי ושיטה לכך
A SELF-FASTENING CAGE
SURROUNDING A MAGNETIC
RESONANCE DEVICE AND
METHODS THEREOF
December 29, 2011 145-התשע"ב טבתב 'ג
ASPECT MAGNET TECHNOLOGIES אספקט טכנולוגיות מגנטים בע"מ
LTD. 03/11/2005 60/732654 US 23//1/0//4 22/1544/6 US
(2011.01 )C12N 76;:68 00//0/0//6
יישומים רפואיים של הפעלה של תאים 1–אנטיגן הומניים באמצעות דקטין–מציגי
THERAPEUTIC APPLICATIONS OF
ACTIVATION OF HUMAN ANTIGEN-
PRESENTING CELLS THROUGH
DECTIN-1 BAYLOR RESEARCH INSTITUTE 23/02/2007 60/891425 US PCT/US/2008/054798 WO/2008/118587
(2011.01 )C07J 76;:6; /2//6/0//4
תולדות ניטרואוקסי של גלוקוקורטיקואידים, תהליך להכנתן
והשימוש בהן להכנת תרופות
NITROOXY DERIVATIVES OF
GLUCOCORTICOIDS, PROCESS FOR
THEIR PREPARATION AND USE
THEREOF IN THE MANUFACTURE
OF MEDICAMENTS NICOX S.A. 02/09/2005 05019155.0 EP PCT/EP/2006/007746 WO/2007/025632
(2011.01 )A61J 76;:8: 06//2/0//4
PHARMA-INFORMATICS SYSTEM אינפורמטיקה–מערכת פארמה
PROTEUS BIOMEDICAL, INC 28/04/2005 60/676145 US 02//4/0//3 4//472/56 US /2//7/0//3 4//52146/ US /5//2/0//4 4//57/113 US PCT/US/2006/016370 WO/2006/116718
December 29, 2011 146-התשע"ב טבתב 'ג
(2011.01 )B08B 76;::6 04/2//0//4
התקן מדידה למדידת דרגת הניקיון של מדיום
MEASURING DEVICE FOR
MEASURING THE DEGREE OF
PURITY OF A MEDIUM SIEMENS AKTIENGESELLSCHAFT 16/12/2005 05027687.2 EP PCT/EP/2006/067791 WO/2007/071478
December 29, 2011 147-התשע"ב טבתב 'ג
-לחוק הפטנטים תשכ"ז 26הודעה לפי סעיף
1976
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
הבקשות שפרטיהן מתפרסמים להלן קובלו לחוק הפטנטים. כל המעונין 17לפי סעיף
להתנגד למתן פטנט על פי בקשה מהבקשות , תוך שלושה חדשים המתפרסמות רשאי
מתאריך יומן זה, להגיש לרשם הפטנטים לחוק הפטנטים 30הודעת התנגדות לפי סעיף
ואילך לתקנות 57בדרך הקבועה בתקנה .1968 –הפטנטים, תשכ"ח
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
פרטי הבקשות במידה ויישימים מובאים לפי סדר זה:
Particulars of the applications, where
applicable, are given in the following order:
Number of application [21] [11] מספר הבקשה
Title of invention [54] שם האמצאה
Application date [22] תאריך הבקשה
מדינת –יך של בקשות החוץ מספר ותאר האגוד
[31] [32] [33] Number and date of foreign
application – convention country.
.Int.Cl [51]* *סיווג בינלאומי
Application for patent of addition [61] בקשה לפטנט מוסף
Divisional application [62] בקשת חלוקה
Applicant [71] המבקש
Inventor [72] הממציא
International Publication Number [87] מס' פרסום של בקשה הבינלאומית
Address for service [74] מען למסירת מסמכים
Abridgement of invention (in the [57] תקציר האמצאה )בשפה בה ערוך הפירוט(
language in which the specification is drawn
up)
**הערה: בקשות הפטנטים שפורסמו ביומן זה סווגו בהתאם לגרסת הסיווג הבינלאומי
שהייתה בתוקף בעת הכנת הבקשות לפרסום.
*Note:, patent applications published in this
journal were classified according to the
International Classification version that was
in force when this journal was prepared.
December 29, 2011 148-התשע"ב טבתב 'ג
493931 [21[]11]
תכשיר יציב של בנזימידאזול ושיטה להכנתו
STABLE BENZIMIDAZOLE
COMPOSITION AND A METHOD
FOR PRODUCING IT
[54]
23.11.2000 [22]
Int. Cl.(2010.01) A61K 09//10, 31//4164, A61P 01//00, C07D 40/1/12 [51]
DEXCEL LTD. [71] דקסל בע"מ, חדרה
ד"ר ד. גרייזר בע"מ, 13הסדנא
רעננה2496, ת.ד.
DR. D. GREIZER LTD.,
13 HASADNA ST., P.O.B. 2496,
RAANANA 43650
[74]
A stable composition of a benzimidazole derivative, the composition comprising:
)a) a neutral core;
)b) an alkaline coating layered on said core;
)c) an active coating, comprising the benzimidazole derivative, layered over said
alkaline coating; and
)d) a single layer comprising neutralized enteric coating material having a pH
value of at least 6.5 layered directly over said active coating, said neutralized
enteric coating material being neutralized with alkaline compound prior to
applying said single layer to said active coating, with the proviso that said
enteric coating material does not include HPMCP (hydroxypropyl
methylcellulose phthalate).
[57]
__________________
145210 [21[]11]
להכנת חומר לקישור PMBC–שימוש בסלקטיבי לתאים, שיטה לגילוי אפופטוזיס
ותכשיר רוקחי לטיפול במחלה המאופיינית ע''י נוכחות אפופטוזים בתאים, רקמות או מבנים
תאיים
USE OF PMBC IN THE
PREPARATION OF AN AGENT
FOR THE SELECTIVE BINDING
OF CELLS, A METHOD FOR THE
DETECTION OF APOPTOSIS AND
A PHARMACEUTICAL
[54]
December 29, 2011 149-התשע"ב טבתב 'ג
COMPOSITION FOR THE
TREATMENT OF A DISEASE
CHARACTERIZED BY THE
PRESENCE OF APOPTOSIS IN
CELLS, TISSUES OR CELLULAR
STRUCTURES
30.08.2001 [22] IL [33] 06.12.2000 [32] 140114 [31]
IL 21.02.2001 141571
Int. Cl.(2010.01) A61K 31//18, 31//195, A61P 09//00, 35//00, 37//00, C07C 31/1/37,
C12Q 01//00
[51]
APOSENSE LTD. [71] אפוסנס בע"מ, פתח תקוה
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
Use of a perturbed membrane binding compound (PMBC), in the preparation of an
agent for selective binding of cells undergoing perturbation of their normal
organization of membrane, said PMBC having the formula (XI) as depicted in the
specification including pharmaceutically acceptable salts and hydrates thereof.
[57]
__________________
146479 [21[]11]
אדנווירוס רקומביננטי המכיל חומצה גרעינית E1אדנוויראלית המכילה החסרה באזור
RECOMBINANT ADENOVIRUS
COMPRISING AN ADENOVIRAL
NUCLEIC ACID COMPRISING A
DELETION IN THE E1 REGION
[54]
16.05.2000 [22] EP [33] 17.05.1999 [32] 99201545.3 [31]
Int. Cl.(2010.01) A61K 48//00, C12N 05//10, 15//34, 15//861 [51]
CRUCELL HOLLAND B.V., THE
NETHERLANDS [71]
ABRAHAM BOUT, MENZO JANS
EMCO HAVENGA, RONALD
VOGELS
[72]
WO/2000/070071 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
December 29, 2011 150-התשע"ב טבתב 'ג
רצליהה2081, ת.ד. A recombinant adenovirus comprising an adenoviral nucleic acid comprising a
deletion in the E1 region, said deletion rendering the recombinant adenovirus
replication defective.
[57]
בקשות חלוקה מבקשה זו
שטרם פורסמו90222215 The applications for division
from this application have
not yet been published
__________________
147349 [21[]11]
שיטה לאיפיון של מצב דלקתי בשימוש פרופילי ביטוי גן מדודים
METHOD FOR EVALUATING AN
INFLAMMATORY CONDITION
USING CALIBRATED GENE
EXPRESSION PROFILES
[54]
28.06.2000 [22] US [33] 28.06.1999 [32] 60/141542 [31]
US 07.04.2000 60/195522
Int. Cl.(2010.01) C12Q 01//68, G01N 33//50, G06F 19//00 [51]
SOURCE PRECISION MEDICINE,
INC., U.S.A. [71]
WO/2001/025473 [87]
ד"ר שלמה כהן ושות', 124אבן גבירול
תל אביב11490, ת.ד.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[74]
The invention provides a method, for evaluating a biological condition of a subject,
comprising: a. obtaining from the subject a sample having at least one of RNAs and
proteins; b. deriving from the sample a first profile data set, the first profile data set
including a plurality of members, each member being a quantitative measure of the
amount of a distinct RNA or protein constituent in a panel of constituents selected so
that measurement of the constituents enables measurement of the biological condition;
and c. producing a calibrated profile data set for the panel, wherein each member of
the calibrated profile data set is a function of a corresponding member of the first
profile data set and a corresponding member of a baseline profile data set for the panel,
the calibrated profile data set providing a measure of the biological condition of the
subject.
[57]
December 29, 2011 151-התשע"ב טבתב 'ג
__________________
515218 [21[]11]
מערכת ושיטה לקביעת זמן עד ירוט
SYSTEM AND METHOD FOR
TIME-TO-INTERCEPT
DETERMINATION
[54]
12.02.2001 [22]
Int. Cl.(2010.01) F41G 07//22 [51]
RAYTHEON COMPANY, U.S.A. [71]
WO/2002/065048 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
A method and system of time-to-intercept determination for a radiation source using
passively-sensed irradiance data. The invention provides a plurality of noise reduction
features to reduce the noise present in the data and improve the accuracy of the time-
to-intercept computation. The method includes reducing data noise by defining an
acceptable noise level and eliminating any excessively noisy data from the time-to-
intercept computation. The method further includes constantly updating the time-to-
intercept computation by using irradiance values that are advanced in time. Other
features of the present invention includes averaging of irradiance values over a time
interval, filtering of the irradiance data received by the method, and triggering at a
predetermined time-to-intercept. The invention also includes a time-to-intercept
system and processor implementing the above method.
[57]
December 29, 2011 152-התשע"ב טבתב 'ג
__________________
152589 [21[]11]
מקליט מידע
DATA RECORDER
[54]
20.11.2001 [22] JP [33] 08.03.2001 [32] 2001-65074 [31]
Int. Cl.(2010.01) G11B 20//10, H04N 07//24 [51]
SONY CORPORATION, JAPAN [71]
WO/2002/075739 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
A data recorder for adequately managing the contents of data and reproduced info even
if a part of AV data is deleted. When a part of a clip is deleted and an ATC-sequence
becomes discontinuous, the value of an offset_STC_id of the first STC sequence on
the ATC sequence is so determined that the value of the stc_id (value for identifying
an STC-sequence) of each STC-sequence contained in the part of the ATC-sequence,
after the ATC discontinuous point. The invention can be applied to a technique of
recording an AV stream on an optical disc.
[57]
December 29, 2011 153-התשע"ב טבתב 'ג
בקשות חלוקה מבקשה זו
שטרם פורסמו92726145 The applications for division
from this application have
not yet been published
__________________
153456 [21[]11]
שיטה לטיפול במים המכילים ברומיד של מתכות אלקליות או ברומיד של מתכות אלקליות
עפרוריות
METHOD OF TREATING WATER
CONTAINING AN ALKALINE
EARTH METAL BROMIDE OR
ALKALI METAL BROMIDE
[54]
15.12.2002 [22] ZA [33] 14.12.2001 [32] 2001/10311 [31]
Int. Cl.(2010.01) A01N 25//22, C01B 11//20, C02F 01//50 [51]
THE GERD BORCHERS FAMILY
TRUST, SOUTH AFRICA
JAN BASTIAAN CILLIERS, SOUTH
AFRICA
MARTHA SOPHIA CILLIERS,
SOUTH AFRICA
[71]
ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
A method of treating water containing an alkaline earth metal bromide or alkali metal
bromide, the method including the steps of: determining the bromine demand of the
water; adding sufficient hypobromous acid solution to the water to satisfy or almost
satisfy the bromine demand; and adding sufficient alkali or alkaline earth metal
hypochlorite solution to activate the alkali or alkaline earth metal bromide in the water
[57]
December 29, 2011 154-התשע"ב טבתב 'ג
and to provide residual bromine in water.
__________________
154008 [21[]11]
תכשירי רוקחות המכילים אורליסטאט כמעכב ליפאז, תהליכים לייצורם, ערכות המכילות
אותם ושימושם בהכנת תרופות לטיפול ומניעת השמנת יתר
PHARMACEUTICAL
COMPOSITIONS COMPRISING
ORLISTAT AS A LIPASE
INHIBITOR, PROCESSES FOR
THEIR PREPARATION, KITS
COMPRISING THEM AND USE
THEREOF IN THE PREPARATION
OF MEDICAMENTS FOR
TREATMENT AND PREVENTION
OF OBESITY
[54]
19.07.2001 [22] EP [33] 28.07.2000 [32] 00116393.0 [31]
Int. Cl.(2010.01) A61K 45//00, 45//06 [51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2002/009815 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention relates to pharmaceutical combinations, compositions and
methods for treating obesity. More particularly, the invention relates to a combination
or composition comprising a lipase inhibitor, preferably orlistat and a bile acid
sequestrant.
[57]
December 29, 2011 155-התשע"ב טבתב 'ג
__________________
155213 [21[]11]
קטונים ושימוש בהם להכנת תכשירים רוקחיים
KETONE COMPOUNDS AND USE
THEREOF IN PREPARATION OF
PHARMACEUTICAL
COMPOSITIONS
[54]
11.10.2001 [22] US [33] 11.10.2000 [32] 60/239232 [31]
Int. Cl.(2010.01) A61K 31//336, 31//665, C07D 47/1/02 [51]
ESPERION THERAPEUTICS, INC.,
U.S.A. [71]
WO/2002/030860 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention relates to novel ketone compounds, compositions comprising
ketone compounds, and methods useful for treating and preventing cardiovascular
diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
comprising administering a composition comprising a ketone compound. The
compounds, compositions, and methods of the invention are also useful for treating
and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated
[57]
December 29, 2011 156-התשע"ב טבתב 'ג
receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis,
hypertension, renal disease, cancer, inflammation, and impotence. In certain
embodiments, the compounds, compositions, and methods of the invention are useful
in combination therapy with other therapeutics, such as hypocholesterolemic and
hypoglycemic agents.
__________________
155249 [21[]11]
אוכלוסיה של תאים מועשרים בתאי אב ביפוטנטים מבודדים של הכבד ושיטות לקבלתה
POPULATION OF CELLS
ENRICHED IN ISOLATED
BIPOTENT HEPATIC
PROGENITORS AND METHODS
FOR OBTAINING THE SAME
[54]
03.10.2000 [22]
Int. Cl.(2010.01) A61K 35//407, A61P 01//16, C12N 05//0735 [51]
UNIVERSITY OF NORTH
CAROLINA AT CHAPEL HILL,
U.S.A.
[71]
WO/2002/028997 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A method of obtaining a mixture of cells enriched in hepatic progenitors is developed
which comprises methods yielding suspensions of a mixture of cell types, and
selecting those cells that are classical MHC class I antigen(s) negative and ICAM-1
antigen positive. The weak or dull expression of nonclassical MHC class I antigen(s)
can be used for further enrichment of hepatic progenitors. Furthermore, the
progenitors can be selected to have a level of side scatter a measure of granularity or
cytoplasmic droplets, that is higher than that in non-parenchymal cells, such as
hemopoietic cells, and lower than that in mature parenchymal cells, such as
hepatocytes. Furthermore, the progeny of the isolated progenitors can express alpha-
fetoprotein and/or albumin and/or CK19. The hepatic progenitors, so isolated, can
grow clonally, that is an entire population of progeny can be derived from one cell.
The clones of progenitors have a growth pattern in culture of piled-up aggregates or
clusters. These methods of isolating the hepatic progenitors are applicable to any
vertebrates including human. The hepatic progenitor cell population is expected to be
useful for cell therapies, for bioartificial livers, for gene therapies, for vaccine
[57]
December 29, 2011 157-התשע"ב טבתב 'ג
development, and for myriad toxicological, pharmacological, and pharmaceutical
programs and investigations.
__________________
155791 [21[]11]
להכנת תכשיר רפואי CD81שימוש בחלבון CD81ושיטה לאבחון בעזרת ביטוי של
USE OF CD81 PROTEIN FOR THE
PREPARATION OF A
PHARMACEUTICAL
COMPOSITION AND METHOD OF
DIAGNOSING USING A CD81
EXPRESSION
[54]
07.11.2001 [22] US [33] 08.11.2000 [32] 60/246868 [31]
Int. Cl.(2010.01) A61K 38//17, 48//00, A61P 35//00, G01N 33//574 [51]
ALBERT EINSTEIN COLLEGE OF
MEDICINE OF YESHIVA
UNIVERSITY, U.S.A.
[71]
WO/2002/058709 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention provides methods for inhibiting proliferation of astrocytes and
astrocytic tumor cells. The present invention further provides methods for treating a
condition associated with a defect in astrocyte proliferation in a subject, and methods
for treating a condition associated with astrocytic tumor cell proliferation in a subject.
Additionally, the present invention is directed to pharmaceutical compositions
comprising CD81 protein or nucleic acid and a pharmaceutically-acceptable carrier.
Finally, the present invention provides a method for determining whether a subject has
an astrocytoma, and a method for assessing the efficacy of astrocytoma therapy in a
subject.
[57]
__________________
156090 [21[]11]
December 29, 2011 158-התשע"ב טבתב 'ג
שחרור מושהה של חומר פעיל ע"י שימוש במערכת הניתנת להשתלה
SUSTAINED DELIVERY OF AN
ACTIVE AGENT USING AN
IMPLANTABLE SYSTEM
[54]
15.01.1997 [22] US [33] 02.02.1996 [32] 08/595761 [31]
Int. Cl.(2010.01) A61M 31//00 [51] DIVISION FROM 125596 [62]
INTARCIA THERAPEUTICS, INC.,
U.S.A. [71]
WO/1997/027840 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
An implantable device for delivering an active agent to a fluid environment of use,
said device comprising an impermeable reservoir and a back-diffusion regulating
outlet in mating relationship, wherein a flow path for the active agent comprises a
pathway formed between the mating surfaces of the reservoir and the back diffusion
regulating outlet.
[57]
__________________
156377 [21[]11]
התקן לאיכון רקמה בתוך גוף של נבדק
APPARATUS FOR LOCATING A
TISSUE WITHIN A BODY OF A
SUBJECT
[54]
10.06.2003 [22] US [33] 17.06.2002 [32] 10/173197 [31]
Int. Cl.(2010.01) A61B 05//00 [51]
BIOSENSE WEBSTER INC., U.S.A. [71]
רוחני בע"מ, ד. קליגלר שירותי קניין תל אביב33111, ת.ד.
D. KLIGLER I.P. SERVICES LTD.,
P.O.B. 33111
TEL AVIV 61330
[74]
Apparatus for locating a tissue within a body of a subject includes an acoustic tag
configured to be fixed to the tissue and adapted, responsive to acoustic waves incident
thereon, to return acoustic echoes. Acoustic tranducers are placed at respective
positions so as to direct the acoustic waves into the body toward the tissue and to
receive the acoustic echoes returned from the tag responsive to the acoustic waves,
generating first signals responsive to the received echoes. Transducer position sensors
are coupled respectively to the acoustic transducers so as to generate second signals
[57]
December 29, 2011 159-התשע"ב טבתב 'ג
indicative of the repective positions of the acoustic transducers in an external frame of
reference. A processing unit processes the first signals and the second signals so as to
determine coordinates of the acoustic tag in the external frame of reference.
__________________
157326 [21[]11]
תכשירי רוקחות בצורה המתאימה לשאיפה PDE IVהמכילים מלח טיאוטרופים ומעכב
באופן ברירתי בצורת אבקה לשאיפה, גז נדיף המכיל אירוסול לשאיפה ותכשיר או תרחיף של
תכשירי רוקחות אלו
PHARMACEUTICAL
COMPOSITIONS CONTAINING
TIOTROPIUM SALTS AND PDE-IV
INHIBITOR, OPTIONALLY IN
THE FORM OF INHALABLE
POWDERS, PROPELLANT-
CONTAINING INHALABLE
AEROSOLS AND INHALABLE
SOLUTIONS OR SUSPENSIONS
COMPRISING SAID
COMPOSITIONS
[54]
26.02.2002 [22] DE [33] 07.03.2001 [32] 10110772.2 [31]
Int. Cl.(2010.01) A61K 09//12, 09//72, 31//00, 31//4745, 31//505, A61P 11//00,
11//08, C07D 45/1/00, 48/7/00
[51]
BOEHRINGER INGELHEIM
PHARMA GMBH & CO. KG,
GERMANY
[71]
WO/2002/069945 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to novel medicament compositions on the basis of
anticholinergics and PDE IV inhibitors, and to the use thereof in the therapy of
respiratory tract diseases.
[57]
__________________
157360 [21[]11]
December 29, 2011 160-התשע"ב טבתב 'ג
פורמולצית פיברינוגן נוזלית עמידה לאחסון ושימושים שלה
STORAGE-STABLE, LIQUID
FIBRINOGEN FORMULATION
AND USES THEREOF
[54]
12.08.2003 [22] DE [33] 13.08.2002 [32] 10237643.3 [31]
DE 20.12.2002 10261126.2
Int. Cl.(2010.01) A61K 38//36, 38//39 [51]
CSL BEHRING GMBH, GERMANY [71]
פרל כהן צדק לצר, 5, רח' שנקר 1 ים-מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
Storage-stable, liquid or viscous liquid fibrinogen formulation, characterized in that,
besides fibrinogen, divalent metal ions in a concentration of up to 100mM and a
complexing agent are present and the fibrinogen formulation is stable at storage
temperatures between 0 and 30 C for at least 1 month.
[57]
__________________
157378 [21[]11]
תהליך להכנת פוליפפטידים
PROCESS FOR PRODUCTION OF
POLYPEPTIDES
[54]
22.02.2002 [22] US [33] 09.03.2001 [32] 60/274384 [31]
Int. Cl.(2010.01) C07K 14//245, C12N 15//09, 15//12, 15//70, 15//71, C12P 21//02 [51]
GENENTECH, INC., U.S.A. [71]
WO/2002/072847 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Vectors for producing polypeptides heterologous to prokaryotes are described
comprising, along with the polypeptide-encoding nucleic acid, anti-termination nucleic
acid that inhibits intragenic transcription termination with a non-lambda promoter
therefor and/or nucleic acid encoding a GreA or GreB protein and a promoter therefor.
Also described are processes for producing a heterologous polypeptide in prokaryotic
host cells utilizing such elements to improve the quality and/or quantity of
heterologous polypeptide produced.
[57]
December 29, 2011 161-התשע"ב טבתב 'ג
__________________
157443 [21[]11]
תכשירים המכילים גורם כימורפואי ואנלוג של אפותילין ושימושים בהם
COMPOSITIONS COMPRISING A
CHEMOTHERAPEUTIC AGENT
AND EPOTHILONE ANALOG AND
USES THEREOF
[54]
05.03.2002 [22] US [33] 14.03.2001 [32] 60/275801 [31]
US 31.08.2001 60/316395
Int. Cl.(2010.01) A61K 31//00, 31//335, C07D 41/3/10 [51]
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A. [71]
WO/2002/072085 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
Compositions and methods are disclosed which are useful of the treatment and
prevention of proliferative disorders.
[57]
__________________
832515 [21[]11]
התקן להערכה תיאורטית כאוטית של מצב אנושי
CHAOS-THEORETICAL HUMAN
FACTOR EVALUATION
APPARATUS
[54]
10.04.2002 [22] JP [33] 16.04.2001 [32] 2001-116408 [31]
Int. Cl.(2010.01) A61B 10//00 [51]
ELECTRONIC NAVIGATION
RESEARCH INSTITUTE, JAPAN
KAKUICHI SHIOMI, JAPAN
MITSUBISHI SPACE SOFTWARE
CO., LTD., JAPAN
[71]
WO/2002/085215 [87]
December 29, 2011 162-התשע"ב טבתב 'ג
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A chaos−theoretical human factor evaluation apparatus includes a Liapunov exponent
calculator (23) for chaos−theoretically analyzing a speech signal generated by
digitizing a speech uttered by a human and calculating a Liapunov exponent and a
Liapunov exponent change detector (24) for detecting a change of the Liapunov
exponent of the speech calculated by the Liapunov index calculator (23). By
calculating the load level in a cerebrum through a change of the Liapunov exponent
detected by the Liapunov exponent change detector (24), it is possible to predict and
determine a mental/physical activity.
[57]
__________________
159426 [21[]11]
3 –ציאנואידול – 5)–'4–1צורות פולימורפיות של – 5–קרבמואילבנזופורן – 2)– 4 –איל( בוטיל –
איל( פיפראזין הידרוכלוריד
POLYMORPHIC FORMS OF 1-4'-
(5-CYANOINDOL- 3-YL) BUTYL-4-
(2-CARBAMOYLBENZOFURAN- 5-
YL)PIPERAZINE
HYDROCHLORIDE
[54]
05.06.2002 [22] EP [33] 19.06.2001 [32] 01113647.0 [31]
Int. Cl.(2010.01) A61K 31//496, A61P 01//14, 09//12, 25//18, 25//22, 25//24, C07D
40/5/00, 40/5/12
[51]
MERCK PATENT GMBH,
GERMANY [71]
WO/2002/102794 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
[74]
December 29, 2011 163-התשע"ב טבתב 'ג
10שדרות אבא אבן הרצליה2081, ת.ד.
HERZLIYA 46120
The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-
cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine, crystalline
modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-
benzofuran-5-yl)-piperazine and amorphous 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-
carbamoyl-benzofuran-5-yl)-piperazine hydrochloride which are suitable in particular
for the preparation of solid medicaments for the treatment or prevention of depressive
disorders, anxiety disorders, bipolar disorders, mania, dementia, substance-related
disorders, sexual dysfunctions, eating disorders, obesity, fibromyalgia, sleeping
disorders, psychiatric disorders, cerebral infarct, tension, for the therapy of side-effects
in the treatment of hypogonadism, secondary amenorrhea, premenstrual syndrome and
undesired puerperal lactation.
[57]
__________________
159506 [21[]11]
פירולופירימידינים כמעכבי חלבון קינאז
PYRROLOPYRIMIDINES AS
PROTEIN KINASE INHIBITORS
[54]
21.06.2002 [22] GB [33] 23.06.2001 [32] 0115393.1 [31]
US 28.06.2001 60/301678
Int. Cl.(2010.01) A61K 31//505, A61P 29//00, 35//00, C07D 48/7/04 [51]
AVENTIS PHARMACEUTICALS
INC., U.S.A. [71]
WO/2003/000695 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
This invention is directed to compounds of the formula (I) to N-oxides, prodrugs, acid
bioisosteres, pharmaceutically acceptable salts or solvates of such compounds, or N-
oxides, prodrugs, or acid bioisosteres of such salts or solvates, to compositions
comprising such compounds, and to methods of treatment comprising administering, to
a patient in need thereof, such compounds and compositions.
[57]
December 29, 2011 164-התשע"ב טבתב 'ג
__________________
160873 [21[]11]
צינור מוליך לשימוש כעדשת מחזיר אור ושיטת שימוש בו
CONDUCTIVE TUBE FOR USE AS
A REFLECTRON LENS AND
METHOD OF USE THEREOF
[54]
15.03.2004 [22] US [33] 19.03.2003 [32] 60/455801 [31]
Int. Cl.(2010.01) H01J 49//40 [51]
BURLE TECHNOLOGIES, INC.,
U.S.A. [71]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
A reflectron lens and method are provided. The reflectron lens comprises a tube having
a continuous conductive surface along the length of the tube for providing an electric
field interior to the tube that varies in strength along the length of the tube. The tube
may comprise glass, and in particular, a glass comprising metal ions, such as lead,
which may be reduced to form the conductive surface. The method includes a step of
introducing a beam of ions into a first end of a dielectric tube having a continuous
conductive surface along the length of the tube. The method further includes a step of
applying an electric potential across the tube to create an electric field gradient that
varies in strength along the length of the tube so that the electric field deflects the ions
to cause the ions to exit the tube through the first end of the tube.
[57]
December 29, 2011 165-התשע"ב טבתב 'ג
__________________
161309 [21[]11]
שיטה וקיט לגילוי גיוס חלבונים לאזור סלולרי של קולטן בתאים שלמים –האינטרא
METHOD AND KIT FOR
MONITORING RECRUITMENT
OF PROTEINS TO THE
INTRACELLULAR DOMAIN OF A
RECEPTOR IN INTACT CELLS
[54]
14.10.2002 [22] IL [33] 14.10.2001 [32] 145918 [31]
Int. Cl.(2010.01) G01N 33//53, 33//68 [51]
HARTMUT ENGELMANN,
GERMANY [71]
HARTMUT ENGELMANN [72]
WO/2003/034073 [87]
אינטרפארם מעבדות בע"מ, 18רחוב הקישון
יבנה151, ת.ד.
INTERPHARM LABORATORIES
LTD.,
18 HAKISHON ST.,
P.O.B. 151,
YAVNE 81101
[74]
December 29, 2011 166-התשע"ב טבתב 'ג
The present invention relates to an immunological method and kit for monitoring
recruitment of a protein to the intracellular domain of a receptor in intact cells.
[57]
__________________
161513 [21[]11]
תכשיר רוקחי נרתיקי הכולל לידוקאין ונשא ביואדהזי ושימושיו להכנת תרופה לטיפול
בדיסריטמיה של הרחם
PHARMACEUTICAL VAGINAL
COMPOSITION COMPRISING
LIDOCAINE AND A
BIOADHESIVE CARRIER, AND
ITS USE IN THE MANUFACTURE
OF A MEDICAMENT FOR THE
TREATMENT OF UTERINE
DYSRHYTHMIA
[54]
28.10.2002 [22] US [33] 29.10.2001 [32] 60/330684 [31]
US 24.10.2002 10/278912
Int. Cl.(2010.01) A61K 09//22, 47//00, 47//12, 47//32, A61P 15//02 [51]
COLUMBIA LABORATORIES
(BERMUDA) LIMITED, BERMUDA [71]
WO/2003/037381 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The invention relates to a pharmaceutical composition for relieving pelvic pain or
infertility associated with uterine dysrhythmia. The composition includes a locally-
administered anti-dysrhythmic treating agent and a bioadhesive extended-release
carrier. The composition may be delivered in an extended release formulation that
includes a bioadhesive, water-swellable , water-insoluble, cross-linked polycarboxylic
acid polymer, such as polycarbophil. The treating agent may be a local anesthetic, such
[57]
December 29, 2011 167-התשע"ב טבתב 'ג
as lidocaine. The invention also relates to a method of treating or preventing pelvic
pain, or treating or improving infertility, by inserting a mixture of an anti-dysrhythmic
treating agent and a bioadhesive carrier into the vagina of the patient to be treated.
בקשות חלוקה מבקשה זו
שטרם פורסמו90220665 The applications for division
from this application have
not yet been published
__________________
161938 [21[]11]
מערכת הכוללת ספר אליקטרני פלוס תוספת שניתן להתחבר אליו
SYSTEM COMPRISING AN
ELECTRONIC BOOK AND A
PROPRIETARY APPENDAGE
[54]
12.05.2004 [22]
Int. Cl.(2010.01) G06F 03//033, 03//14, 15//02, 17//30 [51]
LIGHT BOOK LTD. [71] לייט בוק בע"מ, צפת
ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
A system comprising an light book (10) and a proprietary appendage couplable to said
light book; said light book comprising a visual display screen (12), a data reader,
navigational tools and a first section of a unique identification code for identifying
said light book. Said proprietary appendage comprising a memory (46) and a second
section of unique identification code; such that data in the memory of said proprietary
appendage has a second section of unique identification code that can only be
accessed when said proprietary appendage is connected to said light book having said
first section of unique identification code.
[57]
December 29, 2011 168-התשע"ב טבתב 'ג
__________________
163231 [21[]11]
מכלול נרתיק בעל בטיחות גבוהה ומערכת סגירה
HIGH SECURITY HOLSTER
ASSEMBLY AND ENCLOSURE
SYSTEM
[54]
29.01.2003 [22] US [33] 29.01.2002 [32] 60/352909 [31]
US 29.01.2002 60/352910
Int. Cl.(2010.01) F41C 33//02 [51]
JOHN N. RASSIAS, U.S.A. [71]
WO/2003/064957 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A holster assembly for a firearm includes a shroud (20, 92, 168) with a muzzle
receiving space (31), a firearm holding member (100, 174, 246) and a bias activating
assembly mounted in the shroud (20, 92, 168) for biasing the firearm into a stowed
position against the holding member (100, 174, 246). A hood enclosure (166) is
movable between open and closed positions. The hood enclosure (166) includes a pair
of guide slots (188) within the shroud (20, 92, 168) , a pivot pin (182) and a guide pin
(186). The hood enclosure (166) may include an illumination device (238) mounted to
the firearm, a hip mount platform (256) to mount a hip mount assembly (34), or a
secondary stowage mount (270) to attach a magazine carrier (278), expandable baton
carrier (266), etc.. The shroud (20, 92, 168) includes a detent (178) that receives a
locking safety lever (146) of the firearm. An L-shaped slot (138, 106, 162) receives a
projection from a handle portion (132), a take down button (88), a safety lever (158),
or another side extending projection of the firearm
[57]
December 29, 2011 169-התשע"ב טבתב 'ג
__________________
163312 [21[]11]
לייצור –1CPTשימוש בגורם המעורר פעילות תרופה המטפלת בהשמנת יתר כאמצעי
להורדת משקל
USE OF AN AGENT THAT
STIMULATES CPT-1 ACTIVITY FOR
THE MANUFACTURE OF A
MEDICAMENT FOR TREATING
OBESITY
[54]
10.02.2003 [22] US [33] 08.02.2002 [32] 60/354480 [31]
Int. Cl.(2010.01) A61K 31//195, 31//198, 31//34, 31//381, 45//00 [51]
THE JOHNS HOPKINS UNIVERSITY
SCHOOL OF MEDICINE, U.S.A. [71]
WO/2003/066043 [87]
ריינהולד כהן ושותפיו, א' 26הברזל רחוב
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
This invention provides methods and compositions for inducing weight loss and
maintaining optimum weight comprising administering an agent that stimulates
carnitine palmitoyl transferase - 1 (CPT-1) activity to the patient in need, including
human patients. These methods do not require inhibition of fatty acid synthesis. In
particular, this invention provides methods for development of therapeutics that
selectively enhance fatty acid oxidation, increase energy production, and reduce
adiposity while preserving lean mass, through the pharmacological stimulation of CPT-
1 activity. In a preferred mode, the agent is administered in an amount sufficient to
increase fatty acid oxidation. In another preferred mode, the agent is administered in an
amount sufficient to antagonize malonyl CoA inhibition of CPT-1. In yet another
preferred mode, the agent is administered in an amount sufficient to increase malonyl
CoA level.
[57]
December 29, 2011 170-התשע"ב טבתב 'ג
__________________
163563 [21[]11]
נוגדנים נגד אמילואיד ביתא והשימוש בהם ברפואה
ANTI-AMYLOID BETA
ANTIBODIES AND THEIR USE IN
MEDICINE
[54]
20.02.2003 [22] EP [33] 20.02.2002 [32] 02003844.4 [31]
Int. Cl.(2010.01) A61K 39//395, C07K 14//47, 16//18, G01N 33//68 [51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
MORPHOSYS AG, GERMANY
[71]
WO/2003/070760 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention relates to antibody molecules capable of specifically recognizing
two regions of the R-A4 peptide, wherein the first region comprises the amino acid
sequence AEFRHDSGY as shown in SEQ ID NO: 1 or a fragment thereof and wherein
the second region comprises the amino acid sequence VHHQKLVFFAEDVG as
shown in SEQ ID NO: 2 or a fragment thereof. Furthermore, nucleic acid molecules
encoding the inventive antibody molecules and vectors and hosts comprising said
nucleic acid molecules are disclosed. In addition, the present invention provides for
compositions, preferably pharmaceutical or diagnostic compositions, comprising the
compounds of the invention as well as for specific uses of the antibody molecules,
nucleic acid molecules, vectors or hosts of the invention.
[57]
__________________
163609 [21[]11]
שיטה לקבלת תמונת שמיים של שדה קרב
METHOD FOR OBTAINING A
SKY VIEW OF A BATTLE SITE
[54]
December 29, 2011 171-התשע"ב טבתב 'ג
19.08.2004 [22]
Int. Cl.(2010.01) F41G 07//00 [51]
ISRAEL AEROSPACE התעשייה האוירית לישראל בע"מ, לוד
INDUSTRIES LTD. [71]
ELI SHUKRUN [72] אלי שוקרון
כהן ושותפיו, ריינהולד א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A method for obtaining a sky view of an event site, comprising: (a) launching an
interceptor missile (2) toward at least one detect threat (3); and (b) the interceptor
missile tracking the at least one detected threat, the interceptor missile comprising at
least one detachable vehicle (7) comprising at least one guidable local sensor (8)
configured to sense the event and to communicate the sensed data, and wherein the
tracking uses at least one remote sensor for achieving a kill of the threat at a
designated kill site (4), where the event site is different than the kill site.
[57]
__________________
163626 [21[]11]
נוגדים מאונשים המזהים פפטיד ביטא עמילאויד
HUMANIZED ANTIBODIES THAT
RECOGNIZE BETA AMYLOID
PEPTIDE
[54]
12.03.2003 [22] US [33] 12.03.2002 [32] 60/363751 [31]
Int. Cl.(2010.01) A61K 39//395, A61P 25//28, C07K 16//18, 16//46 [51]
WYETH LLC, U.S.A.
ELAN PHARMA INTERNATIONAL
LTD., IRELAND
[71]
WO/2003/077858 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
December 29, 2011 172-התשע"ב טבתב 'ג
The invention provides improved agents and methods for treatment of diseases
associated with amyloid deposits of Abeta in the brain of a patient. Preferred agents
include humanized antibodies.
[57]
__________________
163763 [21[]11]
שימוש בנגזרת פפטיד להכנת תרופה לטיפול במלנומה ובהמובלסטוזיס
USE OF A PEPTIDE DERIVATIVE
IN THE MANUFACTURE OF A
MEDICAMENT FOR TREATING
MELANOMA AND
HEMOBLASTOSIS
[54]
28.02.2003 [22] RU [33] 28.02.2002 [32] 2002105392 [31]
Int. Cl.(2010.01) A61K 31//16, 31//195, 31//4164, 31//417, 31//4178, 38//05, C07K
05//00, 05//037, 05//06
[51]
OBSCHESTVO S OGRANICHENNOI
OTVETSTVENNOSTIYU
"PHARMENTERPRISES", RUSSIA
[71]
WO/2003/072124 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to the induction method for cell differentiation which consists in
injecting peptide derivatives having the following general formula (I): and used as a
differentiation-inducing factor. Said peptide derivatives are used for curing oncological
diseases, in particular for stabilising melanoma growth, increasing the efficiency of
melanoma immunotherapy and reducing haematological toxicity of chemotherapy. The
utilisation of said peptide derivatives is also disclosed.
[57]
בקשות חלוקה מבקשה זו
שטרם פורסמו90/74315 The applications for division
from this application have
not yet been published
December 29, 2011 173-התשע"ב טבתב 'ג
__________________
164003 [21[]11]
תולדות סולפונילאמיניות, תכשירים רוקחיים המכילים אותן, תהליכים להכנתן ושימושים
בהן להכנת תרופות לעיכוב היסטון דיאצטילאז
SULFONYLAMINO-DERIVATIVES,
COMPOSITIONS THEREOF,
PROCESS OF PREPARATION AND
USES FOR THE MANUFACTURE OF
MEDICAMENTS FOR INHIBITING
HISTONE DEACETYLASE
[54]
11.03.2003 [22] US [33] 13.03.2002 [32] 60/363799 [31]
WO 18.12.2002 PCT/EP02/14481
Int. Cl.(2010.01) A61K 31//4545, A61P 35//00, C07D 20/7/09, 20/7/14, 21/1/28,
21/1/58, 22/3/04, 22/3/12, 22/5/02, 40/1/04, 40/3/04, 40/3/14, 40/5/12, 40/9/12,
40/9/14, 41/3/14, 41/7/12, 47/1/04, 48/7/04, 48/7/08, 49/5/04, 51/3/04
[51]
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM [71]
WO/2003/076401 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
This invention comprises the novel compounds of formula (I) wherein n, m, t, R1, R
2,
R3, R
4, R
5, L, Q, X, Y, Z and have defined meanings, having histone deacetylase
inhibiting enzymatic activity; their preparation, compositions containing them and their
use as a medicine.
[57]
__________________
164577 [21[]11]
תקשורת במערכת מובזרת
COMMUNICATION IN A
DISTRIBUTED SYSTEM
[54]
December 29, 2011 174-התשע"ב טבתב 'ג
14.10.2004 [22]
Int. Cl.(2010.01) H04L 12//66, 29//06, H04M 07//00 [51]
TADIRAN TELECOM LTD. [71] תדיראן טלקום בע"מ, פתח תקוה
אי. סי. איי. טלקום בע"מ, 30רחוב הסיבים
פתח תקוה
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
[74]
A method for conducting a real-time, voice-over IP media type of communication
session between at least two peer users, each associated with a platform comprised in
a distributed communication network, wherein the method comprises: at a platform
comprised in said distributed communication network, creating a data object
associated with a specific user; iynaoroa v ilayvlolr ni ytilorvlonai ni ivor
rvlv na trl ln tvro nloty ni lot nloty ilvlinyci viinrovltr with said
distributed communication network so that that each of said plurality of replications
resides at a different platform associated with the distributed communication network;
and providing a notification at all other platforms associated with said distributed
communication network, indicating the creation or modification of said data object.
[57]
__________________
164664 [21[]11]
שימוש ברצפים פולינוקלאוטידים לייצור תרופה להמרצת תגובות חיסוניות
USE OF POLYNUCLEOTIDE
SEQUENCES IN THE
MANUFACTURE OF A
MEDICAMENT FOR
STIMULATING AN IMMUNE
RESPONSE
[54]
December 29, 2011 175-התשע"ב טבתב 'ג
22.04.2003 [22] US [33] 22.04.2002 [32] 60/374,540 [31]
Int. Cl.(2010.01) A61K 31//70, A61P 35//00, 37//00, C12N 15//117 [51]
BIONICHE LIFE SCIENCES INC.,
CANADA [71]
WO/2003/089642 [87]
איתן, פרל, לצר וכהן צדק, 7רחוב שנקר
הרצליה12688, ת.ד.
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[74]
The present invention relates to 3'-OH, 5'-OH polynucleotide sequence compositions
and methods for activating an immune response in an individual, and more preferably,
for activating an antigen presenting cells in the individual. In one embodiment, the
antigen presenting cell is a dendritic cell. The present invention also includes
compositions and methods for activating dendritic cells in vitro. These dendritic cells
may then be administered to an individual. Preferred 3'-OH, 5'-OH polynucleotide
sequences comprise six bases wherein at least 50% of the bases are guanine and the 5'
base is guanine. The compositions may comprise a phosphodiester or phosphorothioate
backbone.
[57]
__________________
165436 [21[]11]
– 10–טריכלורואצטיל –ביס – 10, 7 IIIדיאצטילבאקאטין
7, 10-BIS-TRICHLOROACETYL-
10 DEACTYLBACCATIN III
[54]
23.02.2000 [22]
Int. Cl.(2010.01) C07D 30/5/14 [51]
INDENA S.P.A., ITALY [71]
WO/2000/052003 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
החיילרמת
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A compound of the formula
[57]
December 29, 2011 176-התשע"ב טבתב 'ג
__________________
191656 [21[]11]
שכבתי עבור גלאי טומוגרפיה –מחזיר אור רב ממוחשבת
MULTI-LAYER REFLECTOR
FOR CT DETECTOR
[54]
07.12.2004 [22]
Int. Cl.(2010.01) A61B 06//03, G01T 01//24 [51]
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC,
U.S.A.
[71]
ושות',זליגסון גבריאלי 31רח' יבנה
תל אביב1426, ת.ד.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[74]
A CT detector comprising: a scintillator array having a plurality of scintillators; a
reflector interstitially disposed between at least two adjacent scintillators, the reflector
including a light absorption element disposed between a pair of reflective elements;
and a reflective layer coated to a top face of the scintillator array, wherein the light
absorption element extends in length to an upper surface of the reflective layer.
[57]
__________________
166241 [21[]11]
פירימידין דיאמין לשימוש בטיפול –4,2תרכובות של מחלות אוטואימוניות
2,4-PYRIMIDINEDIAMINE
COMPOUNDS FOR USE IN THE
TREATMENT OF AUTOIMMUNE
DISEASES
[54]
29.07.2003 [22] US [33] 29.07.2002 [32] 60/399673 [31]
US 31.01.2003 60/443949
December 29, 2011 177-התשע"ב טבתב 'ג
US 06.04.2003 60/452339
US 29.07.2003 10/631029
Int. Cl.(2010.01) A61K 31//506, 31//519 [51]
RIGEL PHARMACEUTICALS, INC.,
U.S.A. [71]
WO/2004/014382 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention provides methods of treating or preventing autoimmune diseases
with 2,4-pyrimidinediamine compounds, as well as methods of treating, preventing or
ameliorating symptoms associated with such diseases. Specific examples of
autoimmune diseases that can be treated or prevented with the compounds include
rheumatoid arthritis and/or its associated symptoms, systematic lups erythematosis
and/or its associated symptoms and multiple sclerosis and/or its associated symptoms.
[57]
בקשות חלוקה מבקשה זו שטרם פורסמו9
0224/55 The applications for division
from this application have
not yet been published
__________________
649416 [21[]11]
ציקלואלקנילאמינים שעברו –הטרואריל מצומדאצילציה, ושימוש שלהם לייצור תכשירי
רוקחות
ACYLATED, HETEROARYL-
CONDENSED
CYCLOALKENYLAMINES AND
THEIR USE FOR THE
MANUFACTURE OF
PHARMACEUTICALS
[54]
24.07.2003 [22] EP [33] 07.08.2002 [32] 02017586.5 [31]
Int. Cl.(2010.01) A61K 31//381, 31//428, 31//435, 31//495, A61P 03//10, 09//00,
09//10, 25//00, C07D 20/9/12, 22/1/18, 23/7/26, 23/9/70, 24/1/36, 27/5/04, 27/7/60,
33/3/50, 33/3/78, 40/1/12, 40/5/12, 40/9/14, 41/3/12, 41/3/14, 41/7/12
[51]
December 29, 2011 178-התשע"ב טבתב 'ג
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY [71]
WO/2004/014372 [87]
איתן, פרל, לצר וכהן צדק, 7רחוב שנקר
הרצליה12688, ת.ד.
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[74]
The present invention relates to acylated, heteroaryl-condensed cycloalkenylamines of
the formula I, (I) in which A, R1, R
2, R
3, R
4, R
5 and n have the meanings indicated in
the claims. The compounds of formula I are valuable pharmacologically active
compounds which are useful in the treatment of various disease states including
cardiovascular disorders such as atherosclerosis, thrombosis, coronary artery disease,
hypertension and cardiac insufficiency. They upregulate the expression of the enzyme
endothelial nitric oxide (NO) synthase and can be applied in conditions in which an
increased expression of said enzyme or an increased NO level or the normalization of a
decreased NO level is desired. The invention furthermore relates to processes for the
preparation of compounds of the formula I, their use, in particular as active ingredients
in pharmaceuticals, and pharmaceutical preparations comprising them.
[57]
__________________
166508 [21[]11]
מערכת להספקת תרופה
DRUG DELIVERY SYSTEM
[54]
18.07.2003 [22] GB [33] 05.08.2002 [32] 0218126.1 [31]
Int. Cl.(2010.01) A61M 05//20 [51]
GLIDE PHARMACEUTICAL
TECHNOLOGIES LIMITED, UNITED
KINGDOM
[71]
WO/2004/014468 [87]
ריינהולד כהן ושותפיו, א' 26ב הברזל רחו
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A drug delivery system is disclosed which may be a throwaway or reusable device for
delivery at least one drug to a patient. Also described is a method for administering a
[57]
December 29, 2011 179-התשע"ב טבתב 'ג
drug using said device and a packaged drug for use with said device. The drug delivery
device (10) comprises a housing (12), a means (14) for generating a force capable of
pushing a drug (16) from a packaging (18) into a human or animal body, a means (20)
for transmitting said force to push the drug (16) from the packaging (18) into the
human and animal body, and a means (38, 42b) for triggering the device. Where the
device is a single use drug delivery (10) a packaged drug (100) forms an integral part
of the device. The packaged drug (100) comprises packaging (18) containing a drug
(16), having a housing (18a, 18b) wit a channel (106) running there through and in
which is disposed a drive pin or other element (108), a skin piercing means (110, 112),
and the drug (16), said housing (18a, 18b) further comprising a region (102) allowing
the packaged drug (100) to be slidably mounted to the drug delivery device (10) and an
end (104) adapted to engage and tension the skin.
__________________
166584 [21[]11]
–4)–2–מתיל–1מטרימי תרופות של –בנזאימידזול –אמידינופנילאמינומתיל(
– N–2)–חומצה קרבוקסלית–איל–5 – N – 2 –פירידיל
, אמיד –הידרוקסיקרבונילאתיל(תכשירים רפואיים המכילים אותם , ושימושם בהכנת תרופות ותהליכים
להכנתם
PRODRUGS OF 1-METHYL-2(4-
AMIDINOPHENYLAMINOMETHYL)-
BENZIMIDAZOL-5-YL- CARBOXYLIC
ACID -(N-2-PYRIDYL-N-2-
HYDROXYCARBONYLETHYL)-AMIDE,
PHARMACEUTICAL COMPOSITIONS
CONTAINING THEM , USE THEREOF IN
PREPARATION OF PHARMACEUTICAL
COMPOSITIONS AND PROCESSES TO
PREPARE THEM
[54]
28.07.2003 [22]
December 29, 2011 180-התשע"ב טבתב 'ג
DE [33] 02.08.2002 [32] 10235639.4 [31]
Int. Cl.(2010.01) A61K 31//4439, A61P 07//02, C07D 40/1/12 [51]
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH, GERMANY [71]
WO/2004/001489 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to novel compounds of general formula (1) wherein R' and R are
defined as in claim 1, the tautomers and the salts thereof, especially the salts thereof
which are physiologically compatible with inorganic or organic acids or bases,
exhibiting valuable properties, especially a thrombin inhibiting effect.
[57]
__________________
166905 [21[]11]
שיטה לשינוי צבע של גביש יהלום, גבישי יהלום המתקבלים בשיטה האמורה ושימושים בהם
METHOD FOR ALTERING THE
COLOUR OF A SINGLE CRYSTAL
DIAMOND, CRYSTAL DIAMONDS
OBTAINED THEREBY AND USES
THEREOF
[54]
05.09.2003 [22] GB [33] 06.09.2002 [32] 0220772.8 [31]
GB 21.02.2003 0304029.2
Int. Cl.(2010.01) C30B 29//04, 33//00 [51]
ELEMENT SIX LIMITED, UNITED
KINGDOM [71]
WO/2004/022821 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A method of producing a single crystal CVD diamond of a desired colour which
includes the steps of providing single crystal CVD diamond which is coloured and heat
treating the diamond under conditions suitable to produce the desired colour. Colours
which may be produced are, for example, in the pink-green range.
[57]
December 29, 2011 181-התשע"ב טבתב 'ג
__________________
166911 [21[]11]
שיטה להפעלת מכונת מכירה אוטומטית ומערכת מכירה
METHOD FOR OPERATING A
VENDING MACHINE AND
VENDING SYSTEM
[54]
07.08.2003 [22] DE [33] 16.08.2002 [32] 10238341.3 [31]
Int. Cl.(2010.01) A47G 29//12, G07F 09//10, 11//62 [51]
DEUTSCHE POST AG, GERMANY [71]
WO/2004/019289 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
The invention relates to a method for operating a vending machine, whereby goods can
be arranged in storage compartments and can be subsequently removed therefrom. The
inventive method is characterised in that offer-related data is captured in a central data
processing unit, whereby matching offers are associated with identical offer
identification codes such that offer identification codes are transmitted to a plurality of
electronic vending machines, and storage compartments which are provided for the
distribution of goods are stocked with goods, and offer identification codes associated
with the goods are captured. The invention also relates to a vending system comprising
a plurality of vending machines, in addition to individual vending machines for
carrying out said method.
[57]
December 29, 2011 182-התשע"ב טבתב 'ג
__________________
167142 [21[]11]
כלי נשק ידני קר כגון אגרופן
HAND HELD COLD WEAPON
SUCH AS A KNUCKLEDUSTER
[54]
28.02.2005 [22]
Int. Cl.(2010.01) F41B 15//08 [51]
אמנון שילוני, שהם אמנון מאור, מודיעין
AMNON SHILONI
AMNON MAOR [71]
בלום, גדור ושות', מגדל הורד 23, קומה 53דרך השלום
גבעתיים
BLUM, GADOR & CO.,
53 HASHALOM RD.,
GIVATAYIM 53454
[74]
A weapon (10) comprising: a hand-grip portion (12), an independent extension (14)
from each end of said hand-grip portion having a hand-engaging extension configured
to extend partially around a hand of a user so as to extend around and protect a
pointer, a ring finger an pinky of a user, thus partially surrounding the hand and
retaining the weapon on the hand when the fingers do not grip the weapon; at least one
portion of at least one of said independent extensions being shaped to create painful
pressure when pressed against an adversary when used as a hand-held weapon; and at
least one additional extension (18) extending from said hand-grip portion in a
direction opposite from said independent extensions, said additional extension being
shaped to create painful pressure when pressed against an adversary.
[57]
__________________
167400 [21[]11]
שיטה, מכשיר ומערכת לאפיון שינה
METHOD, APPARATUS AND
SYSTEM FOR CHARACTERIZING
SLEEP
[54]
18.09.2003 [22] US [33] 19.09.2002 [32] 60/411829 [31]
December 29, 2011 183-התשע"ב טבתב 'ג
US 10.01.2003 60/439029
Int. Cl.(2010.01) A61B 05//04 [51]
רמות ליד אוניברסיטת תל אביב בע"מ, ביבא-תל
RAMOT AT TEL AVIV UNIVERSITY
LTD. [71]
סולנז' אקסלרוד, ארמנדה ליה בהרב, צביקה שנער
SOLANGE AKSELROD, ARMANDA
LIA BAHARAV, ZVIKA SHINAR
[72]
WO/2004/026133 [87]
( בע"מ,1995ג'י.אי.ארליך ) 11,רחוב מנחם בגין 15מגדל איילון, קומה
רמת גן
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[74]
A method of determining a Rapid-Eye-Movement (REM) sleep and a Non-REM
(NREM) sleep from signals of electrical activity recorded from the chest of a sleeping
subject, the signals being measured over a plurality of epochs, the method comprising:
extracting a series of cardiac R-R intervals from the signals; constructing a Poincare
plot of said series of cardiac R-R intervals; calculating a plurality of moments of
inertia with respect to a predetermined line along said Poincare plot, each of said
plurality of moments of inertia being calculated within a predetermined time-window;
and using said plurality of moments of inertia to determine REM sleep and NREM
sleep of the sleeping subject.
[57]
בקשות חלוקה מבקשה זו שטרם פורסמו9
0/43115 The applications for division
from this application have
not yet been published
__________________
167410 [21[]11]
בדיקות העברת אנרגיית תהודת פלורצנטיות (FRET מבוססות )– תא לרעלנים של
קלוסטרידיום, ותאים לשימוש בהן
CELL-BASED FLUORESCENCE
RESONANCE ENERGY
TRANSFER (FRET) ASSAYS FOR
CLOSTRIDIAL TOXINS AND
CELLS FOR USE THEREIN
[54]
04.09.2003 [22] US [33] 27.09.2002 [32] 10/261161 [31]
Int. Cl.(2010.01) C12Q 01//00, G01N 33//52, 33//553 [51]
ALLERGAN, INC., U.S.A. [71]
WO/2004/029576 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
The present invention provides a method of determining clostridial toxin activity by (a)
contacting with a sample a cell containing a clostridial toxin substrate that includes a
[57]
December 29, 2011 184-התשע"ב טבתב 'ג
donor fluorophore; an acceptor having an absorbance spectrum overlapping the
emission spectrum of the donor fluorophore; and a clostridial toxin recognition
sequence containing a cleavage site that intervenes between the donor fluorophore and
the acceptor, where resonance energy transfer is exhibited between the donor
fluorophore and the acceptor under the appropriate conditions; (b) exciting the donor
fluorophore; and (c) determining resonance energy transfer of the contacted cell
relative to a control cell, where a difference in resonance energy transfer of the
contacted cell as compared to the control cell is indicative of clostridial toxin activity.
__________________
167629 [21[]11]
חיים–מערכת לאיסוף ואיחסון מידע ונתוני מדעי
SYSTEM FOR COLLECTING AND
STORING LIFE SCIENCE
INFORMATION AND DATA
[54]
29.09.2003 [22] US [33] 30.09.2002 [32] 60/414637 [31]
AM 20.08.2003 10/644582
Int. Cl.(2010.01) G01N 33//48, G05B 19//42, G06F 19//00 [51]
GENSTRUCT, INC., U.S.A. [71]
WO/2004/031765 [87]
בורוכוב קורח ושות', מגדל כלל עתידים
אביב-תל58100, ת.ד.
BOROCHOV, KORAKH & CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
[74]
A computer system for storing life science information in a database, the computer
system comprising: a processor; an electronic database storage module for storing in
the database a library of machine-readable symbolic representations into which life
science knowledge is adapted to be encoded according to a life sciences ontology, each
machine-readable symbolic representation comprising: at least two unspecified object
identifiers; a relationship connector, wherein the relationship connector relates two of
the at least two object identifiers to each other based on a casual relationship between
the object identifiers; and constraint information that defines which connections among
the object identifiers are permitted so that life sciences knowledge encoded into the
machine-readable symbolic representation is semantically rigorous and based on the
life sciences ontology; and a graphical user interface for managing addition of new life
[57]
December 29, 2011 185-התשע"ב טבתב 'ג
sciences data to a database, the graphical user interface comprising: a display screen
that receives an input selecting one of the machine-readable symbolic representations
as a template to represent the new data based at least in part on the life science
ontology; the graphical user interface restricting input of any data element that does
not conform to the constraint information associated with the selected machine-
readable symbolic representation such that the semantically rigorous relationships for
the life sciences ontology are maintained; the graphical user interface receiving input
of at least one data element that conforms to the constraint information to instantiate
the machine-readable symbolic representation.
__________________
167774 [21[]11]
שיטה להורדה של הנצה ויראלית מתאי יונקים שהודבקו ע"י וירוס מעטפת, נוגדן המשמש
בשיטה זו ושימושים בו
METHOD FOR REDUCING VIRAL
BUDDING FROM A MAMMALIAN
CELL INFECTED BY AN
ENVELOPED VIRUS, AN
ANTIBODY USING THE METHOD
AND USES THEREOF
[54]
01.10.2003 [22] US [33] 01.10.2002 [32] 60/415299 [31]
Int. Cl.(2010.01) C07K 16//18, 16//32 [51]
FUNCTIONAL GENETICS, INC.,
U.S.A. [71]
WO/2004/031209 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention provides methods of using antibodies that bind a TSG101
protein to inhibit or reduce viral production. The invention also provides methods of
using the TSG101 antibodies for the treatment of viral infections, including HIV
infection. The invention further provides methods of detecting viral infected cells
using TSG101 antibodies.
[57]
December 29, 2011 186-התשע"ב טבתב 'ג
__________________
167782 [21][11]
אנטנה עבור מערכת הדמיה תוך גופית
ANTENNA FOR IN-VIVO
IMAGING SYSTEM
[54]
31.03.2005 [22]
Int. Cl.(2010.01) A61B 01//06, 05//05 [51]
GIVEN IMAGING LTD. [71] גיוון אימג'ינג בע"מ, יקנעם
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
ליההרצ12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
An in-vivo imaging device comprising: an antenna folded to form a three-dimensional
antenna; and a support, said support comprising at least one flexible portion
comprising at least one layer, said at least one flexible portion interconnecting two
rigid portions having at least one layer; wherein said antenna is embedded within said
at least one flexible portion of said support and within said two rigid portions of said
support, and wherein a transmitter is disposed on one of said rigid portions.
[57]
__________________
168121 [21[]11]
תרופה לשלפוחית שתן פעילה ביתר המכילה תולדת אניליד של חומצה אצטית כמרכיב הפעיל
REMEDY FOR OVERACTIVE
BLADDER COMPRISING ACETIC
ACID ANILIDE DERIVATIVE AS
THE ACTIVE INGREDIENT
[54]
04.11.2003 [22] JP [33] 07.11.2002 [32] 2002-323792 [31]
Int. Cl.(2010.01) C07D 27/7/00 [51]
ASTELLAS PHARMA INC., JAPAN [71]
WO/2004/041276 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
(R)-2-(2-aminothiazol-4-yl)-4’-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid
anilide or its salt shows a potent bladder relaxation effect in “isolated rat bladder
smooth muscle relaxation test”, dose-dependently lowers the contraction frequency of
rhythmic bladder contractions in “rat rhythmic bladder contraction measurement test”
[57]
December 29, 2011 187-התשע"ב טבתב 'ג
and, moreover, prolongs the urination intervals in “urination function measurement
test on cyclophosphamide-induced overactive bladder model rat”. Owing to these
effects, the above compound is useful as a remedy for overactive bladder.
__________________
168298 [21[]11]
מתמר תקשורת לטלפון נייד, מערכת תקשורת ומערכת הפעלה למתמר תקשורת
MOBILE TELEPHONE GATEWAY
APPARATUS, COMMUNICATION
SYSTEM AND GATEWAY
OPERATING SYSTEM
[54]
01.05.2005 [22] WO [33] 02.11.2003 [32] PCT/IL03/00906 [31]
Int. Cl.(2010.01) H04W 88//06, 92//06 [51]
YOSSY SELA [71] יוסי סלע, ירושלים
יוסי סלע, 39ששת הימים
ירושלים
YOSSY SELA,
39 SHESHET HAYAMIM ST.,
JERUSALEM 97804
[74]
A mobile phone gateway apparatus for providing wireless communication capabilities
through at least second communication network in accordance with at least second
communication protocol, to a mobile phone operative on at least first communication
network in accordance with at least first communication protocol, said mobile phone
gateway comprising: means for protocol conversion between at least said first protocol
and said second protocol; means for data/signaling communication between said
mobile phone gateway and said mobile phone through an electrical signaling
transmission medium; means for controlling and wrapping SIM (subscriber
identification module) functionalities, said SIM functionalities provided to said mobile
phone and to said mobile phone gateway by one or more SIM card logics, said SIM
card logics being the same or different.
[57]
__________________
321683 [21[]11]
רעפי גג קרמים המיוצרים מחמר עתיר סידן ממשית עם מלאן גרניט וכן מלאנים אבקתיים
אחרים ותהליך ליצורם
CERAMIC ROOF TILES FROM
MAMSHIT CALCAREOUS CLAY
AND GRANITE AND OTHER
POWDERED FILLERS AND
[54]
December 29, 2011 188-התשע"ב טבתב 'ג
PROCESS FOR THEIR
MANUFACTURE
02.05.2005 [22]
Int. Cl.(2010.01) C04B 14//04, 14//10, 14//20, 35//00, 35//14 [51]
HASSIN ESH INDUSTRIES LTD. [71] חסין אש תעשיות בע"מ, באר שבע
YOSEF GAL, RON BUCHMAN [72] יוסף גל, רון בוכמן
חסין אש תעשיות בע"מ, 36דרך חברון ת.ד.
באר שבע
HASSIN ESH INDUSTRIES LTD.,
P.O.B. 36 DERECH HEVRON
BEER-SHEVA
[74]
Ceramic roof tiles of red -brown color with shining golden Mica dots on their surface
manufactured by dry mixing of powdered Soft Negev Mamshit clay No.2 with
powdered Granite Eilat stone filler No.1(as described in the specification), sintered at
the temperature range from 760ºC to 950ºC and characterized by the fact that they
contain the crystallographic Gehlenite, Augite, Anorthite, Albite and orthoclase
phases, the said Gehlenite being evidenced by the X-ray reflection peak at d value of
2.859 Ångstrom, Orthoclase is evidenced by reflection peaks at d value of 4.05, 3.28,
2.23 Ångstrom, and a strong broad reflection peak being of
Anorthite+Albite+orthoclase, centered at about d value of 3.21 Ångstrom.
[57]
__________________
168355 [21[]11]
פטמה מלאכותית
ARTIFICIAL NIPPLE
[54]
05.11.2003 [22] US [33] 08.11.2002 [32] 60/424954 [31]
US 29.10.2003 10/696910
Int. Cl.(2010.01) A61J 11//00 [51]
MEDELA HOLDING AG,
SWITZERLAND [71]
WO/2004/043325 [87]
ריינהולד כהן ושותפיו, א' 26ל רחוב הברז רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
An artificial baby-feeding nipple (310) includes a substantially solid nipple portion
(312) with one or more ducts (316) formed there through for conveying fluids through
the nipple. The nipple is radially compressible so as to prevent passage of fluids
through the one or more ducts when so compressed through use of a material having a
low durometer material.
[57]
December 29, 2011 189-התשע"ב טבתב 'ג
__________________
168361 [21[]11]
התקן עם פתח למתן תרופות המכיל מספר ערוצים עם קצבי זרימה משתנים
ORIFICE DEVICE HAVING
MULTIPLE CHANNELS WITH
VARYING FLOW RATES FOR
DRUG DELIVERY
[54]
03.05.2005 [22] US [33] 27.05.2004 [32] 10/855239 [31]
Int. Cl.(2010.01) A61J 03//07, B65D 83//04 [51] 162046 [61]
CORDIS CORPORATION, U.S.A. [71]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
An orifice device for delivering one or more drugs includes an innermember having a
proximal end and a distal end; and a winding helically wound around the inner
member. The winding includes a plurality of distinct wires helically wound in parallel
around the inner member. The winding and the inner member define at least three
separate channels for carrying one or more drugs therethrough. The inlet is at the
proximal end of the winding and an outlet is at the distal end of the winding for the
plurality of distinct wires. In some embodiments at least two of the plurality of distinct
wires have a different dimension. An outer member is used over the winding. Also, at
least two of the at least three separate channels have a different fluid flow rate. In some
embodiments at least two of the at least three separate channels carry a different drug.
[57]
December 29, 2011 190-התשע"ב טבתב 'ג
__________________
168399 [21[]11]
קצף פרמצבטי וקוסמטי
COSMETIC AND
PHARMACEUTICAL FOAM
[54]
24.10.2003 [22] IL [33] 25.10.2002 [32] 152486 [31]
US 29.11.2002 60/429546
Int. Cl.(2010.01) A61K 08//60, 09//00, 09//12, 35//00 [51]
FOAMIX LTD. [71] פואמיקס בע"מ, רחובות
WO/2004/037225 [87]
פואמיקס בע"מ, ,פארק וייצמן לתעשיות מדע 2הולצמן
רחובות4038, ת.ד.
FOAMIX LTD.,
2 HOLZMAN STREET
P.O.B 4038
REHOVOT 74140
[74]
The invention relates to an alcohol-free cosmetic or pharmaceutical foam carrier
comprising water, a hydrophobic solvent, a foam adjuvant agent, a surface-active agent
and a water gelling agent. The cosmetic or pharmaceutical foam carrier does not
contain aliphatic alcohols, making it non-irritating and non-drying. The alcohol-free
foam carrier is suitable for inclusion of both water-soluble and oil soluble
pharmaceutical and cosmetic agents.
[57]
לתקנות 13פירוט זה נבחן בהתאם לתקנה 2746 –הפטנטים5 תשכ"ח
This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968
__________________
December 29, 2011 191-התשע"ב טבתב 'ג
168429 [21[]11]
מוליך בעל חומר מרוכב יהלום/נחושת –מצע חצי ושיטה לייצורו
SEMICONDUCTOR SUBSTRATE
HAVING COPPER/DIAMOND
COMPOSITE MATERIAL AND
METHOD OF MAKING SAME
[54]
24.10.2003 [22] US [33] 07.11.2002 [32] 10/291126 [31]
Int. Cl.(2010.01) H01L 21//44 [51]
KYOCERA AMERICA, INC., U.S.A. [71]
WO/2004/044950 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
A semiconductor package for power transistors of the LDMOS type has a metallic
substrate with a die mounted directly thereon, lead frame insulators mounted thereon
adjacent the die and a plurality of leads mounted on the insulators and electrically
coupled to the die by bond wires. The substrate includes a body having opposite
surfaces comprising pure copper layers, and with the body interior being at least
partially comprised of a copper/diamond composite so as to act as a heat spreader and
provide improved heat removal and low thermal expansion, as well as an electrical
connection for the die. The body may be entirely comprised of a copper/diamond
composite, or it may be comprised of a copper/tungsten composite having a
copper/diamond composites insert therein. The copper/diamond composite is
comprised of diamond, particles within a copper matrix. In a method of making the
copper/diamond composite, diamond particles are coated with multiple layers of
element or inorganic compounds, mixed with a dry-processing binder and compacted
in a die under pressure to form a compacted body. The body is placed on a quantity of
copper, heated in a vacuum or hydrogen atmosphere to evaporate or decompose the
binder, heated in a vacuum or hydrogen atmosphere to 4ause bonding or partial
sintering of the coated diamond particles, then heated in a hydrogen atmosphere to a
temperature slightly above the melting point of copper to melt and draw the copper
into the bonded or partially sintered diamond particles. Following that, the compacted
body is cooled and cut to the desired shape.
[57]
__________________
168606 [21[]11]
December 29, 2011 192-התשע"ב טבתב 'ג
צורת מינון דמויית דף לשחרור ניקוטין בחלל הפה או האף
SHEET LIKE DOSAGE FORM FOR
RELEASING NICOTINE IN THE
ORAL OR NASAL CAVITY
[54]
22.06.2001 [22] DE [33] 04.07.2000 [32] 10032456.8 [31]
Int. Cl.(2010.01) A61K 09//00 [51] DIVISION FROM 153716 [62]
LTS LOHMANN THERAPIE-
SYSTEME AG, GERMANY [71]
WO/2002/002085 [87]
צאטו את לוצאטו,לו גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The invention relates to an especially flat administrable form which decomposes or
dissolves rapidly in an aqueous medium, and is used to rapidly release active
ingredients in the oral cavity, in bodily openings or in bodily cavities. Said
administrable form comprises a matrix which contains at least one water-soluble
polymer in the form of a base substance; in addition to at least one active ingredient;
and is characterised in that the polymer matrix is provided with spaces or cavities, the
content thereof differing with regard to the state of aggregation of the matrix.
[57]
The parent application from which 231524 בקשת הורה לבקשה זו שטרם פורסמה
this application has been divided has
not yet been published
__________________
616868 [21[]11]
December 29, 2011 193-התשע"ב טבתב 'ג
תכשיר לניקוי רצפות המכיל גורם לבקרה על חרקים
FLOOR CLEANING
FORMULATION COMPRISING
AN AGENT FOR CONTROLLING
INSECTS
[54]
19.05.2005 [22]
Int. Cl.(2010.01) C11D 07//32 [51]
SANO BRUNO'S ENTERPRISES סנו מפעלי ברונוס בע"מ, תל אביב
LTD. [71]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A cleaning formulation comprising a cleaning agent and an insect growth regulator
wherein said cleaning agent comprises: 2-5 wt% non-ionic surfactant; 0.5-2 wt% ETA
70; 0.001-0.1 wt% insect growth regulator; 0.3-2 wt% fragrance; and 0.01-1 wt%
stabilizer; and water up to 100 wt%.
[57]
__________________
168718 [21[]11]
נגזרות ביגואניד, תכשירים הכוללים את –הנגזרות, תהליך להכנת תרכובות אנטי
מיקרוביאליות ושימוש בנגזרות בהכנת תרופות
BIGUANIDE DERIVATIVES,
COMPOSITIONS COMPRISING
THE DERIVATIVES, PROCESS
FOR PREPARING AN
ANTIMICROBIAL COMPOUND
AND USE OF THE DERIVATIVES
IN THE PREPARATION OF
MEDICAMENTS
[54]
20.11.2003 [22] US [33] 22.11.2002 [32] 60/428306 [31]
US 18.11.2003 10/716283
Int. Cl.(2010.01) A61K 31//155, A61P 31//04, C07C 27/9/26, 31/7/22, 32/3/20, C07D
31/7/64, 31/9/20
[51]
JACOBUS PHARMACEUTICAL
COMPANY, INC., U.S.A. [71]
WO/2004/048320 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
Biguanide and dihydrotriazine derivatives, preferably substituted asymmetrical
imidodicarbonimidic diamides derived from hydroxylamines, and compositions
[57]
December 29, 2011 194-התשע"ב טבתב 'ג
containing biguanide and dihydrotriazine derivatives are disclosed. In addition,
methods of using the biguanide and dihydrotriazine derivatives, inter alia, as
antimicrobial agents and methods of using the dihydrotriazine derivatives in biological
assays are disclosed. Methods of making the biguanide and dihydrotriazine derivatives
are also disclosed.
בקשות חלוקה מבקשה זו
שטרם פורסמו90//0255 The applications for division
from this application have
not yet been published
__________________
168745 [21[]11]
תכשירים הכוללים רעלן הבוטולינום ואלבומין פלזמה אנושי, שיטה להכנתם ושימוש בהם
להכנת תרופות
COMPOSITIONS COMPRISING
BOTULINUM TOXIN AND A
HUMAN SERUM ALBUMIN,
METHOD FOR PRODUCING THE
SAME AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS
[54]
22.12.2003 [22] US [33] 20.12.2002 [32] 60/435901 [31]
Int. Cl.(2010.01) A61K 47//42, 47//48 [51]
BOTULINUM TOXIN RESEARCH
ASSOCIATES, INC., U.S.A. [71]
WO/2004/060384 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
Botulinum toxin, a well know systemic poison, produces favorable therapeutic effect
by virtue of regionally attaching to nerves within the myoneural junction and possibly
other tissues in a target region of a particular tissue. The present invention provides
compositions of botulinum toxin and a sequestration agent that increase sequestration
and delivery of the botulinum toxin to neural and associated tissues, as compared with
available formulations of botulinum toxins, and thereby produce a beneficial clinical
effect. The sequestration agents of the present invention include proteins, lipids and
carbohydrates. A preferred composition of the present invention comprises a
botulinum toxin and an albumin. The present invention also provides methods of
treating neuromuscular diseases and pain using the disclosed compositions and
methods of making the disclosed compositions.
[57]
December 29, 2011 195-התשע"ב טבתב 'ג
__________________
169307 [21[]11]
נגזרות של ביפניל ושימושן כקוטלי פטריות
BIPHENYL DERIVATIVES AND
THEIR USE AS FUNGICIDES
[54]
15.12.2003 [22] GB [33] 24.12.2002 [32] 0230155.4 [31]
Int. Cl.(2010.01) A01N 43//36, 43//56, 43//78, C07C 21/1/44, 23/3/02, C07D 20/7/34,
23/1/14, 23/1/16, 27/7/56, C07F 07//08
[51]
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND [71]
WO/2004/058723 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
A fungicidally active compound of formula (I): where Het is a substituted 5- or 6-
membered heterocyclic ring; R1 is hydrogen, formyl, CO-C1-4 alkyl, COO-C1-4 alkyl,
C1-4 alkoxy(C1-4)alkylene, CO-C1-4 alkylenoxy(C1-4)alkyl, propargyl or allenyl; R2, R
3,
R4 and R
5 are each, independently, hydrogen, halogen, methyl or CF3; each R
6 is,
independently, halogen, methyl or CF3; R7 is (Z)mC=C(Y
1), (Z)mC(Y
1)=C(Y
2)(Y
3) or
tri(C1-4)alkylsilyl; X is O or S; Y1, Y
2 and Y
3 are each, independently, hydrogen,
halogen, C1-6 alkyl [optionally substituted by one or more substituents each
independently selected from halogen, hydroxy, C1-4 alkoxy, C1-4 haloalkoxy, C1-4
alkylthio, C1-4 haloalkylthio, C1-4 alkylamino, di(C1-4)alkylamino, C1-4 alkoxycarbonyl,
C1-4 alkylcarbonyloxy and tri(C1-4)alkylsilyl], C2-4 alkenyl [optionally substituted by
one or more substituents each independently selected from halogen], C2-4 alkynyl
[optionally substituted by one or more substituents each independently selected from
halogen], C3-7 cycloalkyl [optionally substituted by one or more substituents each
independently selected from halogen, C1-4 alkyl and C1-4 haloalkyl] or tri(C1-
4)alkylsilyl; Z is C1-4 alkylene [optionally substituted by one or more substituents each
independently selected from hydroxy, cyano, C1-4 alkoxy, halogen, C1-4 haloalkyl, C1-4
haloalkoxy, C1-4 alkylthio, COOH and COO-C1-4 alkyl]; m is 0 or 1; and n is 0, 1 or 2;
the invention also relates to novel intermediates used in the preparation of these
compounds, to agrochemical compositions which comprise at least one of the novel
compounds as active ingredient and to the use of the active ingredients or
compositions in agriculture or horticulture for controlling or preventing infestation of
plants by phytopathogenic microorganisms, preferably fungi.
[57]
December 29, 2011 196-התשע"ב טבתב 'ג
__________________
169527 [21[]11]
תולדות פירידין ותהליך להכנתן
PYRIDINE DERIVATIVES AND
PROCESS FOR THEIR
PREPARATION
[54]
12.02.2004 [22] EP [33] 19.02.2003 [32] 03356029.3 [31]
Int. Cl.(2010.01) C07D 40/5/00, 40/5/12, 40/9/12 [51]
BAYER S.A.S., FRANCE [71]
WO/2004/074280 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
Compound of general formula (I): Process for preparing this compound. Novel
intermediate of general formula (E): for the preparation of compound of general
formula (I). Fungicidal composition comprising a compound of general formula (I).
Method for treating plants by applying a compound of general formula (I) or a
composition comprising it.
[57]
December 29, 2011 197-התשע"ב טבתב 'ג
__________________
169881 [21[]11]
טלאים דביקים עבור נתינת גרניסטרון דרך העור
ADHESIVE PATCHES FOR THE
TRANSDERMAL DELIVERY OF
GRANISETRON
[54]
05.02.2004 [22] GB [33] 05.02.2003 [32] 0302662.2 [31]
Int. Cl.(2010.01) A61K 09//70 [51]
STRAKAN INTERNATIONAL
LIMITED, BERMUDA [71]
WO/2004/069141 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
Adhesive patches for the transdermal administration of granisetron, comprise an
acrylic adhesive containing non-acidic nucleophilic moieties which substantially
increase flux of granisetron across the skin.
[57]
__________________
170076 [21[]11]
ר נוגדנים לחלבון מבודד פעיל ביולוגית הקשו VEGFלגורם צמחיה וסקולארי אנדותליאלי
ANTIBODIES TO ISOLATED
BIOLOGICALLY ACTIVE HUMAN
[54]
December 29, 2011 198-התשע"ב טבתב 'ג
אנושי, השימוש בהם ותכשירים רפואיים המכילים אותם
VASCULAR ENDOTHELIAL
GROWTH FACTOR (VEGF)
RELATED PROTEIN, THEIR USE
AND MEDICAMENTS
COMPRISING THEM
30.08.1996 [22] US [33] 08.09.1995 [32] 60/003491 [31]
Int. Cl.(2010.01) A61K 39//395, C07K 14//52, 14//71, 16//24 [51] DIVISION FROM 123332 [62]
GENENTECH, INC., U.S.A. [71]
WO/1997/009427 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A monoclonal antibody which binds to an isolated biologically active human VEGF-
related protein (VRP) and neutralizes a biological activity of said isolated biologically
active human VRP, wherein said isolated biologically active human VRP contains at
least 265 amino acids of Figure 1, as depicted in the specification, which binds
receptor tyrosine kinase Flt4.
.
[57]
__________________
170178 [21[]11]
קלטת ביטוי הכוללת אזור מקדם/מגביר מוקדם אנושי ווקטור הכולל את CMVשל 1מיידי
קלטת הביטוי הנ"ל
EXPRESSION CASSETTE
COMPRISING A HUMAN CMV
IMMEDIATE EARLY 1
PROMOTER/ENHANCER REGION
AND A VECTOR COMPRISING
SAID EXPRESSION CASSETTE
[54]
13.02.2004 [22] US [33] 14.02.2003 [32] 60/448179 [31]
Int. Cl.(2010.01) A61K 48//00, C12N 05//10, 15//79 [51]
BIOGEN IDEC MA INC., U.S.A. [71]
WO/2004/074439 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The disclosure provides an expression cassette and a vector comprising the cassette for
expression of a polynucleotide. The expression cassette includes a promoter/enhancer,
[57]
December 29, 2011 199-התשע"ב טבתב 'ג
an intervening region, and a polyadenylation signal domain. Expression systems and
methods of using the expression cassette and vector are also provided.
__________________
170438 [21[]11]
תהליך לבניית מקטע של מבנה חיצוני על ידי הכנה מראש של חלקי מבנה וחלק מבנה
המוכן מראש המתייחס לתהליך זה
PROCESS FOR THE
CONSTRUCTION OF A SEGMENT
OF AN OPEN-AIR WORK BY
PREFABRICATED STRUCTURAL
MEMBERS AND PREFABRICATED
STRUCTURAL MEMBER RELATED
THERETO
[54]
24.03.2004 [22] IT [33] 28.03.2003 [32] TO2003A000243 [31]
Int. Cl.(2010.01) E02D 29//045 [51]
CARLO CHIAVES, ITALY [71]
WO/2004/085749 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
A process for the construction of a segment of an openair work by prefabricated
structural members of reinforcing concrete, comprises the steps of arranging first and
second prefabricated structural members (18, 19) including an upright portion (22) and
at least a cover portion (26), and the phase of installing the two structural members (18,
19) by resting the free ends (20) of the respective upright portions (22) on respective
foundation portions (12), in such a manner that the two structural members (18, 19) are
arranged symmetrically opposed. Each structural member (18, 19) has a cavity in
correspondence of the respective cover portion (26), the cavities of the two structural
members (18, 19) constituting a continuous channel (34) in order to allow to form a
beam superimposed to the two members (18, 19) and fastened to them, by executing a
casting (36) in said continuous channel (34) during the work.
[57]
December 29, 2011 200-התשע"ב טבתב 'ג
__________________
170726 [21[]11]
UWBמערכת ושיטה לרכישת אותות מכ"מ
SIGNAL ACQUISITION SYSTEM
AND METHOD FOR ULTRA-
WIDEBAND (UWB) RADAR
[54]
07.09.2005 [22]
Int. Cl.(2010.01) G01S 07//288, 13//89 [51]
CAMERO-TECH LTD. [71] ק בע"מ, נתניהט-קמרו
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A signal acquisition system configured to be used with an ultra-wideband radar and
capable of integrating at least one received signal whereby providing a desired
compensation of a signal loss; the system comprising: (a) at least one sampler
configured to sample the received signal and to provide samples of different range
cells; (b) at least one analog integrator coupled to the sampler and configured to
integrate said samples during Na>1 integration cycles whereby providing
compensation of at least part of the signal loss and giving rise to analog integrated
samples; (c) at least one analog/digital converter coupled to the analog integrator and
configured to convert said analog integrated samples into digital samples; (d) at least
one digital integrator coupled to the analog/digital converter and configured to
integrate said digital samples during Nd digital integration cycles whereby
substantially providing the rest of desired signal loss compensation.
[57]
__________________
December 29, 2011 201-התשע"ב טבתב 'ג
170829 [21[]11]
ציס חומצה רטינואית–9תהליך להכנת
PROCESS FOR THE
PRODUCTION OF 9-CIS
RETINOIC ACID
[54]
02.04.2004 [22] EP [33] 11.04.2003 [32] 03008020.4 [31]
Int. Cl.(2010.01) C07C 40/3/20 [51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2004/089887 [87]
יינהולד כהן ושותפיו,ר א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A new industrially applicable process for the production of 9-(Z)-retinoic acid is
described which is characterized by the conversion of an alkali metal salt of 3-methyl-
4-oxocrotonic acid with a C15-triphenyl-phosphonium salt. 9-(Z)-retinoic acid is a
versatile compound for the treatment of numerous dermatological diseases.
[57]
__________________
171177 [21[]11]
שיטה להכנת פולימרים פוטוריאקטיביים עם מולקולות מקובעות עליהם
METHOD FOR THE
PREPARATION OF
PHOTOREACTIVE POLYMERS
WITH MOLECULES
IMMOBILIZED THEREON
[54]
31.03.2003 [22]
Int. Cl.(2010.01) C12N 11//06, 11//08, G01N 33//543 [51]
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH, INDIA [71]
WO/2004/088316 [87]
דר' אייל ברסלר עו"פ, 11תובל גן -רמת
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
[74]
This invention relates to a quick method for preparation of photoreactive polymers and [57]
December 29, 2011 202-התשע"ב טבתב 'ג
immobilization of biomolecules onto these polymers. Particularly, this invention
relates to a microwave-mediated rapid and efficient method for the preparation of
photoreactive polymer having atleast one photoactivable functional group capable of
forming a covalent bond with the biomolecule in a photochemical reaction. Any
matrix either organic or inorganic having a nucleophilic group preferably, amino,
hydroxyl or thiol group can be modified by the invented method. Immobilization of
biomolecules onto the photoreactive polymers was carried out by UV radiation. The
method has applications for immobilization of bio-molecules irrespective of their
functional groups in the fields of molecular biology, proteomics, genomics,
diagnostics, chemical or biochemical industry or other related fields.
__________________
171178 [21[]11]
חום לביצוע הליך בחינה –שיטה מהרה מתווכת אנזימים–באמצעות סורבנט אימוני קשור
RAPID HEAT-MEDIATED
METHOD FOR ENZYME-
LINKED IMMUNOSORBENT
ASSAY PROCEDURE
[54]
31.03.2003 [22]
Int. Cl.(2010.01) G01N 33//543 [51]
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH, INDIA [71]
WO/2004/088315 [87]
דר' אייל ברסלר עו"פ, 11תובל גן -רמת
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
[74]
This invention relates to a rapid and efficient method for carrying out enzyme-linked
immunosorbent assay for detection of minute quantities of biomolecules such as
antigen, antibody etc. This invention particularly relates to heat-mediated
immobilization of antigen or antibody on to the activated surface followed by
performing subsequent steps of ELISA by controlled temperature. The invented
procedure has reduced the total time required for ELISA to around 3 h. The invented
ELISA procedure is rapid, economical, reproducible and simple. The invented
procedure is useful for carrying out ELISA required in clinical diagnostics, molecular
biology, agriculture, food technology, environmental science, etc. The invented
ELISA method is simple, time saving and obviates the time consuming procedure.
This method has the potential for automation.
[57]
__________________
December 29, 2011 203-התשע"ב טבתב 'ג
171217 [21[]11]
מעבד מיקום רב מעברים
MULTIPLE PASS LOCATION
PROCESSOR
[54]
31.03.2004 [22] US [33] 15.04.2003 [32] 10/414982 [31]
Int. Cl.(2010.01) G01S 03//02 [51]
TRUEPOSITION, INC., U.S.A. [71]
WO/2004/092762 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
A multiple pass location processing method, for use in a wireless location system
(WLS), comprises identifying a received transmission as requiring multiple pass
location processing whereby the WLS produces a first, lower quality location estimate
and then subsequently produces a second, higher quality location estimate. The WLS
then produces the first location estimate and provides it to a first location application,
and then produces the second location estimate. The second location estimate may be a
more accurate estimate than the first location estimate and/or of a higher confidence
than the first location estimate. This method is suitable, but not limited, for use in
connection with locating a wireless transmitter involved in an emergency services call
and routing the call to a call center.
[57]
__________________
171363 [21[]11]
December 29, 2011 204-התשע"ב טבתב 'ג
תהליך להפקת מוצרים של טיטניום
PROCESS FOR THE
PRODUCTION OF TITANIUM
PRODUCTS
[54]
11.10.2005 [22]
Int. Cl.(2010.01) A62D 01//00, C01G 23//04 [51]
JOMA INTERNATIONAL AS,
NORWAY [71]
ASHER VITNER [72] אשר ויטנר
וולף, ברגמן וגולר, יםירושל1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
A method for the industrial purification of a titanium feed stream of purity P1, by the
formation of a titanium-double-salt precipitate of purity P2, and a titanium solution
with purity P3, wherein P2>P1>P3, said method comprising the steps of: forming,
from said feed, a medium comprising water, titanium ion, a cation selected from the
group consisting of ammonium, cations of alkali metals, protons and a combination
thereof, and an anion selected from the group consisting of OH, SO4, HSO4, and a
combination thereof, which formed medium is further characterized by the presence of
(a) a double-salt precipitate comprising titanium ion, at least one of said cations and at
least of said anions; and (b) a titanium solution; and wherein the concentration of said
anion in said titanium solution is higher than 15 wt% and the ratio between the
concentrations of said cation and said anion in said titanium solution is higher than 0.4
and lower than 1.6; and; separating at least a portion of said precipitate from said
solution
[57]
__________________
171444 [21[]11]
מערכת שמותאמת לתפקיד כמדחס, מנוע, משאבה ומנוע בעירה פנימית
APPARATUS ADAPTED TO
PERFORM AS COMPRESSOR,
MOTOR, PUMP AND INTERNAL
COMBUSTION ENGINE
[54]
22.04.2003 [22]
Int. Cl.(2010.01) F01C 01//067 [51]
DAS AJEE KAMATH, INDIA [71]
WO/2004/094787 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
[74]
December 29, 2011 205-התשע"ב טבתב 'ג
BEER-SHEVA 84152 באר שבע5352, ת.ד.
A rotary apparatus adapted to perform as, compressor, pump, motor or an internal
combustion engine; said apparatus comprising of two vanes, two hollow cylindrical
sleeves, hollow cylindrical liner, cams and associated linkages, couplings, shaft, clutch
and braking/locking arrangement; said vanes are fitted on to the curved surface of the
sleeves, one vane on each sleeve, such that the vanes are radial to sleeve's curved
surface and at one of the ends of each sleeve so that the vane's surface protrudes out of
the sleeve's end; said sleeves placed such that their ends, fitted with vanes are placed
adjacent, with the vanes angularly displaced; said vanes are placed inside a liner; said
liner's inner surface is contoured along the path traced by vane edge while rotating
about the said axis; said inner surface allows rotation of the vanes about the said axis;
said vanes divide the said enclosure formed inside the liner into two sealed chambers;
enclosure; said two sleeves, are coupled and uncoupled with a shaft by means of
coupling arrangement actuated by cams or other timing devices; said cams or timing
devices are dependent on sleeve position; said cams or timing devices actuate said
braking/locking arrangements such that each vane is held at a predetermined position
alternately, and the vanes are free to rotate through an defined angle alternately; said
cams or timing devices allow both vanes to rotate simultaneously through an
predefined angle; said cams or timing devices defines the angle by which the vanes are
separated, rotated simultaneously or independently.
[57]
__________________
171713 [21[]11]
שימוש בתולדה של חומצה פנוקסיאצטית להכנת תכשיר לטיפול בפעילות יתר של
שלפוחית השתן
USE OF A PHENOXYACETIC
ACID DERIVATIVE FOR
PREPARING A COMPOSITION
FOR TREATING HYPERACTIVE
BLADDER
[54]
December 29, 2011 206-התשע"ב טבתב 'ג
24.03.2004 [22] DE [33] 05.05.2003 [32] 10320084.3 [31]
DE 23.05.2003 10323837.9
Int. Cl.(2010.01) A61K 31//191, 31//192 [51]
KISSEI PHARMACEUTICAL CO.,
LTD., JAPAN [71]
WO/2004/098586 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention relates to a new field of indication for phenoxyacetic acid
derivatives as described in European Patent Application EP 1095932. It has now been
found that the compounds described therein are suitable for the preparation of a
medicament for treating hyperactive bladder (overactive bladder). Accordingly, by
means of these active substances, a method is provided for treating this urological
syndrome.
[57]
__________________
171722 [21[]11]
מערכת גישה למתן שירותי תקשורת שונים ושיטה לשימוש בה
ACCESS SYSTEM FOR THE
PROVISIONING OF DIFFERENT
COMMUNICATION SERVICES
AND METHOD FOR USING
SAME
[54]
01.11.2005 [22]
Int. Cl.(2010.01) H04M 03//42, H04Q 03//00 [51]
ECI TELECOM LTD. [71] והאי. סי. איי. טלקום בע"מ, פתח תק
אי. סי. איי. טלקום בע"מ, 30רחוב הסיבים
פתח תקוה
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
[74]
An access communication system is provided which comprises at least one
aggregation device comprising at least one automated switching matrix for connecting
a plurality of communication devices with a plurality of subscribers. When a new
subscriber is to be connected through the at least one aggregation device, the at least
one automated switching matrix is operative to enable the provisioning of a required
service to the new subscriber either by using one of these communication devices or
by communicating with a communication device installed at a different location and
operative to enable the provisioning of the service required by the new subscriber. By
[57]
December 29, 2011 207-התשע"ב טבתב 'ג
a preferred embodiment the at least one aggregation device and automated switching
matrix and the plurality of communication devices are managed by a single managing
entity.
__________________
172008 [21[]11]
שימוש לקביעת יכולת של אנזים לווסות את רמת הפוספורילציה של פוליפפטיד שעבר
ביוטניליזציה
METHOD FOR DETERMINING
THE ABILITY OF AN ENZYME TO
MODULATE THE
PHOSPHORYLATION STATUS OF
A BIOTINYLATED POLYPEPTIDE
[54]
27.04.2004 [22] DE [33] 22.05.2003 [32] 10323081.5 [31]
Int. Cl.(2010.01) C07K 14//435, C12Q 01//48 [51]
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY [71]
WO/2004/104220 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
The invention relates to the use of a polypeptide for determining the ability of an
enzyme, a functional fragment or a derivative thereof, to modulate the phosphorylation
status of the polypeptide, said invention being characterised in that the polypeptide is
biotinylated.
[57]
__________________
172326 [21[]11]
שיטה להסרת פיגמנטים מחלק עור עם פיגמנטציה
METHOD FOR REMOVING
PIGMENTS FROM A PIGMENTED
SECTION OF SKIN
[54]
10.06.2004 [22] IL [33] 10.06.2003 [32] 156374 [31]
Int. Cl.(2010.01) A61B 17//00, 17//20 [51]
December 29, 2011 208-התשע"ב טבתב 'ג
HAWK MEDICAL TECHNOLOGIES הוק מדיקל טכנולוג'יס בע"מ, ראשון לציון
LTD [71]
WO/2004/107995 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention relates to a method for removing pigments from a pigmented
section of a skin by puncturing the skin at the pigmented section, with a skin
puncturing device which is provided with at least one needle, and then bandaging the
punctured section with a suitable adsorbing pad. The pad contains one or more
materials, such as saline, which will cause the pigments at the punctured section to
migrate into the outer layer of the skin.
[57]
__________________
723541 [21[]11]
אפוליפופרוטאין לשימוש בתבחיך לגילוי של PrPSC
APOLIPOPROTEIN FOR USE IN
AN ASSAY FOR DETECTION OF
PRPSC
[54]
18.06.2004 [22] EP [33] 19.06.2003 [32] 03101795.7 [31]
Int. Cl.(2010.01) G01N 33//68 [51]
MERCK SERONO S.A.,
SWITZERLAND [71]
CLAUDIO SOTO-JARA, KINSEY
MAUNDRELL
[72]
WO/2004/111652 [87]
אינטרפארם מעבדות בע"מ, 18רחוב הקישון
יבנה151, ת.ד.
INTERPHARM LABORATORIES
LTD.,
18 HAKISHON ST.,
P.O.B. 151,
YAVNE 81101
[74]
The use of Apolipoprotein B, Apolipoprotein E, fragments and mimetics thereof is
provided for diagnostic, detection, prognostic and therapeutic applications in prion
diseases. More specifically, the invention provides the use of Apolipoprotein B or
fragments thereof for modulating or identifying modulators of the prion protein
replication which are implicated in thepathogenesis of transmissible spongiform
encephalopathics and other prion diseases.
[57]
December 29, 2011 209-התשע"ב טבתב 'ג
בקשות חלוקה מבקשה זו
שטרם פורסמו90/17/45 The applications for division
from this application have
not yet been published
__________________
172404 [21[]11]
, תכשירים רפואיים VEGFמלכודות מיני המכילים אותן ושימושים של התכשירים
הרפואיים להכנת תרופות
VEGF MINI TRAPS,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME AND USE OF THE
PHARMACEUTICAL
COMPOSITIONS FOR
PREPARING MEDICAMENTS
[54]
29.06.2004 [22] US [33] 30.06.2003 [32] 10/609775 [31]
Int. Cl.(2010.01) A61K 38//17, C07K 14//71, 19//00, C12N 15//12, 15//62 [51]
REGENERON
PHARMACEUTICALS, INC., U.S.A. [71]
WO/2005/000895 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Nucleic acid molecules and multimeric proteins capable of binding vascular
endothelial growth factor (VEGF). VEGF traps are disclosed which are therapeutically
useful for treating VEGF-associated conditions and diseases, and are specifically
designed for local administration to specific organs, tissues, and/or cells.
[57]
__________________
172457 [21[]11]
תרכובות מאוחות המכילות קבוצת אוראידו של 1סוג –המעכבות קולטן של ונילואיד תת
ידי –הקולטן, לטיפול בהפרעות הנגרמות על פעילות של קולטן וינלואיד ותהליך להכנתן
FUSED COMPOUNDS
CONTAINING AN UREIDO
GROUP THAT INHIBIT
VANILLOID RECEPTOR
SUBTYPE 1 (VR1) RECEPTOR
FOR TREATING DISORDERS
CAUSED BY VANILLOID
RECEPTOR ACTIVITY AND
[54]
December 29, 2011 210-התשע"ב טבתב 'ג
PROCESS FOR THEIR
PREPARATION
10.06.2004 [22] US [33] 12.06.2003 [32] 10/459925 [31]
US 09.06.2004 10/864068
Int. Cl.(2010.01) A61K 31//416, 31//472, A61P 13//00, C07D 21/7/02, 23/1/56,
40/1/12, 40/3/12
[51]
ABBOTT LABORATORIES, U.S.A. [71]
WO/2004/111009 [87]
ד"ר שלמה כהן ושות', 124אבן גבירול
תל אביב11490, ת.ד.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[74]
The present invention discloses novel compounds of general formula (I), or a
pharmaceutically acceptable salt or prodrug thereof (in which X1 - X5, R5 - R8b, Z1 - Z2
and Ar1 are defined herein), a method for inhibiting the VR1 receptor in mammals
using these compounds, a method for controlling pain in mammals, and
pharmaceutical compositions including those compounds and a process for making
those compounds.
[57]
בקשות חלוקה מבקשה זו שטרם פורסמו9
024/24502377550/51135 The applications for division
from this application have
not yet been published
__________________
262017 [21[]11]
נרתיקי של תרופות–מתקנים לאספקה תוך
INTRAVAGINAL DRUG
DELIVERY DEVICES
[54]
09.07.2004 [22]
December 29, 2011 211-התשע"ב טבתב 'ג
IE [33] 10.07.2003 [32] S0515 [31]
Int. Cl.(2010.01) A61K 09//00, 45//08, 47//36, 47//38 [51]
WARNER CHILCOTT (IRELAND)
LIMITED, IRELAND [71]
WO/2005/004837 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
The invention relates to an intravaginal drug delivery device comprising at least one
reservoir, the, or each, reservoir containing at least one pharmacologically active agent
dispersed in a carrier system; and a sheath discontinuously surrounding the at least one
reservoir, so that, in use, at least part of that reservoir is directly exposed to the vaginal
environment. Preferably, the sheath defines one or more holes or openings, the, or
each, hole or opening extending through the sheath to the at least one reservoir, so that
at least part of that reservoir is exposed, in use, to the vaginal environment.
[57]
__________________
172783 [21[]11]
ההורג באופן RASGAPפפטיד הנגזר מחלבון סלקטיבי תאים סרטניים
RASGAP DERIVED PEPTIDE FOR
SELECTIVELY KILLING
CANCER CELLS
[54]
30.06.2004 [22] US [33] 30.06.2003 [32] 60/483691 [31]
Int. Cl.(2010.01) A61K 38//17, C07K 14//47 [51]
UNIVERSITE DE LAUSANNE,
SWITZERLAND [71]
CHRISTIAN WIDMANN, JIANG-
YANG YANG, DAVID MICHOD
[72]
WO/2005/000887 [87]
אגמון,-סורוקר 14טון, רחוב שנקר בית נול
הרצליה פיתוח
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
[74]
The present invention relates to a peptide consisting in the N2 sequence of the [57]
December 29, 2011 212-התשע"ב טבתב 'ג
RasGAP protein, a fragment thereof, or a variant thereof which enhances the ability of
a drug to selectively kill cells. Furthermore, it relates to a pharmaceutical composition
comprising as an active substance a pharmaceutically effective amount of said peptide.
__________________
172928 [21[]11]
התקן נעילה לכוונון גובה של מודול
LOCKING DEVICE FOR HEIGHT
ADJUSTMENT OF A MODULE
[54]
25.06.2004 [22] NO [33] 03.07.2003 [32] 20033053 [31]
Int. Cl.(2010.01) A47C 03//28 [51]
STOKKE AS, NORWAY [71]
WO/2005/002946 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
Device (1) for height adjustment of a module, such as a children's seat (3) on a stem
(2) in a trolley or a chair, characterized in that the locking device (1) comprises a
movable casing (4) which partly or completely surrounds the stem (2), a friction
element (5) and a handle (6) which rotates eccentrically in order to tighten the friction
element (5) against the stem (2) and providing friction between the locking device (1)
and the stem (2). The children's seat (3) may comprise a footrest (20) characterized in
that two rails (21) are received in guides (22) integrated in the seat, such that the
footrest (20) may be displaced telescopically in relation to the seat (3).
[57]
__________________
December 29, 2011 213-התשע"ב טבתב 'ג
172944 [21[]11]
קרומית פולימרית מוליכה המכילה תמיסה יונית לשימוש בתאי דלק ושיטה ליצורה
POLYMER ELECTROLYTE
MEMBRANES AND IONIC
LIQUID THEREIN FOR USE IN
FUEL CELLS AND METHOD
FOR ITS PREPARATION
[54]
02.01.2006 [22]
Int. Cl.(2010.01) H01M 08//10 [51]
אוניברסיטת בן גוריון בנגב הרשות למחקר ופיתוח, באר שבע
BEN-GURION UNIVERSITY OF
THE NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
[71]
ELI KORIN, ARMAND אלי קורין, ארמון בטלהיים
BETTELHEIM
[72]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
A method for preparing a Polymer Electrolyte Membrane (PEM), wherein said
method comprises the step of combining a polysiloxane-RTV matrix with an ionic
liquid component to form an electrically conductive membrane, said combination
being carried out by introducing said ionic liquid with a first anion in the
polysiloxane-RTV component and then exchanging said first anion with a second
anion, said second anion being provided in the form of a salt in aqueous solution.
[57]
__________________
172998 [21[]11]
זמני של אנטיגנים של –מתקן ושיטה לזיהוי בו סוג דם
DEVICE AND METHOD FOR
SIMULTANEOUSLY
IDENTIFYING BLOOD GROUP
ANTIGENS
[54]
08.07.2004 [22] DE [33] 09.07.2003 [32] 103 30 982.9 [31]
Int. Cl.(2010.01) G01N 33//80 [51]
MEDION DIAGNOSTICS AG,
SWITZERLAND [71]
WO/2005/005991 [87]
REINHOLD COHN AND ריינהולד כהן ושותפיו,
PARTNERS,
[74]
December 29, 2011 214-התשע"ב טבתב 'ג
א' 26רחוב הברזל רמת החייל
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
The invention relates to a device for simultaneously, qualitatively or quantitatively
identifying a number of analytes in a liquid sample, comprising a membrane (2) with:
a charging zone (5) for applying the liquid sample; at least two indicator zones, which
can interact with the analyte(s), and at least one absorption area (3), which absorbs the
liquid after passing the indicator zones, whereby the indicator zones are located
between the charging zone (5) and an absorption area (3). The invention is
characterized in that the flowing directions from the charging zone (5) through the
respective indicator zones to an absorption area (3) (flow paths) are essentially
parallel, and at least two different flow paths exist. The invention also relates to a
method for identifying a number of analytes or the derivatives thereof in a liquid
sample, consisting in the application of the sample to the charging zone (5) of a
membrane (2) of the device according to one of cited claims 1 to 8, whereby this
sample is present in an amount sufficient for causing the sample liquid to flow through
the indicator zones toward the absorption area (3), and for causing the analytes or the
derivatives thereof in the sample liquid to form a complex in the indicator zones.
[57]
__________________
173022 [21[]11]
תרכובות טטראציקליניות, שיטה לטיפול במצב המגיב לטטראציקליות במטופל שאינו אנושי, תכשיר פרמצבטי ושימוש בהן להכנת תרופוה
TETRACYCLINE COMPOUNDS, A
METHOD OF TREATING A
TETRACYCLINE RESPONSIVE
STATE IN A NON-HUMAN
SUBJECT, A PHARMACEUTICAL
COMPOSITION AND USE
THEREOF FOR THE
PREPARATION OF A
MEDICAMENT
[54]
25.06.2004 [22] US [33] 09.07.2003 [32] 60/486017 [31]
US 25.11.2003 60/525287
US 16.12.2003 60/530123
US 27.04.2004 60/566150
Int. Cl.(2010.01) A61K 31//65, A61P 31//04, C07D 21/1/34 [51]
December 29, 2011 215-התשע"ב טבתב 'ג
PARATEK PHARMACEUTICALS,
INC., U.S.A. [71]
WO/2005/009944 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
The invention pertains to prodrugs of 9-aminomethyl substituted tetracycline
compounds, methods of using the compounds, and pharmaceutical compositions
containing them.
[57]
בקשות חלוקה מבקשה זו שטרם פורסמו9
024/67502046750/41145 The applications for division
from this application have
not yet been published
__________________
173062 [21[]11]
אמינוטטרלינים מותמרים לייצור –2–שימוש ב תרופה לטיפול בדיכאון
USE OF SUBSTITUTED 2-
AMINOTETRALINS FOR THE
MANUFACTURE OF A
MEDICAMENT FOR THE
TREATMENT OF DEPRESSION
[54]
22.07.2004 [22] DE [33] 26.07.2003 [32] 10334187.0 [31]
Int. Cl.(2010.01) A61K 31//341, 31//381, 31//40, A61P 25//24, C07D 20/7/335,
30/7/52, 33/3/20
[51]
UCB PHARMA GMBH, GERMANY [71]
WO/2005/009425 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to the use of a compound of general formula (I) and the
pharmaceutically acceptable salts, racemates or pure entiomers thereof for the
production of a medicament used to treat depression. The substituents are defined as in
the description.
[57]
December 29, 2011 216-התשע"ב טבתב 'ג
__________________
173067 [21[]11]
תערובת אבקות הניתנת לסינטור וקבלת חומר עצמית–מוצק בעל סיכה
POWDER MIXTURE CAPABLE
OF BEING SINTERED TO
PRODUCE A SELF-LUBRICATING
SOLID SUBSTANCE
[54]
10.01.2006 [22] FR [33] 12.01.2005 [32] 0500287 [31]
Int. Cl.(2010.01) B22F 01//00, 03//12, 05//00, C10M 10/3/04, 12/5/22, C22C 01//00,
01//04, 32//00, 38//00, 38//18, F16C 33//04
[51]
SNECMA SERVICES, FRANCE
SNECMA, FRANCE [71]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
A powder mixture suitable for sintering to form a self-lubricating solid material,
comprising a powder of a metal alloy that is a precursor for the matrix of said self-
lubricating solid material, particles of a first solid lubricant for insertion in said matrix
without reacting with said metal alloy during sintering of the powder, and particles of a
second solid lubricant for reacting with a component of said metal alloy during
sintering of the powder in order to form a lubricating phase, characterized in that the
particles of the first solid lubricant are particles of cerium trifluoride CeF3.
[57]
__________________
342217 [21[]11]
מבנה ושיטה להכנת טרנזיסטורים מתוחים , בעלי אזורי מקור ותעלה שאין CMOSמסוג
ביניהם התאמה סימטרית
STRUCTURE AND METHOD OF
MAKING STRAINED
SEMICONDUCTOR CMOS
TRANSISTORS HAVING
LATTICE-MISMATCHED
[54]
December 29, 2011 217-התשע"ב טבתב 'ג
SOURCE AND DRAIN REGIONS
04.08.2004 [22] US [33] 04.08.2003 [32] 10/604607 [31]
Int. Cl.(2010.01) H01L 21//20, 31//0328 [51]
IBM CORPORATION, U.S.A. [71]
WO/2005/017964 [87]
מעבדות יבמ מחלקת קנין רוחני, אוניברסיטת חיפה הר הכרמל
חיפה
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
[74]
A p-type field effect transistor (PFET) (10) and an n-type field effect transistor
(NFET) (12) of an integrated circuit are provided. A first strain is applied to the
channel region (20) of the PFET (10) but not the NFET (12) via a lattice-mismatched
semiconductor layer such as silicon germanium disposed in source and drain regions
(111) of only the PFET (10) and not of the NFET.(12) A process of making the PFET
(10) and NFET (12) is provided. Trenches are etched in the areas to become the source
and drain regions (111) of the PFET and a lattice-mismatched silicon germanium layer
(121) is grown epitaxially therein to apply a strain to the channel region of the PFET
adjacent thereto. A layer of silicon (14) can be grown over the silicon germanium layer
(121) and a salicide (68) formed from the layer of silicon to provide low-resistance
source and drain regions (111).
[57]
__________________
173638 [21[]11]
נגזרות איזוקסאזולין כמעכב קאספאס, תכשיר טיפולי המכיל אותו ושימוש בו למניעת דלקת
ואפופטוזיס
ISOXAZOLINE DERIVATIVES AS
CASPASE INHIBITORS,
THERAPEUTIC COMPOSITIONS
COMPRISING SAME AND USE
THEREOF FOR PREVENTING
INFLAMMATION AND
APOPTOSIS
[54]
26.08.2004 [22] KR [33] 27.08.2003 [32] 10-2003-
0059451
[31]
December 29, 2011 218-התשע"ב טבתב 'ג
Int. Cl.(2010.01) C07D 26/1/04, 41/3/04, 41/3/12, 41/3/14 [51]
LG LIFE SCIENCES LTD.,
REPUBLIC OF KOREA [71]
WO/2005/021516 [87]
ד"ר יצחק הס ושותפיו, 279רחוב הירקון
תל אביב6451, ת.ד.
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[74]
The present invention relates to an isoxazoline derivative as an inhibitor against
various caspases, a process for preparing the same, and a therapeutic composition for
preventing inflammation and apoptosis comprising the same
[57]
__________________
173982 [21[]11]
מתקן, מערכת ושיטה לניהול תקשורת קישור הפוך
APPARATUS, SYSTEM AND
METHOD FOR MANAGING
REVERSE LINK
COMMUNICATION
[54]
08.09.2004 [22] US [33] 08.09.2003 [32] 60/501563 [31]
US 08.09.2003 60/501450
Int. Cl.(2010.01) H04B 07//005, 07//185, H04W 52//24, 52//26 [51]
QUALCOMM INCORPORATED,
U.S.A. [71]
WO/2005/027371 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
In accordance with an exemplary embodiment of the invention, an apparatus, system,
and method efficiently manage reverse link resources by allowing a mobile station to
select between transmitting a payload a standard power level and transmitting a
smaller payload at a boosted power level. The mobile station, therefore, can
autonomously select a QoS (Quality of Service) level for physical layer packets. Based
on reverse link transmission information received from a base station, the mobile
station derives a reverse link transmission guideline defining the power levels and
associated payloads for at least a standard service and boosted service. The mobile
station selects a reverse link transmission power level from a plurality of power levels
including at least a standard reverse link transmission power level associated with a
standard payload size and a boosted reverse link transmission power level associated
[57]
December 29, 2011 219-התשע"ב טבתב 'ג
with a boosted payload size where the standard payload size is greater than the boosted
payload size.
__________________
173997 [21[]11]
אטמים
SEALS
[54]
26.08.2004 [22] GB [33] 05.09.2003 [32] 0320858.4 [31]
Int. Cl.(2010.01) A47B 88//04, F16J 15//02, F25D 23//08, 25//02 [51]
APPLIED DESIGN AND
ENGINEERING LIMITED, UNITED
KINGDOM
[71]
IAN DAVID WOOD [72]
WO/2005/024315 [87]
אגמון,-סורוקר 14בית נולטון, רחוב שנקר
הרצליה פיתוח
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
[74]
A storage compartment comprises a container defining an access aperture closable by a
closure that can be sealed to the container around the aperture and that can be opened
by relative movement between the container and the closure in a lateral direction with
respect to the aperture, the container having a first sealing loop around the aperture and
the closure having a second sealing loop co-operable by alignment with the first
sealing loop to maintain a seal when the closure closes the aperture. The sealing loops
are moved into and out of mutual alignment by said relative movement between the
container and the closure and at least one of the sealing loops includes magnetic means
for attracting the other of the sealing loops to maintain a seal when the sealing loops
are mutually aligned.
[57]
December 29, 2011 220-התשע"ב טבתב 'ג
__________________
174075 [21[]11]
פיפרזין כמעכבי הספיגה –בנזואיל–1נגזרות של של גליצין לטיפול בפסיכוזה
1-BENZOYL-PIPERAZINE
DERIVATIVES AS GLYCINE
UPTAKE INHIBITORS FOR THE
TREATMENT OF PSYCHOSES
[54]
31.08.2004 [22] EP [33] 09.09.2003 [32] 03019682.8 [31]
Int. Cl.(2010.01) A61K 31//495, 31//496, A61P 25//28, C07D 29/5/18, 40/3/04 [51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2005/023261 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The invention relates to compounds of formula (I) wherein Ar is substituted aryl or
unsubstituted or substituted 6-membered heteroaryl, containing one, two or three
nitrogen atoms, and wherein the aryl and the heteroaryl groups may be substituted by
one or more substituents selected from the group consisting of hydroxy, halogen, CN,
(C1C6)-alkyl, (C1-C6)-alkyl substituted by halogen, (C1-C6)-alkoxy, (C1-C6)-alkoxy
substituted by halogen, NR7R
8, C(O)R
9 or SO2R
10; R
1 is hydrogen or (C1-C6)-alkyl; R
2
is halogen, (C1-C6) -alkyl, (C2-C6) -alkenyl, wherein a hydrogen atom may be replaced
by CN, C(O)-R9 or (C1-C6)-alkyl, or is (C2-C6)alkynyl, (C1-C6)-alkyl substituted by
halogen, -(CH2)n-(C3-C7)-cycloalkyl, -(CH2)n-heterocycloalkyl, -C(O)-R9, -(CH2)n-aryl
or -(CH2)n-5 or -6membered heteroaryl containing one, two or three heteroatoms,
selected from the group consisting of oxygen, sulphur or nitrogen wherein aryl,
cycloalkyl, heterocycloalkyl and heteroaryl are unsubstituted or substituted by one or
more substituents selected from the group consisting of hydroxy, halogen, (C1-C6)-
alkyl, (C1-C6)-alkyl substituted by halogen or (C1-C6) alkoxy; R3, R
4 and R
6
independently from each other are hydrogen, hydroxy, halogen, (C1-C6)-alkyl or (C1-
C6)-alkoxy; R5 is NO2, CN, C(O)R
9, SO2R
10 or NR
11R
12 ; R
7 and R
8 independently
from each other are hydrogen or (C1-C6)-alkyl; the other substituents are defined in the
claims; and to pharmaceutically acceptable acid addition salts thereof for the treatment
of psychoses, pain, neurodegenerative disfunction in memory and learning,
schizophrenia, dementia and other diseases in which cognitive processes are impaired,
such as attention deficit disorders or Alzheimer's disease.
[57]
December 29, 2011 221-התשע"ב טבתב 'ג
__________________
174148 [21[]11]
מתקן עזר לקידוח ידני אנכי
DEVICE FOR MANUAL
VERTICAL DRILLING
[54]
07.03.2006 [22]
Int. Cl.(2010.01) B23B 45//00 [51]
GIDEON ALON [71] גדעון אלון, קבוץ מעברות
גדעון אלון, קבוץ מעברות
GIDEON ALON,
KIBUTZ MAABAROT 40230
[74]
הבנוי להוביל תנועה אנכית ביחס לבסיס 2, עמוד חלול 1של חלק, הכולל: בסיס בעל שני צדדים מתקן לקידוח קדח במשטח
המותקנת בתוך בית התפסנית 5הצמוד למוביל המחליק, תפסנית למקדח 3, בית תפסנית למקדח 4וכולל מוביל מחליק
ק בתוך העמוד החלול מאפשר למקדח והניתנת להנעה סיבובית על ידי מניע חיצונית, כאשר המהלך של המוביל המחלי
המהודק בתפסנית לבצע קידוח מעבר לבסיס, כאשר העמוד החלול מותקן על גבי אחד משני הצדדים העיקריים של הבסיס
לצורך הצמדה אל המשטח 6והחלק לקידוח מיועד להיות מוצמד לצד האחר של הבסיס כאשר הבסיס כולל יחידת ואקום
של התפסנית אינו עובר דרך הבסיס.עבודה, וכאשר קו הקידוח
[57]
__________________
174172 [21[]11]
–PSGLמולקולה מולטימרית הקושרת חלבוני
, שימושים שלה וערכה המכילה אותה1
MULTIMERIC COMPOUND THAT
BINDS PSGL-1 PROTEINS, USES
THEREOF AND KITS
COMPRISING THE SAME
[54]
09.09.2004 [22] US [33] 15.09.2003 [32] 10/662906 [31]
Int. Cl.(2010.01) A61K 38//17, C07K 14//435, 14//705, 16//18, 16//28 [51]
ABGENOMICS COOPERATIEF U.A.,
THE NETHERLANDS [71]
WO/2005/027831 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
December 29, 2011 222-התשע"ב טבתב 'ג
רמת החייל
Multimeric compounds that bind to P-Selectin Glycoprotein 1 (PSGL-1) on the surface
of T cells or natural killer (NK) cells can be used to induce T cell or NK cell depletion
and/or to induce T cell or NK cell apoptosis. The multimeric compounds and methods
of the invention can be used to control unwanted T cell-or NK cell-mediated immune
responses in conditions such as inflammatory diseases, autoimmune diseases,
transplant rejection, and allergic diseases.
[57]
__________________
174299 [21[]11]
[ ,תכשירים 3.1.0תולדות ביציקליים ] פרמצפטיים ושימוש בהם
BICYCLIC [3.1.0] DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS AND USE
THEREOF
[54]
14.10.2004 [22] US [33] 14.10.2003 [32] 60/510846 [31]
Int. Cl.(2010.01) A61K 31//403, C07D 20/9/04, 41/3/12 [51]
PFIZER PRODUCTS, INC., U.S.A. [71]
WO/2005/037216 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
The present invention relates to a series of substituted bicyclic [3.1.0]amines of the
Formula I: Wherein A, B, D, Q, V, W, X, Y, Z, R2, R
3, R
4, R
5, R
14, R
15, R
30.o, p, s, t
and q are as defined in the specification, their pharmaceutically acceptable salts,
pharmaceutical compositions thereof, and their use for the enhancement of cognition
and the treatment of the positive and negative symptoms of schizophrenia and other
psychoses in mammals, including humans.
[57]
December 29, 2011 223-התשע"ב טבתב 'ג
__________________
174373 [21[]11]
–)קרבוקסיאלקיל( –1תולדות –בנזאזאפין–ציקלופנטיל קרבונילאמינו
N – חומצה אצטית מותמרתבאמידומתיל, תהליך וחומר ביניים
להכנתן ותרופות המכילות תרכובות אלו
AMIDOMETHYL SUBSTITUTED 1-
(CARBOXYALKYL)-
CYCLOPENTYLCARBONYLAMINO-
BENZAZEPINE-N-ACETIC ACID
DERIVATIVES, PROCESS AND
INTERMEDIATE PRODUCTS FOR THEIR
PREPARATION AND MEDICAMENTS
CONTAINING THESE COMPOUNDS
[54]
23.09.2004 [22] DE [33] 26.09.2003 [32] 10344848.9 [31]
EP 12.01.2004 04100065.4
Int. Cl.(2010.01) A61K 31//55, A61P 09//10, 09//12, 15//10, C07D 22/3/16, 40/1/12,
40/9/12
[51]
SOLVAY PHARMACEUTICALS GMBH,
GERMANY [71]
WO/2005/030795 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Described are novel compounds with neutral endopeptidase (NEP) and/or human
soluble endopeptidase (hSEP) inhibitory activity of the general formula (I), wherein the
substituents R1, R
2 , R
3 and R
4 have the meanings given in the description and also
medicaments containing these compounds, in particular medicaments suitable for
treating or preventing cardiovascular diseases, sexual dysfunction and/or adverse
conditions associated with apoptosis.
[57]
__________________
174374 [21[]11]
December 29, 2011 224-התשע"ב טבתב 'ג
שימוש בתרכובות הדמיה להכנת הרכבים למעקב אחרי מסה אוצורה של תאי בטא של
הלבלב
USE OF IMAGING COMPOUNDS
FOR THE PREPARATION OF
COMPOSITIONS FOR
MONITORING PANCREATIC
BETA CELL MASS OR
MORPHOLOGY
[54]
16.09.2004 [22] US [33] 17.09.2003 [32] 60/503683 [31]
Int. Cl.(2010.01) A61K 10/3/10, 31//175, 31//426, 31//4439, 51//00, 51//04 [51]
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM,
U.S.A.
[71]
WO/2005/027981 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Compositions for imaging beta cells comprise chelator-antidiabetic agent conjugates
and optionally chelated metals.
[57]
__________________
174414 [21[]11]
–( Z])–5מלח מאלאט אנהידרטי קריסטלי של
–H 3–דיהידרו–1,2אוקסו –2–פלואורו–5)–N– [(S 2 ( –2–אילידן( מתיל[–3–אינדול
–2,4–אילפירופיל[–4–מורפולינ–3–הידרוקסי קרבוקסאמיד–3–פירול–H–1–דימתיל
CRYSTALLINE ANHYDROUS
MALEATE SALT OF 5-[(Z)-(5-
FLUORO-2-OXO 1,2-DIHYDRO-
3H-INDOL-3-YLIDENE)
METHYL]-N-[(2S)-2-HYDROXY-3-
MORPHOLIN-4-YLPROPYL]-2,4-
DIMETHYL-1H-PYRROLE-3-
CARBOXAMIDE
[54]
20.09.2004 [22] US [33] 02.10.2003 [32] 60/508104 [31]
Int. Cl.(2010.01) C07D 40/3/06 [51]
PHARMACIA & UPJOHN
COMPANY LLC, U.S.A. [71]
WO/2005/033098 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
[74]
December 29, 2011 225-התשע"ב טבתב 'ג
BEER-SHEVA 84152 The invention relates to non-hygroscopic salts of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-
3H--indol-3-ylidene)methyl]-N-[(2)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-
1 H-pyrrole-3--yarboxamide, shown in structural formula (1) such as maleate salts, and
to crystalline polymorphs of these salts. The invention further relates to pharmaceutical
compositions of 5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3--ylidene)methyl]-N-
[(2S)-2-hydroxy carboxamide salts, and meth roxy-3-morpholin-4-ylpropyl]-2,4-
dimethyl-1 H-pyrrole-3- ds of treating disorders such as cancer using such
compositions.
[57]
__________________
174513 [21[]11]
–אזפין ובנזו –נגזרות מותמרות של דיבנזוסקרטז, –דיאזפין המשמשות כמעכבי גמא
תהליך להכנתן ושימושן בהכנת תרופות לטיפול במחלת האלצהיימר
SUBSTITUTED DIBENZO-
AZEPINE AND BENZO-
DIAZEPINE DERIVATIVES
USEFUL AS GAMMA-SECRETASE
INHIBITORS, A PROCESS FOR
THEIR PREPARATION AND USE
THEREOF IN THE PREPARATION
OF MEDICAMENTS FOR
TREATING ALZHEIMER'S
DESEASE
[54]
27.09.2004 [22] EP [33] 06.10.2003 [32] 03022650.0 [31]
Int. Cl.(2010.01) A61K 31//55, 31//5513, A61P 25//28, C07D 22/3/18, 24/3/12,
40/1/12, 40/3/12, 40/5/12, 40/9/12, 41/7/12, C07F 07//10
[51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2005/040126 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention relates to compounds of the general formula (I) Wherein R1 is -
(CHR’)q-aryl or -(CHR')q-heteroaryl, which are unsubstituted or mono, di- or tri-
[57]
December 29, 2011 226-התשע"ב טבתב 'ג
substituted by lower alkyl, lower alkoxy, CF3 or halogen, or is lower alkyl, lower
alkenyl, -(CH2)n-Si(CH3)3, -(CH2)n-O-lower alkyl, -(CH2)n-S-lower alkyl, -(CH2)q-
cycloalkyl, -(CH2)n-[CH(OH)]m-(CF2)p-CHqF(3-q), or is -(CH2)n-CR2-CF3, wherein the
two R radicals form together with the carbon atom a cycloalkyl ring; R' is hydrogen or
lower alkyl; n is 1, 2 or 3; in is 0 or 1; p is 0, 1, 2, 3, 4, 5 or 6; q is 0, 1, 2 or 3; R2 is
hydrogen or lower alkyl; R3 is hydrogen, lower alkyl, -CH
2CF
2CF3, CH
2CF3,
(CH2)2CF3, CF3, CHF2, CF3, CHF2, CH2F, or is aryl, optionally mono, di or tri-
substituted by halogen, or is (CH2)nNR5R
6, wherein R
5 and R
6 are independently from
each other hydrogen or lower alkyl; R4 is one of the following groups wherein R
7is
hydrogen, lower akl, -(CH2)n-CF3 or -(CH2)n-cycloalkyl; R8 is hydrogen, lower alkyl, -
C(O)-phenyl, -C(O)-lower alkyl, -C(O)O-(CH2)n- cycloalkyl, -C(O)O-(CH2)n-lower
alkyl, -C(O)NH-(CH2)n-lower alkyl or -C(O)NH(CH2).-CyClOalkYl; R9 is hydrogen,
lower alkyl, -(CH2)n-cycloalkyl or -(CH2)n-CF3; and to pharmaceutically suitable acid
addition salts, optically pure enantiomers, racernates or diastereomeric mixtures
thereof for the treatment of Alzheimer's disease..
__________________
174670 [21[]11]
כלי חיתוך
CUTTING TOOL
[54]
30.03.2006 [22]
Int. Cl.(2010.01) B23B 27//00, 27//04, 27//08 [51]
ISCAR LTD. [71] ישקר בע"מ, תפן
GIL HECHT [72] גיל הכט
ישקר בע"מ, תפן11, ת.ד.
ISCAR LTD.,
P.O.B. 11,
TEFEN 24959
[74]
A cutting tool having a tool axis (A) establishing a forward-to-rear direction, the
cutting tool comprising a cutting insert and an insert holder, the cutting insert having
an insert axis (B), and a peripheral side surface comprising a first wall, a second wall,
a third wall and at least one operative cutting section, the insert holder comprises a
forward securing portion and a rear body portion, the forward securing portion
comprises a base and securing surface, the securing surface including a first support, a
second support and a third support which all extend transversely to the base, at least a
portion of the first support abuts at least a portion of the first wall along a first
abutment region, at least a portion of the second support abuts at least a portion of the
second wall along a second abutment region and at least a portion of the third support
[57]
December 29, 2011 227-התשע"ב טבתב 'ג
abuts at least a portion of the third wall along a third abutment region, wherein: the
first and the second abutment regions diverge downwardly, the second and the third
abutment regions diverge rearwardly and the third wall generally faces upwardly.
__________________
174681 [21[]11]
שיטה לייצור מכשיר מיקרואלקטרוני ארוז בוואקום
METHOD OF MANUFACTURING
A PACKAGED VACUUM
MICROELECTRONIC DEVICE
[54]
15.08.2001 [22] US [33] 31.08.2000 [32] 09/652516 [31]
Int. Cl.(2008.04) H01J 1//62 [51] DIVISION FROM 154517 [62]
INTEVAC, INC., U.S.A. [71]
WO/2002/019365 [87]
ן ושותפיו,ריינהולד כה א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A method of manufacturing a packaged vacuum microelectronic device, said device
comprising a rectangular photocathode and a rectangular semiconductor die,
comprising: fabricating a housing of a ceramic material and forming a cavity within
said housing, wherein said die and said cavity exhibit rectangular shapes and said
housing comprises an electrical isolator; inserting said semiconductor die into said
housing; orienting said die within said housing whereby the volume of said housing is
efficiently employed, said die comprising a photodiode array; bonding the rectangular
photocathode to a surface of a transparent closure member; bonding a transparent
closure member to a sealing surface of said housing ,and drawing a vacuum in said
cavity.
[57]
December 29, 2011 228-התשע"ב טבתב 'ג
__________________
174764 [21[]11]
נוליטי במצב מוצק של לייזר התקן לייזר מו משאבת דיודה
LASER DIODE-PUMPED
MONOLITHIC SOLID STATE
LASER DEVICE
[54]
08.10.2004 [22] FR [33] 09.10.2003 [32] 0311809 [31]
Int. Cl.(2010.01) H01S 03//109 [51]
OXXIUS SA, FRANCE [71]
WO/2005/036703 [87]
ושותפיו,ריינהולד כהן א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to an intracavity-doubled laser device, comprising a pumping
laser-diode, a Nd:YAG amplifying medium stimulated by a laser beam with a
fundamental wavelength emitted by the laser diode, the output face of said amplifying
medium being cut at the Brewster angle for said fundamental wavelength and a
birefringent frequency-doubling KNbO3 crystal. The device further comprises an
isotropic medium (3), inserted between the input face (8) of the birefringent crystal,
the amplifying medium (2) and the birefringent crystal (4), being fixed to each other
such as to provide a monolithic resonant cavity. Furthermore, the crystal axis 'c' of the
birefringent crystal includes a non-zero angle ?c with relation to the orthogonal
direction of polarisation of the fundamental wave defined by the Brewster surface.
[57]
__________________
December 29, 2011 229-התשע"ב טבתב 'ג
174786 [21[]11]
מולקולות חומצות גרעין המקודדות וריאנטים של הרגולין, תכשירים ושיטות הכנה ושימוש
NUCLEIC ACID MOLECULES
ENCODING HEREGULIN
VARIANTS, COMPOSITIONS AND
METHODS FOR THEIR
PRODUCTION AND USE
[54]
10.02.1998 [22] US [33] 10.02.1997 [32] 08/799054 [31]
Int. Cl.(2010.01) A61K 38//17, C07K 14//47, 14//475, C12N 15//12 [51] DIVISION FROM 130827 [62]
GENENTECH, INC., U.S.A. [71]
WO/1998/035036 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A nucleic acid molecule encoding a heregulin variant having an amino acid sequence
not found in nature and the ability to bind an ErbB receptor, wherein said variant
comprisses a methionine residue in place of amino acid residues corresponding to
residue numbers 228 to 231 of native human heregulin-beta 1 (SEQ ID NO: 93)
numbered from the N-terminus and said heregulin variant comprises a portion that is at
least 70% identical to the portion from about residue 175 to about residue 230 of
native human heregulin-beta 1 (SEQ ID NO: 93), said heregulin variany having a
greater specificity for the ErbB4 receptor, relative to the ErbB3 receptor, than a
heregulin that differs from the heregulin variant only in that the heregulin comprises
said amino acid residues corresponding to residue numbers 228 to 231 in place of said
methionine.
[57]
__________________
174941 [21[]11]
–2–]הטרואריל)פפרידינ–Nתולדות של איל(מתיל[ בנזאמיד ותכשירים רוקחיים
המכילים אותן
DERIVATIVES OF N-
[HETEROARYL (PIPERIDINE-2-
YL) METHYL] BENZAMIDE AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
[54]
15.10.2004 [22]
December 29, 2011 230-התשע"ב טבתב 'ג
FR [33] 17.10.2003 [32] 0312142 [31]
Int. Cl.(2010.01) C07D 41/7/06 [51]
SANOFI, FRANCE [71]
WO/2005/037781 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
The invention relates to compounds having general formula (I), wherein: R1 represents
H or an alkyl, cycloalkyl, cycloalkylalkyl, phenylalkyl, alkenyl, alkynyl group; R2
represents a pyridinyl, furanyl, thienyl, thiazolyl or oxazolyl group, said group being
optionally substituted; and R3 represents H, one or more substituents selected from
among the halogen atoms and the trifluoromethyl, alkyl, cycloalkyl, alkoxy, phenyl,
cyano, acetyl, benzoyl, thioalkyl, alkylsulfonyl, carboxy or alcoxycarbonyl groups, or
a group having general formula NR4R5 or SO2NR4R5 or CONR4R5 in which R4 and R5
each represent H or an alkyl group or, together with the nitrogen atom bearing same,
form a pyrrolidine, piperidine or morpholine ring, said compound taking the form of a
base, an acid addition salt, a hydrate or a solvate. The invention also relates to the use
of the compound in therapeutics.
[57]
__________________
175017 [21[]11]
משאף לאבקה
POWDER INHALER
[54]
05.11.2004 [22] DE [33] 08.11.2003 [32] 10352277.8 [31]
Int. Cl.(2010.01) A61M 15//00 [51]
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH,
GERMANY
[71]
December 29, 2011 231-התשע"ב טבתב 'ג
WO/2005/044353 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
ילרמת החי
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to an inhaler for the inhalation of powdery medicaments in a
capsule form. Said capsules are inserted, prior to use, into a capsule holder (3)
arranged inside the inhaler (3). After the capsule is inserted into the capsule holder, the
patient can press the actuating element (8) which can be displaced from a resting
position and which co-operates with at least one needle (9) pushed into the capsule
holder. The aim of the invention is to further improve said type of inhalers with respect
to operational comfort. Said aim is achieved by providing an embodiment of an inhaler
wherein the actuating element is embodied as a multifunctional actuating element (8a),
thereby enabling the cover (5) of the lower part (1) to pivot when the closing element
(6) is inserted into a first functional position, and enabling the mouth piece (4), which
is secured to the plate (2), to be removed from the plate in a second functional position
in such a manner that the mouth piece can be pivoted away from the lower part.
[57]
בקשות חלוקה מבקשה זו שטרם פורסמו9
0242245 The applications for division
from this application have
not yet been published
__________________
175225 [21[]11]
, חומצת CD40–נוגדן חד שבטי אנטגוניסט אנטיגרעין המקודדת לנוגדן, שורת תאי היברידומה
המסוגלת לייצר את הנוגדן, שימושים בנוגדן ותכשירים רוקחיים המכילים אותו.
ANTAGONIST ANTI-CD40
MONOCLONAL ANTIBODY, AN
ISOLATED NUCLEIC ACID
ENCODING THE ANTIBODY, A
HYBRIDOMA CELL LINE
CAPABLE OF PRODUCING THE
ANTIBODY, USE OF THE
[54]
December 29, 2011 232-התשע"ב טבתב 'ג
ANTIBODY AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING IT
04.11.2004 [22] US [33] 04.11.2003 [32] 60/517337 [31]
US 26.11.2003 60/525579
US 27.04.2004 60/565710
Int. Cl.(2010.01) A61K 39//395, A61P 29//00, 35//02, 37//00, C07K 16//28, C12N
15//13
[51]
NOVARTIS VACCINES AND
DIAGNOSTICS, INC., U.S.A. [71]
WO/2005/044854 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Methods of therapy for treating diseases mediated by stimulation of CD40 signaling on
CD40-expressing cells are provided. The methods comprise administering a
therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-
binding fragment thereof to a patient in need thereof. The antagonist anti-CD40
antibody or antigen-binding fragment thereof is free of significant agonist activity, but
exhibits antagonist activity when the antibody binds a CD40 antigen on a human
CD40-expressing cell. Antagonist activity of the anti-CD40 antibody or antigen-
binding fragment thereof beneficially inhibits proliferation and/or differentiation of
human CD40expressing cells, such as B cells.
[57]
__________________
175521 [21[]11]
תהליך לטיפוח מיקרואורגניזמים ממין טראוסטוכיטריאלי
PROCESS FOR THE
CULTIVATION OF
MICROORGANISMS OF THE
GENUS THRAUSTOCHYTRIALES
[54]
10.11.2004 [22] DE [33] 10.11.2003 [32] 10352837.7 [31]
Int. Cl.(2010.01) C12N 01//14, C12P 07//64 [51]
NUTRINOVA NUTRITION
SPECIALTIES & FOOD
INGREDIENTS GMBH, GERMANY
[71]
WO/2005/045050 [87]
December 29, 2011 233-התשע"ב טבתב 'ג
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
The invention relates to an optimized method for the production of PUFAs by
cultivating microorganisms of the order thraustochytriales in a fermentation medium
that is pH-stabilized using calcium carbonate and comprises 3 to 15 g/L of CaCO3,
whereupon the PUFAs are isolated from the microorganisms and/or the medium. The
invention particularly relates to novel optimized media having a different CaCO3
content. By using adequate quantities of CaCO3, the process can be significantly
simplified during fermentation while greater quantities of DHA can be obtained at an
increased oil content in the biomass, allowing thraustochytriales microorganisms to be
fermented without controlling the pH, thereby substantially improving and
significantly simplifying PUFA production.
[57]
__________________
175572 [21[]11]
קינאז JAKהטרוציקלים דחוסים, מעכבי סלקטיביים ותכשירים רפואיים המכילים אותם
CONDENSED HETEROCYCLES,
JAK SELECTIVE KINASE
INHIBITORS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM
[54]
12.01.2005 [22] AU [33] 12.01.2004 [32] 2004900103 [31]
Int. Cl.(2010.01) A61K 31//497, C07D 40/3/04, 41/3/14 [51]
YM BIOSCIENCES AUSTRALIA
PTY LTD., AUSTRALIA [71]
WO/2005/066156 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts,
hydrates, solvates, crystal forms or diastereomers thereof, wherein A represents a
variety of six membered nitrogen containing heterocyclic rings, Q is a bond, halogen,
C1-4 alkyl, O, S, SO2, CO or CS and X1, X2, X3 and X4 are optionally substituted by 9
specific substituents or one can be nitrogen. Compositions comprising a carrier and at
least one compound of formula (I) are also provided. Further provided are methods of
treating tyrosine kinase-associated disease states by administering a compound of
[57]
December 29, 2011 234-התשע"ב טבתב 'ג
formula (I) and methods of suppressing the immune system of a subject by
administering a compound of formula (I).
__________________
175722 [21[]11]
תהליך והתקן לייצור פרורים ואבקת גומי
PROCESS AND APPARATUS FOR
MANUFACTURING CRUMB AND
POWDER RUBBER
[54]
16.11.2004 [22] US [33] 17.11.2003 [32] 10/714782 [31]
Int. Cl.(2010.01) B02C 19//18, B09B 05//00, B29B 17//04, C08J 11//04 [51]
LEHIGH TECHNOLOGIES, LLC,
U.S.A. [71]
WO/2005/049656 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
A process and apparatus for manufacturing crumb and powder rubber. The process and
apparatus include a cooling step (12), effectuated by cooling means, wherein the
temperature or cryogenically cooled preprocessed rubber particles is controlled. The
process and apparatus also include a grinding step (20), effectuated by grinding means,
in which degree of grinding, and thus the product particle size range, is controlled.
[57]
__________________
175765 [21[]11]
PROCESS FOR THE PURIFICATION [54] תהליך לטיהור של גאבאפנטין
December 29, 2011 235-התשע"ב טבתב 'ג
OF GABAPENTIN
14.12.2004 [22] IT [33] 16.12.2003 [32] MI2003A002456 [31]
Int. Cl.(2010.01) C07C 22/7/40, 22/9/28 [51]
ZAMBON GROUP S.P.A., ITALY [71]
WO/2005/058797 [87]
ושותפיו,ריינהולד כהן א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A process for the preparation of gabapentin comprising the passage of a salt of the
same through a ionic exchange resin of strong cationic type, the elution of the
gabapentin which has fixed onto the column and the crystallization from organic
solvent, characterized in that the resin is regenerated by using a mineral acid in a molar
quantity between 50 and 90%, is described.
[57]
__________________
175936 [21[]11]
פולימרים מבוססים על סילוקסן או מרוכבים לשימוש בחיישנים כימיים לגלות תרכובות
ניטראט
SILOXANE-BASED POLYMERS
OR COMPOSITES FOR USE IN
CHEMICAL SENSORS FOR
DETECTING NITRATE
COMPOUNDS
[54]
03.12.2004 [22] FR [33] 05.12.2003 [32] 0350984 [31]
Int. Cl.(2010.01) C08L 83//16, G01N 21//00 [51]
COMMISSARIAT A L'ENERGIE
ATOMIQUE, FRANCE [71]
WO/2005/057198 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
The invention relates to the use of at least one type of a polymer comprising a
repetitive structural unit of formula (I), wherein X and Y = a simple link or a linear C1-
C50 group; R1 and R2 = H, CN, C(Z)3, CH(Z)2, CH2Z with Z = halogens; NH2, NHR3,
NR3R4 with R3, R4 = halogens, CH3 or a linear or branched, saturated or unsaturated
C2-C20 hydrocarbon chain, possibly comprising one or several heteroatoms and/or
chemical functions containing at least one heteroatom; at least one R1 and R2 different
[57]
December 29, 2011 236-התשע"ב טבתב 'ג
from H; or a compound which comprises said polymer and one or several conductive
charges and is used as a sensitive material in a sensor for detecting nitrate compounds.
Said invention can be used for detecting explosive materials, controlling/monitoring
air pollution and the quality of environment and for monitoring industrial sites.
__________________
176147 [21[]11]
מתודולוגיה סינטתית לאלקילציה חיזורית של אינדולים C–3בעמדה
SYNTHETIC METHODOLOGY
FOR THE REDUCTIVE
ALKYLATION AT THE C-3
POSITION OF INDOLES
[54]
15.12.2004 [22] US [33] 16.12.2003 [32] 60/529797 [31]
Int. Cl.(2010.01) C07B 37//04, C07D 20/9/18 [51]
WYETH LLC, U.S.A. [71]
WO/2005/058820 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A process for the reductive alkylation at the C-3 position of an indole compound in
which the indole is treated with an aldehyde in the presence of a Lewis acid and a
silicon hydride reducing agent. The process is useful for alkylating the C-3 position of
indoles that contain acid-sensitive substituents at the N-1 position.
[57]
__________________
December 29, 2011 237-התשע"ב טבתב 'ג
176649 [21[]11]
שתלים פולימרים המכילים בעדיפות תערובת לשחרור מבוקר של חומר PLG –ו PEGשל
GNRHפעיל, עדיף
POLYMERIC IMPLANTS,
PREFERABLY CONTAINING A
MIXTURE OF PEG AND PLG, FOR
CONTROLLED RELEASE OF
ACTIVE AGENTS, PREFERABLY
A GNRH
[54]
23.12.2004 [22] US [33] 30.12.2003 [32] 60/533301 [31]
US 19.04.2004 60/563377
US 28.05.2004 60/575199
Int. Cl.(2010.01) A61K 09//00, 09//16, 09//20, 38//24 [51]
DURECT CORPORATION, U.S.A. [71]
JOHN W. GIBSON, ARTHUR J.
TIPTON
[72]
WO/2005/067889 [87]
שות',ד"ר שלמה כהן ו 124אבן גבירול
תל אביב11490, ת.ד.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[74]
Polymeric devices for controlled release of an active agent of interest are provided.
The active agent is provided within a biodegradable polymer system to supply a
polymeric device for controlled release of the active agent. The polymer system is a
copolymer or a polymer blend comprising a hydrophobic component and a hydrophilic
component, and the polymer system does not form a hydrogel when contacted with, or
immersed in an aqueous system, for example when the device is implanted in a
subject. When the device is administered to a subject, for example, when it is
implanted, the device releases the active agent in a controlled fashion without a lag
period, or with a minimal lag period. Methods for producing the polymeric devices are
also provided, as are methods of using the polymeric devices to provide for controlled
release of an active agent in a subject. Preferred hydrophobic component is a PLG.
Preferred hydrophilic Components are a PEG or a methoxyPEG. Preferred peptides are
LHRH, goserelin, leuprolide.
[57]
__________________
231773 [21[]11]
מכונת דפוס דיגיטאלית, רב שלבית, בטכנולוגית מערכת ושיטת הדפסה –הזרקת דיו
MULTI-STAGE INK JET DIGITAL
PRINTING APPARATUS,
METHOD AND SYSTEM
[54]
December 29, 2011 238-התשע"ב טבתב 'ג
10.02.2005 [22] US [33] 12.02.2004 [32] 10/776163 [31]
IL 30.05.2004 162231
Int. Cl.(2010.01) B41J 02//135, 15//04, 33//34, D06B 01//00 [51]
-קורנית דיגיטל טכנולוגיות בע"מ, ראש העין
KORNIT DIGITAL TECHNOLOGIES
LTD. [71]
OFER BEN-ZUR, YOSSI PEARL [72] צור, יוסי פרל-עופר בן
WO/2005/076730 [87]
( בע"מ,1995ג'י.אי.ארליך ) 11,רחוב מנחם בגין 15מגדל איילון, קומה
רמת גן
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[74]
A digital printing machine includes a rigid frame, a first linear motion X axis stage
mounted on the frame, a printing table assembly movable on each linear X axis stage,
a linear motion Y axis stage mounted on the frame perpendicular to the linear X axis
stages, above the printing table assemblies, and an array of inkjet nozzles mounted on
the linear Y axis stage for linear motion perpendicular to the X axis stage, also a
second linear motion X axis stage mounted on the frame parallel to the first axis stage
and arranged for operation independently of the first axis stage, and/or a curing unit
located above the printing table assembly and/or a pre-printing wetting assembly, for
printing over garments, by applying wetting composition on the printed material, prior
to printing.
[57]
__________________
177324 [21[]11]
תכשיר המכיל תאי גזע רב עוצמתיים מתרבים של יונק עליון
COMPOSITION COMPRISING
PROLIFERATING PRIMATE
PLURIPOTENT STEM CELLS
[54]
10.01.2001 [22] US [33] 11.01.2000 [32] 60/175581 [31]
US 22.06.2000 60/213740
US 22.06.2000 60/213739
US 07.07.2000 60/216387
US 21.07.2000 60/220064
US 10.10.2000 09/688031
Int. Cl.(2010.01) C12N 05//0789 [51] DIVISION FROM 141742 [62]
GERON CORPORATION, U.S.A. [71]
December 29, 2011 239-התשע"ב טבתב 'ג
WO/2001/051616 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
בותרחו2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
A composition comprising proliferating primate pluripotent stem cells which is
essentially free of feeder cells and further comprises a soluble preparation from
Engelbreth-Holm-Swarm tumor cells.
[57]
__________________
177414 [21[]11]
שיטה לייצור ציפוי קשה בעל עמידות גבוהה לקורזיה על פריטים המיוצרים ממתכות או
סגסוגות הניתנות לאינוד
METHOD FOR PRODUCING A
HARD COATING WITH HIGH
CORROSION RESISTANCE ON
ARTICLES MADE OF
ANODIZABLE METALS OR
ALLOYS
[54]
05.07.2005 [22] US [33] 23.07.2004 [32] 10/898152 [31]
Int. Cl.(2010.01) C25D 11//02 [51]
אלונים אחזקות אגש"ח בע"מ, קיבוץ אלונים
ALONIM HOLDINGS
AGRICULTURAL COOPERATIVE
SOCIETY LTD.
[71]
ILYA OSTROVSKY [72] איליה אוסטרובסקי
WO/2006/007972 [87]
ד"ר מרק פרידמן בע"מ,, רחוב ז'בוטינסקי 54מגדל משה אביב, ק.
7 גן -רמת
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[74]
A method for coating, a composition suitable for coating and a coating generated with
the method of coating on anodizable metallic surfaces, especially on magnesium rich
and aluminum rich surfaces, is disclosed. The composition is an aqueous solution
including alkali metal or ammonium cations, phosphorus containing anions and silicon
containing anions as well as optionally a peroxide or a compound of Al, Ti, Zr or any
mixture of them. Preferably, the anodizing is carried out with a micro-arc oxidation
process.
[57]
__________________
December 29, 2011 240-התשע"ב טבתב 'ג
177561 [21[]11]
אמינוכוהולים –3מותמר –1תהליך להכנת טהורים מבחינה איננטומרית
PROCESS FOR THE
PREPARATION OF
ENANTIOMERICALLY PURE 1-
SUBSTITUTED-3-
AMINOALCOHOLS
[54]
21.02.2005 [22] EP [33] 19.02.2004 [32] 04003809.3 [31]
EP 28.04.2004 04010043.0
Int. Cl.(2010.01) C07C 21/3/00, C07D 33/3/20, 33/3/22 [51]
LONZA LTD., SWITZERLAND [71]
WO/2005/080370 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
Provided is a process for the preparation of enantiomerically pure 1-substituted-3-
aminoalcohols, particularly of (S)-(-)- and (R)-(+)-3-N-methylamino-l-(2-thienyl)-1-
propanol, by asymmetrically hydrogenating salts of a carboxylic acids with an
aminoketone of formula (II), wherein R1 is selected from the group consisting of 2-
thienyl, 2-furanyl and phenyl, each optionally substituted with one or more halogen
atoms and/or one or more C1-4-alkoxy groups, and wherein R2 is C1-4-alkyl or phenyl,
each optionally substituted with one or more halogen atoms and/or one or more C1-4-
alkyl or C1-4-alkoxy groups, and wherein the corresponding aminoalcohols are
obtained by subsequent hydrolysis of their salts. Furthermore provided are salts of a
carboxylic acid with said aminoketones and the aminoalcohols obtained by
asymmetriacally hydrogenating said aminoketones, respectively.
[57]
__________________
177563 [21[]11]
שיטות להגנה על צמחים על ידי שימוש באבאמקטין ותיאמטוקסאם
METHODS FOR PROTECTING
PLANTS USING ABAMECTIN AND
[54]
December 29, 2011 241-התשע"ב טבתב 'ג
THIAMETHOXAM
07.06.2004 [22] US [33] 16.03.2004 [32] 60/553516 [31]
Int. Cl.(2010.01) A01N 25//00, 43//00, 51//00 [51]
SYNGENTA PARTICIPATIONS AG,
SWITZERLAND [71]
WO/2005/094585 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention provides an at least binary composition for controlling
nematodes and insects or representatives of the order Acarina, which composition
comprises: (A) a nernaticidally effective amount of at least one macrolide, and (B) an
insecticidally effective amount of at least one insecticide selected from the
neonicotinoids.
[57]
__________________
177591 [21[]11]
שיטה לאיבחון סרטן השחלות על ידי השימוש בביומרקרים
METHOD FOR DIAGNOSIS OF
OVARIAN CANCER COMPRISING
BIOMARKERS
[54]
18.01.2005 [22] US [33] 19.02.2004 [32] 60/545581 [31]
US 20.02.2004 60/545900
Int. Cl.(2010.01) C12Q 01//68, G01N 33//48, 33//574 [51]
YALE UNIVERSITY, U.S.A. [71]
WO/2005/083440 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
The claimed invention describes methods to diagnose or aid in the diagnosis of cancer.
The claimed methods are based on the identification of biomarkers which are
particularly well suited to discriminate between cancer subjects and healthy subjects.
These biomarkers were identified using a unique and novel screening method
described herein. The biomarkers identified herein can also be used in the prognosis
and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN
and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.
[57]
December 29, 2011 242-התשע"ב טבתב 'ג
__________________
177761 [21[]11]
–גרגרי עמילן המכילים שמן לאספקת תוספי תועלת למצע
OIL CONTAINING STARCH
GRANULES FOR DELIVERING
BENEFIT-ADDITIVES TO A
SUBSTRATE
[54]
17.03.2005 [22] US [33] 18.03.2004 [32] 10/803586 [31]
Int. Cl.(2010.01) C11D 03//50 [51]
COLGATE-PALMOLIVE
COMPANY, U.S.A. [71]
WO/2005/090538 [87]
זליגסון גבריאלי ושות', 31רח' יבנה
תל אביב1426, ת.ד.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[74]
An oil containing starch granule is provided comprising: (a) a starch to form an
effective matrix for said granule; (b) a perfume oil comprising ingredients having a
calculated Clog P of at least 3, said Clog P being the calculated octanol to water
partition coefficient, said perfume oil being capable of providing a benefit-additive to a
substrate upon contact therewith, said substrate being selected from the group
consisting of fabrics, hard surfaces, hair and skin; and (c) an effective amount of a
defined organic compound for inhibiting the migration of said oil to the surface of said
starch granule.
[57]
__________________
December 29, 2011 243-התשע"ב טבתב 'ג
177778 [21[]11]
הידרוקסי –4תכשירים יציבים כימית של טאמוקסיפן
CHEMICALLY STABLE
COMPOSITIONS OF 4-HYDROXY
TAMOXIFEN
[54]
18.03.2005 [22] EP [33] 22.03.2004 [32] 04290762.6 [31]
US 22.03.2004 10/805530
Int. Cl.(2010.01) A61K 31//138, A61P 35//00, C07C 21/7/64 [51]
LABORATOIRES BESINS
INTERNATIONAL, FRANCE [71]
WO/2005/092310 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A class of chemically stable 4-hydroxy tamoxifen compositions is characterized by
roughly equal amounts of the Z-4-hydroxy tamoxifen and E-4-hydroxy tamoxifen
isomers, such that the potency of the compositions is not affected adversely by the
isomerization that occurs between these two forms. The inventive compositions are
useful for preventing or for treating medical conditions.
[57]
בקשות חלוקה מבקשה זו שטרם פורסמו9
0236755 The applications for division
from this application have
not yet been published
__________________
177886 [21[]11]
מכונת גלילה הקפית ומרכזית משולבת
COMBINED PERIPHERAL AND
CENTRAL REWINDING MACHINE
[54]
15.03.2005 [22] IT [33] 18.03.2004 [32] FI2004A000061 [31]
Int. Cl.(2010.01) B65H 19//30 [51]
FABIO PERINI S.P.A., ITALY [71]
WO/2005/087639 [87]
צדק לצר, פרל כהן 5, רח' שנקר 1ים -מרכז גב
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
[74]
December 29, 2011 244-התשע"ב טבתב 'ג
HERZLIYA 46733 הרצליה12704, ת.ד.
The rewinding machine comprises: a first winding roller (11) and a second winding
roller (13) defining a nip (15) through which said cores are inserted and through which
said web material (N) is fed; and at least one pair of motorized engaging members
(57), to engage the ends of a winding core and transmit a rotational movement to the
core during at least part of the winding cycle of each log. The engaging members and
the first and second winding roller are produced and disposed so that the log being
formed is in contact with said first and said second winding roller. Moreover, a third
winding roller (17) is provided, defining a winding space with said first and said
second winding roller, said third winding roller being movable to allow increase and
completion of winding of each log in said winding space.
[57]
__________________
178002 [21[]11]
שימוש בכמות אפקטיבית של חומר בהכנת , TH2תרופות לטיפול בהפרעה המתווכת על ידי
או לטיפול TH1לקידום תגובה חיסונית של באאוזינופיליה
USE OF A THERAPEUTICALLY
EFFECTIVE AMOUNT OF AN
AGENT IN THE PREPARATION
OF MEDICAMENTS FOR
TREATING A TH2-MEDIATED
DISORDER, PROMOTING A TH1
IMMUNE RESPONSE OR
TREATING EOSINOPHILIA
[54]
14.03.2005 [22] US [33] 12.03.2004 [32] 60/552523 [31]
US 27.10.2004 60/622559
Int. Cl.(2010.01) A61K 38//17, A61P 01//00, 07//00, 11//00, 13//12, 35//00, 37//00,
C07K 14//705
[51]
THE BRIGHAM AND WOMEN'S [71]
December 29, 2011 245-התשע"ב טבתב 'ג
HOSPITAL, INC., U.S.A.
BETH ISRAEL DEACONESS
MEDICAL CENTER, U.S.A. WO/2005/090573 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The invention relates to methods of modulating immune responses in a subject, such as
by administering to the subject agents which modulate tim-1, tim-2 or tim-4 activity,
or which modulate the physical interaction between tim-1 and tim-4 or between tim-2
and a tim-2 ligand. Immune responses include, but are not limited to, autoimmune
disorders, transplantation tolerance, and Thl and Th2-mediated responses and
disorders. The invention also relates to novel assays for identifying agents which
modulate the physical interaction between tim-1 and tim-4. In addition, the invention
relates to novel soluble tim-4 polypeptides and to nucleic acids which encode them.
[57]
__________________
178041 [21[]11]
מערכת אישית להעברת הודעות מולטימדיה
PERSONALIZED MULTIMEDIA
MESSAGING SYSTEM
[54]
23.03.2004 [22]
Int. Cl.(2010.01) H04L 12//58 [51]
NDS LIMITED, UNITED KINGDOM [71]
WO/2005/091537 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
A method for providing a personalized multimedia messaging service, wherein the
method includes obtaining an MMS message (800). Recipient according to
preferences of the at least one targeted recipient (900), thereby producing a
personalized MMS message (910), and transmitting the personalized MMS message to
the at least one targeted recipient indicate (1000) that the at least one targeted recipient
is not interested in receiving the personalized MMS message.
[57]
December 29, 2011 246-התשע"ב טבתב 'ג
בקשות חלוקה מבקשה זו שטרם פורסמו9
02222450222235 The applications for
division from this
application have not yet
been published
__________________
178202 [21[]11]
מערכת ושיטה ליצור דינאמי של שלוחת חיפוש נבחרת
SYSTEM AND METHOD FOR
DYNAMICALLY GENERATING A
SELECTABLE SEARCH
EXTENSION
[54]
30.07.2004 [22] US [33] 03.05.2004 [32] 60/566947 [31]
US 09.07.2004 10/887085
Int. Cl.(2010.01) G06F 03//00, 17//30 [51]
MICROSOFT CORPORATION,
U.S.A. [71]
WO/2005/111868 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A system and related techniques accept user-inputted search terms to perform a search
for files within a file system hierarchy. A user searches a current level of a file system
(120) by entering a search term in a search term input box (112) of a user interface
(104). A search box (114) is dynamically created and may present an extension of the
search to a different level (122) in the file system in an attempt to locate more or
further matching files or hits. The extension of the search may be automatically
generated when an initial search fails to produce any results. When the user does select
the selectable search box, the user's search may be seamlessly extended to other files,
folders, trees or other points or levels in the files system. Search results may be
continuously or dynamically updated as the user enters more characters or other data.
[57]
December 29, 2011 247-התשע"ב טבתב 'ג
__________________
178433 [21[]11]
מותמרים בעמדה –תולדות פנול או תיאופנול חד H3היעילות כליגנדים של 4או 3
3- OR 4-MONOSUBSTITUTED
PHENOL AND THIOPHENOL
DERIVATIVES USEFUL AS H3
LIGANDS
[54]
19.04.2005 [22] EP [33] 07.05.2004 [32] 04291187.5 [31]
GB 04.03.2005 0504564.6
Int. Cl.(2010.01) C07D 30/9/06 [51]
WARNER-LAMBERT COMPANY
LLC., U.S.A. [71]
WO/2005/108384 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of
formula (1) and to processes for the preparation of, intermediates used in the
preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-
monosubstituted phenol and thiophenol derivatives are H3 ligands and are useful in
numerous diseases, disorders and conditions, in particular inflammatory, allergic and
respiratory diseases, disorders and conditions.
[57]
December 29, 2011 248-התשע"ב טבתב 'ג
__________________
178446 [21[]11]
בחירת ורכישת מערכת למתקן אלחוטי
SYSTEM SELECTION AND
ACQUISITION FOR A WIRELESS
DEVICE
[54]
09.03.2005 [22] US [33] 09.04.2004 [32] 60/561019 [31]
US 25.01.2005 11/043359
Int. Cl.(2010.01) H04M 03//00, H04W 48//18, 88//06 [51]
QUALCOMM INCORPORATED,
U.S.A. [71]
WO/2005/104513 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
Wireless devices with different capabilities may use a single file containing multiple
(e.g., two) PRLs for system selection and acquisition. A first PRL in the file has a first
(e.g., IS-683-A) format and includes PRL information for, e.g., 1x systems. A second
PRL has a second (e.g., IS-683-C) format and includes PRL information for, e.g., 1x
and 1xEV-DO systems or just 1xEV-DO systems. A legacy wireless device supporting
only IS-683-A would read and use the first PRL for system selection and acquisition
and ignore the second PRL. A wireless device supporting IS-683-C would read the
second PRL and (1) use the second PRL by itself if it contains PRL information for
both 1x and 1xEV-DO systems or (2) combine the first and second PRLs to generate a
combined PRL if the second PRL contains PRL information for only 1xEV-DO
systems.
[57]
December 29, 2011 249-התשע"ב טבתב 'ג
__________________
178515 [21[]11]
אוליגופפטידים להפחתת ריכוז גבוה של אוריאה בדם
OLIGOPEPTIDES FOR
REDUCING ELEVATED BLOOD
UREA CONCENTRATION
[54]
08.04.2005 [22] US [33] 08.04.2004 [32] 10/821256 [31]
Int. Cl.(2010.01) A61K 38//06, 38//07 [51]
BIOTEMPT, B.V., THE
NETHERLANDS [71]
WO/2005/097163 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
The invention includes a method of reducing urea concentration in a subject's serum.
Such a method comprises administering to the subject (e.g., a mammal such as a
human) a composition comprising an oligopeptide (or oligopeptides) having activity in
reducing urea concentration in the subject's serum as determined by a mouse renal
reperfusion test, wherein the oligopeptide comprises the sequence QGV or MTRV
(SEQ ID NO:1) (e.g., AQGV (SEQ ID NO:2) or MTRV (SEQ ID NO:1)).
[57]
__________________
869417 [21[]11]
שיטה ומערכת לדחיסת תיקים לאחסון ופעילות על תיקים דחוסים
METHOD AND SYSTEM FOR
COMPRESSION OF FILES FOR
STORAGE AND OPERATION ON
COMPRESSED FILES
[54]
21.04.2005 [22] US [33] 26.04.2004 [32] 60/565298 [31]
Int. Cl.(2010.01) G06F 05//10, 17//30, H03M 07//30 [51]
STOREWIZ INC., U.S.A. [71]
WO/2005/103878 [87]
R&D, SUZANNE EREZ, IBM R&Dסוזן ארז, מעבדות יבמ
LABORATORIES,
[74]
December 29, 2011 250-התשע"ב טבתב 'ג
אוניברסיטת חיפה, הר הכרמל חיפה
HAIFA UNIVERSITY,
HAIFA 31905
A method and system for creating, reading and writing compressed files (44) for use
with a file access storage. The compressed data of a raw file (41) are packed into
plurality of compressed units (46) and stored as compressed file (44). One or more
corresponding compressed units (46A) may be read and/or updated with no need of
restoring the entire file whilst maintaining de-fragmented structure of the compressed
file (44).
[57]
__________________
790031 [21[]11]
שיטה ומערכת לאיחסון זהויות ארעיות של WLAN–I
METHOD OF AND SYSTEM FOR
STORAGE OF I-WLAN
TEMPORARY IDENTITIES
[54]
04.05.2005 [22] US [33] 06.05.2004 [32] 60/568625 [31]
US 15.03.2005 11/080918
Int. Cl.(2010.01) H04L 09//32, 12//28, 29//06 [51]
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN [71]
WO/2005/109818 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
A temporary-identity-storage method for user equipment includes receiving
authentication challenge information and at least one temporary identity, processing
the authentication challenge information, and determining whether the processing step
results in successful authentication. The user equipment includes mobile equipment
and a subscriber identity module. Responsive to a determination that the authentication
was successful, the received at least one temporary identity is considered to be valid. If
the received at least one temporary identity is at least one pseudonym and an
appropriate data file to the store the at least one pseudonym is available in the
subscriber identity module, the at least one pseudonym is stored and any previously-
[57]
December 29, 2011 251-התשע"ב טבתב 'ג
stored pseudonym is over-written in the subscriber identity module. If the received at
least one temporary identity is at least one pseudonym and an appropriate data file to
the store the at least one pseudonym is not available in the subscriber identity module,
the at least one pseudonym is stored and any previously-stored pseudonym is over-
written in the mobile equipment.
__________________
179254 [21[]11]
תילריוסיס–חיסון אנטי
ANTI-THEILERIOSIS VACCINE
[54]
12.05.2005 [22] IN [33] 14.05.2004 [32] 880/DEL/2004 [31]
IN 26.10.2004 2103/DEL/2004
Int. Cl.(2010.01) A61K 39//002, 39//018 [51]
NATIONAL RESEARCH
DEVELOPMENT CORPORATION,
INDIA
[71]
WO/2005/109991 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
יילרמת הח
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A process for the preparation of anti-theileriosis vaccine comprising the steps of
isolating lymphoid cells infected with schizonts of Theileria annulata present in an
infected animal, culturing the infected cells in a growth medium, subjecting said
cultured cells to the step of in-vitro propagation by-serial passaging, developing cloned
curltures from a single cell by limiting dilution technique and further passaging these,
karyotyping the cells in the medium to ascertain the diploid character, and obtaining
viable cells with maximum infectivity rates, determining macroschizont nuclear
number, subjecting a number of viable cells with diploid character to the step of
cryoprotectant in liquid nitrogen in the presence of a cryoprotectant in the said growth
medium to obtain a suspension of viable cells, testing these cultures at different
passages and in varying dose levels in groups of calves for ascertaining their
[57]
December 29, 2011 252-התשע"ב טבתב 'ג
pathogencity / antigenicity, determining passage level and dose for the safety and
efficacy of candidate vaccine, its safe use in new born calves and pregnant cows, time
taken to induce immunity, serological responses and erect on haematological
parameters, and testing its efficacy under wide field conditions in the susceptible stock.
__________________
179370 [21[]11]
נגזרות נפתלן, תהליך לייצורן, תכשירים לים אותן, ושימושן בהכנת רפואיים המכי
תרופות
NAPHTHALENE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS
[54]
24.05.2005 [22] EP [33] 02.06.2004 [32] 04102460.5 [31]
Int. Cl.(2010.01) A61K 31//445, 31//47, 31//5375, 31//541, 31//546, A61P 03//04,
C07D 21/1/44, 29/5/08, 40/1/12, 41/1/12, 41/3/12, 41/7/12
[51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2005/117865 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
שבעבאר 5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention relates to compounds of formula (I) wherein A, R1 and R
2 are as
defined in the description and claims, and pharmaceutically acceptable salts thereof, to
the preparation of such compounds and pharmaceutical compositions containing them.
The compounds are useful for the treatment and/or prevention of diseases which are
associated with the modulation of H3 receptors.
[57]
__________________
December 29, 2011 253-התשע"ב טבתב 'ג
179699 [21[]11]
מדידות ביומטריות באמצעות הדמייה מולטיספקטרלית
MULTISPECTRAL IMAGING
BIOMETRICS
[54]
26.05.2005 [22] US [33] 01.06.2004 [32] 60/576364 [31]
US 11.08.2004 60/600867
US 17.09.2004 60/610802
US 18.02.2005 60/654354
US 25.04.2005 11/115075
US 25.04.2005 11/115100
US 25.04.2005 11/115101
Int. Cl.(2010.01) G06K 09//00 [51]
LUMIDIGM, INC., U.S.A. [71]
WO/2006/093508 [87]
ד"ר שלמה כהן ושות', 124אבן גבירול
תל אביב11490, ת.ד.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[74]
Methods and systems are provided for performing a biometric measurement on an
individual. A purported skin site of the individual is illuminated under a plurality of
distinct optical conditions during a single illumination session. Light scattered beneath
a surface of the purported skin site is received separately for each of the plurality of
distinct optical conditions. A multispectral image of the purported skin site is derived
from the received light. A biometric function is performed with the derived
multispectral image.
[57]
__________________
179737 [21[]11]
December 29, 2011 254-התשע"ב טבתב 'ג
תולדות אינדול, תכשירים רפואיים המכילים ת תרופות לטיפול או מניעת אותן ושימושן בהכנ
H3מחלות הקשורות למודולציה של רצפטורי
INDOLE DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF IN
THE PREPARATION OF
MEDICAMENTS FOR TREATING
OR PREVENTING DISEASES
ASSOCIATED WITH
MODULATION OF H3
RECEPTORS
[54]
13.06.2005 [22] EP [33] 21.06.2004 [32] 04102839.0 [31]
Int. Cl.(2010.01) A61K 31//4439, A61P 03//04, 43//00, C07D 40/1/12, 40/1/14,
40/3/12, 40/3/14, 41/3/14
[51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2005/123716 [87]
צאטו,לוצאטו את לו גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention relates to compounds of formula (I) wherein X, R1, R
2, R
3, R
4
and R5 are as defined in the description and claims, and pharmaceutically acceptable
salts thereof, to the preparation of such compounds and pharmaceutical compositions
containing them. The compounds are useful for the treatment and/or prevention of
diseases which are associated with the modulation of H3 receptors.
[57]
__________________
179802 [21[]11]
תמסורת תקורה לשירותי שידור נתוני בקרה ושירותי שידור מרובב במערכת תקשורת
אלחוטית
TRANSMISSION OF OVERHEAD
INFORMATION FOR
BROADCAST AND MULTICAST
SERVICES IN A WIRELESS
COMMUNICATION SYSTEM
[54]
03.06.2005 [22]
December 29, 2011 255-התשע"ב טבתב 'ג
US [33] 04.06.2004 [32] 60/577083 [31]
Int. Cl.(2010.01) H04L 01//00, 05//02 [51]
QUALCOMM INCORPORATED,
U.S.A. [71]
WO/2005/122627 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
To transmit overhead information for broadcast and multicast services in a system that
utilizes multiple radio technologies, time slots used for OFDM in a super-frame are
initially ascertained. Overhead information for multiple streams to be sent in the time
slots used for OFDM is generated. The overhead information conveys the time slots
and the coding and modulation used for the streams and may be given in various
forms. Multiple records may be formed for the overhead information for the streams.
The overhead information for the streams is processed and time division multiplexed
with the data for the streams in the super-frame. Information indicating the time slots
used for OFDM in the super-frame may be sent separately or included in the overhead
information. An indicator may also be appended to each stream to indicate whether
there is any change in the overhead information for the stream in the next super-frame.
[57]
__________________
798101 [21[]11]
התקן ותהליך לקירור והזרמה מחדש של טיח קירות שנשרף
APPARATUS AND PROCESS FOR
COOLING AND DE-STEAMING
CALCINED STUCCO
[54]
19.05.2005 [22] US [33] 15.07.2004 [32] 10/891964 [31]
Int. Cl.(2010.01) F25D 23//12 [51]
UNITED STATES GYPSUM
COMPANY, U.S.A. [71]
WO/2006/019456 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
December 29, 2011 256-התשע"ב טבתב 'ג
The present invention is an apparatus and process for cooling and de-steaming hot
calcined stucco used in the production of gypsum boards or bagged plaster. The
apparatus is a fluid bed stucco cooler and comprises a cooler housing having a plenum
having a stucco inlet and stucco outlet. The stucco cooler includes a rotating disk in the
plenum. The rotating disk includes nozzle for spraying fluid, and is attached to a
rotable shaft extending from the side of the cooler also includes a fluidization pad and
agitator to help to mix the air and the stucco powder to insure fluidization, prevent
channeling, and prevent the stucco powder from building up on the various
components. The air also forces steam from the hot calcined stucco out through an air
outlet located at the top of the stucco cooler, thereby de-steaming the stucco. The
stucco flows through the plenum and passes over the cooling coils, thereby cooling the
stucco as it reaches the stucco outlet.
[57]
__________________
179893 [21[]11]
בניות אבני חן שימושי במיוחד ליהלומים
GEMSTONE CONSTRUCTIONS
PARTICULARLY USEFUL FOR
DIAMONDS
[54]
06.12.2006 [22] IL [33] 21.11.2006 [32] 179471 [31]
Int. Cl.(2010.01) A44C 17//02 [51]
JACKOB TSROR [71] גן-יעקב צרור, רמת
ע"מ,( ב1995ג'י.אי.ארליך ) 11,רחוב מנחם בגין 15מגדל איילון, קומה
רמת גן
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[74]
A gemstone construction comprising: a plurality of individual gemstones assembled
together by a common frame to define a composite gemstone unit having a girdle, a
crown on one side of the girdle and a pavilion on the opposite side of the girdle; each
of said individual gemstones defining a segment of said composite gemstone unit and
[57]
December 29, 2011 257-התשע"ב טבתב 'ג
including a girdle segment of the composite gemstone unit girdle, a crown segment of
the composite gemstone unit crown and a pavilion segment of the composite gemstone
unit pavilion; the girdle and crown segments of at least some of said individual
gemstones having an outer face to serve as the outer face of the composite gemstone
unit girdle and crown; the girdle segment of at least some of said individual gemstones
having at least one flat, smooth, inner face in contact with a corresponding flat,
smooth, inner face of the girdle segment of another individual gemstone in the
composite gemstone unit; said common frame engaging the girdle segments of said
individual gemstones to press the flat, smooth, inner faces of the individual gemstones
into firm contact with each other such that the composite gemstone unit appears
substantially seamless to the naked eye.
__________________
180004 [21[]11]
שיטה והתקן לריבוב מוגבר בהעברת אות ללויין
METHOD AND APPARATUS FOR
ENHANCED UPLINK
MULTIPLEXING
[54]
05.07.2005 [22] US [33] 19.07.2004 [32] 60/588960 [31]
US 25.04.2005 11/113763
Int. Cl.(2010.01) H04B 07//00, 07//216, H04J 03//02, 03//16, H04W 28//16 [51]
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A. [71]
WO/2006/019562 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A method and apparatus for enhanced uplink multiplexing are disclosed. A set of [57]
December 29, 2011 258-התשע"ב טבתב 'ג
combinations of MAC-d flows (and/or logical channels) that are allowed to be
multiplexed within a MAC-e PDU is defined for a WTRU. The WTRU MAC-e entity
selects a combination among a set of allowed combinations for multiplexing MAC-d
flows for each MAC-e PDU. Certain MAC-d flow combinations may be defined that
can not be blocked from transmission even when the WTRU is in a transmit power
restricted state. The amount of data from each logical channel or corresponding MAC-
d flow that can be multiplexed within a MAC-e PDU may be defined to ensure
guaranteed data rates. When the WTRU is in a restricted power condition, an
indication of the restricted power condition may be passed to the Node-B with the EU
transmission.
בקשות חלוקה מבקשה זו שטרם פורסמו9
0242255 The applications for division
from this application have
not yet been published
__________________
180213 [21[]11]
מקבע לקוורץ המשמש לעיבוד נתחי מוליכים למחצה ושיטה לייצור של המקבע
QUARTZ GLASS JIG FOR
PROCESSING SEMICONDUCTOR
WAFERS AND METHOD FOR
PRODUCING THE JIG
[54]
30.03.2006 [22] DE [33] 15.04.2005 [32] 102005017739.5 [31]
Int. Cl.(2010.01) C03B 19//14, C03C 03//06, H01L 21//00 [51]
HERAEUS QUARZGLAS GMBH & CO.
KG, GERMANY [71]
WO/2006/108766 [87]
פישר וילר ג'ונס, 26הברזל
רמת החייל
FISHER WEILER JONES,
26 HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
An ideal quartz glass for a wafer holder for application in an etching environment is [57]
December 29, 2011 259-התשע"ב טבתב 'ג
characterised both by high purity and also a high dry etching resistance. According to
the invention, such a quartz glass may be achieved, whereby the quartz glass is doped
with nitrogen, at least in a region near the surface, has an average content of metastable
hydroxy groups of less than 30 wt. ppm, the fictive temperature is less than 1250 °C
and the viscosity at a temperature of 1200 °C is at least 1013 dPas. A commercial
method for production of such a quartz glass comprises the following method steps:
fusion of a SiO2 raw material to give a quartz glass blank, whereby the SiO2 raw
material or the quartz glass blank is subjected to a dehydration process, heating of the
SiO2 raw material or the quartz glass blank to a nitriding temperature in the range
between 1050 °C and 1850 °C under an atmosphere containing ammonia, a
temperature treatment, by means of which the quartz glass of the quartz glass blank is
brought to a fictive temperature of 1250 °C or less and a surface treatment of the quartz
glass blank to give the quartz glass holder.
__________________
180219 [21[]11]
ערכה לגילוי חומרי נפץ
SPOT TEST KIT FOR
EXPLOSIVES DETECTION
[54]
23.06.2005 [22] US [33] 24.06.2004 [32] 60/583161 [31]
US 22.06.2005 11/159451
Int. Cl.(2010.01) G01N 01//02 [51]
THE REGENTS OF THE
UNIVERSITY OF CALIFORNIA,
U.S.A.
[71]
PHILIP F. PAGORIA, RICHARD E.
WHIPPLE, PETER J. NUNES, JOEL
DEL ECKELS, JOHN G. REYNOLDS,
ROBIN R. MILES, MARINA L.
CHIARAPPA-ZUCCA
[72]
WO/2006/093517 [87]
December 29, 2011 260-התשע"ב טבתב 'ג
אגמון,-סורוקר 14בית נולטון, רחוב שנקר
הרצליה פיתוח
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
[74]
An explosion tester system comprising a body, a lateral flow membrane swab unit
adapted to be removeably connected to the body, a first explosives detecting reagent, a
first reagent holder and dispenser operatively connected to the body, the first reagent
holder and dispenser containing the first explosives detecting reagent and positioned to
deliver the first explosives detecting reagent to the lateral flow membrane swab unit
when the lateral flow membrane swab unit is connected to the body, a second
explosives detecting reagent, and a second reagent holder and dispenser operatively
connected to the body, the second reagent holder and dispenser containing the second
explosives detecting reagent and positioned to deliver the second explosives detecting
reagent to the lateral flow membrane swab unit when the lateral flow membrane swab
unit is connected to the body.
[57]
__________________
180331 [21[]11]
פירידון, תכשירים –2–קרבמואיל–3נגזרות של רפואיים המכילים אותן ושימושים שלהן
3-CARBAMOYL-2 PYRIDONE
DERIVATIVES,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USES THEREOF
[54]
28.10.2005 [22] JP [33] 28.10.2004 [32] 2004-313947 [31]
JP 31.05.2005 2005-159995
Int. Cl.(2010.01) A61K 31//435, 31//436, 31//4365, 31//4412, 31//4436, 31//4439,
31//444, 31//4545, 31//455, 31//4704, 31//496, 31//506, 31//517, 31//5377, 31//55,
[51]
December 29, 2011 261-התשע"ב טבתב 'ג
31//675, A61P 17//04, 25//02, 37//08, 43//00, C07D 21/3/80, 21/3/82, 21/3/85, 21/5/54,
21/5/56, 22/1/16, 40/1/06, 40/1/12, 40/5/06, 40/5/12, 41/3/12, 41/7/12, 49/1/052,
49/5/04, C07F 09//58
SHIONOGI & CO., LTD., JAPAN [71]
WO/2006/046778 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
A compound represented by the general formula (I): (wherein R1 is optionally
substituted C1-8 alkyl, etc.; R2 is C1-6 alkyl and R
3 is C1-6 alkyl, etc., provided that R
2
and R3 may be bonded to each other to form an optionally substituted 5- to 10-
membered nonaromatic carbocycle; R4 is hydrogen, etc.; and G is a group selected
among, e.g., groups represented by the formula (X) (wherein R5 is hydrogen, etc.; X
1 is
a single bond, etc.; X2 is, e.g., optionally substituted C1-8 alkylene optionally having
one or two atoms or groups selected between -O- and -N(R6)- (R
6 is hydrogen, etc.);
X3 is a single bond, etc.; Y is -O-, etc.; and Z is hydrogen, etc.)), a pharmaceutically
acceptable salt of the compound, or a solvate of either. These compounds have
cannabinoid receptor agonistic activity. Also provided are a medicinal composition, an
atopic dermatitis remedy, and an anti-itching agent, especially an anti-itching agent for
oral administration or for external use, which each contains any of those compounds as
an active ingredient.
[57]
__________________
180338 [21[]11]
תצורות דינמיות של פרוטוקולי אינטרנט לציוד מסוף המחובר להתקן אלחוטי
DYNAMIC CONFIGURATION OF
IP FOR A TERMINAL
EQUIPMENT ATTACHED TO A
WIRELESS DEVICE
[54]
28.06.2005 [22]
December 29, 2011 262-התשע"ב טבתב 'ג
US [33] 30.06.2004 [32] 10/882522 [31]
Int. Cl.(2010.01) H04L 29//12 [51]
QUALCOMM INCORPORATED,
U.S.A. [71]
WO/2006/004753 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
Techniques for dynamically configuring IP and providing IP connectivity for a
terminal equipment '110' attached to a wireless device '120' are described. The
wireless device obtains from a wireless network '130' a dynamically assigned IP
address, an IP gateway's IP address, a subnet mask, or none or any combination
thereof. Wireless device determines a host IP address (which may be the dynamically
assigned IP address), a router IP address (which may be the gateway IP address or a
spoofed IP address), a server IP address (which may be the router IP address), and a
subnet mask (which may be obtained from the wireless network or spoofed by the
wireless device). Wireless device, acting as a DHCP server, provides IP configuration
for the terminal equipment, acting as a DHCP client. Wireless device thereafter
forwards IP packets exchanged between the terminal equipment and wireless network
and processes DHCP packets from the terminal equipment.
[57]
__________________
180411 [21[]11]
, תכשירים PARPתולדות קווינאזולינון כמעכבי רוקחיים המכילים אותן, השימוש בהן ושיטות
להכנתן
QUINAZOLINONE DERIVATIVES
AS PARP INHIBITORS,
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM, USES AND METHODS OF
PREPARATION THEREOF
[54]
28.06.2005 [22] EP [33] 30.06.2004 [32] 04076887.1 [31]
Int. Cl.(2010.01) A61K 31//517, 31//5375, A61P 03//10, 09//00, 09//10, 13//12,
17//00, 19//10, 21//00, 25//00, 25//28, 31//18, 35//00, 43//00, C07D 23/9/88, 40/1/12,
40/3/12, 40/3/14, 40/5/14, 41/3/14, 41/7/14
[51]
JANSSEN PHARMACEUTICA, N.V.,
BELGIUM [71]
December 29, 2011 263-התשע"ב טבתב 'ג
WO/2006/003146 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention provides compounds of formula (I), their use as PARP inhibitors
as well as pharmaceutical compositions comprising said compounds of formula (I)
wherein R1, R
2, R
3, L, X, Y and Z have defined meanings.
[57]
__________________
180440 [21[]11]
ת בהירות גבוההבעל Xמקור דחוס לקרן
COMPACT SOURCE OF A HIGH-
BRIGHTNESS X-RAY BEAM
[54]
28.12.2006 [22] FR [33] 03.01.2006 [32] 0650007 [31]
Int. Cl.(2010.01) H01J 35//10 [51]
ALCATEL LUCENT, FRANCE [71]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Device for the emission of X-rays, comprising: a vacuum chamber (7), limited by a
sealed wall (1f), a vacuum pump (1), including in a sealed peripheral casing (1f) a
stator (1b), a rotor (1a) and means of slaving (10a-10e) the rotor, allowing its stable
rotation at very high speed, and connected to the vacuum chamber to generate and
maintain a vacuum, a cathode (3), in the vacuum chamber, adapted to generate an
electron flux (4), a rotating anode (2), in the vacuum chamber, driven in rotation
around a rotation axis (I-I), and receiving in its periphery (2a) the electron flux coming
from the cathode to emit X-rays (6) towards an output (11), the rotating anode is
connected to the rotor of the vacuum pump, arranged coaxially with the rotor, the
sealed peripheral casing of the vacuum pump itself constitutes all or part of the sealed
wall of the vacuum chamber, and characterized in that the device also comprises at
least two cooling elements (8, 9), fixed to the stator of the vacuum pump or to the
sealed peripheral casing, arranged respectively opposite each of the main radial faces
(2b, 2c) of the rotating anode to absorb the thermal energy from radiation emitted by
[57]
December 29, 2011 264-התשע"ב טבתב 'ג
the rotating anode in operation.
__________________
180486 [21[]11]
מלחים של תולדת בנזימידאזול עם אמינים ותהליך לייצרם
SALTS OF BENZIMIDAZOLE
DERIVATIVE WITH AMINES AND
PROCESS FOR PRODUCTION
THEREOF
[54]
05.08.2005 [22] JP [33] 06.08.2004 [32] 2004-230094 [31]
Int. Cl.(2010.01) A61K 31//4439, A61P 01//04, C07D 40/1/12 [51]
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN [71]
WO/2006/013960 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
The invention provides (1) a process for the production of alkali metal salts of 2-[{4-
(3-methoxypropoxy)-3- methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole which
are useful as gastric acid secretion inhibitor, antiulcer agent, and other drugs and (2)
salts of 2-[{4-(3-methoxypropoxy) -3-methylpyridin-2-yl}methylsulfinyl]-1H-
benzimidazole with amines which are intermediates for the production of the alkali
metal salts and a process for the production of the same. Specifically, salts represented
by the general formula (I): wherein A+ is an isopropylammonium ion, a sec-
butylammonium ion, or a cyclopentylammonium ion.
[57]
December 29, 2011 265-התשע"ב טבתב 'ג
__________________
180487 [21[]11]
גורם המשחרר קורטיקוטרופין לטיפול בהפרעות עיצביות
CORTICOTROPIN RELEASING
FACTOR (CRF) FOR TREATMENT
OF NEURAL DISORDERS
[54]
08.07.2005 [22] GB [33] 08.07.2004 [32] 0415359.9 [31]
GB 21.10.2004 0423386.2
Int. Cl.(2010.01) A61K 38//17, 38//22 [51]
AIMSCO LIMITED, UNITED
KINGDOM [71]
WO/2006/021814 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
Analysis of a goat serum product with many therapeutic effects is described. The
product is identified as containing proopiomelanocortin (POMC) and Corticotropin
releasing factor (CRF) peptides, as well as breakdown products of these peptides. We
describe methods of treatment of diseases including cancers, multiple sclerosis, and
neural disorders using these peptides and their products, as well as medicaments
including such peptides and methods of producing the peptides.
[57]
__________________
180516 [21[]11]
סלילים מיניאטוריים על בסיס עם מעגל חשמלי מודפס
MINIATURE COILS ON CORE
WITH PRINTED CIRCUIT
[54]
02.01.2007 [22] US [33] 06.01.2006 [32] 11/327058 [31]
Int. Cl.(2010.01) H04R 09//06 [51]
BIOSENSE WEBSTER, INC., U.S.A. [71]
רוחני בע"מ, ד. קליגלר שירותי קניין תל אביב33111, ת.ד.
D. KLIGLER I.P. SERVICES LTD.,
P.O.B. 33111
TEL AVIV 61330
[74]
December 29, 2011 266-התשע"ב טבתב 'ג
A method for producing a coil assembly, comprising: overlaying printed circuit traces
on a core by printing the circuit traces onto the core, the traces comprising terminals
for coupling to conductive connections on a base on which the coil assembly is to be
mounted; wrapping two or more wires around the core and printed circuit traces so as
to define two or more coils, wrapped in different, respective directions, the wires
having respective ends; and coupling the ends of the wires to the printed circuit traces,
so as to connect the wires through the traces to the terminals.
[57]
__________________
180524 [21[]11]
–5)–4]–5}–4–הידרוקסי–Nתהליך להכנת –איל(–4–תיאזול–3,1–מתיל–2–איסופרופיל
בנזאמידין–פנטוקסי{–פנוקסי[
PROCESS FOR PREPARING N-
HYDROXY-4-{5-[4-(5-ISOPROPYL-
2-METHYL-1,3-THIAZOL-4-YL)-
[54]
December 29, 2011 267-התשע"ב טבתב 'ג
PHENOXY]-PENTOXY}-
BENZAMIDINE
05.07.2005 [22] KR [33] 05.07.2004 [32] 10-2004-
0052070
[31]
Int. Cl.(2010.01) C07D 27/7/22 [51]
DONG WHA PHARMACEUTICAL
CO., LTD., REPUBLIC OF KOREA [71]
JIN SOO LEE, SEOK HOON AHN,
YOUNG GOO JIN, JAE HOON
PARK, DONG HYUK SHIN, EUN
HEE CHO, HWAN BONG CHANG,
YOUNG HO JUNG
[72]
WO/2006/004368 [87]
ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
This invention relates to an improved method of preparing N-hydroxy-4-{5- [4- (5-
isopropyl-2-methyl-l, 3-thiazol-4-yl) phenoxy] pentoxy}benzamidine .
[57]
__________________
180758 [21[]11]
–'3',2–פלואורו–'2פוספונאטים של אנלוג של דידאוקסיאדנוזין, תכשירים –'3',2–דידהידרו
המכילים אותם ושימושים בהם להכנת תרופות HIVלעיכוב
PHOSPHONATES OF A 2 -
FLUORO-2' ,3' -DIDEHYDRO-2' ,3'
-DIDEOXYADENOSINE
ANALOGUE, PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AND USE THEREOF FOR
THE PREPARATION OF
MEDICAMENTS FOR INHIBITING
HIV
[54]
27.07.2005 [22] US [33] 27.07.2004 [32] 60/591811 [31]
Int. Cl.(2010.01) A61K 31//662, 31//7076, 47//48, A61P 31//18, C07F 09//6561,
C07H 19//16
[51]
GILEAD SCIENCES, INC., U.S.A. [71]
WO/2006/015261 [87]
December 29, 2011 268-התשע"ב טבתב 'ג
תפיו,ריינהולד כהן ושו א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention is related to phosphorus substituted anti-viral inhibitory compounds,
compositions containing such compounds, and therapeutic methods that include the
administration of such compounds, as well as to processes and intermediates useful for
preparing such compounds.
[57]
__________________
180781 [21[]11]
אנלוגים פוספונאטים של תרכובות מעכבות HIV
PHOSPHONATE ANALOGS OF
HIV INHIBITOR COMPOUNDS
[54]
26.07.2005 [22] US [33] 27.07.2004 [32] 60/591811 [31]
Int. Cl.(2010.01) A61K 31//662, 47//48, C07F 09//38 [51]
GILEAD SCIENCES, INC., U.S.A. [71]
WO/2006/110157 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention is related to phosphorus substituted anti-viral inhibitory compounds,
compositions containing such compounds, and therapeutic methods that include the
administration of such compounds, as well as to processes and intermediates useful for
preparing such compounds.
[57]
__________________
180995 [21[]11]
מתקן היברידי עבור ריפויי תא
HYBRID DEVICE FOR CELL
THERAPIES
[54]
20.07.2005 [22] US [33] 29.07.2004 [32] 60/591919 [31]
December 29, 2011 269-התשע"ב טבתב 'ג
Int. Cl.(2010.01) A61F 02//02, A61K 09//22, A61M 05//142, C12M 03//00 [51]
THE UNIVERSITY OF MIAMI,
U.S.A. [71]
WO/2006/020288 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
A device for receiving implanted biological material includes a porous outer wall
defining an inner space, a fluid manifold assembly for selectively infusing at least one
immunosuppresive and growth factor media to said space, and a pump structure
operatively coupled to the manifold assembly. The device may comprise an additional
plunger body for being disposed in said space and so as to define a peripheral gap
between the plunger and the perforated wall of the device.
[57]
__________________
181024 [21[]11]
והרכבים הכוללים TRPV 1אגוניסטים של אותם
TRPV1 AGONISTS AND
FORMULATIONS CONTAINING
THEM
[54]
06.07.2005 [22] IT [33] 30.07.2004 [32] MI2004A001566 [31]
Int. Cl.(2010.01) A61K 31//16, A61P 13//00, 25//00, C07C 23/5/26, 23/5/28, C07D
30/3/46
[51]
INDENA S.P.A., ITALY [71]
WO/2006/010445 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The compounds of the general formula (I) in which X is represented by two hydrogen
atoms, a pi-bond, oxygen or methylene; R2 is a C6-C12 aryl, or arylalkyl residue; R3 is
hydrogen, 2-hydroxyethyl or 2-aminoethyl are useful for the treatment of pathologies
mediated by vanilloid receptors type I.
[57]
__________________
December 29, 2011 270-התשע"ב טבתב 'ג
181119 [21[]11]
שלבי של גששים רפואיים–כיול דו
TWO-STAGE CALIBRATION OF
MEDICAL PROBES
[54]
01.02.2007 [22] US [33] 09.02.2006 [32] 11/351135 [31]
Int. Cl.(2010.01) G01N 01//00, 27//00, G01Q 40//00 [51]
BIOSENSE WEBSTER INC., U.S.A. [71]
וחני בע"מ,ד. קליגלר שירותי קניין ר תל אביב33111, ת.ד.
D. KLIGLER I.P. SERVICES LTD.,
P.O.B. 33111
TEL AVIV 61330
[74]
Medical apparatus, comprising: a probe, having a proximal end and a distal
end, which is adapted for insertion into a body of subject, the probe
comprising: a sensor, which outputs a sensor signal ;a first microcircuit,
which stores first calibration data with respect to the sensor; and a first
connector at the proximal end of the probe, electrically coupled at least to the
sensor; a probe adapter, comprising: a second connector, which is arranged to
mate with the first connector; a signal processing circuit, which is coupled to
process the sensor signal so as to output a processed signal; a second
microcircuit, which stores second calibration data with respect to the signal
processing circuit; a microcontroller, which is arranged to receive the first and
second calibration data from the first and second microcircuits, respectively,
and to compute combined calibration data based on the first and second
calibration data; and a third connector, electrically coupled at least to the
signal processing circuit, and a console, comprising: a fourth connector,
which is arranged to mate with the third connector, and signal analysis
circuitry, which is coupled to receive at least the processed signal from the
fourth connector and is arranged to analyze the processed signal using the
combined calibration data provided by the probe adapter.
[57]
__________________
181274 [21[]11]
צבע –שיטה והתקן לארכיטקטורה רבת פיקסלי בעלת שליטה יחידה
METHOD AND APPARATUS
PROVIDING SINGLE BUMP,
[54]
December 29, 2011 271-התשע"ב טבתב 'ג
MULTI-COLOR PIXEL
ARCHITECTURE
17.11.2005 [22] US [33] 03.12.2004 [32] 11/003637 [31]
Int. Cl.(2010.01) H01L 31//101 [51]
RAYTHEON COMPANY, U.S.A. [71]
WO/2006/062721 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
An infrared detector has a multi-layer structure to simultaneously detect IR energy in
different spectral bands without changing polarity of a bias imposed across the
detector. Two absorption layers are separated by a barrier layer that imposes an
electrical potential barrier to one of the absorption layers. Under low bias in one
direction, only one layer generates a photocurrent. Under a higher bias in the same
direction, both layers generate a photocurrrent. Additional absorption layers may be
added to detect additional bands of energy, where the additional absorption layers
generate photocurrent under a bias in another direction. Two, three, and four band
detection is disclosed. Where absorbing layers within a single unit cell absorb under
different bias direction, the barrier layer between those different bias direction layers
suppresses a diffusing electron current. A method for detecting and resolving energy
absorbing in two, three, and four different energy bands is also provided.
[57]
__________________
181317 [21[]11]
דיאמינו חומצה שיקימית–5, 4תהליך להכנת
PROCESS FOR THE
PREPARATION OF 4,5-DIAMINO
SHIKIMIC ACID
[54]
24.08.2005 [22] EP [33] 02.09.2004 [32] 04104227.6 [31]
Int. Cl.(2010.01) C07C 22/7/10, 22/7/18, 22/9/48 [51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
December 29, 2011 272-התשע"ב טבתב 'ג
WO/2006/024436 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention relates to a process for the preparation of a 4,5-diamino shikimic
acid derivative of formula (I) and pharmaceutically acceptable addition salts thereof
wherein R1, R
1’ are independent of each other H or alkyl, R
2 is an alkyl and R
3, R
4 are
independent of each other H or an alkanoyl, with the proviso that not to both R3 and R
4
are H. 4,5-diamino shikimic acid derivatives of formula I, especially the (3R,4R,5S)-5-
amino-4-acetylamino-3- (1-ethyl-propoxy)-cyclohex-l-ene-carboxylic acid ethyl ester
and its pharmaceutically acceptable additional salts are potent inhibitors of viral
neuraminidase.
[57]
__________________
181462 [21[]11]
תהליך לייצור תולדות אמינים בעלות פעילות אופטית
PROCESS FOR PRODUCTION OF
OPTICALLY ACTIVE AMINE
DERIVATIVES
[54]
12.09.2005 [22] JP [33] 13.09.2004 [32] 2004-265307 [31]
Int. Cl.(2010.01) A61K 31//343, A61P 25//20, C07D 30/7/77 [51]
TAKEDA PHARMACEUTICAL
COMPANY LIMITED, JAPAN [71]
WO/2006/030739 [87]
ות',סנפורד ט. קולב וש , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
An industrial process for producing high-purity optically active amine derivatives in
high yield while inhibiting the formation of by-products, which comprises subjecting
(E)-2- (1, 6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethylamine to asymmetric
reduction, catalytically reducing the obtained product at a reaction temperature of 40 to
[57]
December 29, 2011 273-התשע"ב טבתב 'ג
100 C and a pH of 3 to 9, subjecting the obtained (S)-2-(1,6,7,8-tetrahydro -2H-indeno
[5,4-b]furan-8-yl)ethylamine to propionylation, and then crystallizing the reaction
mixture.
בקשות חלוקה מבקשה זו
שטרם פורסמו90/532/5 The applications for division
from this application have
not yet been published
__________________
181510 [21[]11]
שיטת כיול של מיקום יחסי של מדידים במערכת זיהוי ירי
METHOD FOR CALIBRATING
RELATIVE SENSOR POSITIONS
OF SENSORS IN A SHOOTER
DETECTION SYSTEM
[54]
11.08.2005 [22] US [33] 24.08.2004 [32] 10/925876 [31]
Int. Cl.(2010.01) G01S 05//22 [51]
RAYTHEON BBN TECHNOLOGIES
CORP., U.S.A. [71]
WO/2006/098755 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
Shockwave-only solutions that estimate shooter position and shot trajectory are
extremely sensitive to the quality and precision of the shock time-of-arrival (TOA)
measurements as well as the accuracy to which relative sensor positions in space are
known. Over the life of a long-deployed system, the sensor positions can shift and the
performance of some sensors may degrade for various reasons. Such changes can
degrade the performance of deployed shooter estimation systems. Disclosed are
systems and methods that can be used to calibrate sensor positions based on shock and
muzzle measurements processed from a series of shots fired from a known location
and in a known direction, as well as an approach for dynamically adapting shock-only
shooter estimation algorithms to compensate for sensor degradation and/or loss.
[57]
December 29, 2011 274-התשע"ב טבתב 'ג
בקשות חלוקה מבקשה זו שטרם פורסמו9
0/65755 The applications for division
from this application have
not yet been published
__________________
181562 [21[]11]
כרסום בעל פעילות משופרת
HIGH-PERFORMANCE END
MILL
[54]
26.02.2007 [22]
Int. Cl.(2010.01) B23C 01//00 [51]
HANITA METAL WORKS LTD. [71] חניתה מפעלי מתכת בע"מ, שלומי
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
A high-performance end mill comprising a shank portion and at least one cutting
portion divided into a plurality of teeth by flutes disposed between said teeth, the
radial teeth at the cutter extremity each having a cutting edge extending outwardly
from the centre of the tool's extremity and a gash cut profile wherein the maximum
axial depth of said gash cut measured in the direction parallel to the cutter axis is less
than 0.15D where D is the outer diameter of the cutter.
[57]
__________________
December 29, 2011 275-התשע"ב טבתב 'ג
181639 [21[]11]
מערכת לאינטגרציה לאחר הקלטה ראשונית
POST PRODUCTION
INTEGRATION PLATFORM
[54]
28.02.2007 [22]
Int. Cl.(2010.01) G06K 01//00 [51]
MICHAEL BRUGGEMAN [71] מייקל ברוגמן, רמת גן
אפלפלד זר פישר וילר חברת עורכי דין, 16מגדל ב.ס.ר. קומה 2בן גוריון
גן -רמת
APPELFELD ZER FISHER WEILER,
LAW FIRM,
B.S.R TOWER 1, FLOOR 16
2 BEN GURION ST.
RAMAT GAN 52573
[74]
A system for integrating video, three-dimensional animation and sound file formats
into a unified environment for performing manipulations on said files, said system
comprising a unified visual manipulation working environment, wherein said
environment comprises: an import module for receiving a plurality of visual content
objects encoded with a respective original source format within a plurality of different
media formats, wherein the plurality of visual content objects comprises at least one
two-dimensional video stream and at least one three-dimensional, time varying
animated object; a unified timeline module for combining the plurality of visual
content objects in time synchronization to be played on a single timeline; a processing
module enabling separate manipulation of at least two selected visual content objects
within the plurality of visual content in a non destructive manner retaining the
respective original source format characteristics of each of the visual content objects;
and a Visual Three-Dimensional Integration Interface adapted to simultaneously
display a combination of the plurality of visual content objects in a three-dimensional
environment, the Visual Three-Dimensional Integration Interface adapted to integrate
and manipulate respective timelines of at least one visual content object within the
plurality of visual content objects and preview a two-dimensional representation of the
combination, wherein said Visual Three-Dimensional Integration Interface includes: a
two-dimensional video surface layer adapted to display the at least one two-
dimensional video stream, a three-dimensional animation view platform adapted to
display the at least one three-dimensional, time varying animated object, and a
consolidation layer for displaying the combination, wherein the three-dimensional
animation view platform is illustrated as a space between the consolidation layer and
the video surface layer and is adapted to manipulate in three dimensions, in response
to operator input, the at least one three-dimensional, time varying animated object
with respect to the at least one two-dimensional, video stream simultaneously
displayed on the two-dimensional video surface layer, and wherein frames of the
consolidation layer and of the video surface layer are locked together and are
manipulated via a scale control adapted to at least one of either increase and decrease a
relative size of images and three-dimensional time varying objects within confines of
the consolidation layer and the two-dimensional video surface layer as compared to
one another, and change a relative positioning of images and three-dimensional, time
varying objects displayed in the consolidation layer and the two-dimensional video
surface layer as compared to one another, the images and three-dimensional, time
[57]
December 29, 2011 276-התשע"ב טבתב 'ג
varying object comprising three-dimensional animation objects sitting on the three-
dimensional animation platform and at least one two-dimensional video stream sitting
on the two-dimensional video surface layer.
__________________
182170 [21[]11]
שיטה לליטוש מתכות אצילות באמצעות הרכב מכני עם תוסף פולימר–כימי
METHOD FOR POLISHING
NOBLE METALS WITH CMP
COMPOSITION CONTAINING A
POLYMER ADDITIVE
[54]
11.10.2005 [22] US [33] 12.10.2004 [32] 10/963108 [31]
Int. Cl.(2010.01) B24B 37//00 [51]
CABOT MICROELECTRONICS
CORPORATION, U.S.A. [71]
WO/2006/044417 [87]
זליגסון גבריאלי ושות', 31רח' יבנה
תל אביב1426, ת.ד.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[74]
The invention provides a method of polishing a substrate comprising contacting a
substrate comprising a noble metal on a surface of the substrate with a chemical-
mechanical polishing system comprising (a) a polishing component selected from the
group consisting of an abrasive, a polishing pad, and a combination thereof, (b) an
oxidizing agent, (c) an ethylene-oxide containing polymer, and (d) a liquid carrier, and
abrading at least a portion of the noble metal with the chemical-mechanical polishing
system to polish the substrate.
[57]
__________________
182301 [21[]11]
למיתוג על ידי השתקה של סיגנל שיטה והתקן נקלט
METHOD AND APPARATUS FOR
SQUELCH GATING A
RECEIVING SIGNAL
[54]
27.03.2007 [22]
December 29, 2011 277-התשע"ב טבתב 'ג
EP [33] 07.04.2006 [32] 06 007 405.1 [31]
EP 04.01.2007 07 000 145.8
Int. Cl.(2010.01) H04B 01//10 [51]
ROHDE & SCHWARZ GMBH & CO.
KG, GERMANY [71]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
A method and an apparatus for squelch gating a receiving signal depending on the
level of phase noise in said receiving signal determines sampled amplitudes and
sampled phases of said receiving signal, determines sampled phase noise by
differentiating subsequent sampled phases, determines a squelch signal by rectifying
and averaging said sampled phase noise, determines a start point of gating after a
rising of said squelch signal above a higher threshold delayed by a first delay time,
determines an end point of gating after a dropping of said squelch signal below a lower
threshold delayed by a second delay time and gates said sampled amplitudes from said
start point of gating until said end point of gating.
[57]
__________________
182396 [21[]11]
–N–דיאצטיל –10סינטטי להכנת –תהליך חצי פקליטקסל וחומרי ביניים עבורו–דיבנזואיל
SEMISYNTHESIS PROCESS FOR
THE PREPARATION OF 10-
DEACETYL-N-DEBENZOYL-
PACLITAXEL AND
INTERMEDIATES THEREFOR
[54]
07.10.2005 [22] US [33] 08.10.2004 [32] 60/616840 [31]
EP 08.10.2004 04425752.5
EP 11.04.2005 05007888.0
Int. Cl.(2010.01) C07D 30/5/14, 41/1/12 [51]
INDENA S.P.A., ITALY [71]
WO/2006/037653 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to a process for the preparation of 10-deacetyl-Ndebenzoyl-
paclitaxel, a synthon useful for the preparation of taxanes with antitumour activity, and
[57]
December 29, 2011 278-התשע"ב טבתב 'ג
intermediates for the preparation thereof. The invention also discloses a process for the
preparation of Docetaxel starting from said compound of formula (I).
בקשות חלוקה מבקשה זו שטרם פורסמו9
0/607/5 The applications for division
from this application have
not yet been published
__________________
182473 [21[]11]
כלי טייס ממונע רקטה המכיל רכיב קינטי וקצף מתכלה
ROCKET-PROPELLED VEHICLE
COMPRISING KINETIC MEDIA
AND DECOMPOSABLE FOAM
[54]
19.10.2005 [22] US [33] 20.10.2004 [32] 10/969724 [31]
Int. Cl.(2010.01) B64G 01//00 [51]
RAYTHEON COMPANY, U.S.A. [71]
WO/2007/001419 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
A high energy, e.g. ultraviolet (UV) catalyzed decomposing foam (124) encapsulating
kinetic media (122) forms a payload (120) to be boosted in space and provides an
ultra-light weight means for intercepting an incoming missile or other target (140,
142). The decomposed foam releases the kinetic media (at designed rates so as to
preserve a required density of media on target) to intercept the target and destroy it.
The use of the decomposing foam significantly lowers the weight and cost an improves
the probability of success of destroying the target.
[57]
December 29, 2011 279-התשע"ב טבתב 'ג
__________________
182747 [21[]11]
מערכת מיצלות הפוכות הכוללת מרכיב פעיל טיפולי המסיס במים ותכשיר רפואי הכולל
אותה
REVERSE-MICELLAR SYSTEM
COMPRISING A HYDROSOLUBLE
THERAPEUTICALLY ACTIVE
AGENT AND PHARMACEUTICAL
COMPOSITION COMPRISING IT
[54]
02.11.2005 [22] EP [33] 02.11.2004 [32] 04025991.3 [31]
Int. Cl.(2010.01) A61K 09//00, 09//107, 09//48, 38//00 [51]
MEDESIS PHARMA SA, FRANCE [71]
WO/2006/048772 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
אר שבעב5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention relates generally to reverse-micellar system comprising a
hydrosoluble therapeutically active agent. Reverse micelles according to the invention
are particularly useful to deliver drugs. The present invention also relates to
pharmaceutical composition comprising said reverse micelles and methods for
preparing the same.
[57]
__________________
182824 [21[]11]
שיטה לניהול משאבים בפלטפורמה לשירותי טלקומוניקציה ו/או ניהול רשת, פלטפורמה
METHOD FOR MANAGING [54]
December 29, 2011 280-התשע"ב טבתב 'ג
ומוצר של תוכנת מחשב עבורה
RESOURCES IN A PLATFORM
FOR TELECOMMUNICATION
SERVICES AND/OR NETWORK
MANAGEMENT,
CORRESPONDING PLATFORM
AND COMPUTER PROGRAM
PRODUCT THEREFOR
28.10.2004 [22]
Int. Cl.(2010.01) H04L 12//24 [51]
TELECOM ITALIA S.P.A., ITALY [71]
GIUSEPPE COVINO, ROSARIO
ALFANO, FABRIZIO BOBBIO,
GIUSEPPE CASSONE, DANILO
GOTTA, MARISA PORTA, MARCO
UGHETTI
[72]
WO/2006/045337 [87]
ידמן בע"מ,ד"ר מרק פר 7, רחוב ז'בוטינסקי 54מגדל משה אביב, ק.
גן -רמת
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[74]
The invention relates to a method and system for managing resources in the
telecommunications services and networks. The method and system regard execution
of processes (WF1, ..., WFn) by distributed agents (A1, A2, A3) on processing
machines (H) to perform predetermined tasks on the network, and are characterized
by: setting target data including goals on processes (WF1, …, WFn) and constraints on
resource utilization to be met by the system; monitoring computational resources
utilization and processes execution by agents, and collecting performance data
representative of resource utilization and process execution; comparing the collected
performance data with the set data, a penalty being established when performance data
do not fulfil target data; and re-allocating resources for process execution by agents
(A1, A2, A3) so as to minimize the penalty determined on the basis of said
comparison.
[57]
December 29, 2011 281-התשע"ב טבתב 'ג
__________________
183013 [21[]11]
סינתזה כימית מכוונת ע"י חומצת גרעין מבנית, הרכב ושיטה לביצוע החלפת מודולת נשא
האוליגונוקליאוטיד
STRUCTURAL NUCLEIC ACID
GUIDED CHEMICAL SYNTHESIS
COMPOSITION AND METHOD
OF PERFORMING
OLIGONUCLEOTIDE CARRIER
MODULE SUBSTITUTION
[54]
08.11.2005 [22] EP [33] 08.11.2004 [32] 04105597.1 [31]
US 07.06.2005 60/687849
US 11.10.2005 60/725347
Int. Cl.(2010.01) C07B 61//00, C12N 15//10 [51]
VIPERGEN APS, DENMARK [71]
WO/2006/048025 [87]
זליגסון גבריאלי ושות', 31רח' יבנה
תל אביב1426, ת.ד.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[74]
Disclosed is a composition comprising a nucleic acid and a chemical compound, said
composition forming a star structure defining 3 or more stems extending from a
reaction center. The stems are formed by a nucleic acid duplex and the chemical
compound has been formed in the reaction center as the reaction product of 3 or more
chemical groups. The advantage of the composition is that a close proximity is
provided between the chemical groups in the reaction center, thereby promoting a
reaction. The invention also relates to a method for preparation of the composition.
The advantage of the method is that it does not require the pre-synthesis of a large
number of templates and that it is not dependent upon codon/anti-codon recognition
for an encoded molecule to be formed.
[57]
__________________
183028 [21[]11]
December 29, 2011 282-התשע"ב טבתב 'ג
פרופילאמינופנטאן –2–איל(–2–)בנזופוראנ–1(–) לשימוש בטיפול בתלות בסמים
(-)-1-BENZOFURAN-2-YL)-2-
PROPYLAMINOPENTANE FOR
USE IN THE TREATMENT OF
SUBSTANCE DEPENDENCE
[54]
21.11.2005 [22] JP [33] 25.11.2004 [32] 2004-339996 [31]
Int. Cl.(2010.01) A61K 31//343, A61P 25//00, C07D 30/7/81 [51]
FUJIMOTO CO., LTD., JAPAN
NATIONAL UNIVERSITY
CORPORATION KYUSHU
UNIVERSITY, JAPAN
[71]
WO/2006/057211 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
To provide a therapeutic agent for drug dependence which prevents the flash-back of
or a relapse into a compulsive drug intake behavior based on the urge to, e.g., an
addictive substance such as amphetamine, opium, barbiturate type morphine,
psychedelic, cocaine, hemp, cannabis, alcohol, or volatile organic solvents. (-)-1-
(Benzofuran-2-yl)-2propylaminopentane or a pharmacologically acceptable acid
addition salt thereof is useful as a therapeutic agent for drug dependence which
prevents the flash-back of or a relapse into a compulsive drug intake behavior based on
the urge to, e.g., an addictive substance.
[57]
__________________
018303 [21[]11]
אלמנטים אנדופרוסטטיים עבור מחבר קרסול
ENDOPROSTHETIC ELEMENTS
FOR AN ANKLE JOINT
[54]
08.11.2005 [22] AT [33] 08.11.2004 [32] A 1862/2004 [31]
Int. Cl.(2010.01) A61F 02//24, 02//42 [51]
ALPHAMED MEDIZINTECHNIK
FISCHER GMBH, AUSTRIA [71]
WO/2006/047805 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
December 29, 2011 283-התשע"ב טבתב 'ג
The invention relates to a talus component (1) for a multi-part ankle-joint prosthesis,
said component having an underside (3), which faces the bony talus after implantation.
Said component is characterised in that the underside that faces the bony talus is
configured as a concave ball segment.
[57]
__________________
183054 [21[]11]
ותכשירי רוקחות LNAאוליגונוקלאוטידים המכילים אותם
LNA OLIGONUCLEOTIDES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
[54]
09.11.2005 [22] US [33] 09.11.2004 [32] 60/626563 [31]
US 25.01.2005 60/647186
US 15.07.2005 60/699721
US 07.10.2005 60/724621
Int. Cl.(2010.01) C07H 21//00, 21//04, C12N 15//11 [51]
ENZON PHARMACEUTICALS, INC.,
U.S.A.
SANTARIS PHARMA A/S,
DENMARK
[71]
WO/2006/050734 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
The present disclosure relates to an LNA oligonucleotide consisting of a sequence
selected from the group consisting of 5'-(Tx GxGxcsasasasgscsastscscsTXGX T-3' and 5'-
(GX )TXTXascstsgscscststscsTXTX A-3', wherein capital letters designate a beta-D-oxy-
LNA nucleotide analogue, small letters designate a 2-deoxynucleotide, underline
designates either a beta-D-oxy-LNA nucleotide analogue or a 2-deoxynucleotide,
[57]
December 29, 2011 284-התשע"ב טבתב 'ג
subscript 's' designates a phosphorothioate link between neighbouring
nucleotides/LNA nucleotide analogues, and subscript 'x' designates either a
phosphorothioate link or a phosphorodiester link between neighbouring
nucleotides/LNA nucleotide analogues, and wherein the sequence is optionally
extended by up to five 2-deoxynucleotide units. The LNA oligonucleotides are useful
for modulating the expression of hypoxia-inducible factor-la (HIF-1a), e.g. in the
treatment of cancer diseases, inhibiting angiogenesis, inducing apoptosis, preventing
cellular proliferation, or treating an angiogenic disease, e.g. diabetic retinopathy,
macular degeneration (ARMD), psoriasis, rheumatoid arthritis and other inflammatory
diseases.
__________________
183157 [21[]11]
תכשירים בסיסיים נטולי מים הניתנים ליצירה אמולסיות המכילים קו אנזים –עצמית של מיקרו
10Q בריכוז גבוה
HIGH CONCENTRATION SELF-
MICROEMULSIFIABLE
ANHYDROUS COENZYME Q10
BASE COMPOSITIONS
[54]
16.11.2004 [22]
Int. Cl.(2010.01) A61K 09//10, 09//48, 38//43 [51]
BIOAVAILABILITY, INC, U.S.A. [71]
WO/2006/080903 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
A method and composition are presented for enhancing the dissolution and
bioavailable properties of CoQ10 nutritional supplements and/or therapeutic agents for
a human being and other mammals. The method includes preparing an anhydrous self-
microemulsifying base composition by combining: CoQ10, a water-immiscible, and a
non-ionic surfactant, containing polyethylene glycol. For an orally administered
CoQ10 nutritional supplement in a capsule formulation, a unit dosage from the
composition is added to a dissolvable capsule, preferably a soft gelatin capsule, in
[57]
December 29, 2011 285-התשע"ב טבתב 'ג
order to form the nutritional supplement. When a capsule containing the self-
microemulsifying composition enters the digestive tract, the temperature of the body's
digestive juices warms the composition, causing any of the CoQ10 that may have re-
crystallized out of the composition to become re-dissolved into the composition before
the capsule dissolves. The re-dissolution of CoQ10 is bioavailable when the capsule
dissolves. Upon dissolution of the capsule, the self-microemulsifying composition
comes into contact with the digestive juices and naturally forms micellar-type
bioavaible microemulsions, consisting of micelles containing CoQ10. In addition to
the capsule formulation, the invention includes parenteral, liquid, topical and
ophthalmic formulations.
__________________
183200 [21[]11]
תכשיר רוקחי הכולל דפסיפפטידים קוטלי טפילים פנימיים למניעת זיהום אנכי של יונק
לא אנושי עם טפילים פנימיים
PHARMACEUTICAL
COMPOSITION COMPRISING
ENDOPARASITICIDAL
DEPSIPEPTIDES FOR PREVENTING
VERTICAL INFECTION OF A NON
HUMAN MAMMAL WITH
ENDOPARASITES
[54]
03.11.2005 [22] DE [33] 16.11.2004 [32] 102004055316.5 [31]
Int. Cl.(2010.01) A61K 38//15, A61P 33//00 [51]
BAYER ANIMAL HEALTH GMBH,
GERMANY [71]
WO/2006/053641 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to the use of endoparasitic depsipeptides for the production of
medicaments for prevention of vertical endoparasite infections.
[57]
__________________
December 29, 2011 286-התשע"ב טבתב 'ג
183320 [21[]11]
מיזוג מידע ממעקב ומהדמיה
TRACKING AND IMAGING
DATA FUSION
[54]
20.05.2007 [22]
Int. Cl.(2010.01) G06T 07//20 [51]
רפא"ל מערכות לחימה מתקדמות בע"מ, חיפה
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. [71]
RON ZOHAR, DAVID REINITZ [72] רון זוהר, דוד רייניץ
ד"ר מרק פרידמן בע"מ, 7, רחוב ז'בוטינסקי 54מגדל משה אביב, ק.
גן -רמת
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[74]
A method of monitoring a target, which includes tracking the target using a tracking
modality, thereby obtaining an estimated track of the target, imaging the target using
an imaging modality, thereby obtaining an image of the target, associating the
estimated track with the image, and displaying at least one datum related to the image
along with the estimated track.
[57]
__________________
183323 [21[]11]
מערכת פנאומטית ומורכבת לניתוחים בעלת צילינדרי אויר אינטגרלים
SURGICAL SYSTEM HAVING
PNEUMATIC MANIFOLDS WITH
INTEGRAL AIR CYLINDERS
[54]
20.05.2007 [22] US [33] 19.05.2006 [32] 11/437301 [31]
US 28.06.2006 11/477035
Int. Cl.(2010.01) A61B 01//00 [51]
ALCON, INC., SWITZERLAND [71]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
A surgical system having all of the various pneumatic control sub-systems integrally
mounted on a common manifold. The various required control mechanisms such as
valves are likewise integrally mounted to the common manifold. Air cylinders for
valve actuation are directly installed into the manifolds, and pressurized air for the air
[57]
December 29, 2011 287-התשע"ב טבתב 'ג
cylinders is supplied to the cylinders through the manifolds. Such a construction
eliminates the need to use external air tubing to supply the air cylinders with
pressurized air, thereby improving reliability and simplifying construction.
__________________
183368 [21[]11]
תיקון סטיות כרומטיות בעדשות תוך עיניות
INTRAOCULAR LENSES WITH
ENHANCED OFF-AXIS VISUAL
PERFORMANCE
[54]
21.05.2007 [22] US [33] 31.05.2006 [32] 11/443766 [31]
December 29, 2011 288-התשע"ב טבתב 'ג
Int. Cl.(2010.01) G02C 07//06 [51]
ALCON, INC., SWITZERLAND [71]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
A multi-element or multi-surface intraocular lens (10,22) (IOL), comprising: a
posterior optical surface (24b, 14a, 14b), and an anterior optical surface (24a, 12a,
12b), wherein at least one optical surface (24b, 14a, 14b) is adapted to provide
compensation for one aberration type and at least one optical surface (24a, 12a, 12b) is
adapted to provide compensation for another aberration type characterized in that a
combination of:the degree of asphericity of the optical surfaces; the Abbe number of
the lens material; the radii of curvature of the optical surfaces; the axial separation of
the optical surfaces; the degree of alignment of the optical axes of the optical surfaces,
are selected to cooperatively reduce, or substantially eliminate, the longitudinal
chromatic aberrations exhibited by the intraocular lens (10), and/or to cooperatively
provide compensation for the natural chromatic aberrations of the eye, whereby a
plurality of monochromatic, polychromatic and oblique aberrations may be
independently corrected and off-axis visual performance is enhanced by providing
customized IOLs exhibiting compensation for different aberrations and/or different
amounts of aberration correction.
[57]
__________________
183398 [21[]11]
טריז עבור כרטיס מודול של מעגל –מנעול אלקטרוני
WEDGELOCK FOR ELECTRONIC
CIRCUIT CARD MODULE
[54]
10.11.2005 [22] US [33] 24.11.2004 [32] 10/995535 [31]
Int. Cl.(2010.01) H05K 07//14 [51]
ELTA SYSTEMS LTD. [71] אלתא מערכות בע"מ, אשדוד
WO/2006/056971 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
December 29, 2011 289-התשע"ב טבתב 'ג
An arrangement is suggested for introducing a plate element, for which heat needs to
be dissipated by means of conduction, into a slot of a chassis which is adapted to
absorb the heat. The slot comprises a back wall adapted to contact the plate element
upon its insertion, an opposing front wall, and a base wall. The plate element
comprises margins adapted for carrying the arrangement. The arrangement comprises a
seat located on the margins. The arrangement further comprises a wedgelock moveably
attached to the seat, having two slot engaging surfaces adapted to contact the front and
base walls of the slot, and a seat engaging portion adapted to contact the seat. The
arrangement further comprises an actuating mechanism adapted to cause a movement
of the wedgelock in a direction toward the front wall and in a direction toward the base
wall of the slot until a tight contact is established between the slot engaging surfaces of
the wedgelock and the slot's front and base walls, while maintaining a tight contact
between the seat engaging portion of the wedgelock and the seat and between the
module and the back wall of the slot.
[57]
__________________
183490 [21[]11]
פורמולציות מצופות לשחרור תרופות
COATED DRUG DELIVERY
FOMULATIONS
[54]
29.11.2005 [22] US [33] 30.11.2004 [32] 10/999831 [31]
Int. Cl.(2010.01) A61K 09//127 [51]
WESTERN UNIVERSITY OF
HEALTH SCIENCES, U.S.A. [71]
WO/2006/060325 [87]
,DR. YITZHAK HESS & PARTNERS ד"ר יצחק הס ושותפיו,
279 HAYARKON ST.,
[74]
December 29, 2011 290-התשע"ב טבתב 'ג
279רחוב הירקון תל אביב6451, ת.ד.
P.O.B. 6451,
TEL AVIV 61063
The invention relates generally to methods of making formulations for delivering
biological agents to a patient. In one aspect, proliposomal drug-delivery systems for
medicaments are provided. In another aspect, coated proliposomal formulations for
poorly water soluble drugs, and methods for making the same, are provided. Certain
embodiments of the present invention provide enhanced stability and bioavailability
for pharmaceutical formulations.
[57]
בקשות חלוקה מבקשה זו שטרם פורסמו9
0242/25 The applications for division
from this application have
not yet been published
__________________
183492 [21[]11]
ירוט חוקי של צלילי צילצול חזרה אישיים
LAWFUL INTERCEPTION OF
PERSONALIZED RING BACK
TONES
[54]
04.11.2005 [22] EP [33] 16.12.2004 [32] 04445128.4 [31]
Int. Cl.(2010.01) H04M 03//22, 03//42, 19//02 [51]
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN [71]
WO/2006/063903 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
Systems and methods for legal interception of the transmission of personalized ring
back tones as they are sent from a network such as a mobile telephone network
associated with a subscriber to a caller in response to a call placed by the caller to the
subscriber to allow monitoring of personalized ring back tones and/or their associated
call content data. The personalized ring back tone is intercepted at an intercept access
[57]
December 29, 2011 291-התשע"ב טבתב 'ג
point on the network, where the systems and methods of the invention then transmit
the intercepted personalized ring back tone to an authorized person or entity, such as a
law enforcement agency.
__________________
183500 [21[]11]
שיטה ומכשיר להעיר בן אדם
METHOD AND APPARATUS FOR
WAKING A PERSON
[54]
05.12.2005 [22] US [33] 03.12.2004 [32] 60/632535 [31]
Int. Cl.(2010.01) G08B 06//00, H04B 03//36 [51]
SAFEAWAKE, LLC, U.S.A. [71]
WO/2006/060679 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A system and method for waking a person includes the provision of tactile stimulation
in a repeating interrupted pattern upon the detection of an alarm signal indicative of an
event for which the person should be awakened. In one embodiment, a device for
waking a person comprises a circuit for generating a driver signal in response to an
alarm signal, the driver signal having a repeating interrupted pattern; an electrically
controlled switching device having a control input, a power input and a power output,
the power input being connectable to a power source, the control input being
connected to receive the driver signal from the circuit; and a tactile stimulation device
connected to the power output of the electrically controlled switching device, the
tactile stimulation device being configured to produce a tactile stimulation.
[57]
December 29, 2011 292-התשע"ב טבתב 'ג
__________________
183594 [21[]11]
פיפראזין מתאנון, תהליכים –נגזרות של פניללייצורן, תרופות המכילות אותן ושימושן בהכנת
תרופות לטיפול במחלת אלצהיימר
PHENYL-PIPERAZINE
METHANONE DERIVATIVES,
PROCESS FOR THEIR
PREPARATION, MEDICAMENTS
CONTAINING THEM AND USE
THEREOF IN THE
MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF ALZHEIMER'S
DISEASE
[54]
01.12.2005 [22] EP [33] 09.12.2004 [32] 04106440.3 [31]
Int. Cl.(2010.01) A61K 31//496, 31//498, A61P 25//28, C07D 27/7/82, 40/1/04,
40/3/04, 41/3/04, 41/7/04, 41/7/14
[51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2006/061135 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention relates to compounds of the general formula (I) wherein R1 is
the group (A) or (B) or (C) or (D); R2 is a non aromatic heterocycle, or is OR' or
N(R')2; R' is lower alkyl, lower alkyl substituted by halogen or -(CH2)n-cycloalkyl; R'
is lower alkyl; R3 is NO2, CN or SO2R'; R
4 is hydrogen, hydroxy, halogen, NO2, lower
alkyl, lower alkyl, substituted by halogen, lower alkoxy, SO2R' or C(O)OR'; R5/R
6/R
7
are hydrogen, halogen, lower alkyl or lower alkyl, substituted by halogen; X1/X
1’ are
CH or N, with the proviso that X1/X
1’ are not simultaneously CH; X
2 is O, S, NH or
N(lower alkyl); n is 0, l or 2; and to pharmaceutically active acid addition salts and to
[57]
December 29, 2011 293-התשע"ב טבתב 'ג
their use in the treatment of neurological and neuropsychiatric disorders.
__________________
837391 [21[]11]
תהליך להכנת מלוקסיקם ומלח אשלגן של מלוקסיקם בדרגת ניקיון גבוהה
PROCESS FOR PREPARATION OF
HIGH-PURITY MELOXICAM AND
MELOXICAM POTASSIUM SALT
[54]
16.12.2005 [22] HU [33] 18.12.2004 [32] P0402634 [31]
Int. Cl.(2010.01) C07D 41/7/12 [51]
EGIS GYOGYSZERGYAR NYRT,
HUNGARY [71]
WO/2006/064298 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention provides a process for the preparation of high purity meloxicam of the
Formula (II). The meloxicam raw product is reacted with the solution of potassium
hydroxide or potassium carbonate, whereby high purity meloxicam potassium sait
monohydrate is produced. Said sait is subsequently treated with minerai or organic
acid to yield high-purity meloxicam.
[57]
__________________
183773 [21[]11]
מסגרת של דלת וחלון
DOOR AND WINDOW FRAME
[54]
07.06.2007 [22] IT [33] 15.06.2006 [32] TO2006A000435 [31]
December 29, 2011 294-התשע"ב טבתב 'ג
Int. Cl.(2010.01) E05C 09//18 [51]
SAVIO S.P.A., ITALY [71]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
Door and window frame, comprising: a movable quadrangular frame formed by four
section bars each having an outer side provided with a longitudinal groove, in which
the longitudinal groove comprises a base, two parallel lateral walls and two edges
oriented towards each other and defining an undercut engagement area at each of said
lateral walls, a first undercut engagement area being adjacent to a first face of the
frame and a second undercut engagement area being adjacent to a second face of the
frame, and a drive assembly comprising a plurality of actuating members and a
plurality of transmission rods that engage respective longitudinal grooves, each of said
actuating members and each of said transmission rods having a single tenon that
engages only one of said undercut engagement area, characterised in that the tenons of
the actuating member and of the transmission rods all engage said first undercut
engagement area of the respective groove.
[57]
__________________
183776 [21[]11]
שיטה להרכבת מתקן הנעה על מסגרת של דלת או חלון
METHOD FOR MOUNTING A DRIVE
ASSEMBLY FOR DOOR AND
WINDOW FRAMES
[54]
07.06.2007 [22] IT [33] 15.06.2006 [32] TO2006A000434 [31]
Int. Cl.(2010.01) E05D 15//52 [51]
SAVIO S.P.A., ITALY [71]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
Drive assembly for door and window frames, comprising at least one actuating
member and at least one transmission rod fastened to the actuating member. The
transmission rod comprises a central portion and two lateral portions positioned at
opposite sides relative to the central portion and forming two channel-shaped
longitudinal guides, the central portion having a longitudinal groove positioned
between the longitudinal guides, the longitudinal groove of the central portion being
closed by a base. The transmission member has a connecting portion including two
longitudinal ribs with ends shaped in such a way as to establish a telescopic coupling
[57]
December 29, 2011 295-התשע"ב טבתב 'ג
with the longitudinal guides of the transmission rod and a central portion positioned
between said ribs and provided with a threaded hole in which is inserted a screw
having a tip that is able to cut a hole in the base of the transmission rod at said
longitudinal groove.
__________________
183777 [21[]11]
שיטה להרכבת איבר תומך על מסגרת של דלת או חלון
METHOD FOR MOUNTING AN
AUXILIARY MEMBER ON A DOOR
OR WINDOW FRAME
[54]
07.06.2007 [22] IT [33] 15.06.2006 [32] TO2006A00434 [31]
Int. Cl.(2010.01) E05D 15//52 [51]
SAVIO S.P.A., ITALY [71]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
Method for mounting an auxiliary member (130) on a window or door frame (10)
already installed and whereon is mounted a drive assembly (22) comprising at least
one actuating member (24, 25, 26, 27, 28) and at least one transmission rod (30, 32)
mounted in at least one slot (18, 20) of the frame (10). The method comprises the steps
of: providing, between the auxiliary member (130) and said rod (30, 32), a coupling
that is slidable in a longitudinal direction and fixed in any direction orthogonal to the
direction of sliding, and forming a through hole (118) in the rod by means of a screw
(106) carried by the auxiliary member (130), and fastening the auxiliary member to
said rod (30, 32) by the engagement of a tip (110) of said screw (106) with said
through hole (118).
[57]
December 29, 2011 296-התשע"ב טבתב 'ג
__________________
183881 [21[]11]
–מערכת ביוריאקטור עבור טיפול ביולוגי רב שופכין–שלבי במי
BIOREACTOR SYSTEM FOR
MULTI-STAGE BIOLOGICAL
WASTEWATER TREATMENT
[54]
11.12.2005 [22] US [33] 13.12.2004 [32] 11/008922 [31]
Int. Cl.(2010.01) C02F 03//06 [51]
AQUARIUS TECHNOLOGIES INC.,
U.S.A. [71]
EFIM MONOSOV, ROMAN
NIKOLEVSKY, VLADIMIR PUZIY,
MARIA MONOSOV
[72]
WO/2006/064494 [87]
שלום למפרט אי.פ.והנדסה בע"מ, 59יקינטון
מעלות1078, ת.ד.
SHALOM LAMPERT IP &
ENGINEERING LTD.,
59 YAKINTON ST.
P.O.B. 1078
MAALOT 21520
[74]
A bioreactor system including at least one flexible substrate (10) for supporting
biomass growth having a plurality of threads (50) an at least two cross support
elements (52), wherein openings defined by adjacent threads and adjacent cross
support openings have an aspect ratio exceeding 50:1.
[57]
__________________
183891 [21[]11]
מכשיר לגילוי וספירה של יריות הנורות על ידי כלי ירי אוטומטי או חצי אוטומטי, וכלי ירי
DEVICE FOR DETECTING AND [54]
December 29, 2011 297-התשע"ב טבתב 'ג
המצויד במכשיר
COUNTING SHOTS FIRED BY AN
AUTOMATIC OR SEMI-
AUTOMATIC FIRE ARM, AND
FIRE ARM EQUIPPED WITH
SUCH A DEVICE
13.06.2007 [22] BE [33] 18.07.2006 [32] 2006/0396 [31]
Int. Cl.(2010.01) F41A 09//53 [51]
FN HERSTAL S.A., BELGIUM [71]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A device adapted to form a typical signature for a fire arm and for the type of
ammunition comprises an accelerometer with a pass band which is sensitive to shocks
in the axial direction of a barrel and a microprocessor for analyzing a signal of the
accelerometer while firing. The microprocessor is equipped with an algorithm to count
the number of shots to be fired, based on the discernment and recording of a shot to be
fired on the basis of the detection, in the signal of the accelerometer, of all or part of
the characteristic elements of the acceleration signature which is typical in the type of
fire arm and of in different types of ammunition to be used. These characteristic
elements are recorded beforehand in a memory of the device.
[57]
__________________
184083 [21[]11]
שיטה ומערכת לגילוי מערכת ובחירת משתמש
METHOD AND SYSTEM FOR
SYSTEM DISCOVERY AND USER
SELECTION
[54]
December 29, 2011 298-התשע"ב טבתב 'ג
17.01.2006 [22] US [33] 18.01.2005 [32] 60/645367 [31]
US 27.12.2005 11/318700
Int. Cl.(2010.01) H04W 36//14, 88//06 [51]
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A. [71]
WO/2006/078627 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention includes a method and apparatus for mobility handling across different
wireless technologies by efficiently performing alternate network discovery and
enabling a mobile station to select the most desirable candidate radio access
technology, depending on parameters such as location and network policy settings.
[57]
__________________
184145 [21[]11]
מערכת לריפוי דרך העור המכילה שני תאים בעלת אפשרות הפעלה של רווית יתר וקידום
חדירה מבוקרת ותהליך לייצורה.
TRANSDERMAL THERAPEUTIC
SYSTEM COMPRISING TWO
COMPARTMENTS WITH
ACTIVATABLE OVERSATURATION
AND CONTROLLED PERMEATION
PROMOTION AND PROCESS FOR
MANUFACTURING THE SAME
[54]
08.12.2005 [22] DE [33] 24.12.2004 [32] 102004062614.6 [31]
Int. Cl.(2010.01) A61K 09//70 [51]
LTS LOHMANN THERAPIE-SYSTEME
AG, GERMANY [71]
WO/2006/072329 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
[74]
December 29, 2011 299-התשע"ב טבתב 'ג
,P.O.B. 5352 באר שבע5352, ת.ד.
BEER-SHEVA 84152 The invention relates to a transdermal therapeutic system (TTS) that is essentially
composed of two compartments and that is provided with activatable oversaturation
and controlled permeation promotion. The invention more particularly relates to a
TTS, wherein an oversaturated active ingredient solution is produced in an active-
substance-containing polymer matrix when the system is applied to the skin, caused by
the controlled supply of one or several substances promoting permeation of the
pharmaceutical active ingredient; the two compartments which make up the inventive
transdermal therapeutic system; and the production of said transdermal therapeutic
system from the two compartments.
[57]
__________________
184161 [21[]11]
מתקן ושיטה לטיפול במוצר נוזלי
DEVICE AND METHOD FOR
TREATMENT OF A LIQUID
PRODUCT
[54]
22.12.2005 [22] RU [33] 23.12.2004 [32] 20040137687 [31]
Int. Cl.(2010.01) A23L 03//015, B05B 17//00 [51]
MILLISECOND TECHNOLOGIES
CORPORATION, U.S.A. [71]
WO/2006/067604 [87]
ד"ר יצחק הס ושותפיו, 279רחוב הירקון
תל אביב6451, ת.ד.
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[74]
A method and device related to a liquid product pressure and (optionally) temperature
treatment method reduces the level of microorganisms in the liquid product to a
preselected level. Utilizing the method, liquid product is diffused in a chamber with
the speed of pressure variation of liquid product in one embodiment of about 109
Pa/sec. The preferred speed of the diffused drops is about 10m/sec. The liquid product
can optionally be heated before or during diffusion, and is preferably heated as a
diffused liquid product by mixing it with superheated steams The device includes a
chamber and a diffuser in communication with the chamber. Optionally, the device
may include a heating apparatus, such as a steam generator connected via a pressure
control valve to a steam super heater, a cooling chamber connected via a pressure
control valve with a condenser, a vacuum pump in communication with the chamber,
units for condensation and collecting finished products and a vacuum control unit in
communication with the chamber.
[57]
December 29, 2011 300-התשע"ב טבתב 'ג
__________________
184200 [21[]11]
משטח ביניים המתאים במיוחד למבנה אלקטרונית אורתוגגונלי של מערכת
MIDPLANE ESPECIALLY
APPLICABLE TO AN
ORTHOGONAL ARCHITECTURE
ELECTRONIC SYSTEM
[54]
23.12.2005 [22] US [33] 24.12.2004 [32] 60/638973 [31]
US 01.07.2005 11/173927
Int. Cl.(2010.01) H01R 13//648 [51]
AMPHENOL CORPORATION, U.S.A. [71]
THOMAS COHEN, MARK W.
GAILUS, JOHN R. DUNHAM
[72]
WO/2006/071890 [87]
ד"ר דוד אגרנוב, אבא-אלוני15, ת.ד.
DR. DAVID AGRANOV,
P.O.B. 15,
ALONEY-ABA
36005
[74]
A midplane has a first side to which contact ends of a first differential connector are
connected and a second side opposite the first side to which contact ends of a second
differential connector are connected. The midplane includes a plurality of vias
extending from the first side to the second side, with the vias providing first signal
launches on the fist side and second signal launches on the second side. The first signal
launches are provided in a plurality of rows, with each row having first signal launches
along a first line and first signal launches along a second line substantially parallel to
the first line. The second signal launches are provided in a plurality of columns, with
each column having second signal launches along a third line and second signal
[57]
December 29, 2011 301-התשע"ב טבתב 'ג
launches along a fourth line substantially parallel to the third line.
__________________
184310 [21[]11]
–1H–מתילפרופיל(–2)–1–מתיל–2 אמין–4–[נפתירידין5,1][C–5,4אימידאזו]
PROCESS FOR PREPARING 2-
METHYL-1-(2-METHYLPROPYL)-
1H-IMIDAZO[4,5-
C][1,5]NAPHTHYRIDIN-4-AMINE
[54]
28.12.2005 [22] US [33] 30.12.2004 [32] 60/641129 [31]
US 16.08.2005 60/708679
Int. Cl.(2010.01) C07D 47/1/12 [51]
MEDA AB, SWEDEN [71]
WO/2006/074046 [87]
וולף, ברגמן וגולר, יםירושל1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
The invention provides various processes for preparing 2-methyl-1-(2-methylpropyl)-
1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.
[57]
__________________
December 29, 2011 302-התשע"ב טבתב 'ג
184362 [21[]11]
מחסום רכב עם תאורה
VEHICLE BARRIER WITH
LIGHT
[54]
02.07.2007 [22]
Int. Cl.(2010.01) F21V 33//00 [51]
GAMASONIC LTD. [71] אביב -גמסוניק בע"מ, תל
LAZAR IZARDEL [72] לזר איזרדל
דקל פטנט בע"מ, 27,חדר 18מנוחה ונחלה
רחובות
DEKEL PATENT LTD.,
18 MENUHA VENAHALA ST.,
REHOVOT 76209
[74]
An assembly comprising: a vehicle barrier arranged for moving from a first
position that permits a vehicle to move past the vehicle to a second position
that prevents a vehicle from moving past the vehicle barrier; and a light
mounted on said vehicle barrier that moves with said vehicle barrier, wherein
when said vehicle is in the first position said light is illuminated in a first
color and in the second position said light is illuminated in a second color.
[57]
__________________
184438 [21[]11]
מקרולידים, תהליך להכנתם, תכשירים המכילים אותם ושימושם בהכנת רוקחיים
תרופות לטיפול במחלות דלקתיות
MACROLIDES, PROCESS FOR
THEIR PREPARATION,
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME AND USE THEREOF
IN THE MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF
INFLAMMATORY DISEASES
[54]
13.01.2006 [22] US [33] 13.01.2005 [32] 60/643841 [31]
US 09.09.2005 60/715828
Int. Cl.(2010.01) A61K 31//7042, 31//7048, 31//7052, A61P 29//00, C07H 17//08 [51]
GLAXO GROUP LIMITED, UNITED
KINGDOM [71]
WO/2006/087644 [87]
לוצאטו את לוצאטו, יה, עומר גן תעשי
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
[74]
December 29, 2011 303-התשע"ב טבתב 'ג
,P.O.B. 5352 באר שבע5352, ת.ד.
BEER-SHEVA 84152 The present invention relates to novel semi-synthetic macrolides having anti-
inflammatory activity. More particularly, the invention relates to 14- and 15-membered
macrolides substituted at the 4' position, to their pharmaceutically acceptable
derivatives, to processes and intermediates for their preparation, to pharmaceutical
compositions containing them and to their activity and use in the treatment of
inflammatory diseases and conditions in humans and animals, especially those diseases
associated with excessive secretion of TNF-alpha, IL-1, IL-8, IL-2 or IL-5; and/or
inhibitor of excessive lymphocyte proliferation; and/or excessive granulocyte
degranulation.
[57]
__________________
184877 [21[]11]
סילון פלזמה בלחץ אטמוספרי
ATMOSPHERIC-PRESSURE
PLASMA JET
[54]
06.02.2006 [22] EP [33] 04.02.2005 [32] 05447017.4 [31]
Int. Cl.(2010.01) H05H 01//24 [51]
VLAAMSE INSTELLING VOOR
TECHNOLOGISCH ONDERZOEK
(VITO), BELGIUM
[71]
WO/2006/081637 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
The present invention is related to a plasma jet apparatus for performing plasma
processing of an article, comprising: - An elongated central electrode (2,15), - An
elongated cylindrical outer electrode (1) or two outer electrodes (15,16) surrounding
said central electrode and being coaxial with said central electrode, or two electrodes
substantially parallel to the central electrode, - An electrical insulator (3) or insulators
(18,19) disposed between said outer electrode(s) and said central electrode, wherein a
discharge lumen having a distal end and a proximal end is defined between said central
electrode and said electrical insulator(s), - A supply opening (6) disposed at said distal
end of said discharge lumen for supplying a plasma producing gas to said discharge
lumen, - A power source (9) for providing a voltage between said central electrode and
said outer electrode characterised in that said electrical insulator has a radial or
outward extension (40,20) at said proximal end beyond the outer surface of said outer
electrode(s).
[57]
December 29, 2011 304-התשע"ב טבתב 'ג
__________________
184887 [21[]11]
שיטה לייעול חיבורי רדיו ברשתות קציה ניידותטלקומוני
METHOD OPTIMISING RADIO
CONNECTIONS IN MOBILE
TELECOMMUNICATIONS
NETWORKS
[54]
25.01.2006 [22] GB [33] 27.01.2005 [32] 0501754.6 [31]
Int. Cl.(2010.01) H04L 12//28 [51]
HUTCHISON WHAMPOA THREE G
IP (BAHAMAS) LIMITED,
BAHAMAS
[71]
WO/2006/079802 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A method of optimising radio connections in cellular mobile communications network
on the basis of the user equipment and data service being used. The network allocates
Access Point Names to various user equipment/data service combinations. In turn the
Access Point Names are allocated Quality Service parameters which are appropriate to
the corresponding user equipment and data service. When a user terminal requests a
data service with a particular Access Point Name, the radio connection is established
with a Quality of Service which is appropriate to the user equipment and data service
currently being used.
[57]
December 29, 2011 305-התשע"ב טבתב 'ג
__________________
184983 [21[]11]
–פוריל(פירימידינ–2)–4–אמינו–2]–5גביש של און ותהליכים –(H 1)2–מתילפירידינ–1–איל[–5
לייצורו
CRYSTAL OF 5-[2-AMINO-4-(2-
FURYL)PYRIMIDIN-5-YL]-1-
METHYLPYRIDIN-2(1H)-ONE
AND PROCESSES FOR
PRODUCING THE SAME
[54]
20.03.2006 [22] US [33] 21.03.2005 [32] 60/663580 [31]
Int. Cl.(2010.01) A61K 31//506, C07D 40/5/14 [51]
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN [71]
HITOSHI HARADA, HIROSHI
ISHIHARA, YOSHIAKI SATO,
HIROYUKI CHIBA, TEIJI
TAKIGAWA
[72]
WO/2006/101081 [87]
ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
Crystal of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1H)-one
exhibiting, in powder X-ray diffractometry, diffraction peaks at diffraction angles
(2&thetas;±0.2°) of 12.8°, 18.1° and/or 23.5°. This crystal excels in photostability,
thereby being suitable for use as an active ingredient of preventive/therapeutic agents
for diseases, such as costiveness.
[57]
December 29, 2011 306-התשע"ב טבתב 'ג
__________________
185100 [21[]11]
פעמי המכיל גורם מנקב עור–מכלול לשימוש חד
DISPOSABLE ASSEMBLY
CONTAINING A SKIN PIERCING
ELEMENT
[54]
07.02.2006 [22] GB [33] 07.02.2005 [32] 0502840.2 [31]
Int. Cl.(2010.01) A61B 05//15, A61M 37//00 [51]
GLIDE PHARMACEUTICAL
TECHNOLOGIES LIMITED, UNITED
KINGDOM
[71]
WO/2006/082439 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to devices used in the fields of drag delivery or sampling. More
particularly, it relates to a disposable assembly which is fitted to an actuator device
which causes the skin piercing element to enter the skin to deliver a drug (or other
substance) or take a sample. Preferably the assembly is 'made safe' after actuation,
such that the disposable assembly can't be reused and more preferably still the skin
piercing element is safely housed in the assembly such that it does not constitute a
'sharps' risk.
[57]
__________________
185147 [21[]11]
נטולי יכולת שכפול כחיסונים RNAוירוסי
REPLICATION-DEFICIENT RNA
VIRUSES AS VACCINES
[54]
10.02.2006 [22] DE [33] 11.02.2005 [32] 10 2005 006 [31]
December 29, 2011 307-התשע"ב טבתב 'ג
388.8
Int. Cl.(2010.01) A61K 48//00, C07K 14//005, 14//115, C12N 15//86 [51]
MAX-PLANCK-GESELLSCHAFT
ZUR FOERDERUNG DER
WISSENSCHAFTEN E.V.,
GERMANY
[71]
WO/2006/084746 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The invention relates to a genome replication-deficient and transcription-competent
negative strand RNA virus which can be used for expressing transgenes and especially
for developing vaccines. The viral genome contains a mutation in at least one of the
genes N, L, or P.
[57]
__________________
185228 [21[]11]
מערכת לשידור רדיו ושיטה להפעלתו
RADIO TRANSMISSION SYSTEM
AND METHOD FOR THE
OPERATION THEREOF
[54]
06.02.2006 [22] DE [33] 15.02.2005 [32] 102005006909.6 [31]
DE 28.06.2005 102005030108.8
Int. Cl.(2010.01) H04L 29//06 [51]
ROHDE & SCHWARZ GMBH & CO.
KG, GERMANY [71]
WO/2006/087118 [87]
איתן מהולל, עורכי דין ועורכי קבוצת פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
The invention relates to a radio transmission system comprising a plurality of
processing layers for the transmission of data packets between various radio appliances
in a radio channel. A first functional unit (11) in a physical radio transmission layer
analyses the radio channel and determines the quality (QoC) of the radio channel. A
second functional unit (12) in a back-up layer controls the access to the radio channel
according to the actual quality (QoC) of the radio channel and the priority of the data
packets to be transmitted according to the quality (QoS) of the service carried out by
[57]
December 29, 2011 308-התשע"ב טבתב 'ג
the data packets. A third functional unit (14) in a switching layer controls the switching
of the data packets. A control unit (13) then releases the data packets for switching by
means of the third functional unit (14) only when the quality (QoS) of the service
carried out by the data packets corresponds sufficiently with the quality (QoC) of the
radio channel determined in the first functional unit (11).
__________________
185534 [21[]11]
מערכת ושיטה למדידת תכולה של מיכל
SYSTEM AND METHOD FOR
MEASURING CONTENT OF A BIN
[54]
27.02.2006 [22] US [33] 28.02.2005 [32] 60/656373 [31]
Int. Cl.(2010.01) G01F 17//00, 23//296 [51]
-, תלא.פ.מ. פתרונות אוטומציה בע"מ אביב
A.P.M. AUTOMATION SOLUTIONS
LTD. [71]
OFIR PERL, YOSSI ZLOTNICK [72] אופיר פרל, יוסי זלוטניק
WO/2006/090394 [87]
ד"ר מרק פרידמן בע"מ,, רחוב ז'בוטינסקי 54מגדל משה אביב, ק.
7 גן -רמת
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
[74]
A system for measuring a height of a content of a bin, comprising: (a) at least one
transmitter for transmitting a pulse of acoustic energy towards an upper surface of the
content; (b) an array of at least three non-collinear receivers for receiving an echo of
said pulse, each said receiver producing a respective signal in response to said echo;
and (c) a processing apparatus, for jointly transforming said signals into at least one
measured distance from said array to said upper surface, that includes:
i. for each said receiver, a correlator for correlating a waveform of
[57]
December 29, 2011 309-התשע"ב טבתב 'ג
said pulse with said respective signal, thereby producing a correlated signal, and
ii. a beamformer for computing at least one direction of arrival of said
correlated signals from said upper surface to said array.
__________________
185631 [21[]11]
שיטה וערכה לקביעת הרגישות של דוגמא של ארלוטיניב וגורם כימותרפי ביולוגית לשילוב
METHOD AND KIT FOR
DETERMINING THE
SENSITIVITY OF A BIOLOGICAL
SAMPLE TO A COMBINATION OF
ERLOTINIB AND A
CHEMOTHERAPEUTIC AGENT
[54]
10.05.2006 [22] EP [33] 11.05.2005 [32] 05010244.1 [31]
EP 23.05.2005 05011070.9
Int. Cl.(2010.01) G01N 33//573, 33//574 [51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2006/119980 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention relates to a method of determining whether a biological sample
comprising human lung cancer cells is sensitive to a combination of an epidermal
growth factor receptor inhibitor and a chemotherapeutic agent by determining the
overexpression of a phosphorylated AKT protein and/ or a phosphorylated MAPK
protein in the biological sample. The invention is also related to methods for deriving a
candidate agent or for selecting a composition for inhibiting the progression of lung
cancer in a patient wherein a phosphorylated Akt protein and/ or a phosphorylated
MAPK protein is used.
[57]
December 29, 2011 310-התשע"ב טבתב 'ג
__________________
185696 [21[]11]
מוצמדמחבר עם קצה וחלקי צד רחב
COUPLER WITH EDGE AND
BROADSIDE COUPLED
SECTIONS
[54]
01.03.2006 [22] US [33] 08.03.2005 [32] 11/075608 [31]
Int. Cl.(2010.01) H01P 05//18 [51]
WERLATONE, INC., U.S.A. [71]
WO/2006/096445 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273ת.ד. ,
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
Couplers (40) are disclosed that include first and second mutually coupled conductors
(48, 50). The coupled conductors may be regular or irregular in configuration, and for
example, may be linear, including rectilinear or with one or more curves, bends or
turns (78), such as forming a ring, coil, spiral (74, 76) or other loop (70, 72). One or
more sections (42, 44 46) of a coupler (40) may be on different levels and separated by
a dielectric medium, such as air or a dielectric substrate. Coupled conductors (48, 50)
may be facing each other on the same or spaced-apart dielectric surfaces, such as
opposing surfaces of a common substrate, and each conductor (48, 50) may include
one or more portions (48c, 48d, 48e, 50c, 5Od, 5Oe) on each side or surface of a
substrate. In some examples, a coupler (40) may include plural coupled sections (42,
44, 46), with conductors (48, 50) in one section (44) being only broadside coupled, and
conductors (48, 50) in another section (42) being edge-coupled.
[57]
__________________
185874 [21[]11]
BOX AND LID [54] קופסה ומכסה
December 29, 2011 311-התשע"ב טבתב 'ג
07.03.2006 [22] SE [33] 11.03.2005 [32] 0500579-8 [31]
US 11.03.2005 60/660469
Int. Cl.(2010.01) A24F 23//02, B65D 43//08 [51]
GALLAHER SNUS AB, SWEDEN [71]
WO/2006/096117 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
A box comprising an open container (2) and a lid (3) for closing the open container
(2), the box (1) in a closed state comprising two base surfaces (4, 5), one of which
consists of the bottom wall (4) of the open container and the other of the top wall (5) of
the lid (3), together with at least one lateral surface, which is formed by a container
side (6) and a lid side (7). When the box (1) is in the closed state the container side (6)
and the lid side (7) at least partial overlap one another. An inward facing, inclined slide
surface (19) is furthermore arranged on the inside of the top wall (5) of the lid (3) in
order, when closing the open container (2), to allow displacement of the lid (3) into the
correct closing position relative to the container (2). The slide surface (19) runs along
and adjacent to the lid side (7) at an angle relative to the top wall (5) and the lid side
(7) and is remote from the lid side (7).
[57]
__________________
185888 [21[]11]
שמן עמיד בפני חום המאפשר סינרגיה המכיל DHA–ו EPAמסוג 3חומצות אומגה
SYNERGISTICALLY HEAT
STABLE OIL MEDIA
COMPRISING
EICOSAPENTAENOIC ACID
(EPA) AND
DOCOSAHEXAENOIC ACID
(DHA)
[54]
11.03.2005 [22]
Int. Cl.(2010.01) A23D 09//00, 09//06, A61P 03//06, 09//10, C11B 05//00 [51]
December 29, 2011 312-התשע"ב טבתב 'ג
RECON OIL INDUSTRIES
PRIVATE LIMITED, INDIA [71]
WO/2006/095357 [87]
פישר וילר ג'ונס, 26הברזל
ילרמת החי
FISHER WEILER JONES,
26 HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A synergistically heat stable therapeutically active triglyceride and cholesterol
controlling oil composition including the usually highly unsaturated Eicosa Pentaenoic
Acid (EPA) and Docosa Hexaenoic Acid (DHA). The invention avoids limitations of
presently available impure sources of EPA / DHA such as fish oil, algae and the like
and provides for a synergistically stable edible oil formulation involving the Eicosa
Pentaenoic Acid and Docosa Hexaenoic acid of at least 50% to less than 100% purity
in a free of any encapsulated / protected form in combination with synergistically
stability contributing oil constituents / ingredients. The invention also provides for
benefit applications / uses of the surprising and unexpected heat stability of the
beneficial actives EPA and DHA. The invention is therefore directed to serve in
possible provision of variety of alternative media including heat stable media for
regular consumption of EPA / DHA and provide for maintenance of safe and healthy
lifestyle.
[57]
__________________
186203 [21[]11]
מערכת לניטור טמפרטורות נמוכות עבור טחמחסומים מתחת לפני הש
LOW TEMPERATURE
MONITORING SYSTEM FOR
SUBSURFACE BARRIERS
[54]
21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]
Int. Cl.(2010.01) E21B 47//06, 47//12, G01K 11//32 [51]
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
[71]
WO/2006/115945 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention provides a system for monitoring temperature of a subsurface low
temperature zone, that includes a plurality of freeze wells (114) configured to form the
low temperature zone; at least one monitor well; one or more lasers; a fiber optic cable
[57]
December 29, 2011 313-התשע"ב טבתב 'ג
(146) coupled to at least one laser (142), and an analyzer (144) coupled to the fiber
optic cable. A portion of the fiber optic cable is positioned in at least one monitor well.
At least one laser is configured to inject light pulses into at least one end of the fiber
optic cable. The analyzer is configured to receive return signals from the light pulses.
The invention also provides methods for monitoring temperature of a subsurface low
temperature zone.
__________________
186206 [21[]11]
יצור נוזל מתהליך היפוך פנימישיטות ומערכות ל
METHODS AND SYSTEMS FOR
PRODUCING FLUID FROM AN IN
SITU CONVERSION PROCESS
[54]
21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]
Int. Cl.(2010.01) E21B 36//00, 43//24 [51]
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
[71]
WO/2006/116092 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention provides systems that include a plurality of heat sources (102)
configured to heat a portion of a formation; at least one production well (106) in the
formation, a pump system, and a production conduit coupled to the pump system. The
bottom portion of the production well is a sump positioned in an underburden of the
formation that is below the heated portion of the formation. Fluids are allowed to flow
from the heated portion of the formation flow into the sump. The pump system in
combination with the production conduit transport fluids in the sump out of the
formation. The invention also provides methods to remove a portion of the fluids from
the formation.
[57]
December 29, 2011 314-התשע"ב טבתב 'ג
__________________
186207 [21[]11]
של מחממים אורכיים שינוי תכונות לאורכם בעלי טמפרטורה מוגבלת
VARYING PROPERTIES ALONG
LENGTHS OF TEMPERATURE
LIMITED HEATERS
[54]
21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]
Int. Cl.(2010.01) E21B 36//04, 43//24 [51]
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
[71]
WO/2006/116130 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A system for heating a subsurface formation is described. The system includes an
elongated heater in an opening in the formation. The elongated heater includes two or
more portions along the length of the heater that have different energy outputs. At least
one portion of the elongated heater includes at least one temperature limited portion
(240) with at least one selected temperature at which the portion provides a reduced
heat output. The heater is configured to provide heat to the formation with the different
energy outputs . The heater heats one or more portions of the formation at one or more
selected heating rates.
[57]
December 29, 2011 315-התשע"ב טבתב 'ג
__________________
186211 [21[]11]
מערכות לתהליך המרה במקומו המקורי המשתמשות בקודח בארות בלפחות שני איזורים
של הפורמציה
IN SITU CONVERSION PROCESS
SYSTEMS UTILIZING
WELLBORES IN AT LEAST TWO
REGIONS OF A FORMATION
[54]
21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]
Int. Cl.(2010.01) E21B 36//04, 43//24 [51]
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
[71]
WO/2006/116133 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A system for heating a subsurface formation is described. The system includes a
plurality of elongated heaters (244) located in a plurality of openings in the formation.
At least two of the heaters are substantially parallel to each other for at least a portion
of the lengths of the heaters. At least two of the heaters have first end portions (234) in
a first region of the formation and second end portions (238) in a second region of the
formation. A source of time-varying current (254) is configured to apply time-varying
current to at least two of the heaters. The first end portions of the heaters are
configured to be applied with substantially the same voltage. The second portions of
the heaters are configured to be applied with substantially the same voltage.
[57]
December 29, 2011 316-התשע"ב טבתב 'ג
__________________
186214 [21[]11]
תהליך המרה פנימי המנצל מערכת חימום פנימית סגורה
IN SITU CONVERSION PROCESS
UTILIZING A CLOSED LOOP
HEATING SYSTEM
[54]
21.04.2006 [22] US [33] 22.04.2005 [32] 60/674081 [31]
Int. Cl.(2010.01) C10L 03//08, E21B 36//00, 36//04, 43//24 [51]
SHELL INTERNATIONALE
RESEARCH MAATSCHAPPIJ B.V.,
THE NETHERLANDS
[71]
WO/2006/116096 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention provides an in situ conversion system for producing hydrocarbons from
a subsurface formation, that includes: a plurality of u-shaped wellbores in the
formation; piping positioned in at least two of the u-shaped wellbores; a fluid
circulation system coupled to the piping, and an electrical power supply. The fluid
circulation system is configured to circulate hot heat transfer fluid through at least a
portion of the piping to form at least one heated portion of the formation. The electrical
power supply is configured to provide electrical current to at least a portion of the
piping (220) located below an overburden in the formation to resistively heat at least a
portion of the piping and the heat transfers from the piping to the formation. The
invention also provides methods of using the in situ conversion system to produce
hydrocarbons from the subsurface formation.
[57]
December 29, 2011 317-התשע"ב טבתב 'ג
__________________
186288 [21[]11]
מערכת להקרנת וידיאו במהירות משתנה
TRICK MODE SYSTEM
[54]
18.01.2006 [22] US [33] 07.04.2005 [32] 60/669134 [31]
Int. Cl.(2010.01) H04J 01//02, H04L 09//08, H04N 05//783, 07//167 [51]
NDS LIMITED, UNITED KINGDOM [71]
WO/2006/106498 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
A method is described for trick mode playback (10), the method including selecting a
key- frame in recording (20) substantially in the vicinity of a trick mode playback
starting position (30), preparing a decryption key associated with a key period
including the selected key-frame, sending the prepared decryption key to a
descrambler (70), thereby enabling decryption of video beginning at the selected key-
frame, sending a first number P seconds of decrypted video frames, starting a the
selected key-frame, at a predetermined speed for a predetermined number of seconds,
to a video decoder, in parallel to the sending P seconds of video frames, choosing at
least a second video section (50) to stream to the video decoder, sending a decryption
key associated with the chosen second video section to the descrambler (70), and
repeating the steps of selecting, preparing, sending the prepared decryption key, and
sending a first number P seconds of decrypted video frames.
[57]
December 29, 2011 318-התשע"ב טבתב 'ג
__________________
186384 [21[]11]
מיות של מבהירים אופטיים, תמיסות מישימוש בהן עבור הרכבי ציפוי לנייר וכן תהליכי
ציפוי נייר העושים בהן שימוש
AQUEOUS SOLUTIONS OF
OPTICAL BRIGHTENERS, USE
THEREOF FOR COATING
COMPOSITIONS FOR PAPER AND
PAPER COATING PROCESSES
USING SAME
[54]
05.04.2006 [22] EP [33] 08.04.2005 [32] 05007691.8 [31]
Int. Cl.(2010.01) C07D 40/3/12, D21H 21//30 [51]
CLARIANT FINANCE (BVI)
LIMITED, BRITISH VIRGIN
ISLANDS
[71]
WO/2006/108785 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The instant invention relates to storage stable aqueous solutions of stilbene optical
brighteners with polyvinyl alcohols which can be directly used by the papermaker in
that they may be diluted with water and/or be metered directly into a coating
composition, to provide coated papers of a particularly high whiteness.
[57]
__________________
December 29, 2011 319-התשע"ב טבתב 'ג
186491 [21[]11]
קולטן לטיפול –אדרנו 2–טים של בטאאגוניס עור הקשורה לרקמה מחברת–במחלת
BETA-2 ADRENOCEPTOR
AGONISTS FOR TREATING
CONNECTIVE TISSUE DISEASES
OF THE SKIN
[54]
12.04.2006 [22] DK [33] 13.04.2005 [32] PA200500529 [31]
Int. Cl.(2010.01) A61K 45//00 [51]
ASTION PHARMA A/S, DENMARK [71]
WO/2006/108424 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention provides effective and safe medicaments for the treatment of
connective tissue diseases of the skin, particularly with respect to the treatment of
cutaneous forms of Lupus Erythematous. The medicaments comprise as the
therapeutically active ingredient a beta2 adrenoceptor agonist. The invention
furthermore relates to dermatological compositions without skin sensitization
properties and which contain enantiomerically pure or enriched R-enantiomers of a
beta2 adrenoceptor agonist.
[57]
__________________
186517 [21[]11]
סריגי לבטיחות כלי רכב–מעקה רב
VEHICLE SAFETY MULTI-RAIL
PARAPET
[54]
04.04.2006 [22] GB [33] 12.04.2005 [32] 0507358.0 [31]
GB 05.10.2005 0520191.8
Int. Cl.(2010.01) E01D 19//10, E01F 13//00, 15//00 [51]
VARLEY AND GULLIVER
LIMITED, UNITED KINGDOM [71]
WO/2006/109019 [87]
זליגסון גבריאלי ושות', 31רח' יבנה
תל אביב1426, ת.ד.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[74]
A vehicle safety parapet comprises a plurality of rails (18, 24, 28) supported at varying [57]
December 29, 2011 320-התשע"ב טבתב 'ג
heights on uprights (12). A first of the rails comprises a steel box-section supported at
each upright by bracketing means (20) configured to collapse when a horizontal impact
load is applied to the rail, such that the first rail is displaced towards the upright. At
least one other rail extends from the uprights by a greater distance than the first rail
when the bracketing means has collapsed.
__________________
186577 [21[]11]
שיטה והתקן לחיזוי יחס אות להפרעה
SIR PREDICTION METHOD AND
APPARATUS
[54]
10.04.2006 [22] US [33] 14.04.2005 [32] 11/105797 [31]
Int. Cl.(2010.01) H04B 17//00, H04W 52//22 [51]
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL), SWEDEN [71]
WO/2006/108587 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
The present invention provides a method and apparatus for generating SIR estimates
early in a time interval that include the benefits of interference suppression without
requiring the computation of specific interference suppression elements. In particular,
the present invention generates an SIR estimate for a RAKE receiver during a current
time interval based on channel estimates generated based on the received signal(s). By
applying an offset derived during a previous time interval to the RAKE SIR estimate,
the present invention generates a second SIR estimate for a generalized RAKE
receiver.
[57]
December 29, 2011 321-התשע"ב טבתב 'ג
__________________
186680 [21[]11]
שיטה לייצור מלחי מתכת טריאלקלים של חומצה דיאתנואית עם –N,N–מתילגליצין
ל תוצרי לוואיתכולה נמוכה ש
METHOD FOR PRODUCING
METHYLGLYCINE-N,N-
DIETHANOIC ACID
TRIALKALIMETAL SALTS WITH A
LOW BY-PRODUCT CONTENT
[54]
02.05.2006 [22] DE [33] 06.05.2005 [32] 102005021055.4 [31]
Int. Cl.(2010.01) C07C 22/7/26 [51]
BASF SE, GERMANY [71]
WO/2006/120129 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to a method for producing a light-coloured methylglycine-N,N-
diethanoic acid trialkali metal salt with a low by-product content, by the alkaline
hydrolysis of methylglycine diacetonitrile, said method comprises steps that are carried
out in the order (a) to (f): (a) mixing of the methylglycine diacetonitrile with an
aqueous alkali lye at a temperature of = 30 °C; (b) the aqueous alkali methylglycine
diacetonitrile suspension is then reacted at a temperature ranging between 10 and 30
°C for a period of 0.1 to 10 h, to form a solution; (c) the solution obtained in step (b) is
then reacted at a temperature ranging between 30 to 40 °C for a period of 0.1 to 10 h;
(d) optionally the solution obtained in step (c) is reacted at a temperature ranging
between 50 and 80 °C for a period of between 0.5 and 2 h; (e) optionally the solution
obtained in step (c) or (d) is reacted at a temperature ranging between 110 and 200 °C
for a period of between 5 and 60 min; (f) hydrolysis and isolation of ammonia from the
solution obtained in step (c), (d) or (e) by stripping at a temperature of between 90 and
105 °C.
[57]
December 29, 2011 322-התשע"ב טבתב 'ג
__________________
186786 [21[]11]
מכסה להתקן תותב פנימי עבור טיפול במפרצת
COVERING FOR AN
ENDOPROSTHETIC DEVICE FOR
ANEURYSM TREATMENT
[54]
03.03.2006 [22] US [33] 19.04.2005 [32] 60/673304 [31]
Int. Cl.(2010.01) A61F 02//06 [51]
MEDINOL LTD. [71] אביב-מדינול בע"מ, תל
JACOB RICHTER [72] יעקב ריכטר
WO/2006/111801 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
The present invention relates to covered endoprosthetic devices. Covered
endoprosthetic devices comprise an endoprosthesis and a sheath. The sheath comprises
a central portion and outer portions, wherein the central portion preferentially restricts
or causes a restriction of blood flow. Blood flow can be reduced by the central portion
of the sheath by varying the permeability of the sheath or by having projections on the
sheath that slow blood flow. Permeability may be provided by perforations or holes in
the material of the sheath or by varying the polymer structure that makes up the sheath
itself. The outer portions of the sheath do not substantially reduce blood flow. Methods
of using sheath-covered endoprosthetic devices of the invention to treat aneurysms,
especially aneurysms in proximity to small perforator vessels or arteries, are also
encompassed.
[57]
December 29, 2011 323-התשע"ב טבתב 'ג
בקשות חלוקה מבקשה זו שטרם פורסמו9
0/645050/64525 The applications for division
from this application have
not yet been published
__________________
186988 [21[]11]
תאי של –תהליך ומערכת לתכנון מחדש חוץגנטי ואפיגנטי והשימוש בתא תאים באופן
מתוכנן מחדש להכנת תכשיר רוקחות
PROCESS AND SYSTEM FOR
GENETIC AND EPIGENETIC IN
VITRO REPROGRAMMING OF
CELLS AND USE OF A
REPROGRAMMED CELL IN THE
PREPARATION OF A
PHARMACEUTICAL
COMPOSITION
[54]
04.05.2006 [22] FR [33] 04.05.2005 [32] 0551180 [31]
FR 07.10.2005 0553058
FR 21.11.2005 0553533
Int. Cl.(2010.01) A61K 08//98, A61L 27//38, 27//50, A61Q 19//08, C12N 05//16 [51]
FRED ZACOUTO, FRANCE [71]
WO/2007/000523 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
מת החיילר
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to an epigenetic and genetic treatment method and system. The
invention can be used to rejuvenate an adult cell nucleus without passing through an
embryonic stage and to obtain a tissue that is genetically-rejuvenated and autologous in
[57]
December 29, 2011 324-התשע"ב טבתב 'ג
relation to the original nucleus, comprising the temporary introduction of a nucleus
into an enucleated oocyte (genetic rejuvenation), followed by oocyte extraction prior to
cell division. The treated nucleus can then be introduced into an adult cytoplasm
originating from the nucleus. In this way, cell divisions from the rejuvenated nucleus
take place in an adult autologous cytoplasm and the resulting cells immediately take
the form of adult, differentiated and functional cells. The rejuvenated autologous tissue
thus created can then be grafted without rejection to the adult tissue of the organism
from the treated nucleus.; Throughout the inventive procedure, the treated cytoplasms
and nuclei remain permanently in the adult state and no artificial cell differentiation is
necessary. In this way, the invention is different from standard deep cloning in which
the treated cells must return to the embryonic stage and which involves artificial cell
differentiation. In addition, the tissues derived from standard cloning are not
immunologically compatible with the original adult tissues from the treated nucleus
since the cell division thereof takes place in the oocyte which represents a foreign
cytoplasm to the nucleus. Moreover, standard cloning enables the creation of whole
organisms unlike the inventive method and system which can only be used to treat a
single tissue.; The possible applications of the invention include, for example, the
repair of necrotic tissues, such as a myocardial infarction, and damaged tissues, such as
the retina (RMD), heart failure, renal failure, liver failure and osteoporosis, the
treatment of cancers that occur with age, such as prostate cancer, rectal cancer, colon
cancer, etc. The anodyne implantation of a small volume of autologous, rejuvenated,
still-healthy cells from the affected organ should inhibit the aforementioned cancers
and the metastases thereof.
__________________
187048 [21[]11]
נעל
SHOE
[54]
30.10.2007 [22] TW [33] 30.10.2006 [32] 095140135 [31]
Int. Cl.(2010.01) A43B 09//06, 13//00, 13//28, 15//00, B29D 35//00, 35//06 [51]
CHEN MING-TE, TAIWAN R.O.C. [71]
ד"ר יורם צביון, , פארק התעשיה 2רח' הטוחן
קיסריה3148, ת.ד.
DR. YORAM TSIVION,
2 HATOCHEN ST.
P.O.B. 3148,
CAESAREA 38900
[74]
A shoe, comprising: a vamp (200), comprising a lateral vamp (210) and a bottom vamp
(220); a connecting medium apparatus (230), comprising a first plane (231) enclosing
said lateral vamp, a second plane (232) connected to said first plane and extending
outward, a third plane (233) connected to said second plane and extending downward,
and a fourth plane (234) connected to said third plane and extending inward, wherein
said second plane comprises a plurality of holes (235); and an outsole (240) enclosing
said connecting medium apparatus and said bottom vamp, wherein a material forming
[57]
December 29, 2011 325-התשע"ב טבתב 'ג
said outsole fills a gap between said fourth plane of said connecting medium apparatus
and said bottom vamp and said holes in said second plane.
__________________
187093 [21[]11]
גלגל המונע בכח לרכב צבאי
POWER-DRIVEN WHEEL FOR A
MILITARY VEHICLE
[54]
01.11.2007 [22] IT [33] 15.12.2006 [32] TO2006A
000894
[31]
Int. Cl.(2010.01) B60K 07//00, 17//04 [51]
OTO MELARA S.P.A., ITALY [71]
וצאטו את לוצאטו,ל גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The application relates to a power-driven wheel for a military vehicle, comprising an
axial-flow electric motor and a hub connected functionally to said motor and rotating
about an axis. The motor comprises an output member housed partially inside said
hub. Further, the wheel is provided with an epicyclic reducer interposed functionally
between said hub and said output member.
[57]
__________________
December 29, 2011 326-התשע"ב טבתב 'ג
187519 [21[]11]
רכיבי מכלל סיבובי לטורבינה
ROTOR ASSEMBLY FOR A
TURBINE
[54]
20.11.2007 [22] US [33] 28.11.2006 [32] 11/564064 [31]
Int. Cl.(2010.01) B23P 15//02, 15//04, F04D 29//38 [51]
GENERAL ELECTRIC COMPANY,
U.S.A. [71]
זליגסון גבריאלי ושות', 31רח' יבנה
תל אביב1426, ת.ד.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[74]
A rotor assembly for a turbine, said rotor assembly comprising:
a first portion (210) of a rotor component forged from a first material, said first
material being alpha/beta processed; and a second portion (230) of said rotor
component separately forged from a second material that is the same material as said
first material, said second portion being beta processed, wherein said first material and
said second material comprise titanium-based alloys and said second portion is welded
to said first portion at a first axial position.
[57]
__________________
187604 [21[]11]
תכשירי רוקחות המכילים אנטגוניסט לטיפול במחלת סטיל 6 –לאינטרלוקין
PHARMACEUTICAL
COMPOSITIONS CONTAINING
AN INTERLEUKIN-6
ANTAGONIST FOR TREATMENT
OF STILL'S DISEASE
[54]
December 29, 2011 327-התשע"ב טבתב 'ג
02.04.2002 [22] JP [33] 02.04.2001 [32] 2001-103627 [31]
JP 06.04.2001 2001-109131
Int. Cl.(2010.01) A61K 38//20, 39//395, 45//00, A61P 19//02, C07K 16//28 [51] DIVISION FROM 158079 [62]
CHUGAI SEIYAKU KABUSHIKI
KAISHA, JAPAN [71]
WO/2002/080969 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
A therapeutic agent for treatment of Still's disease comprising an antibody against
interleukin-6 (IL-6) receptor as an active ingredient.
[57]
The parent application from which 236/57 בקשת הורה לבקשה זו שטרם פורסמה
this application has been divided has
not yet been published
__________________
187667 [21[]11]
שיטה ומערכת לניווט של מחט אל איבר בגוף של מטופל
SYSTEM AND METHOD FOR
NAVIGATING A SURGICAL
NEEDLE TOWARD AN ORGAN
OF THE BODY OF A PATIENT
[54]
26.11.2007 [22] US [33] 27.11.2006 [32] 60/861118 [31]
Int. Cl.(2010.01) A61B 17//34, 19//00 [51]
MEDIGUIDE LTD. [71] מדיגייד בע"מ, חיפה
בורוכוב קורח ושות', מגדל כלל עתידים
אביב-תל58100, ת.ד.
BOROCHOV, KORAKH & CO.,
15TH FLOOR, ATIDIM TOWER,
KIRYAT ATIDIM,
P.O.B. 58100,
TEL AVIV 61580
[74]
System (100) for navigating a surgical needle (106) toward a target organ of the body
of a patient, the system comprising: a removable mandrel (108) located within said
surgical needle, said removable mandrel to be moved in and moved out of said surgical
needle; a medical positioning system (MPS) sensor (110) located at the tip of said
removable mandrel; an electromagnetic field generator (104) for generating an
electromagnetic field; and an MPS (102) coupled with said MPS sensor and with said
electromagnetic field generator, said MPS sensor producing an output according to
said electromagnetic field, said MPS determining the position of said tip of said
[57]
December 29, 2011 328-התשע"ב טבתב 'ג
removable mandrel in a coordinate system respective of said MPS, according to said
output of said MPS sensor, said MPS producing an indication respective of said
position, to enable navigation of said surgical needle toward said target organ.
__________________
187808 [21[]11]
חיישן מבוסס גריד המשלב זיהוי כריכה ללא תגית והגברת נגיהת אור ומערכת קריאה עבור
חיישן
GRATING-BASED SENSOR
COMBINING LABEL-FREE
BINDING DETECTION AND
FLUORESCENCE
AMPLIFICATION AND READOUT
SYSTEM FOR SENSOR
[54]
20.07.2006 [22] US [33] 11.08.2005 [32] 60/707579 [31]
US 02.09.2005 60/713694
US 28.02.2006 60/778160
US 07.04.2006 60/790207
Int. Cl.(2010.01) G01N 21//55 [51]
SRU BIOSYSTEMS, INC., U.S.A. [71]
WO/2007/019024 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
A grating-based sensor is disclosed that has a grating structure constructed and
designed for both evanescent resonance (ER) fluorescence detection and label-free
detection applications. Some embodiments are disclosed which are optimized for ER
detection in an air mode, in which the sample is dry. Other embodiments are optimized
for ER detection in liquid mode, in which the sample is suspended in liquid medium
such as water. One and two-dimensional gratings are also disclosed, including gratings
characterized by unit cells with central posts, central holes, and two-level, two-
dimensional gratings. A readout system for such sensors is also disclosed. One
embodiment includes a first light source optimized for collecting label -free detection
data, a second light source optimized for collecting ER fluorescence amplification
data, and at least one detector. In one embodiment, the detector is an imaging system
[57]
December 29, 2011 329-התשע"ב טבתב 'ג
and includes a CCD camera for collecting both ER and label-free data. In other
embodiments, the at least one detector takes the form of a spectrometer for collection
of label-free data and a photomultiplier for collecting ER data. In other embodiments,
a single light source such as a tunable laser or broad band light source is used.
__________________
878131 [21[]11]
הרכב פרמצבטי לשמירה על רמה קבועה של 24עד 12סטרואיד ניורואקטיבי בפלסמה למשך
שעות לאחר השימוש
PHARMACEUTICAL
COMPOSITION PROVIDING A
STEADY STATE PLASMA LEVEL
OF A NEUROACTIVE STEROID
FOR 12-24 HOURS FOLLOWING
ADMINISTRATION
[54]
09.06.2006 [22] US [33] 09.06.2005 [32] 60/688905 [31]
Int. Cl.(2010.01) A61K 09//16, 09//20, 31//58, A61P 25//00 [51]
EURO-CELTIQUE S.A.,
LUXEMBOURG [71]
WO/2006/131392 [87]
ד"ר שלמה כהן ושות', 124אבן גבירול
תל אביב11490, ת.ד.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[74]
The present invention relates to pharmaceutical compositions of the neuroactive
steroid 3alpha-hydroxy-3beta-methoxymethyl-21-(1′-imidazolyl)-5alpha-pregnan-20-
one or a pharmaceutically-acceptable salt or solvate thereof., with properties desirable
for use in treating mood disorders and the like. The pharmaceutical compositions
provide sustained therapeutic plasma levels of 3alpha-hydroxy- 3beta-methoxymethyl-
21-(1′-imidazolyl)-5alpha-pregnan-20-one. The present invention also relates to
methods of treating these disorders by administering the pharmaceutical compositions.
[57]
December 29, 2011 330-התשע"ב טבתב 'ג
בקשות חלוקה מבקשה זו
שטרם פורסמו902427250222225 The applications for division
from this application have
not yet been published
__________________
187840 [21[]11]
נגזרות של חומצות תיאזול קרבוקסיליות ושימושיהן בטיפול בהפרעות במערכת העצבים
ההיקפית
THIAZOLE CARBOXYLIC ACIDS
DERIVATIVES AND THEIR USE
IN THE TREATMENT OF
PERIPHERAL NERVE SYSTEM
DISORDERS
[54]
02.06.2006 [22] JP [33] 03.06.2005 [32] 2005-164458 [31]
Int. Cl.(2010.01) A61K 31//426, 45//00, C07D 27/7/20 [51]
ONO PHARMACEUTICAL CO.,
LTD., JAPAN [71]
WO/2006/129788 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
An EP2 agonist which may have an EP3 agonistic effect has an effect of regenerating
and/or protecting nerves, and is therefore useful as a therapeutic agent for a disease of
the peripheral nervous system, such as a lower or upper motor neuron disease, a nerve
root disease, plexopathy, thoracic outlet compression syndrome, peripheral
neuropathy, neurofibromatosis and neuromuscular transmission disease. An EP2
agonist which has an EP3 agonistic effect is a safe and effective agent for the
regeneration and/or protection of nerves which has little influence on the circulatory
system.
[57]
בקשות חלוקה מבקשה זו מו9שטרם פורס
0/51035 The applications for division
from this application have
not yet been published
__________________
188067 [21[]11]
December 29, 2011 331-התשע"ב טבתב 'ג
שים מצינורות התקן לשבירה לרסיסים והסרת גו וחללים בגוף
DEVICE FOR FRAGMENTING
AND REMOVING
CONCRETIONS FROM BODY
DUCTS AND CAVITIES
[54]
12.12.2007 [22]
Int. Cl.(2010.01) A61B 17//22, 18//26 [51]
LITHOTECH MEDICAL LTD. [71] ליתוטק מדיקל בע"מ, קצרין
ריינהולד כהן ושותפיו, א' 26רזל רחוב הב
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A medical device and method for breaking a concretion in a body into smaller pieces
and removing the pieces from the body are described. The device comprises a dilator
sheath, a lithotripsy probe, a tubular member, and a retrieval basket. The dilator sheath
is adapted to penetrate into a passage of the body to reach the location where the
concretion is located. The lithotripsy probe is configured for shattering the concretion
into smaller pieces. The tubular member is mounted within the dilator sheath adapted
to permit the lithotripsy probe to be inserted into the tubular member. The retrieval
basket is coupled to the tubular member, and configured for entrapping the concretion
and the smaller pieces for their extraction from the body. The retrieval basket
comprises a structure constituted by a plurality of filaments extending from a basket
proximal end towards a basket distal end, and then returning to the proximal end after
forming a plurality of filament loops in the basket distal portion, and a plurality of
filament strands at the basket proximal portion.
[57]
__________________
188199 [21[]11]
תרכובת ציקלובוטאן מותמרת, תהליך הכנתה ושימושה הרפואי
SUBSTITUTED CYCLOBUTANE
COMPOUND, ITS PREPARATION
PROCESS AND ITS MEDICAL USE
[54]
21.06.2006 [22] CN [33] 24.06.2005 [32] 200510027131.X [31]
Int. Cl.(2010.01) A61K 31//4412, C07C 69//74, C07D 40/1/08 [51]
SHANGHAI INSTITUTE OF MATERIA
MEDICA, CHINESE ACADEMY OF
SCIENCES, CHINA
[71]
ZHOU CAIHONG, MINGWEI WANG,
NA LI, GUANGXING WANG, XIN XIE,
QING LIU, FAJUN NAN
[72]
WO/2006/136101 [87]
December 29, 2011 332-התשע"ב טבתב 'ג
אגמון,-סורוקר 14טון, רחוב שנקר בית נול
הרצליה פיתוח
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
[74]
Substituted cyclic compounds of formula (I) or formula (II) are provided. The
preparation methods of said compounds and the uses of glucagons like peptide-1
receptor (GLP-1R) regulators in the prophylaxis or treatment of metabolic disorder,
which include but not limit to diabetes, insulin-resistance and obesity etc., are also
provided.
[57]
__________________
188228 [21[]11]
לאמינאט עמיד לירי וערכת טראומה
BULLET PROOF LAMINATE AND
TRAUMA PACK
[54]
16.06.2006 [22] EP [33] 23.06.2005 [32] 05013518.5 [31]
Int. Cl.(2010.01) B32B 05//26 [51]
TEIJIN ARAMID GMBH, GERMANY [71]
WO/2006/136323 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to a trauma pack comprising at least one panel of a plastic
material and at least one textile fabric layer affixed to the panel and made of yarns with
fibres having a tensile strength of at least 900 MPa, wherein the plastic material of the
panel is a self-reinforced thermoplastic material made of filaments, fibres, tapes or
strips of a polyolefin polymer, and wherein at least one textile fabric layer is bonded
over its entire surface to the self-reinforced thermoplastic material.
[57]
December 29, 2011 333-התשע"ב טבתב 'ג
__________________
188246 [21[]11]
ראש מברשת למברשת שיניים
BRUSH HEAD FOR A
TOOTHBRUSH
[54]
03.08.2006 [22] CH [33] 08.08.2005 [32] 1307/05 [31]
Int. Cl.(2010.01) A46B 09//00, 09//04, A46D 01//00 [51]
GABA INTERNATIONAL AG,
SWITZERLAND [71]
WO/2007/016802 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Disclosed is a brush head (1) for a toothbrush, comprising a grip part (11), a head part
(12), and a bristle area with bunches of bristles (201, 202, 203, 204, 301, 302, 303,
304, 401, 402, 501, 502, 601, 602, 701, 702) that are inserted therein. At least one of
said bunches of bristles (301, 302, 303, 304) is inclined. The inventive brush head (1)
is characterized in that at least some of the bristles in at least one of the inclined
bunches of bristles (301, 302, 303, 304) are pointed.
[57]
__________________
188264 [21[]11]
December 29, 2011 334-התשע"ב טבתב 'ג
תרבית תרחיף של תאי גזע עובריים ממקור אנוש
SUSPENSION CULTURE OF
HUMAN EMBRYONIC STEM
CELLS
[54]
20.06.2006 [22] US [33] 22.06.2005 [32] 60/693266 [31]
Int. Cl.(2010.01) C12N 05//02 [51]
GERON CORPORATION, U.S.A. [71]
WO/2007/002086 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
This disclosure provides an improved system for culturing human embryonic stem
cells. The cells are cultured in suspension so as to maximize the production capacity of
the culture environment. The new culture system of this invention allows for bulk
proliferation of hES cells in a more cost-effective manner, which facilitates
commercial production of important products for use in human therapy.
[57]
__________________
188469 [21[]11]
–מחסנית לערבוב סטרילי של תרכובת דופאזית, במיוחד לשרפים אקריליים בעלי שני
מרכיבים
CARTRIDGE FOR STERILE
MIXING OF A TWO-PHASE
COMPOUND, PARTICULARLY FOR
TWO-COMPONENT ACRYLIC
RESINS
[54]
16.05.2006 [22] IT [33] 28.06.2005 [32] VI2005A000187 [31]
Int. Cl.(2010.01) A61B 17//56, A61F 02//46 [51]
TECRES S.P.A., ITALY [71]
GIOVANNI FACCIOLI, RENZO [72]
December 29, 2011 335-התשע"ב טבתב 'ג
SOFFIATTI
WO/2007/000631 [87]
ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
The present invention has its application in the field of devices and methods for the
product physical and chemical mixing and refers particularly to a cartridge for sterile
mixing of a two-phase compound. The cartridge consists of a first tubular body (2)
defining a first collection chamber (3) for a solid phase, a second tubular body (4)
defining a second collection chamber (5) for a liquid phase, means for transferring (6)
the liquid phase from the second (5) to the first chamber (3), means for mixing (7) the
phases. The means for mixing (7) comprise agitator means (8) acting on the mixture
inside the first chamber (3) with the first tubular body (2) in substantially stationary
conditions, so as to favour the dispersion of the solid phase inside the liquid phase thus
obtaining a compound with uniform physical and mechanical properties.
[57]
__________________
188582 [21[]11]
מהדקים ניתוחיים והתקני הידוק
SURGICAL FASTENERS AND
DEVICES FOR SURGICAL
FASTENING
[54]
06.07.2006 [22] US [33] 06.07.2005 [32] 60/696516 [31]
Int. Cl.(2010.01) A61B 17//064 [51]
איי.בי.איי ישראל ביומדיקל אינוביישנס בע"מ
I.B.I. ISRAEL BIOMEDICAL
INNOVATIONS LTD. [71]
December 29, 2011 336-התשע"ב טבתב 'ג
WO/2007/004228 [87]
ריינהולד כהן ושותפיו, א' 26הברזל רחוב
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention provides a surgical fastener. The fastener has a first element defining an
axis of the fastener, and or more prongs attached to the first element at hinge regions.
Deploying the fastener involves bending the prongs at the hinges so as to increase the
distance of the prong tips from the axis and locking the fastener in this deployed
configuration. The invention also provides a surgical fastening device and a method
for attaching a surgical fastener to a site of a body tissue.
[57]
__________________
188600 [21[]11]
תהליך להכנת אסאומאפראזול
METHOD FOR PREPARING
ESOMEPRAZOLE
[54]
11.07.2006 [22] KR [33] 28.07.2005 [32] 10-2005-
0068761
[31]
Int. Cl.(2010.01) A61P 01//04, C07D 40/1/12 [51]
HANMI HOLDINGS CO., LTD.,
REPUBLIC OF KOREA [71]
WO/2007/013743 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
Optically pure esomeprazole and its salt can be simply prepared by dissolving (S)-(-)-
binol, a weak base and the racemic form of omeprazole in a mixture of a water-
compatible organic solvent and water at a high temperature, cooling the mixed solution
[57]
December 29, 2011 337-התשע"ב טבתב 'ג
to crystallize the inclusion complex of esomeprazole and (S)-(-)-binol, and removing
the (S)-(-)-binol moiety from the crystallized inclusion complex.
__________________
188641 [21[]11]
מערכות התאמה מותאמות במיוחד לשם תיקון תנוחות כיסא
FITTING SYSTEMS ADAPTED
ESPECIALLY FOR FIXING SEAT
POSITIONS
[54]
25.07.2006 [22] US [33] 25.07.2005 [32] 60/702133 [31]
Int. Cl.(2010.01) B60N 02//08, B64D 11//06 [51]
WEBER AIRCRAFT LP, U.S.A. [71]
WO/2007/014184 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
Fitting systems and assemblies are detailed. The assemblies are designed principally
(although not necessarily exclusively) for use with aircraft seats and supply positive
adjustable positioning of a seat or other object, typically actuated with a single turn (or
less) of a single tool
[57]
__________________
188645 [21[]11]
מכשיר למדידת כף רגל
FOOT MEASURING DEVICE
[54]
07.01.2008 [22]
Int. Cl.(2010.01) A43D 01//00, 01//02, 01//06 [51]
FITRACKS INC., U.S.A. [71]
ELIAHO GERBY, NOAM אליהו ג'רבי, נועם דננברג, יובל בכור
DANENBERG, YUVAL BECHOR
[72]
December 29, 2011 338-התשע"ב טבתב 'ג
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
An apparatus for measuring the dimensions of human feet, comprising: (a) a base (20)
which comprises and supports electrical and optical components; (b) a cover, which
fits over said base to protect said components, and defines the borders of two
essentially rectangular wells in the upper surface of said base, into which said feet to
be measured are placed; (c) pressure pads containing a sensor matrix, which are used
to provide structural and additional information of said feet; (d) a multitude of
emmiter/detector pairs )24,24',25,25'(, which are used to make length and width
measurements of said feet; (e) computational means, which calculate said dimensions
from said measurements; and (f) display means, which display said dimensions, said
structural information and other pre-determined information characterized in that said
computational means comprises an algorithm which uses information supplied by said
pressure pads to correct errors in said length and width measurments caused by
misplacement of said feet in said wells and said emitters and corresponding detector
are provided in two contiguous levels, wherein the upper is offset by one half of the
width of an individual emitter/detector.
[57]
__________________
188649 [21[]11]
השיטה לקביעה אוטונומית של קואורדינטות המיקום של אובייקט בתנועה והמכשיר ליישומו
METHOD AND DEVICE FOR
AUTONOMOUS
DETERMINATION OF THE
LOCATION COORDINATES OF A
MOVING OBJECT
[54]
08.01.2008 [22]
Int. Cl.(2010.01) G01C 21//00 [51]
מיכאל נאומוב, תל אביב אביב -גאורגי נאומוב, תל
MICHAEL NAUMOV
GEORGE NAUMOV [71]
MICHAEL NAUMOV, [74] מיכאל נאומוב,
December 29, 2011 339-התשע"ב טבתב 'ג
3חצור תל אביב
3 HATZOR ST.,
TEL AVIV
Method of autonomous determination of the location of the coordinates of a moving
object comprising the following stages: determination of the true course;
determination of the projections of the linear acceleration vector onto the lines of
crossing the horizontal plane and the planes going through the vertical axis of the
moving object and through, correspondingly, the longitudinal and traverse axis of said
object through its lines parallel to said axes; determination of the projections of the
ground speed vector onto said lines of crossing; determination of the location of the
coordinates of the moving object by means of said projections.
[57]
__________________
188670 [21[]11]
נגזרות פירידין ונגזרות פירימידין ושיטות לשימוש בהן
PYRIDINE AND PYRIMIDINE
DERIVATIVES AND METHODS
OF USE THEREOF
[54]
21.08.2006 [22] US [33] 24.08.2005 [32] 60/710671 [31]
Int. Cl.(2010.01) A61K 31//4409, 31//496, 31//506, 31//5377, A61P 35//00, 35//04,
43//00, C07D 21/3/75, 23/9/47, 40/1/12
[51]
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN [71]
TOMOHIRO MATSUSHIMA,
HIROSHI OBAISHI, KEIKO
TAKAHASHI, SETSUO FUNASAKA,
SHUJI SHIROTORI
[72]
WO/2007/023768 [87]
ר אנד קו בע"מ,ג'יי אמ בי, פקטו רחוב המרפא, הר חוצבים
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
A compound represented by the general formula: (I) (wherein R1 means a 3- to 10-
membered nonaromatic heterocyclic group or the like; R2 and R
3 mean a hydrogen
atom; R4, R
5, R
6 and R
7 are the same or different and mean a hydrogen atom, a halogen
atom, a C1-6 alkyl group or the like; R8 means a hydrogen atom or the like; R
9 means a
3- to 10-membered nonaromatic heterocyclic group or the like; n means an integer of 1
to 2; and X means a group represented by the formula -CH= or a nitrogen atom), a salt
thereof or a hydrate thereof has an excellent hepatocyte growth factor receptor (HGFR)
inhibitory action, and exhibits an anti-tumor action, angiogenesis inhibitory action or
cancer metastasis inhibitory action.
[57]
December 29, 2011 340-התשע"ב טבתב 'ג
__________________
188757 [21[]11]
צעי להעברת רמות דחיסה, מערכת, שיטה ואמ במערכת של צורה זורמת
SYSTEMS, METHODS AND
MEDIA FOR TRANSITIONING
COMPRESSION LEVELS IN A
STREAMING IMAGE SYSTEM
[54]
13.07.2006 [22] US [33] 19.07.2005 [32] 11/184345 [31]
Int. Cl.(2010.01) H04N 07//50 [51]
IBM CORPORATION, U.S.A. [71]
WO/2007/009941 [87]
מעבדות יבמ מחלקת קנין רוחני, אוניברסיטת חיפה הר הכרמל
חיפה
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
[74]
Systems, methods and media for transitioning compression levels of a streaming image
system are disclosed. One embodiment provides a method for transitioning
compression levels between image frames in a streaming image system. Embodiments
may include receiving by a smoothing module a request for a new compression level
associated with an image frame. Embodiments may also generally include performing
by the smoothing module a smoothing heuristic by generating a multi-frame
smoothing routine based on an initial compression level, a target compression level,
and a number of frames to achieve the target compression level. Embodiments may
also include setting by the smoothing module the new compression level for the image
frame based on the generated multi-frame smoothing routine. Further embodiments
may include transmitting by the smoothing module an indication of the new
compression level to a content encoder.
[57]
December 29, 2011 341-התשע"ב טבתב 'ג
__________________
189030 [21[]11]
תכשירים המכילים פטריית זנב תרנגול הודו תמצית שלהאו FERM BP–10633מיזן
COMPOSITIONS COMPRISING
TURKEY TAIL MUSHROOM
STRAIN FERM BP-10633 OR ITS
EXTRACT
[54]
28.07.2006 [22] JP [33] 28.07.2005 [32] 2005-218554 [31]
Int. Cl.(2010.01) A01G 01//04, A01H 15//00, A61K 36//07, C12N 01//14 [51]
NIKKEN SOHONSHA
CORPORATION, JAPAN [71]
WO/2007/013588 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
Disclosed is a strain of turkey tail mushroom (Trametes versicolor) having excellent
biological activities (Accession number: FERM BP-10633). The strain is excellent in
platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect,
anti-mutagenic effect, anti-tumor effect, anti-hypertensive effect and
immunomodulating effect. When the strain is used in combination with a microalga or
other basidiomycete, the effect of the strain is improved synergistically. The strain has
a high safety, is less likely to cause an adverse side effect even when used
continuously for a prolonged period of time, and can be used effectively in a beverage,
cosmetic, pharmaceutical or the like that is intended to be used for the
prevention/improvement of an inflammation, an allergy, a tumor or other disease. The
strain has extremely increased hypha growth property and shows extremely higher
physiological functions compared to conventional strains and therefore can be used
stably.
[57]
December 29, 2011 342-התשע"ב טבתב 'ג
__________________
189168 [21[]11]
התקן לטיפול במצעים, בפרט לגלוונם
DEVICE FOR THE TREATMENT
AND IN PARTICULAR
GALVANIZING OF SUBSTRATES
[54]
03.08.2006 [22] DE [33] 03.08.2005 [32] 102005038450.1 [31]
Int. Cl.(2010.01) C25D 17//06 [51]
GEBR. SCHMID GMBH & CO.,
GERMANY [71]
WO/2007/014778 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
The invention relates to a contacting device for a galvanization apparatus (11),
comprising contacting rollers (20) with a continuous rigid external face (26, 27) which
is joined to a jacket section (22). The jacket section (22) is provided with an inner
opening (23) that is wider than a rotating shaft (30) on which the contacting roller (20)
sits. This allows the contacting roller (20) to be moved in a radial direction, electric
contacting and securing of a basic position being obtained via springs (32). The
movability of the contacting roller (20) ensures good contact as the contacting roller
(20) rests against substrates (16) even when the substrates (16) are uneven. The contact
pressure can be relatively small.
[57]
__________________
189206 [21[]11]
INTERRUPT CONTROLLER [54]הפרעה להפקת תועלת של תיכנות ערכי עדיפות
December 29, 2011 343-התשע"ב טבתב 'ג
של בקר
UTILISING PROGRAMMABLE
PRIORITY VALUES
24.10.2006 [22] GB [33] 21.12.2005 [32] 0526007.0 [31]
Int. Cl.(2010.01) G06F 13//24 [51]
ARM LIMITED, UNITED KINGDOM [71]
WO/2007/071894 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
An interrupt controller (2) is provided with priority registers (6) storing priority values
P0-P9 used to determine prioritisation between received interrupt signals I0-I9. A
priority value accessing circuit (10) provides multiple mappings to the priority values
stored in dependence upon the priority value manager (16, 18), seeking to make an
access. In this way, a first priority value manager (18), such as a secure operating
system, can be given exclusive access to the highest priority values whilst a second
priority value manager (16), such as a non-secure operating system, can be given
access to a range of priority values as stored which are of a lower priority and yet as
written or read by the non-secure operating system appear to the non-secure operating
system to have a different, such as higher, priority level.
[57]
__________________
189284 [21[]11]
השיטה והמכשיר לקביעה אוטונומית של זווית הסחיפה של אובייקט בתנועה
METHOD AND DEVICE FOR
AUTONOMOUS
DETERMINATION OF THE
ANGLE OF DRIFT OF A MOVING
OBJECT
[54]
05.02.2008 [22]
Int. Cl.(2010.01) G01C 21//00 [51]
December 29, 2011 344-התשע"ב טבתב 'ג
אביב -מיכאל נאומוב, תל אביב -גאורגי נאומוב, תל
MICHAEL NAUMOV
GEORGE NAUMOV [71]
מיכאל נאומוב, 3חצור
אביב -תל
MICHAEL NAUMOV,
3 HATZOR ST.,
TEL AVIV 69016
[74]
The present technical solution provided is intended for the accurate determination of
angle of drift only by the means located inside the moving object, without applying
any radiations and gyroscopes as well as without using any sources of information and
orientation on the Earth and on any other heavenly bodies. The determination of such
kind is provided for the first time and is considered to be of paramount importance for
navigational and meteorological purposes. The present solution is based on the
determination of the horizontal projections of the linear acceleration vector by means
of the sensors of said acceleration.
[57]
__________________
189342 [21[]11]
טכנולוגיה למתן שרותי תקשורת למספר קווי תקשורת באמצעות ציוד עודף
TECHNOLOGY FOR PROVIDING
TELECOMMUNICATION
SERVICES TO MULTIPLE
OPTICAL COMMUNICATION
LINES BY EQUIPMENT HAVING
REDUNDANCY
[54]
07.02.2008 [22]
Int. Cl.(2010.01) H04Q 11//00 [51]
ECI TELECOM LTD. [71] . איי. טלקום בע"מ, פתח תקוהאי. סי
אי. סי. איי. טלקום בע"מ, 30רחוב הסיבים
פתח תקוה
ECI TELECOM LTD.,
30 HASIVIM ST.,
PETACH TIKVA 49517
[74]
A system for serving N optical communication lines by a redundant set of modules in
an optical network; where the set of modules comprises N >1 main modules and one
backup module, N optical splitters, 2N fiber connections and a control means. In the
system, each of the N optical splitters is connected to two different modules of the set
by two respective fiber connections out of the 2N connections, while each of the N
optical splitters is also coupled to one of the N optical communication lines. The
arrangement is such that the control means selectively activates/inactivates any of the
fiber connections for respectively enabling/blocking transfer of data therealong; the
control means thus ensures that each specific line of the N optical communication
lines is always served by either one or another of two different modules.
[57]
December 29, 2011 345-התשע"ב טבתב 'ג
__________________
189514 [21[]11]
מערכת גישור לוגית ושיטה
LOGICAL BRIDGING SYSTEM
AND METHOD
[54]
13.02.2008 [22] US [33] 14.02.2007 [32] 60/889809 [31]
US 04.05.2007 60/916065
Int. Cl.(2010.01) H04L 12//28 [51]
מארוול ישראל )אמ.איי.אס.אל( בע"מ, יוקנעם
MARVELL ISRAEL (M.I.S.L) LTD. [71]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
A bridge for routing data packets on a network, the bridge comprising: a physical
ingress port to receive a data packet from the network; a classification engine to assign
source logical port information to the data packet based on characteristics of the data
packet, wherein an assigned logical ingress port is decoupled from the physical ingress
port; a bridging engine downstream of the classification engine to learn the source
logical port information and to forward the data packet to a logical egress port based
on a destination address of the data packet; and a logical port mapping engine to map
the logical egress port to a physical egress port at which the data packet is to be
egressed.
[57]
בקשות חלוקה מבקשה זו שטרם פורסמו9
024/7/5 The applications for division
from this application have
not yet been published
__________________
189664 [21[]11]
פירידין ותולדות –תולדות אוקסזול/תיאזולויצורן, אוקסזול/תיאזול, תהליך לי–בנזו
ותכשירים רוקחיים הכוללים אותן
OXAZOLO/THIAZOLO-PYRIDINE
DERIVATIVES AND BENZO-
OXAZOLE/THIAZOLE
DERIVATIVES, PROCESS FOR
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME
[54]
December 29, 2011 346-התשע"ב טבתב 'ג
21.08.2006 [22] EP [33] 02.09.2005 [32] 05108035.6 [31]
Int. Cl.(2010.01) A61K 31//423, 31//424, 31//428, 31//429, A61P 03//00, 17//00,
19//02, C07D 41/3/12, 41/7/12, 49/8/04, 51/3/04
[51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2007/025897 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352. , ת.ד
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
This invention is concerned with compounds of the formula (I) wherein X, A, B, R1,
R2 and G are as defined in the description and claims, and pharmaceutically acceptable
salts thereof. The invention further relates to pharmaceutical compositions containing
such compounds, to a process for their preparation and to their use for the treatment
and/or prevention of diseases which are associated with the modulation of SST
receptors subtype 5.
[57]
__________________
189666 [21[]11]
בנזאמידים מותמרים בפירידינאמינוסולפוניל P450 3A4 (4A3כמעכבים של ציטוכרום
CYP)
PYRIDINAMINOSULFONYL
SUBSTITUTED BENZAMIDES AS
INHIBITORS OF CYTOCHROME
P450 3A4 (CYP3A4)
[54]
11.09.2006 [22] US [33] 23.09.2005 [32] 60/720151 [31]
US 03.10.2005 60/723115
US 11.10.2005 60/725469
US 25.01.2006 60/762256
US 07.08.2006 60/821664
Int. Cl.(2010.01) A61K 31//4406, A61P 39//00, C07D 21/3/00 [51]
PFIZER PRODUCTS, INC., U.S.A. [71]
WO/2007/034312 [87]
December 29, 2011 347-התשע"ב טבתב 'ג
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention provides compounds of formula (I), or pharmaceutically
acceptable salts or solvates thereof, methods for their preparation, methods for their
use, and pharmaceutical formulations comprising them.
[57]
__________________
189716 [21[]11]
שיטה ומערכת להשגת גישה לערוץ גישה –FDMAאקראי לקשר מהארץ ללוויין במערכת
SC
METHOD AND APPARATUS FOR
ACCESSING AN UPLINK
RANDOM ACCESS CHANNEL IN
A SINGLE CARRIER FREQUENCY
DIVISION MULTIPLE ACCESS
SYSTEM
[54]
22.08.2006 [22] US [33] 23.08.2005 [32] 60\710599 [31]
Int. Cl.(2010.01) H04B 07//204, H04J 01//00, H04W 52//48, 52//50, 74//08 [51]
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A. [71]
WO/2007/024791 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A method and apparatus for accessing a contention-based uplink random access
channel (RACH) in a single carrier frequency division multiple access (SC-FDMA)
system are disclosed. A wireless transmit/receive unit (WTRU) randomly selects a
RACH subchannel and a signature among a plurality of available RACH subchannels
and signatures. The WTRU transmits a preamble using the selected signature via the
[57]
December 29, 2011 348-התשע"ב טבתב 'ג
selected RACH subchannel at a predetermined or computed transmission power. A
base station monitors the RACH to detect the preamble and sends an acquisition
indicator (AI) to the WTRU when a signature is detected on the RACH. When
receiving a positive acknowledgement, the WTRU sends a message part to the base
station. If receiving a negative acknowledgement or no response, the WTRU
retransmits the preamble.
__________________
189804 [21[]11]
רפידה תחתית נגד פצעי לחץ ותוכנית לרפידה של מיטה המכילה רפידה תחתית נגד פצעי
לחץ
ANTIDECUBITAL UNDERLAY PAD
AND BED PAD DESIGN
COMPRISING AN ANTIDECUBITAL
UNDERLAY PAD
[54]
24.07.2006 [22] DE [33] 31.08.2005 [32] 102005041520.2 [31]
Int. Cl.(2010.01) A47C 27//00, A61G 07//057 [51]
OPED AG, SWITZERLAND [71]
DANIELA HAPPEL [72]
WO/2007/025611 [87]
הנרי סיני, 4המייסדים
רעננה669, ת.ד.
HENRY SINAI,
IP-PARTNERSHIP
P.O.B 669
RAANANA 43350
[74]
An antidecubital underlay pad having a receiving casing with a top side of the casing
and a bottom side of the casing, the casing being segmented along a plurality of
segmentation axes to form underlay segments, such that the underlay segments are
provided with a moulded body filling comprising a plurality of moulded bodies and are
bordered by segmentation lines running along the segmentation axes, characterized in
that the segmentation lines (11) have multiple changes in direction in their course
along the segmentation axes (13) and at least the top side (16) of the casing is designed
to be elastic at least in a supporting area and is pre-stressed by the moulded body
filling.
[57]
December 29, 2011 349-התשע"ב טבתב 'ג
__________________
189823 [21[]11]
שיטה ומערכת להכנת אריג בטכניקת SPUNBOND
METHOD AND APPARATUS FOR
MAKING A SPUNBOND WEB
[54]
28.02.2008 [22] EP [33] 08.03.2007 [32] 07004747/7 [31]
Int. Cl.(2010.01) D01D 05//088, 05//098, D04H 01//00, 03//16 [51]
REIFENHAUSER GMBH & CO. KG
MASCHINENFABRIK, GERMANY [71]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A method for the manufacture of a spunbond non-woven web fabric from filaments, in
particular of a thermoplastic plastic, wherein the filaments are spun from at least one
spinning device, wherein the filaments are subsequently cooled in a cooling chamber
and then stretched in a stretching unit, wherein the filaments are subsequently guided
through at least one diffuser and are then deposited on a deposition belt to form the
non-woven fabric web, wherein the non-woven fabric web is guided out of the wetting
unit and is subsequently initially consolidated by means of a high pressure water jet
treatment on the deposition belt, and wherein the non-woven fabric web is
subsequently drawn off from the deposition belt and is further treated.
[57]
__________________
189909 [21[]11]
אלמנטים מודולאריים, רשת, מבנה תומך, מבנה ותהליך לייצורם
MODULAR ELEMENTS,
NETWORK, SUPPORTING
STRUCTURE, CONSTRUCTION
[54]
December 29, 2011 350-התשע"ב טבתב 'ג
AND PROCESS FOR OBTAINING
THEM
07.08.2006 [22] RO [33] 22.09.2005 [32] A200500806 [31]
Int. Cl.(2010.01) E04B 02//00, 02//26, E04C 02//26 [51]
LAURENTIU DUMITRU BREAZ,
ROMANIA [71]
WO/2007/081233 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
The invention relates to modular elements made of insulating materials for
constructions, provided with at least one network element in the interior; to a network
obtained by connecting modular elements; to a supporting structure achieved by
casting a hardening material in the network achieved by connecting the modular
elements and joining them through the supporting structure, as well as to the process
for obtaining thereof. The modular element has an interior network element made up
of at least two main half-joints and optionaly it may have one or more secondary half-
joints, connected through vertical and oblique channels. The network obtained by
assembling the modular elements is made up of main and secondary joints, connected
trough vertical, horizontal and oblique channels. The unitary supporting structure is
obtained by casting a material that will be harden in the unitary network for the entire
construction. The process for obtaining the construction according to the invention
consists of the following: connection of modular elements and the casting of material
that hardens in the network defined through the connection of modular elements and
the creation of a unitary supporting structure.
[57]
__________________
189972 [21[]11]
December 29, 2011 351-התשע"ב טבתב 'ג
פורמולציה המכילה היילורונן והשימוש בה להכנת תרופה ומנעיה של מחלות תאיות
FORMULATION COMPRISING
HYALURONAN AND USE
THEREOF FOR PREPARING A
MEDICAMENT FOR TREATMENT
OR PROPHYLAXIS OF
CELLULAR DISEASES IN A
SUBJECT
[54]
04.09.2006 [22] US [33] 07.09.2005 [32] 60/715293 [31]
US 31.03.2006 60/788589
Int. Cl.(2010.01) A61K 31//726, 31//728, 39//395, A61P 35//00 [51]
ALCHEMIA ONCOLOGY PTY
LIMITED, AUSTRALIA [71]
WO/2007/028196 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention relates generally to treatment and prophylactic protocols for
cellular diseases or disorders, such as diseases and disorders associated with abnormal
cellular proliferation. More particularly, the present invention provides compositions
comprising therapeutic antibodies and hyaluronan and their use in the treatment or
prophylaxis of cellular diseases and disorders.
[57]
__________________
190011 [21[]11]
מנעול רב שימושי
MULTIFUNCTIONAL LOCK
[54]
20.07.2006 [22] CN [33] 09.09.2005 [32] 200520075364.2 [31]
CN 25.01.2006 200620068971.0
Int. Cl.(2010.01) E05B 29//04 [51]
MALAFON ELECTRONIC (SUZHOU)
CO. LTD., CHINA [71]
VINCENT GAN, YANG SHEN [72]
WO/2007/028308 [87]
קו בע"מ,ג'יי אמ בי, פקטור אנד רחוב המרפא, הר חוצבים
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
A multifunctional lock comprises a lock shell (1), a lock bar (3), movable tooth pieces
(4), a support (5) for sliding blocks, sliding blocks (6) and a guide slot unit (8) for the
[57]
December 29, 2011 352-התשע"ב טבתב 'ג
insertion of a key. Wherein, an elastic element is provided between the lock bar and
the support, the sliding blocks at least partially extend into the keyway of the unit.
When the lock is unlocked, a projection of the unit has two operating positions, in one
of which the projection is received into the cut of the shell and the upper teeth of the
tooth pieces disengage from the bottom teeth of the sliding blocks, in another it is out
of the cut and the upper teeth engage with the bottom teeth. The key of the lock can be
changed many times.
__________________
190071 [21[]11]
תמיכהמכלול איבר
SUPPORT MEMBER ASSEMBLY
[54]
12.09.2006 [22] SG [33] 16.09.2005 [32] 200505952-2 [31]
Int. Cl.(2010.01) E04B 02//00, 02//06, 02//58 [51]
DYNTEK PTE LTD., SINGAPORE [71]
WO/2007/032746 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A support member system (100) is disclosed herein. In a preferred embodiment, the
system (100) comprises an elongate support member (102, 103) having an effective
length, an elongate member engagement portion (130, 135) arranged to engage with
one end of the elongate support member (102, 103) to extend the member's effective
length, and a base portion (110) for engaging with a support structure (8, 9). The base
portion (110) including connection means (114, 116) for releasably connecting the
base portion (110) selectively to the elongate member engagement portion (130, 135)
[57]
December 29, 2011 353-התשע"ב טבתב 'ג
or to the elongate support member (102, 103).
__________________
190088 [21[]11]
ללא שימוש ברכיבים Aייצור וטיהור חלבון נגזרים מבעלי חיים
PROTEIN A PRODUCTION AND
PURIFICATION WITHOUT USING
ANIMAL DERIVED
COMPONENTS
[54]
14.09.2006 [22] US [33] 20.09.2005 [32] 60/718759 [31]
Int. Cl.(2010.01) C07K 14//195, 14//31, C12N 01//20 [51]
AVANTOR PERFORMANCE
MATERIALS, INC., U.S.A. [71]
WO/2007/035410 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
Purification of vegetarian (non-animal derived) Protein A using a multidimensional
purification process to remove undesirable non-animal derived components.
[57]
__________________
190454 [21[]11]
התקן לניקוי פני שטח באמצעות כח מגהסוני
APPARATUS FOR CLEANING
SUBSTRATE USING MEGASONIC
[54]
December 29, 2011 354-התשע"ב טבתב 'ג
POWER
30.09.2003 [22] US [33] 30.09.2002 [32] 10/261839 [31]
US 30.06.2003 10/611140
Int. Cl.(2010.01) H01L 21//00 [51] DIVISION FROM 161550 [62]
LAM RESEARCH CORPORATION,
U.S.A. [71]
JOHN M. DE LARIOS, JAMES P.
GARCIA, CARL A. WOODS,
MICHAEL RAVKIN, FRITZ
REDEKER, JOHN BOYD, AFSHIN
NICKHOU
[72]
WO/2004/030052 [87]
ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
A head used in a substrate preparation apparatus, having a head surface, the head
configured to be disposed proximate to a surface of a substrate, comprising: at least
one first source inlet for delivering a first fluid to the surface of the substrate through
the head; at least one second source inlet for delivering a second fluid to the surface of
the substrate through the head, the second fluid being different than the first fluid; at
least one source outlet for removing each of the first fluid and the second fluid from
the surface of the substrate, at least a portion of the at least one source outlet being
located in between the at least one first source inlet and the at least one second source
inlet; and a transducer disposed in the head for applying acoustic energy at a location
between the at least one of a first source inlet and the source outlet; wherein the head
surface has flat surface regions, and the head surface is defined so that the at least one
of the first source inlet, the second source inlet and the source outlet are defined by
discrete holes that reside at the head surface and extend through the flat surface regions
of the head surface.
[57]
__________________
190585 [21[]11]
ות שיטה לאבחון תסחיפי קרישה ומחל בעורקים הכליליים של הלב
METHOD FOR THE DIAGNOSIS OF
THROMBOEMBOLIC AND
CORONARY HEART DISEASES
[54]
30.09.2006 [22] DE [33] 12.10.2005 [32] 102005048899.4 [31]
December 29, 2011 355-התשע"ב טבתב 'ג
Int. Cl.(2010.01) C12Q 01//68 [51]
SANOFI AVENTIS, FRANCE [71]
WO/2007/042165 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
The invention relates to a method for the In-vitro diagnosis of thromboembolic
disorders and/or coronary heart diseases. The nucleotide in position 470 of a nucleic
acid, coded for human EGLN2-protein, or the amino acid in position 58 of the human
EGLN2-protein of a sample from a person is determined.
[57]
__________________
190673 [21[]11]
מימן פוספאט של אנטגוניסט לרצפטור –דו–מלח 2Dפרוסטגלאנדין
DIHYDROGEN PHOSPHATE
SALT OF A PROSTAGLANDIN D2
RECEPTOR ANTAGONIST
[54]
12.10.2006 [22] US [33] 13.10.2005 [32] 60/726290 [31]
Int. Cl.(2010.01) A61K 31//505, C07D 23/9/46, 23/9/47 [51]
AVENTIS PHARMACEUTICALS
INC., U.S.A. [71]
WO/2007/047378 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
The present invention is directed to the dihydrogen phosphate salt of 2-(3-{6-[2-(2,4-
dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methyl-propionic
acid of Formula (III), a pharmaceutical composition comprising a pharmaceutically
effective amount of the compound of Formula (III), and a pharmaceutically acceptable
carrier; and a method of treating a patient suffering from a PGD2-mediated disorder
including, but not limited to, allergic disease (such as allergic rhinitis, allergic
conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic
mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis
shock, bronchoconstriction, bronchitis, urticaria, eczema, diseases accompanied by
itch (such as atopic dermatitis and urticaria), diseases (such as cataract, retinal
detachment, inflammation, infection and sleeping disorders) which is generated
secondarily as a result of behavior accompanied by itch (such as scratching and
beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion
[57]
December 29, 2011 356-התשע"ב טבתב 'ג
injury, cerebrovascular accident, chronic rheumatoid arthritis, pleurisy, ulcerative
colitis and the like, by administering to said patient a pharmaceutically effective
amount of the compound of Formula (III).
__________________
190731 [21[]11]
ייצור של אוליגודנדרוציטים מתאי גזע שהופקו משלייה
PRODUCTION OF
OLIGODENDROCYTES FROM
PLACENTA-DERIVED STEM
CELLS
[54]
13.10.2006 [22] US [33] 13.10.2005 [32] 60/727601 [31]
Int. Cl.(2010.01) C12N 05//0735 [51]
ANTHROGENESIS CORPORATION,
U.S.A. [71]
WO/2007/047465 [87]
ד"ר שלמה כהן ושות', 124אבן גבירול
תל אביב11490, ת.ד.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[74]
The present invention provides methods and compositions for the production of glial
cells and oligodendrocytes from placenta stem cells. The invention further provides for
the use of these glia and oligodendrocytes in the treatment of, and intervention in, for
example, trauma, ischemia and degenerative disorders of the central nervous system
(CNS), particularly in the treatment of demyelinating diseases such as multiple
sclerosis.
[57]
December 29, 2011 357-התשע"ב טבתב 'ג
__________________
190869 [21[]11]
שיטה לייצור תאי גזע ממקור אנושי על ידי שפעול רביית בתולים של בייציות ממקור אנושי
METHOD OF PRODUCING
HUMAN STEM CELLS BY
PARTHENOGENIC ACTIVATION
OF HUMAN OOCYTES
[54]
19.10.2006 [22] US [33] 21.10.2005 [32] 60/729177 [31]
US 02.11.2005 60/733309
US 11.01.2006 60/758443
US 14.06.2006 60/813799
Int. Cl.(2010.01) C12N 05//0735 [51]
INTERNATIONAL STEM CELL
CORPORATION, U.S.A. [71]
WO/2007/047979 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
)Methods of producing human stem cells are disclosed for parthenogenetically
activating human oocytes by manipulation of O2 tension, including manipulation of
Ca2+
under high O2 tension and contacting oocytes with serine threonine kinase
inhibitors under low O2 tension, isolating inner cell masses (ICMs) from the activated
oocytes, and culturing the cells of the isolated ICMs under high O2 tension. Moreover,
methods are described for the production of stems cells from activated oocytes in the
absence of non-human animal products, including the use of human feeder
cells/products for culturing ICM/stem cells. Stem cells produced by the disclosed
methods are also described.
[57]
December 29, 2011 358-התשע"ב טבתב 'ג
__________________
191066 [21[]11]
יטה והתקן לטיפול במים למניעת אורגניזם ש מימיים
METHOD AND APPARATUS FOR
WATER TREATMENT TO
ELIMINATE AQUATIC
ORGANISMS
[54]
27.10.2006 [22] ZA [33] 28.10.2005 [32] 2005/10473 [31]
Int. Cl.(2010.01) C02F 01//36 [51]
RESOURCE BALLAST
TECHNOLOGIES (PROPRIETARY)
LIMITED, SOUTH AFRICA
[71]
WO/2007/049139 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
A method and apparatus for treating water such as ballast water in ships in order to
eliminate aquatic organisms in the water. The water is led under pressure through a
conduit into a chamber of greater cross-section than that of the conduit so that an
abrupt reduction in pressure occurs. Cavitation ensues, leading to the release of
dissolved gases. Ultrasonic vibration is generated and is applied to the water, exerting
a pounding effect that weakens or destroys the organisms present. Other means may be
used to generate further mechanical, electrical, and chemical forces in the water which
attack the organisms.
[57]
__________________
191077 [21[]11]
ISOLATED ANTIBODY WHICH [54]( NTDטרמינלי )–Nנוגדן מבודד הנקשר לאזור
December 29, 2011 359-התשע"ב טבתב 'ג
לגילוי IN–VITRO, שיטות γ–HRGשל העושות שימוש בנוגדן כזה γ–HRGולטיהור
ושימוש בנוגדן כזה להכנת תרופות
BINDS TO THE N-TERMINAL
DOMAIN (NTD) OF Γ-HRG, IN-
VITRO METHODS FOR
DETECTING AND PURIFYING Γ-
HRG USING SUCH ANTIBODY
AND USE OF SUCH ANTIBODY IN
THE PREPARATION OF
MEDICAMENTS
08.07.1997 [22] US [33] 12.07.1996 [32] 60/021640 [31]
Int. Cl.(2010.01) A61K 39//395, C07K 16//22, C12N 15//12, 15//13 [51] DIVISION FROM 127892 [62]
GENENTECH, INC., U.S.A. [71]
WO/1998/002541 [87]
רוביץ ושות',ש. הו 31רחוב אחד העם
תל אביב2499, ת.ד.
S. HOROWITZ & CO.,
31 AHAD HAAM ST.,
P.O.B. 2499,
TEL AVIV 65202
[74]
An isolated antibody which binds to the N-terminal domain (NTD) of γ-HRG, which
has the ability to bind to the ErbB3 and/or ErbB4 receptor and comprises an amino
acid sequence selected from the group consisting of: (a) the amino acid sequence for γ-HRG in SEQ ID No:2; (b) naturally occuring allelic variants or isoforms of 9a) having at least 80% amino
acid sequence identity with human γ-HRG of SEQ ID No:2; and
(c) the amino acid sequence of (a) or (b) which has only one or two amino acid
substitutions.
[57]
__________________
191078 [21[]11]
–Nפוליפפטידים הכוללים רצף עוקב של אזור , חומצות גרעין, וקטורים, γ–HRGטרמינלי של
תאי מאכסן, תכשירי רוקחות, שיטות לייצור ושימוש בפוליפפטידים כאלה
POLYPEPTIDES COMPRISING A
CONSECUTIVE SEOUENCE OF
THE Γ-HRG, N-TERMINAL
DOMAIN, NUCLEIC ACIDS,
VECTORS, HOST CELLS,
PHARMACEUTICAL
COMPOSITIONS, METHODS FOR
PRODUCING AND USE OF SUCH
POLYPEPTIDES
[54]
December 29, 2011 360-התשע"ב טבתב 'ג
08.07.1997 [22] US [33] 12.07.1996 [32] 60/021640 [31]
Int. Cl.(2010.01) A61K 38//18, C07K 14//47, 14//475, C12N 15//12, 15//16, 15//63,
15//70, 15//74, 15//79
[51]
DIVISION FROM 127892 [62]
GENENTECH, INC., U.S.A. [71]
WO/1998/002541 [87]
ש. הורוביץ ושות', 31רחוב אחד העם
תל אביב2499, ת.ד.
S. HOROWITZ & CO.,
31 AHAD HAAM ST.,
P.O.B. 2499,
TEL AVIV 65202
[74]
An isolated polypeptide comprising a consecutive sequence of at least thirty amino
acids of the gamma-HRG N-terminal domain (NTD) of SEQ ID NO:4.
[57]
__________________
191417 [21[]11]
קומבינציות של מפעילי קולטן מסוג פרוקסיזום ( ומעכבי ספיגת PPARאקטיבטד )–פרוליפרטור
סטרול
COMBINATIONS OF
PEROXISOME PROLIFERATOR-
ACTIVATED RECEPTOR (PPAR)
ACTIVATOR(S) AND STEROL
ABSORPTION INHIBITOR(S)
[54]
25.01.2002 [22] US [33] 26.01.2001 [32] 60/264396 [31]
US 21.09.2001 60/323839
Int. Cl.(2010.01) A61K 31//397, 31//70, 45//06, 47//12, 47//20, 47//34, 47//38, A61P
03//04, 03//10, 09//04, 09//10, C07D 20/5/08, 20/5/12, 40/1/04, 40/3/12, 40/5/10,
40/9/04, 41/3/10, C07H 03//04, 17//02
[51]
DIVISION FROM 156445 [62]
SCHERING CORPORATION, U.S.A. [71]
WO/2002/058732 [87]
ד"ר שלמה כהן ושות', 124אבן גבירול
תל אביב11490, ת.ד.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[74]
The present invention provides compositions, therapeutic combinations and methods
including: (a) at least one peroxisome proliferator-activated receptor activator; and (b)
at least one substituted azetidinone or substituted b-lactam sterol absorption inhibitor
which can be useful for treating vascular conditions, diabetes, obesity and lowering
plasma levels of sterols.
[57]
December 29, 2011 361-התשע"ב טבתב 'ג
__________________
191606 [21[]11]
לדת כלי התקן להעמסת מערכת כלי נשק של ש רכב
DEVICE FOR MOUNTING A
WEAPON SYSTEM ON A
VEHICLE CHASSIS
[54]
13.11.2006 [22] FR [33] 21.11.2005 [32] 0511826 [31]
Int. Cl.(2010.01) F41A 23//34 [51]
NEXTER SYSTEMS, FRANCE [71]
WO/2007/057550 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to a device for mounting a weapon system on a vehicle chassis,
which device comprises a false chassis (12) which bears the weapon system and is
secured to the chassis (4) by a connection means (17). This device is characterized in
that the connection means comprises at least two attachment points (17) formed by
lugs (18) secured to the chassis (4), which lugs each bear a rod (20) on which a block
(22) secured to the false chassis (12) is mounted, which block is able both to move
translationally and pivot with respect to the rod (20).
[57]
__________________
191614 [21[]11]
MCD MCD SHELL [54]מעטפת
December 29, 2011 362-התשע"ב טבתב 'ג
10.10.2006 [22] SE [33] 23.11.2005 [32] 0502564-8 [31]
Int. Cl.(2010.01) F42B 12//76 [51]
BAE SYSTEMS BOFORS AB,
SWEDEN [71]
TORSTEN RONN [72]
WO/2007/061350 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -במרכז ג
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
The present invention relates to a method for firing explosive-filled, fragmentation
shells (1) that disperse fragments on the pre-programmed detonation of their own
explosive (7) so as to reduce the risk of accidental injury to unprotected personnel and
damage to materiel, which at the moment of firing are undeservedly situated between
the firing weapon and the target. The invention also encompasses shells (1) produced
or modified according to said method.
[57]
__________________
191679 [21[]11]
שיטה לאבחון מחוץ לגוף של מחלת דלקתית של עייםהמ
IN VITRO METHODS FOR
DIAGNOSING INFLAMMATORY
BOWEL DISEASE
[54]
30.11.2006 [22] US [33] 01.12.2005 [32] 11/293616 [31]
Int. Cl.(2010.01) C12N 05//16, C12Q 01//68, G01N 33//53 [51]
PROMETHEUS LABORATORIES
INC., U.S.A. [71]
WO/2007/064964 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
The present invention provides methods, systems, and code for accurately classifying
whether a sample from an individual is associated with inflammatory bowel disease
(IBD) or a clinical subtype thereof. In particular, the present invention is useful for
[57]
December 29, 2011 363-התשע"ב טבתב 'ג
classifying a sample from an individual as an IBD sample using a statistical algorithm
and/or empirical data. The present invention is also useful for differentiating between a
clinical subtype of IBD such as Crohn's disease (CD) and ulcerative colitis (UC) using
a statistical algorithm and/or empirical data. Thus, the present invention provides an
accurate diagnostic prediction of IBD or a clinical subtype thereof and prognostic
information useful for guiding treatment decisions.
__________________
191720 [21[]11]
למכשיר קירור ליצירת תנאי נקודת הט
DEWPOINT COOLING DEVICE
[54]
28.11.2006 [22] NL [33] 28.11.2005 [32] 1030538 [31]
Int. Cl.(2010.01) F24F 05//00 [51]
OPTIMAIR HOLDING B.V.I.O., THE
NETHERLANDS
WILLEM MEIJER, THE
NETHERLANDS
[71]
WO/2007/061298 [87]
פישר וילר ג'ונס, 26הברזל
רמת החייל
FISHER WEILER JONES,
26 HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to a device for cooling an airflow, comprising at least one
cooling channel with an inflow opening for the airflow for cooling and an outflow
opening for the cooled airflow, at least one evaporating channel separated from the
cooling channel by a transfer wall and having an inflow opening, which is connected
to the outflow opening of the cooling channel, and an outflow opening, means for
wetting the side of the transfer wall directed toward the evaporating channel, and
means for dehumidifying the airflow in the cooling channel. The dehumidifying means
can comprise a polymer with lower critical solution temperature (LCST polymer) with
which the side of the transfer wall directed toward the cooling channel can be covered
or from which it can be manufactured. The cooling device can further have means for
[57]
December 29, 2011 364-התשע"ב טבתב 'ג
regenerating the dehumidifying means.
__________________
191738 [21[]11]
התקן לנעילת חיבור צינורות
PIPE JOINT LOCKING DEVICE
[54]
11.10.2006 [22] JP [33] 07.12.2005 [32] 2005-352883 [31]
Int. Cl.(2010.01) F16K 35//00, F16L 15//00, 19//00, 35//00 [51]
FUJIKIN INCORPORATED, JAPAN [71]
WO/2007/066452 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
A pipe joint locking device that can prevent a pipe joint from being erroneously
loosened after tightening and in which sealing ability at a seal section of the pipe joint
is not impaired even force rotating a pipe member is applied to it. The pipe joint
locking device has a first structure member (11) and a second structure member (12).
The first structure member (11) has an installation section (21) attached to an
externally threaded joint member (2) such that the installation section is not rotatable
relative to the joint member, a cover section (22) engaged from below to the outer
perimeter surface of a cap nut (5), and a connection section (23) engaged from below
to a pipe member (3). The second structure member (12) has a cover section (31)
engaged from above to the outer perimeter surface of the cap nut (5) and a connection
section (32) engaged from above to the pipe member (3). The connection section (23)
of the first structure member (11) and the connection section (32) of the second
structure member (12) are connected such that they are fixed to a portion (3a)
projecting from the cap nut (5) of the pipe member (3).
[57]
December 29, 2011 365-התשע"ב טבתב 'ג
__________________
191824 [21[]11]
והשימוש בו להכנת תכשיר IL–22נוגדן כנגד רוקחי לטיפול בהפרעות הקשורות בדלקת עור
ANTI IL-22 ANTIBODY AND ITS
USE IN THE PREPARATION OF
PHARMACEUTICAL
COMPOSITIONS FOR
ALLEVIATING DISORDERS
CHARACTERIZED BY SKIN
INFLAMMATION
[54]
30.11.2006 [22] US [33] 02.12.2005 [32] 60/741640 [31]
US 16.08.2006 60/822597
Int. Cl.(2010.01) A61K 38//20, 39//395, A61P 29//00, 35//00, 37//00, C07K 16//18,
16//24, 16//28
[51]
GENENTECH, INC., U.S.A. [71]
WO/2007/126439 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Compositions and methods are provided for the diagnosis and treatment of
inflammation and autoimmune disorders, such as psoriasis. Compositions and methods
for modulating IL-23 or IL-22 signaling are provided.
[57]
December 29, 2011 366-התשע"ב טבתב 'ג
בקשות חלוקה מבקשה זו
9שטרם פורסמו0222765 The applications for division
from this application have
not yet been published
__________________
191839 [21[]11]
וחלונותשיטה להרכבת בקרת שליטה לדלתות
METHOD FOR MOUNTING A
CONTROL ASSEMBLY FOR
DOORS AND WINDOWS
[54]
29.05.2008 [22] EP [33] 23.07.2007 [32] 07425450.9 [31]
Int. Cl.(2010.01) E05B 63//00 [51]
SAVIO S.P.A., ITALY [71]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
Method for mounting a control assembly (12) for doors or windows, in which the door
or window comprises a frame including a metallic section bar (10) having an outer
wall (24) and a longitudinal groove (30) with an undercut section and an open edge
contained in a plane that is orthogonal to said outer face and in which the control
assembly comprises: a handle (14) having a base (32), a rotatable grip (34) and a
rotatable control pin (36) rotatably connected to the grip, a transmission device (16)
having an input member (56) able to be coupled with the control pin of the handle and
at least one carriage (74) movable in rectilinear direction and connected to the input
member by means of a mechanism (60, 62, 68, 70, 72) able to transform the rotary
motion of the input member into a rectilinear motion of said carriage, a rod (18) able to
slidably engage said groove and a connecting member (20) able to be fastened to the
rod, characterised in that the method comprises the steps of: positioning said rod in
said groove with said connecting member positioned slidably on the rod, applying the
transmission mechanism to the section bar, mutually connecting said carriage and said
connecting member so that the connecting member is fixed to said carriage for
movements in the longitudinal direction of the groove and after mutually connecting
said carriage and the connecting member, fastening the connecting member to the rod.
[57]
__________________
December 29, 2011 367-התשע"ב טבתב 'ג
191897 [21[]11]
שיטה לגילוי רעלים מבוססת על ביוסנסור ומערכות לאנאליזה של איכות מים ואוויר
המבוססות עליה
BIOSENSOR-BASED METHOD
FOR THE DETECTION OF
TOXINS AND WATER AND AIR
QUALITY ANALYSIS SYSTEMS
BASED THEREON
[54]
13.12.2006 [22] US [33] 14.12.2005 [32] 11/302844 [31]
Int. Cl.(2010.01) C12Q 01//02, 01//22 [51]
UT-BATTELLE, LLC, U.S.A. [71]
WO/2007/070828 [87]
לוצאטו את לוצאטו, יה, עומר גן תעשי
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
A water or air quality analysis system (10) and related method is biosensor-based for
detecting toxins. The water or air to be analyzed includes a plurality of photosynthetic
organisms therein, wherein toxins including chemical, biological or radiological agents
alter a nominal photosynthetic activity of the photosynthetic organisms. A
photodetector (12) is for measuring photosynthetic activity of the plurality of
photosynthetic organisms. An electronics package (30) includes a processor coupled to
the photodetector for analyzing the photosynthetic activity to indicate a presence of a
toxin in the water or air. The analysis includes obtaining at a first time a measured
photosynthetic activity curve for the photosynthetic organisms, and comparing the
measured curve to a reference photosynthetic activity curve to determine differences
therebetween. The presence of specific toxins, or precursors thereof, are then identified
if present in the air or water using the differences.
[57]
__________________
December 29, 2011 368-התשע"ב טבתב 'ג
191952 [21[]11]
קביעת פורמט לכתובת, התואם לפורמטיםאחרים של תכובות בהן נעשה שימוש לפניה
למרחבי כתובות בעלי גודל שונה
PROVIDING AN ADDRESS
FORMAT COMPATIBLE WITH
DIFFERENT ADDRESSING
FORMATS USED FOR
ADDRESSING DIFFERENT SIZED
ADDRESS SPACES
[54]
16.04.2007 [22] US [33] 04.05.2006 [32] 11/381712 [31]
Int. Cl.(2010.01) G06F 03//06 [51]
IBM CORPORATION, U.S.A. [71]
WO/2007/128652 [87]
מעבדות יבמ מחלקת קנין רוחני, אוניברסיטת חיפה הר הכרמל
חיפה
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
[74]
Provided are a method, system, and article of manufacture for providing an address
format compatible with different addressing formats used for addressing different sized
address spaces. An address format is used in an operating system to address storage
space in a storage device comprising a first region and a second region of storage
space. A first group of applicat ions uses the address format to only address the storage
space in the first region and is not coded to use the address format to access the second
region and a second group of applications uses the address format to address the
storage space in the first and second regions.
[57]
__________________
December 29, 2011 369-התשע"ב טבתב 'ג
192005 [21[]11]
מערכת גיר מערכת גיר שימושית במיוחד כ משתנה המשכית
TRANSMISSION SYSTEM
PARTICULARLY USEFUL AS A
CONTINUOUSLY VARIABLE
TRANSMISSION
[54]
10.12.2006 [22] US [33] 10.12.2005 [32] 60/597567 [31]
Int. Cl.(2010.01) B62M 09//00, 09//06, F16H 15//00, 15//42 [51]
CVTRON LTD. [71] סויטרון בע"מ, ת"א
RAN SIMAN-TOV [72] טוב-רן סימן
WO/2007/066342 [87]
( בע"מ,1995ג'י.אי.ארליך ) 11,רחוב מנחם בגין 15מגדל איילון, קומה
רמת גן
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[74]
A transmission system includes first and second transmission members to be
selectively coupled to each other or decoupled from each other The first transmission
member includes at least one gripping device having a plurality of spaced gπpping
elements, and the said second transmission member includes a plurality of coupling
elements receivable in an interleaved manner between the gπpping elements of the
gripping device The gπpping elements of the gripping device being displaceable by a
lateral compressive force (a) to displace them towards each other to firmly grip the
coupling elements of the second transmission member and thereby to establish a
nonslip coupling between the two transmission members, and (b) away from each
other to decouple the two transmission members from each other In a described
preferred embodiment, the first transmission member includes a pair of rotatable
conical members over which the second transmission member is wound.
[57]
__________________
192011 [21[]11]
מערכת ושיטה לניהול תכולת מים בנוזל
SYSTEM AND METHOD FOR
MANAGING WATER CONTENT
IN A FLUID
[54]
07.12.2006 [22] US [33] 07.12.2005 [32] 60/748123 [31]
Int. Cl.(2010.01) B01D 05//00, E03B 03//28, F25D 17//00 [51]
DUCOOL LTD. [71] דוקול בע"מ, קבוץ החותרים
December 29, 2011 370-התשע"ב טבתב 'ג
WO/2007/066212 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
A system and method for managing water content in a fluid (19, 38) includes a
collection chamber (12) for collecting water from the fluid (19) with a desiccant (20),
and a regeneration chamber (14) for collecting water from the desiccant (20) and
transferring it to a second fluid (38). An evaporator (28) cools the desiccant (20)
entering the collection chamber (12), and a second evaporator 52) cools the second
fluid (38) to extract the water. The evaporators (28, 54) use a refrigerant, the flow of
which is controlled by a flow control valve (70). When the temperature in the second
evaporator (54) drops below a set point, the refrigerant flow to the second evaporator
(54) is stopped, and the refrigerant flow to the first evaporator (28) is increased. This
increases the water collection in the collection chamber (12), and causes a rise in the
temperature in the second evaporator (54). The valve (70) is then opened to increase
the cooling in the second evaporator (54).
[57]
__________________
192087 [21[]11]
מערכת מטען נפץ רבת משימות
MULTIFUNCTIONAL EXPLOSIVE
SYSTEM
[54]
06.12.2006 [22] EP [33] 12.12.2005 [32] 05027055.2 [31]
Int. Cl.(2010.01) F42B 03//02 [51]
RECCONN AG, SWITZERLAND [71]
WO/2007/068386 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Explosive apparatus having at least two cuboid mouldings, which have at least one [57]
December 29, 2011 371-התשע"ב טבתב 'ג
firing hole, composed of explosive material, whose edge lengths have a ratio of 1:2:4
and having a container (1) with at least one aperture (80) to an internal area (60) with a
square outline, whose side length corresponds at least approximately to the longest
edge length of the moulding, and whose height corresponds at least approximately to
the shortest edge length of the moulding, or to an integer multiple of this. The
mouldings can be placed in the internal area (60) of the container (1) such that at least
the firing hole in one of the mouldings is aligned with the aperture (80) in the container
(1), and the aperture (80) is intended for introduction of an explosive capsule into the
firing hole of the relevant moulding.
__________________
193003 [21[]11]
שיטה והתקן "מבחן פתוח" להכנסת דוגמה לאנליזת מס ספקטרומטריה
OPEN PROBE METHOD AND
DEVICE FOR SAMPLE
INTRODUCTION FOR MASS
SPECTROMETRY ANALYSIS
[54]
23.07.2008 [22]
Int. Cl.(2010.01) G01N 21//01 [51]
AVIV AMIRAV [71] אביב עמירב, הוד השרון
AVIV AMIRAV, ALEXANDER אביב עמירב, אלכסנדר גורדין
GORDIN
[72]
דר' אייל ברסלר עו"פ, 11תובל גן -רמת
DR. EYAL BRESSLER,
11 TUVAL ST.,
RAMAT GAN 52522
[74]
An open probe method for sample introduction into a mass spectrometer is disclosed,
comprising the steps of: loading a sample holder with sample compounds to be
analyzed; heating a probe oven; introducing said sample compounds in said sample
holder into said heated probe oven; flowing inert gas into said heated probe oven;
vaporizing said sample in said heated probe oven by the combined effect of oven
temperature and inert gas flow; entraining said vaporized sample in said inert gas; and,
[57]
December 29, 2011 372-התשע"ב טבתב 'ג
transferring said vaporized sample in inert gas into an ion source of a mass
spectrometer; wherein said heated probe oven remains open to the ambient atmosphere
during sample introduction and analysis; said inert gas is flowing in said heated probe
oven in two directions of a transfer line to a mass spectrometer ion source and to the
oven opening; said vaporized sample in inert gas is transferred through a heated
transfer line directly into the ionization chamber of an ion source of a mass
spectrometer. An apparatus for this method of sample introduction is also disclosed.
The primary advantage of this method and apparatus is that the heated probe oven
remains open to the ambient atmosphere during sample introduction and analysis
thereby enabling faster sample analysis.
__________________
193030 [21[]11]
מקדח קרמי לקדיחה במהירות גבוהה בחומר מרוכב
CERAMIC DRILL BIT FOR HIGH-
SPEED DRILLING OF
COMPOSITES
[54]
24.07.2008 [22] FR [33] 26.07.2007 [32] 0705457 [31]
Int. Cl.(2010.01) B23B 51//00, 51//02 [51]
SNECMA, FRANCE [71]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
A drill bit comprising a shank, a body in the form of a truncated cone extending as far
as the shank and the base of which is located at a free axial end of the drill bit, said end
having at least two main cutting edges joined together by two central edges, said body
having two lips and two flutes extending in a helical fashion alternately around a
longitudinal rotation axis of the drill bit, the lips and the flutes extending from the free
axial end to the shank of the drill bit, each lip having a land and each flute having a
main cutting face adjacent a land and adjacent a main cutting edge, said main cutting
edge forming an intersection with a flank face at the free axial end of the drill bit, the
flank faces each being extended, on the side with the lips, by a rake face, two recesses
extending from the central edges to the periphery of the drill bit and forming two
secondary cutting faces, at least one end portion of the body of the drill bit being made
of a ceramic, wherein each land is radially extended, toward the rotation axis of the
drill bit, by a curved bevel, followed by a flank face, such that the intersection between
each curved bevel and the adjacent flute is formed by an edge whose radially external
end is further away axially, along the rotation axis of the drill bit, from the shank of the
[57]
December 29, 2011 373-התשע"ב טבתב 'ג
drill bit than a radially internal end of said edge, and wherein the curved bevels are
each extended, on the side with the rake faces, by a bevel.
__________________
193059 [21[]11]
תרכיז חומוס נטול חומר משמר ותהליך להכנתם
PRESERVATIVE-FREE HUMMUS
CONCENTRATE AND PROCESS
FOR ITS PREPARATION
[54]
01.02.2007 [22] IL [33] 02.02.2006 [32] 173523 [31]
Int. Cl.(2010.01) A23L 01//212 [51]
אלי הוגו בודמן חנה-מרסלו אדריאן אדטו, פרדס
ELI HUGO BUDMAN
MARCELO ADRIAN ADATTO [71]
WO/2007/088540 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
An edible paste concentrate consisting of ground chickpeas, cooked and dried, and
crushed sesame seeds is provided. The paste has a shelf life of at least three months,
and when mixed with water, provides a dip or a spread with the flavor and texture of
freshly prepared hummus. Also provided is a process for manufacturing a spread or a
dip from chickpeas or other legumes.
[57]
__________________
193071 [21[]11]
2–[3,4–TRANS-[1R, 2S]-2-[3,4-[54]–[R1,S2]–טרנס
December 29, 2011 374-התשע"ב טבתב 'ג
–דיפלוארופניל[ציקלופרופנאמיניום[R2]–2–פנילאתנואט–2–חידרוקסי
DIFLUOROPHENYL]CYCLOPROPANAMINIUM-
[2R]-2-HYDROXY-2-PHENYLETHANOATE
31.05.2001 [22] GB [33] 02.06.2000 [32] 0013487.4 [31]
SE 06.06.2000 0002101-4
Int. Cl.(2010.01) C07C 21/1/40, 24/7/22, 67//347, 69//00, 69//743 [51] DIVISION FROM 152778 [62]
ASTRAZENECA AB, SWEDEN [71]
ADRIAN CLARK, ELFYN JONES, ULF LARSSON,
ANNA MINIDIS
[72]
WO/2001/092200 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The compound trans-(1R,2S)-2-(3,4difluorophenyl)cyclopropanaminium(2R)-2-hydroxy-2-
phenylethanoate.
[57]
בקשות חלוקה מבקשה זו שטרם
פורסמו9
0225265 The applications for division from this
application have not yet been published
__________________
193223 [21[]11]
מערכת ושיטה לאימות מילים לא מזוהות OCRבמערכת
METHOD AND SYSTEM FOR
VERIFICATION OF
UNCERTAINLY RECOGNIZED
WORDS IN AN OCR SYSTEM
[54]
15.02.2007 [22] NO [33] 17.02.2006 [32] 20060787 [31]
Int. Cl.(2010.01) G06K 09//00 [51]
LUMEX AS, NORWAY [71]
WO/2007/094684 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The present invention provides a method and system for confirming uncertainly
recognized words as reported by an Optical Character or speech Recognition process
by using spelling alternatives as search arguments for an Internet search engine. The
measured number of hits for each spelling alternative is used to provide a confirmation
measure for the most probable spelling alternative. Whenever the confirmation
[57]
December 29, 2011 375-התשע"ב טבתב 'ג
measure is inconclusive, a plurality of search strategies are used to reach a measured
result comprising zero hits except for one spelling alternative that is used as the correct
alternative.
__________________
193310 [21[]11]
נוגדן כנגד פוליפפטיד אשר מגיב עם פרקין ותכשירים רפואיים המכילים אותו
ANTIBODY DIRECTED AGAINST
A POLYPEPTIDE THAT
INTERACTS WITH PARKIN AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME
[54]
15.02.2001 [22] FR [33] 17.02.2000 [32] 00/01980 [31]
US 18.04.2000 60/198489
Int. Cl.(2010.01) A61K 39//395, A61P 25//28, C07K 16//18 [51] DIVISION FROM 151211 [62]
INSERM (INSTITUT NATIONALE
DE LA SANTE ET DE LA
RECHERCHE MEDICALE), FRANCE
AVENTIS PHARMA S.A., FRANCE
[71]
WO/2001/060857 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
Antibody or antibody fragment or derivative, characterized in that it is directed against [57]
December 29, 2011 376-התשע"ב טבתב 'ג
a polypeptide that interacts with parkin, said polypeptide comprising a sequence
having at least 80% identity to SEQ ID NO: 2, or comprising the sequences SEQ ID
NO: 13, SEQ ID NO: 15, SEQ ID NO: 43 OR SEQ ID NO: 45.
__________________
193387 [21[]11]
מערכת מיגון
PROTECTION SYSTEM
[54]
12.08.2008 [22] CH [33] 13.08.2007 [32] 01282/07 [31]
Int. Cl.(2010.01) B60N 02//42 [51]
MOWAG GMBH, SWITZERLAND [71]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The protection system is used especially for the protection against a fatal effect of
vertical accelerations triggered by a landmine on the passengers of an armoured
vehicle. For this, the sitting unit consisting of a seat body (7) and a backrest (8) is held
movable in vertical direction and is coupled with an end area (15) of a longitudinally
variable damping device (11), whose other end (13) is connected to the roof (4) of the
vehicle (2) through a carrying equipment (6). In addition, the sitting unit is carried
with vertical distance from the vertical guide (18) in a lower guide path (19)
transversally directed so that the sitting unit executes both a downward as well as a
tilting movement relative to the vehicle together with a passenger (3) during loading
through vertical acceleration. In this way, an improved usage of the constructively
limited effective length of the damping device (11) occurs so that the effect of the
protection system is essentially improved. It is sensible to apply the same principle for
the protection of all objects, which must be protected against the reaching or exceeding
of a maximum load due to a too large acceleration or deceleration.
[57]
December 29, 2011 377-התשע"ב טבתב 'ג
__________________
193502 [21[]11]
מגבר כוח למערכת כבלים
POWER BOOSTER FOR CABLE
SYSTEMS
[54]
17.08.2008 [22]
Int. Cl.(2010.01) G05F 01//14, H02J 09//06 [51]
מונד-דויד זילברברג, תל קיבוץ חולדהש"ח שנאי חולדה,
DAVID ZILBERBERG
H.T. HULDA TRANSFORMERS [71]
זליגסון גבריאלי ושות', 31רח' יבנה
תל אביב1426, ת.ד.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[74]
A device for regulating the voltage level at a desired section of a telecommunications
network, said device comprising: an input port, connected to a portion of said network
and receiving an input RF telecommunications signal with an input AC voltage;
isolating circuitry, connected with said input port, for isolating said input AC voltage
from said input RF telecommunications signal; a transformer, connected with said
isolating circuitry, said transformer comprising a primary winding receiving said
isolated input AC voltage and a secondary winding; a plurality of relays, connected to
respective points of said secondary winding of said transformer, said relays operative
for providing a selected voltage gain by selectively switching on a connection from
said secondary winding of said transformer, thereby deriving a regulated AC voltage
at a predetermined level; control circuitry, connected with said transformer and with
said relays, said control circuitry operative for monitoring said input AC voltage, and
selectively activating a selected relay while deactivating the other relays, to provide
said selected voltage gain; recombining circuitry, connected with said relays, for
recombining said regulated AC voltage with said isolated input RF
telecommunications signal to produce a recombined regulated AC voltage and RF
telecommunications signal; and an output port, connected to said recombining
[57]
December 29, 2011 378-התשע"ב טבתב 'ג
circuitry and to another portion of said network, said output port providing said
recombined regulated AC voltage and RF telecommunications signal to said another
portion of said network.
__________________
193789 [21[]11]
שיטה ואפנון של אור אופטי המופנה מרחבית
OPTICALLY ADDRESSED
SPATIAL LIGHT MODULATOR
AND METHOD
[54]
02.03.2007 [22] US [33] 02.03.2006 [32] 60/778704 [31]
Int. Cl.(2010.01) G02F 01//13, 01//135 [51]
COMPOUND PHOTONICS, U.S.A. [71]
WO/2007/103274 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
An optical device has an electrically insulating first barrier layer disposed over a first
electrode layer, a photoconductive layer disposed over the first barrier layer, and a
carrier confining layer disposed over the photoconducting layer. The carrier confining
layer defines a volume throughout which a plurality of carrier traps are dispersed.
Further, an electrically insulating second barrier layer is disposed over the carrier
confining layer, a light blocking layer is disposed over the second barrier layer for
blocking light of a selected wavelength band. A reflective layer is disposed over the
light blocking layer for reflecting light within the selected wavelength band, a
birefringent or dispersive layer is disposed over the reflective layer, and an optically
[57]
December 29, 2011 379-התשע"ב טבתב 'ג
transmissive second electrode layer is disposed over the birefringent or dispersive
layer. A method is also disclosed, as are additional layers intervening between those
detailed above.
__________________
193848 [21[]11]
סטנט היברידי מסגסוגת מתכת אמורפית וחומר ביוקומפטבילי
HYBRID STENT HAVING AN
AMORPHOUS METAL ALLOY
AND BIOCOMPATIBLE
MATERIAL
[54]
14.03.2007 [22] US [33] 15.03.2006 [32] 11/377769 [31]
Int. Cl.(2010.01) A61F 02//88, A61K 51//04, A61L 31//02, 31//10 [51]
MEDINOL LTD. [71] אביב-מדינול בע"מ, תל
WO/2007/105088 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
An expandable stent is provided, wherein the stent is advantageously formed of at least
one amorphous metal alloy and a biocompatible material. The stent is formed from flat
metal in a helical strip which is wound to form a tubular structure. The tubular
structure is not welded but rather is wrapped or coated with a biocompatible material
in order to maintain the amorphous metal in its tubular configuration. Said stent can be
balloon expanded or self expanding.
[57]
December 29, 2011 380-התשע"ב טבתב 'ג
__________________
193866 [21[]11]
שיטות והתקנים ליצירת מטרות דמי למכ"ם
METHODS AND SYSTEMS FOR
GENERATING VIRTUAL RADAR
TARGETS
[54]
01.03.2007 [22] IL [33] 03.04.2006 [32] 174746 [31]
Int. Cl.(2010.01) G01S 07//40 [51]
ISRAEL AEROSPACE INDUSTRIES התעשייה האוירית לישראל בע"מ, לוד
LTD. [71]
WO/2007/113790 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND
PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A virtual radar target generator, comprising: a transceiver and a controller coupled to
the transceiver, wherein the transceiver is adapted to receive a signal transmitted from
a radar antenna, store signal information representative of the received signal within a
digital radio frequency memory and transmit an output signal representative of a
virtual target such that at least a fraction of the output signal is received by the radar
antenna; wherein the controller is adapted to determine a timing of the transmission of
the output signal in response to a virtual distance between the virtual target and the
radar antenna, a required virtual target direction and direction information
representative of a direction of the radar antenna; wherein the transceiver further
comprises a transmission antenna, the transmission antenna and the radar antenna
being positioned within a space that is at least partially defined by a radome, and
wherein the transmission antenna transmits the output signal towards the radome such
that at least a fraction of the output signal is reflected towards the radar antenna.
[57]
December 29, 2011 381-התשע"ב טבתב 'ג
__________________
193932 [21[]11]
התקן ושיטה להתפשטות אלמנטים מתכתיים
DEVICE AND METHOD FOR
WIDENING METAL ELEMENTS
[54]
28.02.2007 [22] DE [33] 08.03.2006 [32] 102006010795.0 [31]
Int. Cl.(2010.01) B21D 31//04 [51]
PROTEKTORWERK FLORENZ
MAISCH GMBH & CO. KG,
GERMANY
[71]
WO/2007/101594 [87]
פרל כהן צדק לצר, 5, רח' שנקר 1ים -מרכז גב
הרצליה12704, ת.ד.
PEARL COHEN ZEDEK LATZER,
5 SHENKAR ST.,
P.O.B. 12704,
HERZLIYA 46733
[74]
A device and a method for widening elongated metal elements (11, 65) which move in
the longitudinal direction and are planar at least in certain regions are described. The
device comprises at least two clamping sections (19, 38, 49, 50) which are opposite
one another and of which one is arranged and designed for clamping a first
longitudinal side (22, 67) of the metal element in place and the other is arranged and
designed for clamping a second longitudinal side of the metal element in place, said
second longitudinal side being opposite the first longitudinal side of the metal element.
The clamping sections are each provided on a support unit (15, 35, 36, 39, 40), by
means of which the clamping sections, during the forward movement of the metal
element, are automatically moved apart essentially perpendicularly to the direction of
movement of the metal element.
[57]
December 29, 2011 382-התשע"ב טבתב 'ג
__________________
194135 [21[]11]
מערכת מיתוג חשמלית ומתג המכיל סוגר וברגים לחיזוקו
ELECTRICAL SWITCHING
APPARATUS AND CIRCUIT
BREAKER INCLUDING A
MOLDED ENCLOSURE AND
MACHINE SCREWS
REINFORCING THE SAME
[54]
12.04.2007 [22] US [33] 12.04.2006 [32] 11/402732 [31]
Int. Cl.(2010.01) H01H 71//02 [51]
EATON CORPORATION, U.S.A. [71]
WO/2007/116307 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A circuit breaker comprising: an arc chamber; separable contacts proximate said arc
chamber; an operating mechanism structured to open and close said separable contacts;
a trip unit cooperating with said operating mechanism to trip open said separable
contacts; a molded enclosure comprising a first molded portion and a second molded
portion; a plurality of thread cutting screws fastening said first molded portion to said
second molded portion; and a plurality of machine screws, wherein said first molded
portion and said second molded portion cooperate to form a plurality of exterior side
walls, wherein said exterior side walls define an interior volume, wherein said interior
volume encloses said separable 4Q contacts, said arc chamber and at least a portion of
said operating mechanism, wherein said exterior side walls include a first wall portion
[57]
December 29, 2011 383-התשע"ב טבתב 'ג
proximate said operating mechanism and a second wall portion proximate said trip
unit, wherein a first one of said machine screws is intermediate the first wall portion
and the second wall portion of a first one of said exterior side walls, wherein a second
one of said machine screws is intermediate the first wall portion and the second wall
portion 50 of a second one of said exterior side walls, and wherein said first and
second ones of said machine screws hold said first molded portion to said second
molded portion and restrict expansion of said first and second ones of said exterior side
walls away from said interior volume.
__________________
194244 [21[]11]
מימי ושיטה להכנתו תרחיף רוקחי
AQUEOUS PHARMACEUTICAL
SUSPENSION AND A PROCESS
FOR PREPARATION OF THE
SAME
[54]
10.05.2007 [22] GB [33] 19.05.2006 [32] 0610058.0 [31]
GB 23.05.2006 0610246.1
GB 30.04.2007 0708375.1
Int. Cl.(2010.01) A61K 09//10, 31//5415, 31//723, 31//79 [51]
NORBROOK LABORATORIES
LIMITED, IRELAND [71]
WO/2007/135362 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
An aqueous pharmaceutical suspension comprising: (i) at least one non-steroidal anti-
inflammatory drug; (ii) an aqueous buffer system; (iii) xanthan gum; (iv) polyvinyl
pyrrolidone; and (v) glycerol wherein the suspension is free from pregelatinised starch,
[57]
December 29, 2011 384-התשע"ב טבתב 'ג
amino polycarboxylic acid, microcrystalline cellulose, hydroxypropylmethyl cellulose,
polyoxyethylene sorbitan monooleate, silicon dioxide and taste modifying agents
selected from the group consisting of bulk sweeteners, intense sweeteners, flavouring
agents and mixtures thereof.
__________________
194287 [21[]11]
גרנולאט מפוזר במים, תהליך להכנתו והשימוש סדרים נפשיים–בו להכנת תכשיר לטיפול באי
WATER DISPERSIBLE
GRANULATE, A PROCESS FOR
ITS PREPARATION AND ITS USE
IN THE MANUFACTURE OF A
COMPOSITION FOR
TREATMENT OF MENTAL
DISORDERS
[54]
23.03.2007 [22] EP [33] 21.04.2006 [32] 06075938.8 [31]
Int. Cl.(2010.01) A23L 01//304, 02//02, 02//38, 02//385, 02//39, 02//60 [51]
UNILEVER PLC, UNITED
KINGDOM [71]
WO/2007/122053 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
One aspect of the invention relates to a water-dispersible granulate having a mass
weighted average diameter of at least 100 m, said granulate comprising: 40-90 wt.% of
carbohydrates; 2-30 wt.% of lipids containing at least 1% unsaturated fatty acids by
weight of the granulate and at least 30 mg/kg of a pro-oxidative metal selected from
the group consisting of iron, copper and combinations thereof; wherein at least 50
wt.% of the lipids is present as non- dispersed lipids. Despite the fact that the present
granulate contains a substantial amount of unsaturated fatty acids as well as a high
level of iron and/or copper, said granulate is nonetheless very stable against oxidation.
The granulate of the present invention is easy to manufacture by a process that does
not employ emulsification or pro-oxidative conditions.; The present invention also
provides a process for the manufacture of the aforementioned granulate.
[57]
__________________
December 29, 2011 385-התשע"ב טבתב 'ג
194297 [21[]11]
קצה מיקרוסקופ בעל חיישן סורק מונוליטי עם ודל ננומטרי הנוצר בגידול יחס מימדים גבוה ובג
ננומטרי
MONOLITHIC HIGH ASPECT
RATIO NANO-SIZE SCANNING
PROBE MICROSCOPE (SPM) TIP
FORMED BY NANOWIRE
GROWTH
[54]
08.03.2007 [22] US [33] 23.03.2006 [32] 11/388132 [31]
Int. Cl.(2010.01) G01N 23//00 [51]
IBM CORPORATION, U.S.A. [71]
WO/2008/054467 [87]
מעבדות יבמ מחלקת קנין רוחני, אוניברסיטת חיפה הר הכרמל
חיפה
IBM LABORATORIES,
HAIFA UNIVERSITY,
HAIFA 31905
[74]
A method of forming a scanning probe comprising: forming an array of cantilevers;
forming a silicon pyramid having sidewalls and a tip by anisotropic etching over each
of said cantilevers; depositing a catalyst on the sidewalls and the tip of said silicon
pyramid; growing a plurality of nanowires from said catalyst over said sidewalls and
said tip of said silicon pyramid; and removing nanowires from said sidewalls of said
silicon pyramid.
[57]
__________________
194299 [21[]11]
–שיטות לקביעת סיכון לעמידות לWARFARIN
METHODS FOR DETERMINING
PREDISPOSITION TO WARFARIN
RESISTANCE
[54]
28.03.2007 [22] US [33] 28.03.2006 [32] 60/786350 [31]
US 01.08.2006 60/834559
Int. Cl.(2010.01) C12Q 01//68 [51]
מחקרים ,תשתית ושירותים -תל השומר גן -רפואיים בע"מ, רמת
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE
AND SERVICES LTD.
[71]
EVA GAK, HILLEL HALKIN [72] אוה ג'ק, הלל הלקין
December 29, 2011 386-התשע"ב טבתב 'ג
WO/2007/110869 [87]
( בע"מ,1995ג'י.אי.ארליך ) 11,רחוב מנחם בגין 15מגדל איילון, קומה
רמת גן
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[74]
The present invention is of the high association of the 5417T allele of the
VKORC1 gene with high coumarin dose requirements and which can be used to
determine the predisposition of an individual to coumarin resistance .
Specifically, the present invention provides methods and kits for determining
the predisposition of an individual to coumarin resistance and for predicting
the responsiveness of an individual to coumarin treatment.
[57]
__________________
194464 [21[]11]
מסוע סרק לקו ייצור
CONVEYOR IDLER ASSEMBLY
[54]
30.03.2007 [22] AU [33] 31.03.2006 [32] 2006901674 [31]
AU 03.11.2006 2006906126
Int. Cl.(2010.01) B65G 39//12 [51]
ALLENVEE HOLDINGS PTY LTD.,
AUSTRALIA [71]
WO/2007/112484 [87]
ד"ר יצחק הס ושותפיו, 279רחוב הירקון
תל אביב6451, ת.ד.
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[74]
A conveyor idler assembly (10) for supporting a conveyor belt (11) comprising a
support frame (12) having at least one elongated linear or longitudinally curved
support beam (16) which extends transversely of the conveyor belt (11) and at least
one idler cassette (13) having an idler roller (30), the cassette (13) being mounted to
the support beam (16) for slidable movement therealong.
[57]
__________________
December 29, 2011 387-התשע"ב טבתב 'ג
194656 [21[]11]
פורמולציה שעברה ייבוש בהקפאה המכילה נגיף–צימוד של ניקוטין וחלקיק דמוי
LYOPHILIZED FORMULATION
COMPRISING A NICOTINE-
VIRUS-LIKE PARTICLE
CONJUGATE
[54]
11.05.2007 [22] EP [33] 12.05.2006 [32] 06113895.4 [31]
Int. Cl.(2010.01) A61K 09//19, 39//385, 47//06 [51]
CYTOS BIOTECHNOLOGY AG,
SWITZERLAND [71]
WO/2007/131972 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The present invention is in the fields of medicine, public health, vaccine and drug
formulation. The invention provides composition formulations comprising a nicotine-
carrier conjugate and a stabilizer, wherein said stabilizer comprises a non-reducing
disaccharide and a non-ionic surfactant. The composition formulations are stable after
a long time of storage at room temperature.
[57]
__________________
194687 [21[]11]
כבתי ושיטה לייצורוש–פילם רב
MULTILAYERED FILM AND
METHOD FOR MANUFACTURING
SAME
[54]
11.04.2007 [22] DE [33] 14.04.2006 [32] 102006018060.7 [31]
Int. Cl.(2010.01) B32B 09//02, 27//36, B65D 65//46 [51]
BIO-TEC BIOLOGISCHE
NATURVERPACKUNGEN GMBH &
CO. KG, GERMANY
[71]
WO/2007/118828 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A multilayered film is shown and described that is used in particular for packaging,
which comprises at least one first layer A and at least one second layer B, wherein
layer A contains thermoplastic polyester and layer B contains thermoplastic starch. The
[57]
December 29, 2011 388-התשע"ב טבתב 'ג
multilayered film according to the invention is characterized by excellent barrier
properties, low sensitivity to moisture, and good mechanical strength.
__________________
194909 [21[]11]
מערכת ושיטה לניטור רכבים ונהגים
SYSTEM AND METHOD FOR
MONITORING VEHICLES AND
DRIVERS
[54]
17.04.2007 [22] US [33] 26.04.2006 [32] 60/745632 [31]
Int. Cl.(2010.01) G08B 17//00 [51]
ILAN ROSEN [71] אילן רוזן, בנימינה
WO/2007/122607 [87]
ד"ר יורם צביון, , פארק התעשיה 2רח' הטוחן
קיסריה3148, ת.ד.
DR. YORAM TSIVION,
2 HATOCHEN ST.
P.O.B. 3148,
CAESAREA 38900
[74]
Implementing the system and method in accordance with the present invention affords
ability to determine whether a driver is guilty of bearing a faulty set of driving
regulatory documents DRDs. The law-enforcement agent using the system and method
in accordance with the present invention is able to identify remotely vehicles having
faulty DRDs. In accordance with the present invention, the currently used hard copies
of the DRD are supplemented or altogether replaced by stored data in a digital storage
medium. The storage medium can be installed in the driver's car or the data may be
stored in a centralized law enforcement database. The police may access the database
in order to retrieve information regarding the validity of the driver's permits. In the
scenario wherein the digital storage medium is located in the driver's car, typically one
or more smart cards or RFID cards or flash memory devices or discs may be used to
store the current data.
[57]
__________________
195661 [21[]11]
December 29, 2011 389-התשע"ב טבתב 'ג
מכשיר הכולל מעבר שאיבה להכנת משקה מחומר אבקתי ונוזל חם וכמו כן מעבר הוצאה
DEVICE WITH A SUCTION DUCT
FOR PREPARING A BEVERAGE
FROM A POWDERY SUBSTANCE
AND A HOT LIQUID AS WELL AS
AN EXTRACTION DUCT
[54]
31.05.2007 [22] NL [33] 02.06.2006 [32] 1031947 [31]
Int. Cl.(2010.01) A47J 31//40, 31//60 [51]
BRAVILOR HOLDING B.V., THE
NETHERLANDS [71]
RAMON EDUARD VERHOEVEN,
JOHANNES JACOBUS VAN
STEENDEREN DE KOK, CARLOS
NICOLAAS JOZEF MARIA
KOOPMAN
[72]
WO/2007/142519 [87]
( בע"מ,1995ג'י.אי.ארליך ) 11,רחוב מנחם בגין 15מגדל איילון, קומה
רמת גן
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[74]
Preparing device (1) for preparing a beverage from a powdery substance and a hot
liquid, the device comprising: at least one mixing chamber (11) for mixing a quantity
of the powdery substance and a quantity of the hot liquid; an inlet (38) into the mixing
chamber for the quantity of hot liquid; an inlet (21) into the mixing chamber for the
quantity of powdery substance; an extractor hood (4) placed on the mixing chamber;
an extraction duct connected to the extractor hood and provided with suction means,
such as a ventilating fan, for extracting vapour and dust particles from the mixing
chamber via the extraction duct (3) and the extractor hood; a first housing (26)
accommodating further components of the preparing device, such as electrical
components and pipework, in which the extraction duct extends entirely along the
exterior of the first housing, as well as an extraction duct.
[57]
__________________
December 29, 2011 390-התשע"ב טבתב 'ג
196221 [21[]11]
יוני כרום וגליום עבור הגברת קצב הסרת תחמוצת
GALLIUM AND CHROMIUM IONS
FOR OXIDE REMOVAL RATE
ENHANCEMENT
[54]
10.07.2007 [22] US [33] 21.07.2006 [32] 11/491055 [31]
Int. Cl.(2010.01) B24B 01//00, C09K 03//14 [51]
CABOT MICROELECTRONICS
CORPORATION, U.S.A. [71]
WO/2008/013668 [87]
זליגסון גבריאלי ושות', 31רח' יבנה
תל אביב1426, ת.ד.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[74]
The invention provides a chemical-mechanical polishing composition comprising
silica, a compound in an amount sufficient to provide 0.2 mM to 10 mM of a metal
cation selected from the group consisting of gallium (III), chromium (II), and
chromium (III), and water, wherein the polishing composition has a pH of 1 to 6. The
invention further provides a method of chemically-mechanically polishing a substrate
with the aforementioned polishing composition.
[57]
__________________
196257 [21[]11]
פלטת עצם העקב
CALCANEAL PLATE
[54]
17.07.2007 [22] US [33] 18.07.2006 [32] 60/831647 [31]
US 17.01.2007 60/880910
US 16.07.2007 11/879118
Int. Cl.(2010.01) A61B 17//58 [51]
ORTHO-HELIX SURGICAL
DESIGNS, INC., U.S.A. [71]
WO/2008/011018 [87]
סנפורד ט. קולב ושות', , מרמורק 4שער הגיא
רחובות2273, ת.ד.
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[74]
December 29, 2011 391-התשע"ב טבתב 'ג
The present invention is a fully contoured calcaneal plate having substantially no
planar surfaces except at the origin. The contoured plate includes radiused sections,
one extending inferior to superior is curved inferior to superior in a shape which is
close to cylindrical and which approximates the shape of the cuboid bone. The second
radiused section is curved in the vicinity of the anterior strut, and in particular at the
inferior portion of the plate, to accommodate the peroneal tubercle. The plate has a
rectangular or modified ovoid body section and a dog boned shaped tail with triangular
placed holes for fixation.
[57]
__________________
196327 [21[]11]
–1,1,1הידרוגנציה אסימטרית של טריפלואורואצטון
ASYMMETRIC
HYDROGENATION OF 1,1,1-
TRIFLUOROACETONE
[54]
17.07.2007 [22] EP [33] 27.07.2006 [32] 06117928.9 [31]
Int. Cl.(2010.01) C07C 29//145 [51]
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND [71]
WO/2008/012240 [87]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The invention relates to the preparation of enantiomerically pure (S)-1,1,1-trifluoro-2-
propanol by an asymmetric hydrogenation of 1,1,1-trifluoroacetone which process
comprises hydrogenating 1,1,1-trifluoroacetone in the presence of a ruthenium
phosphine complex represented by formula Ru(E)(E')(L)(A) wherein E, E' are both
chloro or E is hydrogen and E' is BH4; L is a chiral diphosphine ligand; and A is an
optionally chiral diamine comprising the variants a) in the presence of a weak base and
with or without an additive in case when E and E' are both chloro or b) in the absence
of a base and an additive in case when E and E' are hydrogen and BH4.
[57]
December 29, 2011 392-התשע"ב טבתב 'ג
__________________
196716 [21[]11]
ארוגים אלסטים וחומר מרוכב –בדים בלתי ארוג הכולל אותם–בלתי
ELASTIC SPUNBONDED
NONWOVEN AND COMPOSITE
NONWOVEN COMPRISING THE
SAME
[54]
06.08.2007 [22] EP [33] 14.08.2006 [32] 06016946.3 [31]
Int. Cl.(2010.01) B32B 27//02, D01F 08//16, D04H 03//00 [51]
ALBIS SPA, ITALY [71]
WO/2008/019775 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The spunbonded nonwoven (W) has high elastic recovery properties and comprises a
plurality of multi-component filaments. Each filament, preferably of the sheath/core
type, comprises at least a first polymeric component and a second polymeric
component. The first polymeric component comprises thermoplastic polyurethane, and
the second polymeric component comprises an elastic propylene-based olefin
copolymer, and more particularly an ethylene propylene copolymer, preferably
comprising at least 80wt% of propylene units. Said spunbonded nonwoven (W) can be
easily thermal- bonded with polyolefin-based nonwoven layer(s), especially
polypropylene-based layer(s), in order to make a composite nonwoven, particularly
suitable for the hygienic industry (e.g., diapers(.
[57]
__________________
197032 [21[]11]
קישורים בעל יכולת ניווט עם ממשקי –התקן רב עבודה מרובים
STEERABLE MULTI-LINKED
DEVICE HAVING MULTIPLE
WORKING PORTS
[54]
14.08.2007 [22] US [33] 14.08.2006 [32] 60/822280 [31]
US 24.10.2006 60/862636
December 29, 2011 393-התשע"ב טבתב 'ג
Int. Cl.(2010.01) A61B 01//00 [51]
CARDIOROBOTICS, INC., U.S.A. [71]
WO/2008/022114 [87]
י קבוצת איתן מהולל, עורכי דין ועורכ פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
A steerable multi-linked device. The device includes a first multi-linked mechanism
and a second multi-linked mechanism. The first mechanism defines a first plurality of
grooves. The second mechanism defines a second plurality of grooves. The first and
second pluralities of grooves cooperate to define at least two working ports along a
length of the device. At least one of the first and second mechanisms are steerable.
[57]
__________________
197165 [21[]11]
מסרק נגד כינים
LICE COMB
[54]
23.08.2007 [22] AU [33] 23.08.2006 [32] 2006904564 [31]
Int. Cl.(2010.01) A01K 13//00, A45D 24//02, 24//10 [51]
DAVID JACOB SCHWARTZ,
AUSTRALIA
MOSHE MAOR, AUSTRALIA
[71]
MOSHE MAOR, EDWARD JOSEPH
KHOURY, ROBERT CHARLES
ALEXANDER CULLEY
[72]
WO/2008/022387 [87]
אגמון,-סורוקר 14טון, רחוב שנקר בית נול
הרצליה פיתוח
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
[74]
A lice comb (10) comprising a plurality of parallel teeth (12) having upper surfaces [57]
December 29, 2011 394-התשע"ב טבתב 'ג
(16) and lower surfaces (18). Each pair of adjacent teeth (12) includes a first set of
projections (22) on a side surface (24) of one tooth and a second set of projections (26)
on a side surface (28) of the adjacent tooth. The first set of projections (22) are
provided along at least a portion of the length of the tooth such that hair moving
downwardly between the pair of teeth (12) passes through gaps (32) defined between
the first set of projections (22). The second set of projections (26) are interspersed
between and in a direction toward the lower surface (18) of the teeth (12) such that the
strands of hair passing through the gaps (32) are deflected in a direction parallel to the
teeth (12) in use by the second set of projections (26).
__________________
197377 [21[]11]
גן ניאומיצין פוספוטרנספראז שעבר שינוי ושיטות המשתמשות בגן הנ"ל
MODIFIED NEOMYCIN
PHOSPHOTRANSFERASE GENE
AND METHODS USING SAID
GENE
[54]
25.11.2003 [22] DE [33] 29.11.2002 [32] 10256081.1 [31]
DE 08.07.2003 10330686.2
Int. Cl.(2010.01) C12N 09//12, 15//85 [51] DIVISION FROM 168806 [62]
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH,
GERMANY
[71]
WO/2004/050884 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Modified neomycin phosphotransferase gene characterized in that the modified
neomycin phosphotransferase gene codes for a different amino acid than the wild-type
neomycin phosphotransferase gene at at least one of the following positions: either at
amino acid position 182, 227 or 261, whereby the modified neomycin
[57]
December 29, 2011 395-התשע"ב טבתב 'ג
phosphotransferase gene compared with the wild-type gene codes for glycine at amino
acid position 182, for alanine or valine at amino acid position 227, or for glycine at
amino acid position 261, whereby the modified neomycin phosphotransferase which is
encoded by the neomycin phosphotransferase gene has a lower enzyme activity than
the wild-type neomycin phosphotransferase.
טרם בקשת הורה לבקשה זו ש
פורסמה2466/4 The parent application from which
this application has been divided has
not yet been published
__________________
197988 [21[]11]
ו פרגמנט של הנוגדן הנקשר ספציפית נוגדן א PC–LECTINלפוליפפטיד
ANTIBODY OR FRAGMENT
THEREOF THAT SPECIFICALLY
BINDS TO A PC-LECTIN
POLYPEPTIDE
[54]
11.08.2000 [22] US [33] 12.08.1999 [32] 60/148935 [31]
Int. Cl.(2010.01) A61K 39//395, C07K 14//435, 14//705, 16//18, C12N 05//12 [51] DIVISION FROM 147902 [62]
AGENSYS, INC., U.S.A. [71]
WO/2001/012811 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
An antibody or fragment thereof that specifically binds to a PC-LECTIN polypeptide
encoded by a polynucleotide selected from the group:
a polynucleotide comprising SEQ ID NO:1, wherein T can also be U,
a polynucleotide comprising SEQ ID NO: 1, from nucleotide residue number 201
through nucleotide residue number 2378, wherein T can also be U,
a polynucleotide encoding a PC-LECTIN protein comprising the amino acid sequence
of SEQ ID NO:2.
[57]
__________________
198076 [21[]11]
cPPTקטור רטרווירוס המכיל אזורי שימוש בו של לנטיוירוס ווקטור רטרווירוס CTS–ו
USE OF A RETROVIRAL VECTOR
COMPRISING CPPT AND CTS
[54]
December 29, 2011 396-התשע"ב טבתב 'ג
REGIONS OF LENTIVIRAL AND A
RETROVIRAL VECTOR
10.10.2000 [22] US [33] 12.10.1999 [32] 60/158387 [31]
Int. Cl.(2010.01) A61K 48//00, C12N 15//867 [51] DIVISION FROM 148900 [62]
INSTITUT PASTEUR, FRANCE
INSTITUT NATIONAL DE LA
SANTE ET DE LA RECHERCHE
MEDICALE -I.N.S.E.R.M., FRANCE
[71]
WO/2001/027304 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Use of a retroviral vector, comprising cPPT and CTS regions of lentiviral origin in
which the LTR is deleted for the promoter and enhancer of U3, for increasing in vitro
the rate of import of a nucleic acid in a host cell nucleus and medical uses thereof.
[57]
__________________
198861 [21[]11]
1E–תרביות של תאי אלמוות מסוג
CULTURES OF E1-IMMORTALIZED
CELLS
[54]
06.05.2004 [22] WO [33] 09.05.2003 [32] PCT/EP03/50155 [31]
WO 01.09.2003 PCT/EP03/50390
WO 04.12.2003 PCT/EP03/50940
WO 30.01.2004 PCT/EP04/50061
Int. Cl.(2010.01) C12N 05//10 [51] DIVISION FROM 171680 [62]
CRUCELL HOLLAND B.V., THE
NETHERLANDS [71]
CHRISTOPHER ADAM YALLOP [72]
WO/2004/099396 [87]
קבוצת איתן מהולל, עורכי דין ועורכי פטנטים,
10שדרות אבא אבן הרצליה2081, ת.ד.
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O.B. 2081,
HERZLIYA 46120
[74]
A culture of cells wherein the culture of cells is a serum-free suspension culture of
human embryonic retina cells immortalized by adenovirus E1 sequences, wherein cells
[57]
December 29, 2011 397-התשע"ב טבתב 'ג
in the culture of cells produce a recombinant protein, the serum-free suspension culture
comprises culture medium exchanged at a rate of at least 1 culture volume/day, said
culture of cells comprises at least 40X106 viable cells/ml which can be maintained for
at least five days without a cell bleed, and at least 80% of the total cells are viable, and
wherein said cells are PER.C6 cells as represented by the cells deposited under
ECACC No. 96022940.
__________________
199658 [21[]11]
להעברת קבצים RTPמערך
RTP PAYLOAD FORMAT
[54]
02.06.2004 [22] US [33] 03.07.2003 [32] 10/612851 [31]
Int. Cl.(2010.01) H04L 29//06 [51] DIVISION FROM 162304 [62]
MICROSOFT CORPORATION,
U.S.A. [71]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
A method comprising computer-instructions executable by a processor, the method
changing a plurality of single media packets into a composite packet, wherein: each
single media packet includes: a payload of one data stream, wherein the payload is
encrypted and has an arbitrary block size; a payload header for the payload and
including a boundary for the arbitrary block size; the composite packet corresponds to
the plurality of single media packets and includes: one or more payloads of a like data
stream and corresponding to the respective payloads of the plurality of single media
packets; and a payload profile format header for each payload in the composite packet
and corresponding to the payload headers of the plurality of single media packets,
wherein the payload profile format header has a payload boundary for a respective
payload in the composite packet that identifies an order thereof in the plurality of
single media packets
[57]
__________________
200172 [21[]11]
December 29, 2011 398-התשע"ב טבתב 'ג
תהליך להכנת דפטומיצין
PROCESS FOR THE
PRODUCTION OF DAPTOMYCIN
[54]
30.07.2009 [22] EP [33] 01.08.2008 [32] 08161630.2 [31]
Int. Cl.(2010.01) A61K 31//00, C12P 21//04 [51]
ANTIBIOTICOS S.P.A., ITALY [71]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
Process for the production of daptomycin by fermentation of Streptomyces
roseosporus in the presence of n-decanal or cuphea oil as sources of the n-decanoyl
side chain.
[57]
__________________
959200 [21[]11]
פורמולציות נוזליות של מלחים –4)–2]–4של
מתילפנילסולפניל(פניל[פיפרדין
LIQUID FORMULATIONS OF SALTS OF 4-[2-(4-
METHYLPHENYLSULFANYL)PHENYL]PIPERIDINE
[54]
14.03.2008 [22] DK [33] 20.03.2007 [32] PA200700423 [31]
WO 15.06.2007 PCT/DK2007/050076
DK 14.12.2007 PA200701790
Int. Cl.(2010.01) A61K 31//451 [51]
H. LUNDBECK A/S, DENMARK [71]
WO/2008/113358 [87]
ד"ר שלמה כהן ושות', 124אבן גבירול
תל אביב11490, ת.ד.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[74]
Liquid formulations of the DL-lactic acid, the glutaric acid, the L-asρartic acid and the
glutamic acid salts of 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine and their use in the
manufacture of a medicament to be used in the treatment of CNS diseases are provided.
[57]
__________________
December 29, 2011 399-התשע"ב טבתב 'ג
201461 [21[]11]
מערכת ושיטה להתראת בטיחות תינוק
INFANT SAFETY ALERT
SYSTEM AND METHOD
[54]
01.08.2009 [22]
Int. Cl.(2010.01) B60N 02//26, B60R 21//015, G08B 21//24 [51]
עידן נחמני, קרית ביאליק
IDAN NACHMANI
YAMIT NACHMANY, U.S.A.
MOSHE ATTIAS, U.S.A.
[71]
IDAN NACHMANI, YAMIT עידן נחמני
NACHMANY, MOSHE ATTIAS
[72]
גיל לבנה, ניהנת152, ת.ד.
GIL LIVNE,
P.O.BOX 152
NETANYA 42101
[74]
Apparatus for alerting on an infant left in a vehicle, the apparatus comprising: an
occupant sensor installed on an infant seat deployable in a vehicle, configured to sense
presence of an infant within the infant seat, an infrared light sensor installed on the
infant seat, configured to sense infrared light being emitted within the vehicle, and an
alarm activator installed on the infant seat and connected to the occupant sensor and
the infrared light sensor, configured to activate an alarm upon the presence of the
infant being sensed by the occupant sensor and the infrared light being sensed by the
infrared light sensor.
[57]
לתקנות 13פירוט זה נבחן בהתאם לתקנה 2746 –הפטנטים5 תשכ"ח
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
__________________
December 29, 2011 400-התשע"ב טבתב 'ג
201639 [21[]11]
חומרי ביניים להכנת גורמים היפנוטיים ים לטווח קצרמשככ
INTERMEDIATES FOR
PREPARATION OF SHORT-
ACTING SEDATIVE HYPNOTIC
AGENTS
[54]
24.01.2003 [22] US [33] 25.01.2002 [32] 60/351385 [31]
US 09.05.2002 60/379219
Int. Cl.(2010.01) C07C 69//614 [51] DIVISION FROM 162862 [62]
THERAVANCE, INC., U.S.A. [71]
WO/2004/037750 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention provides compounds compositions and methods useful for inducing or
maintaining general anesthesia or sedation in mammals.
[57]
__________________
201694 [21[]11]
התקן הזרקה
INJECTION DEVICE
[54]
03.06.2008 [22] DE [33] 08.06.2007 [32] 202007008068.9 [31]
DE 08.09.2007 202007012637.9
Int. Cl.(2010.01) A61M 05//20 [51]
BAYER PHARMA
AKTIENGESELLSCHAFT, GERMANY [71]
WO/2008/148518 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
December 29, 2011 401-התשע"ב טבתב 'ג
Disclosed is an injection device comprising parts, the relative movement of which
causes the active substance to be injected. For this purpose, a receptacle (103, 203),
into and in which a carpule/syringe can be inserted and mounted, is retained in a
housing (101, 201), the receptacle (103, 203) can be moved by means of a carriage
(108, 208), and a plunger (104, 204) that applies a force to the piston/s (111A, 111B;
211) of the carpule/syringe is movably retained in the receptacle (103, 203). A traction
rope (114, 214) which is deflected by means of a roll (109, 209) mounted on the
carriage (108, 208) is provided for performing the pricking stroke, injection stroke, and
retracting stroke. One end of the traction rope (114, 214) is connected to the receptacle
(103, 204) while the other end thereof is connected to a tension spring (110, 210) that
is retained on the housing (101, 201). Automatically and/or manually actuatable
mechanisms between the housing (101, 201), the receptacle (103, 203), the plunger
(104, 204), and the carriage (108, 208) control the reciprocal coupling thereof to the
traction rope (114, 214) and thus the sequence of the pricking stroke, injection stroke,
and retracting stroke and are fitted with at least one means that allows the user to adjust
the progress profile of at least one of the strokes.
[57]
__________________
203533 [21[]11]
[פירידין C–3,4פיראזולו ]–תרכובת טטרההידרו XAהמכילה לקטם פעילה כמעכבת פקטור
ותכשירים פרמצבטיים המכילים אותה לטיפול בהפרעות טרומבואמבוליות
LACTAM-CONTAINING
TETRAHYDRO-PYRAZOLO [3,4-
C] PYRIDINE COMPOUNDS
USEFUL AS FACTOR XA
INHIBITORS AND
PHARMACEUTICAL
COMPOSITIONS COMPRISING
THE SAME FOR TREATING
THROMBOEMBOLIC DISORDERS
[54]
17.09.2002 [22] US [33] 21.09.2001 [32] 60/324165 [31]
Int. Cl.(2010.01) A61K 31//437, 31//444, A61P 07//02, 43//00, C07D 47/1/04 [51]
December 29, 2011 402-התשע"ב טבתב 'ג
DIVISION FROM 160693 [62]
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A. [71]
WO/2003/026652 [87]
ד"ר שלמה כהן ושות', 124אבן גבירול
תל אביב11490, ת.ד.
DR. SHLOMO COHEN & CO.,
124 IBN GABIROL ST.,
P.O.B. 11490,
TEL AVIV 62038
[74]
The present application describes lactam-containing compounds and derivatives
thereof of Formula I: P¿4?-P-M-M¿4? or pharmaceutically acceptable salt forms
thereof, wherein ring P, if present is a 5-7 membered carbocycle or heterocycle and
ring M is a 5-7 membered carbocycle or heterocycle. Compounds of the present
invention are useful as inhibitors of trypsin-like serine proteases, specifically factor
Xa.
[57]
__________________
204984 [21[]11]
וחומצות גרעין VEGFחלבוני איחוי קושרי הםהמקודדות ל
VEGF BINDING FUSION
PROTEINS AND NUCLEIC ACIDS
ENCODING THE SAME
[54]
29.06.2004 [22] US [33] 30.06.2003 [32] 10/609775 [31]
Int. Cl.(2010.01) A61K 38//17, C07K 14//71, 19//00, C12N 15//12, 15//62 [51] DIVISION FROM 172404 [62]
REGENERON
PHARMACEUTICALS, INC., U.S.A. [71]
WO/2005/000895 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
An isolated nucleic acid molecule encoding a fusion polypeptide which binds and
inhibits VEGF consisting of components (RlR2) x, wherein X >= 1, R1 is vascular
endothelial cell growth factor (VEGF) receptor component Ig domain 2 of Flt-1 and
R2 is Ig domain 3 of FIk-1.
[57]
__________________
December 29, 2011 403-התשע"ב טבתב 'ג
205242 [21[]11]
אוקסזולידינונים מותמרים, שיטות להכנתם, תכשירים המכילים אותם ושימוש בהם להכנת
תרופות לטיפול במחלות
SUBSTITUTED
OXAZOLIDINONES, PROCESSES
FOR THEIR PREPARATION,
COMPOSITIONS COMPRISING
THEM AND USES THEREOF FOR
THE MANUFACTURE OF
MEDICAMENTS FOR THE
TREATMENT OF DISEASES
[54]
11.12.2000 [22] DE [33] 24.12.1999 [32] 19962924.2 [31]
Int. Cl.(2010.01) C07D 41/3/00 [51] DIVISION FROM 149896 [62]
BAYER PHARMA
AKTIENGESELLSCHAFT,
GERMANY
[71]
WO/2001/047919 [87]
ריינהולד כהן ושותפיו, א' 26רחוב הברזל
רמת החייל
REINHOLD COHN AND PARTNERS,
26A HABARZEL ST.,
RAMAT HACHAYAL 69710
[74]
The invention relates to the field of blood coagulation, more specifically it relates to
novel oxazolidinone derivatives of the general formula (I), to methods for producing
them as well as to their use as active substances for medicaments for the prophylaxis
and/or the treatment of diseases.
[57]
בקשת הורה לבקשה זו שטרם פורסמה
227674 The parent application from which
this application has been divided has
not yet been published
__________________
December 29, 2011 404-התשע"ב טבתב 'ג
206869 [21[]11]
שיטה ומכשיר לתהליך פוטוכימי
METHOD AND DEVICE FOR A
PHOTOCHEMICAL PROCESS
[54]
27.01.2009 [22] AT [33] 31.01.2008 [32] A152/2008 [31]
AT 03.06.2008 A889/2008
Int. Cl.(2010.01) C12M 01//00 [51]
ECODUNA OG, AUSTRIA [71]
WO/2009/094680 [87]
שילון צוקרשטיין ושות', 19המגדל העגול, קומה 1זריאלי מרכז ע
תל אביב
SHILON ZUCKERSTEIN & CO.,
AZRIELI CENTER 1, ROUND
TOWER, 19TH FLOOR,
TEL AVIV 67021
[74]
The invention relates to a method and a device for a photochemical, such as
photocatalytic and/or photosynthetic process, particularly for the breeding and
production or hydrocultivation of preferably phototrophic microorganisms. A reactor,
particularly a biosolar reactor (1), comprising at least one reactor element (2), is
provided. The reactor element (2) is formed by two perpendicular pipes (3) connected
at the bottom. Furthermore, an inlet (4) and an outlet (5) are provided at the upper
reactor edge. The meander-shaped conductance of the reaction medium (6) is carried
out perpendicularly or inclined at an angle at least once from the top down or in the
direction of gravity, and from the bottom up or against the direction of gravity. Both
the introduction and removal of the reaction medium (6) into and from the reactor are
preferably carried out continuously, without pressure and freely to the atmosphere via
the upper reaction medium surface, wherein due to the hydrostatic pressure
compensation and leveling a flow of the reaction medium (6) that is stress-free for the
microorganisms is produced.
[57]
לתקנות 13פירוט זה נבחן בהתאם לתקנה 2746 –הפטנטים5 תשכ"ח
This specification was examined in accordance
with regulation 35 of the Patent Regulations,
5728 - 1968
__________________
705420 [21[]11]
יהלום גביש יחיד
SINGLE CRYSTAL DIAMOND
[54]
14.07.2004 [22] US [33] 14.07.2003 [32] 60/486435 [31]
Int. Cl.(2010.01) C30B 33//02 [51]
December 29, 2011 405-התשע"ב טבתב 'ג
DIVISION FROM 173100 [62]
CARNEGIE INSTITUTION OF
WASHINGTON, U.S.A. [71]
WO/2005/007935 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
A single crystal diamond grown by microwave plasma chemical vapor deposition has a
fracture toughness of 11-20 MPa m 1/2.
[57]
__________________
207067 [21[]11]
מערכת למתן טרנסדרמלי של ביופרנאורפין לשימוש לטיפול בכאב
TRANSDERMAL DELIVERY
SYSTEMS OF BUPRENORPHINE
FOR USE IN TREATING PAIN
[54]
24.02.1998 [22] US [33] 24.02.1997 [32] 60/038919 [31]
US 29.09.1997 60/939068
Int. Cl.(2010.01) A61K 09//70, 31//485, 45//00, A61P 25//04, 25//36, C07D 48/9/12 [51] DIVISION FROM 201437 [62]
EURO-CELTIQUE S.A.,
LUXEMBOURG [71]
WO/1998/036728 [87]
וולף, ברגמן וגולר, ירושלים1352, ת.ד.
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[74]
The use of buprenorphine in the preparation of a medicament for a method of
effectively treating pain in humans is achieved by administering buprenorphine in a
manner indicative of first order pharmacokinetics over an initial three-day dosing
interval, such that a maximum plasma concentration from about 20 pg/ml to about
[57]
December 29, 2011 406-התשע"ב טבתב 'ג
1052 pg/ml is attained, and thereafter maintaining the administration of buprenorphine
for at least an additional two-day dosing interval in a manner indicative of zero order
kinetics, such that the patients experience analgesia throughout the at least two-day
additional dosing interval.
__________________
209736 [21[]11]
שיטות ומערכות לעיבוד תחתית באמצעי סהרון נוזל דינמי
METHODS AND SYSTEMS FOR
PROCESSING A SUBSTRATE
USING A DYNAMIC LIQUID
MENISCUS
[54]
29.09.2003 [22] US [33] 30.09.2002 [32] 10/261839 [31]
US 24.12.2002 10/330843
US 24.12.2002 10/330897
US 31.03.2003 10/404692
US 24.06.2003 10/603427
Int. Cl.(2010.01) H01G 02//02 [51] DIVISION FROM 161684 [62]
LAM RESEARCH CORPORATION,
U.S.A. [71]
JOHN M. DE LARIOS, JAMES P.
GARCIA, CARL A. WOODS,
MICHAEL RAVKIN, FRED C.
REDEKER
[72]
WO/2004/032160 [87]
ג'יי אמ בי, פקטור אנד קו בע"מ, רחוב המרפא, הר חוצבים
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
A system and method of moving a meniscus from a first surface to a second surface
includes forming a meniscus between a head and a first surface. The meniscus can be
moved from the first surface to an adjacent second surface, the adjacent second surface
being parallel to the first surface. The system and method of moving the meniscus can
also be used to move the meniscus along an edge of a substrate.
[57]
December 29, 2011 407-התשע"ב טבתב 'ג
The parent application from which 242462 בקשת הורה לבקשה זו שטרם פורסמה
this application has been divided has
not yet been published
__________________
209737 [21[]11]
שיטות ומערכות לעיבוד תחתית באמצעי סהרון נוזל דינמי
METHODS AND SYSTEMS FOR
PROCESSING A SUBSTRATE
USING A DYNAMIC LIQUID
MENISCUS
[54]
29.09.2003 [22] US [33] 30.09.2002 [32] 10/261839 [31]
US 24.12.2002 10/330843
US 24.12.2002 10/330897
US 31.03.2003 10/404692
US 24.06.2003 10/603427
Int. Cl.(2010.01) H01G 02//02 [51] DIVISION FROM 161684 [62]
LAM RESEARCH CORPORATION,
U.S.A. [71]
JOHN M. DE LARIOS, JAMES P.
GARCIA, CARL A. WOODS,
MICHAEL RAVKIN, FRED C.
REDEKER
[72]
WO/2004/032160 [87]
ג'יי אמ בי, פקטור אנד קו בע"מ, בים רחוב המרפא, הר חוצ
ירושלים45087, ת.ד.
JMB, FACTOR & CO. LTD.,
HAR HOTZVIM HI-TECH PARK,
P.O.B. 45087,
JERUSALEM 91450
[74]
A system and method of moving a meniscus from a first surface to a second surface
includes forming a meniscus between a head and a first surface. The meniscus can be
moved from the first surface to an adjacent second surface, the adjacent second surface
[57]
December 29, 2011 408-התשע"ב טבתב 'ג
being parallel to the first surface. The system and method of moving the meniscus can
also be used to move the meniscus along an edge of a substrate.
The parent application from which 242462 בקשת הורה לבקשה זו שטרם פורסמה
this application has been divided has
not yet been published
__________________
210701 [21[]11]
גלגל המונע בכח לרכב צבאי
POWER-DRIVEN WHEEL FOR A
MILITARY VEHICLE
[54]
01.11.2007 [22] IT [33] 15.12.2006 [32] TO2006A
000894
[31]
Int. Cl.(2010.01) B60K 07//00, 17//04 [51] DIVISION FROM 187093 [62]
OTO MELARA S.P.A., ITALY [71]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The invention relates to a power-driven wheel (1) having an axis (A) and comprising
an axial-flow motor (4) coaxial with said axis (A), a casing (5) housing said motor (4),
and a tubular hub (2) connected functionally to said motor (4). In order to facilitate
repairs, said casing (5) comprises a housing (6) with an open axial end (14) defining a
seat for said motor (4), and an end member (8) releasably engaging said open axial end
(14) of said housing (6) to grip said motor (4) inside said casing (5). The wheel (1) is
connectable to a frame (45) of a vehicle by connecting means (43) interposed between
said wheel (1) and said frame (45) so that, when said end member (8) is removed from
said housing (6), said motor (4) can be withdrawn completely through said open axial
end (14).
[57]
December 29, 2011 409-התשע"ב טבתב 'ג
__________________
210702 [21[]11]
גלגל המונע בכח לרכב צבאי
POWER-DRIVEN WHEEL FOR A
MILITARY VEHICLE
[54]
01.11.2007 [22] IT [33] 15.12.2006 [32] TO2006A
000894
[31]
Int. Cl.(2010.01) B60K 07//00, 17//04 [51] DIVISION FROM 187093 [62]
OTO MELARA S.P.A., ITALY [71]
לוצאטו את לוצאטו, גן תעשייה, עומר
באר שבע5352, ת.ד.
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[74]
The invention relates to a power-driven wheel (1) comprising an axial-flow motor (4),
a hub (2) connected functionally to said motor (4) and a tyre (3) angularly integral with
said hub (2). Motion transmission means (22) are interposed functionally between an
output member (7) of said motor (4) and said hub (2), and housed inside said hub (2).
To allow for inflation and deflation of the tyre, the wheel further comprises fluidic
connecting means (50) connecting an inner tube of said tyre (3) to the outside,
extending at least partly through said hub (2) and housed at least partly inside said
transmission means (22).
[57]
December 29, 2011 411-התשע"ב טבתב 'ג
PATENTS פטנטים
פטנטים שניתנו
PATENTS GRANTED
162214 161843 161735 161721 161472 160843 160598 160182
164783 164773 163843 163770 163285 163066 162854 162405
183220 183099 183046 182937 182797 165022 165002 164845
183916 183901 183868 183804 183539 183348 183286 183257
184819 184623 184599 184498 184462 184263 184107 183946
185537 185475 185375 184992 184952 184931 184922 184884
186327 186213 186163 186160 185992 185880 185765 185692
186858 186831 186769 186748 186725 186698 186676 186449
187542 187352 187313 187266 187182 187125 186962 186922
188545 188543 188527 188130 188017 187965 187853 187548
147979 147881 113909 189350 189200 189086 188875 188568
166501 166433 166390 166085 165304 165248 165226 150148
167194 167173 167145 167060 167058 167013 166830 166755
167937 167862 167623 167567 167436 167273 167218 167209
169720 169519 169409 169123 169008 168405 168371 168359
190805 190685 190597 190560 190546 190494 190414 170108
192219 191828 191769 191666 191662 191580 191048 190896
193730 193534 193365 193262 193006 192849 192771 192273
195749 195539 195020 194842 194579 194548 194361 194074
171798 171643 171119 170689 154589 134527 197546 196060
172590 172484 172469 172410 172101 171956 171870 171851
173303 173031 172922 172901 172815 172801 172702 172674
175534 175533 175433 174716 174705 174065 173802 173773
198978 198096 176471 176380 176357 176342 175632 175597
205779 205411 202827 202468 202331 201428 200260 199123
157922 157374 156770 145821 144988 143394 207587 207057
177870 177728 177453 177335 177191 177148 176765 176556
178672 178518 178452 178353 178192 178102 178006 177939
179281 179239 179127 179028 178830 178824 178757 178705
180047 179885 179792 179695 179658 179606 179594 179412
181058 180986 180933 180277 180236 180172 180135 180060
182161 181836 181821 181569 181522 181464 181195 181179
208800 208799 208460 182669 182513 182350 182306 182236
December 29, 2011 412-התשע"ב טבתב 'ג
פטנטים שחודשו
PATENTS RENEWED
107977 107974 107969 107967 107870 107868 107822 107675
108014 108013 108007 108003 108002 108000 107999 107980
108118 108115 108061 108051 108029 108027 108018 108017
108240 108235 108234 108204 108171 108154 108129 108126
122420 122375 122327 122300 122292 122273 121280 110388
122587 122578 122563 122556 122529 122497 122430 122429
122671 122669 122666 122632 122631 122630 122602 122601
122776 122771 122768 122767 122732 122716 122711 122695
125635 125386 125281 124478 123012 122871 122840 122777
129695 129694 129558 129338 126531 126016 125866 125715
129999 129979 129938 129937 129912 129911 129836 129792
130187 130178 130125 130120 130109 130085 130026 130013
130293 130278 130277 130267 130255 130247 130243 130239
130418 130403 130351 130345 130330 130311 130309 130298
130515 130501 130492 130482 130464 130459 130450 130449
130594 130575 130558 130549 130534 130533 130528 130524
130918 130793 130764 130734 130657 130653 130629 130601
141877 138708 136934 136396 135242 134356 132194 131429
146924 146823 146737 146694 146386 144988 142009 141916
147102 147100 147058 147050 147016 146999 146985 146981
150282 149933 147506 147276 147221 147213 147137 147110
153558 153187 153145 153114 151159 150629 150617 150381
155689 155662 155497 155428 155373 155097 154577 153816
155939 155922 155900 155806 155805 155771 155760 155709
156085 156084 156083 156080 156076 156058 156055 155992
156175 156171 156154 156103 156102 156091 156088 156086
156243 156242 156241 156240 156239 156238 156206 156204
156277 156270 156258 156251 156248 156247 156245 156244
156331 156325 156310 156308 156306 156303 156280 156278
156395 156389 156371 156369 156361 156353 156346 156341
156427 156423 156421 156415 156410 156403 156398 156396
156480 156476 156456 156446 156444 156440 156437 156432
156550 156542 156532 156531 156523 156516 156508 156505
156630 156588 156586 156568 156564 156563 156562 156553
156678 156661 156658 156657 156646 156644 156640 156635
156889 156878 156810 156766 156764 156723 156694 156693
157505 157201 157164 157161 157002 156975 156967 156928
158526 158376 158352 158309 158102 157867 157741 157633
161031 160843 160784 160659 160498 160432 159451 159305
161784 161746 161741 161735 161589 161379 161084 161051
163653 163600 163102 163066 162405 162376 162111 162063
164910 164845 164803 164377 164228 164222 164135 163843
December 29, 2011 413-התשע"ב טבתב 'ג
165528 165510 165309 165304 165264 165248 165038 165022
166981 166802 166445 166433 166243 165966 165719 165717
167465 167382 167273 167218 167173 167103 167082 167060
168359 168323 168207 168118 167937 167750 167652 167641
169337 169032 169024 168980 168739 168632 168631 168555
170354 169775 169704 169683 169677 169657 169575 169535
171693 171666 171638 171520 171192 170972 170721 170689
172470 172469 172454 172447 172323 172101 172075 171870
172674 172644 172591 172586 172571 172542 172541 172500
172856 172838 172837 172819 172805 172702 172695 172680
174062 173773 173505 173303 173031 172995 172917 172904
174848 174797 174729 174676 174642 174618 174606 174510
175859 175552 175508 175507 175228 175217 175077 175070
176610 176512 176433 176357 176336 176270 176150 175925
177327 177191 177119 177033 176765 176717 176655 176635
178050 177986 177980 177939 177808 177684 177648 177557
179109 179080 179028 179006 178830 178810 178576 178353
179451 179402 179395 179356 179286 179255 179124 179117
180047 180046 179955 179830 179779 179749 179658 179466
181047 180740 180670 180556 180413 180384 180172 180116
181850 181643 181522 181503 181460 181239 181195 181058
183156 183091 182924 182860 182690 182494 181864 181863
183391 183360 183348 183286 183264 183257 183256 183220
183574 183573 183550 183548 183547 183546 183437 183435
183763 183745 183722 183707 183689 183683 183655 183640
183950 183946 183930 183924 183917 183872 183812 183786
184081 184080 184068 184044 184019 184009 184007 184005
184823 184784 184770 184462 184300 184297 184245 184156
185635 185475 185452 185341 185233 185230 184952 184886
186895 186882 186858 186550 186382 186317 186226 186213
187965 187853 187653 187542 187402 187313 187294 187030
188815 188527 188408 188403 188169 188130 188017 187994
190494 190164 190070 189559 189552 189463 189197 188875
192052 191886 191874 191662 190720 190685 190597 190546
195446 194548 194274 193365 192827 192765 192687 192273
197059 197052 196372 196048 195677 195539 195448 195447
200260 199438 199123 198448 198051 197993 197520 197164
207492 205693 204960 203892 202308 201967 201966
December 29, 2011 414-התשע"ב טבתב 'ג
פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
120388 120380 120361 120358 120350 120332 120328 120295
120455 120442 120436 120435 120430 120425 120420 120407
120652 120612 120554 120523 120512 120504 120492 120465
120746 120723 120719 120709 120700 120696 120688 120656
120838 120824 120821 120817 120813 120806 120796 120751
122647 122565 122526 122525 122520 122318 122139 122011
138499 138011 123629 123201 122931 122916 122823 122699
141740 141727 141676 141638 141632 141592 141584 140951
177775 158522 158490 156650 155664 141822 141777 141758
132616 132071 131019 130955 129789 178204 178018 177777
142416 142325 142227 142208 142156 141989 141963 141961
142825 142784 142774 142773 142732 142611 142455 142431
143997 143217 143073 143042 143013 142994 142892 142884
168162 167726 167646 167193 167179 145799 145774 143998
151095 151084 151083 151075 150985 150792 168588 168462
151416 151392 151373 151336 151329 151311 151249 151248
151630 151626 151596 151524 151492 151471 151447 151428
151699 151695 151687 151674 151669 151668 151647 151637
151786 151766 151756 151751 151736 151708 151706 151703
151913 151899 151894 151878 151864 151850 151822 151789
152050 152045 152023 151989 151983 151976 151948 151922
152172 152149 152132 152124 152085 152077 152073 152063
152376 152327 152307 152300 152298 152249 152229 152215
152482 152463 152461 152459 152448 152392 152388 152379
152615 152600 152551 152550 152534 152495 152488 152487
152789 152745 152730 152728 152677 152664 152657 152650
153057 152971 152932 152868 152835 152817 152814 152798
104829 183570 161963 161962 161961 154072 153233 153205
104965 104957 104954 104915 104891 104880 104839 104830
105062 105061 105058 105056 105017 105009 105003 104984
105306 105204 105203 105183 105146 105141 105131 105063
105449 105403 105382 105371 105369 105345 105344 105329
105554 105516 105513 105498 105470 105468 105465 105456
105622 105619 105614 105607 105593 105592 105591 105588
105709 105695 105684 105658 105642 105637 105627 105625
125764 125709 125590 125504 124848 124572 124426 105710
125912 125911 125895 125893 125869 125850 125796 125772
126054 126028 125987 125986 125969 125968 125954 125939
126146 126120 126115 126097 126091 126086 126075 126057
126248 126237 126219 126212 126207 126204 126180 126176
126354 126338 126337 126304 126296 126283 126282 126262
December 29, 2011 415-התשע"ב טבתב 'ג
126423 126420 126403 126395 126371 126368 126363 126358
126581 126556 126541 126497 126496 126486 126478 126470
126628 126614 126607 126605 126596 126591 126584 126582
126853 126823 126770 126754 126717 126677 126646 126643
126969 126968 126944 126918 126917 126911 126897 126854
127015 127013 126989 126976 126975 126973 126971 126970
146001 127726 127218 127177 127130 127111 127044 127033
149030 148538 148537 147532 147430 147339 147226 146935
פטנטים שחודשו לעשרים שנהPATENTS RENEWED FOR 20 YEARS
183176
צווי הארכה שחודשו
EXTENSION ORDERS RENEWED
102138 94634
פטנטים שפג תוקפם
PATENTS EXPIRED
97464 97455 97426 97425 97413 97396 97376 97328
97584 97565 97532 97516 97503 97487 97485 97465
97623 97620 97619 97602 97596 97594 97592 97585
97646 97645 97644 97641 97635 97633 97632 97631
97709 97701 97695 97693 97690 97677 97674 97658
97740 97730 97729 97727 97723 97720 97715 97714
97867 97851 97837 97800 97779 97746 97744 97741
97924 97915 97914 97912 97910 97904 97892 97884
98025 98014 98008 98002 97992 97982 97944 97935
98100 98081 98077 98060 98055 98033 98028 98027
98161 98157 98152 98143 98137 98127 98126 98101
111029 111028 110820 107309 107308 104253 98175 98163
170719 165071 119396 112575 111030
December 29, 2011 416-התשע"ב טבתב 'ג
פטנטים שלגביהם הוגשו בקשות להארכת תקופת
ההגנה על פי פרק ד' סימן לחוק הפטנטים 1ב'
Patents for which
applications have been filed
for extension of the patent
term under chapter 4, part
B1 of the Patens Law
מס' פטנט בסיסי?
225353 No. of basic patent:
:Proprietors שם המבקש?
BIOVITRUM AB (PUBL)
:27.11.2011Date of application תאריך הגשת הבקשה?
December 29, 2011 417-התשע"ב טבתב 'ג
NOTICE הודעה
לחוק 60לפי סעיף 1967-הפטנטים, תשכ"ז
Under section 60 of the
Patent Law, 5727-1967
הוגשה בקשה להחזר תוקפו של הפטנט המפורט מטה,
שתוקפו פקע מחמת אי תשלום אגרות החידוש
הקבועות:
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent 203137 מס' הפטנט
Acceptance published in ///7/0 קיבול פורסם ביומן מס'?
journal no:
:Proprietors שם בעל הפטנט?
CECA S.A.
:Title of invention שם האמצאה? קריוגנית של גזים תעשייתיים -אמצעי סופח5 תהליך לייצורו והשימוש בו להפרדה לא
ADSORBENT, PROCESS FOR THE PRODUCTION THEREOF AND USE THEREOF
FOR THE NON- CRYOGENIC SEPARATION OF INDUSTRIAL GASES
כל אדם רשאי להתנגד שה האמורה תוך לבק
שלושה חודשים מתאריך יומן פטנטים זה, כפי שנקבע
92לחוק ובתקנה 61בסעיף -לתקנות הפטנטים, תשכ"ח
1968
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as
prescribed by section 61 of
the law and by regulation 92
of the Patent Regulations,
5728-1968
December 29, 2011 418-התשע"ב טבתב 'ג
NOTICE הודעה
לחוק 60לפי סעיף 1967-הפטנטים, תשכ"ז
Under section 60 of the
Patent Law, 5727-1967
הוגשה בקשה להחזר תוקפו של הפטנט המפורט מטה,
שתוקפו פקע מחמת אי תשלום אגרות החידוש
הקבועות:
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent 213236 מס' הפטנט
Acceptance published in 0//3/0 קיבול פורסם ביומן מס'?
journal no:
:Proprietors שם בעל הפטנט?
אודיס תעשיית אביזרי השקיה בע"מ
ODIS IRRIGATION EQUIPMENT LTD.
:Title of invention שם האמצאה? משקע עבור נוזלים בעלי עכירות גבוהה
SETTLER FOR HIGH-TURBIDITY LIQUIEDS
כל אדם רשאי להתנגד לבקשה האמורה תוך
שלושה חודשים מתאריך כפי שנקבע יומן פטנטים זה,
92לחוק ובתקנה 61בסעיף -לתקנות הפטנטים, תשכ"ח
1968
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as
prescribed by section 61 of
the law and by regulation 92
of the Patent Regulations,
5728-1968
December 29, 2011 419-התשע"ב טבתב 'ג
NOTICE הודעה
לחוק 60לפי סעיף 1967-הפטנטים, תשכ"ז
Under section 60 of the
Patent Law, 5727-1967
הוגשה בקשה להחזר תוקפו של הפטנט המפורט מטה,
שתוקפו פקע מחמת אי תשלום אגרות החידוש
הקבועות:
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent 236006 מס' הפטנט
Acceptance published in 7//3/0 קיבול פורסם ביומן מס'?
journal no:
:Proprietors שם בעל הפטנט?
ידע חברה למחקר ופיתוח בע"מYEDA RESEARCH AND DEVELOPMENT CO. LTD.
:Title of invention שם האמצאה?
להכנת תכשירי רוקחות לטיפול במחלות אוטואימוניות של 26Cשימוש באסטרים של חומצות שומניות איברים ספציפיים
USE OF ESTERS OF C18 FATTY ACIDS FOR THE PREPARTION OF
MEDICAMENTS FOR TREATMENT OF ORGAN - SPECIFIC AUTOIMMUNE
DISEASES
כל אדם רשאי להתנגד לבקשה האמורה תוך
שלושה חודשים מתאריך יומן פטנטים זה, כפי שנקבע
92לחוק ובתקנה 61בסעיף -לתקנות הפטנטים, תשכ"ח
1968
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as
prescribed by section 61 of
the law and by regulation 92
of the Patent Regulations,
5728-1968
December 29, 2011 420-התשע"ב טבתב 'ג
NOTICE הודעה
לחוק 60לפי סעיף 1967-הפטנטים, תשכ"ז
Under section 60 of the
Patent Law, 5727-1967
הוגשה בקשה להחזר תוקפו ה, של הפטנט המפורט מטשתוקפו פקע מחמת אי תשלום אגרות החידוש
הקבועות:
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent 237312 מס' הפטנט
Acceptance published in 7//3/0 קיבול פורסם ביומן מס'?
journal no:
:Proprietors שם בעל הפטנט?
מוסד הטכניון למחקר ופיתוח בע"מ
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
:Title of invention שם האמצאה? שיטה להכנת קורולים המותמרים באופן סלקטיבי וקורולים מותמרים חדשים
METHOD FOR THE PREPARATION OF SELECTIVELY-SUBSTITUTED CORROLES
AND NEW SUBSTITUTED CORROLES
כל אדם רשאי להתנגד לבקשה האמורה תוך
שלושה חודשים מתאריך יומן פטנטים זה, כפי שנקבע
92לחוק ובתקנה 61בסעיף -לתקנות הפטנטים, תשכ"ח
1968
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as
prescribed by section 61 of
the law and by regulation 92
of the Patent Regulations,
5728-1968
December 29, 2011 421-התשע"ב טבתב 'ג
NOTICE הודעה
לחוק 60לפי סעיף 1967-הפטנטים, תשכ"ז
Under section 60 of the
Patent Law, 5727-1967
הוגשה בקשה להחזר תוקפו של הפטנט המפורט מטה,
שתוקפו פקע מחמת אי תשלום אגרות החידוש
הקבועות:
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent 241645 הפטנט מס'
Acceptance published in 7//5/0 קיבול פורסם ביומן מס'?
journal no:
:Proprietors שם בעל הפטנט?
BASF AKTIENGESELLSCHAFT
:Title of invention שם האמצאה? שיטה לטיהור קוטל חרקים
METHOD OF PURIFYING A PESTICIDE
תנגד כל אדם רשאי להלבקשה האמורה תוך
שלושה חודשים מתאריך יומן פטנטים זה, כפי שנקבע
92לחוק ובתקנה 61בסעיף -לתקנות הפטנטים, תשכ"ח
1968
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as
prescribed by section 61 of
the law and by regulation 92
of the Patent Regulations,
5728-1968
December 29, 2011 422-התשע"ב טבתב 'ג
NOTICE הודעה
לחוק 60לפי סעיף 1967-הפטנטים, תשכ"ז
Under section 60 of the
Patent Law, 5727-1967
הוגשה בקשה להחזר תוקפו של הפטנט המפורט מטה,
שתוקפו פקע מחמת אי תשלום אגרות החידוש
:הקבועות
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent 243264 מס' הפטנט
Acceptance published in 6//3/0 קיבול פורסם ביומן מס'?
journal no:
:Proprietors הפטנט?שם בעל
מולטילוק טכנולוגיות בע"מ
MUL-T-LOCK TECHNOLOGIES LTD.
:Title of invention שם האמצאה? כיווני–מנעול צילינדר רב
MULTI-DIRECTIONAL CYLINDER LOCK
כל אדם רשאי להתנגד לבקשה האמורה תוך
שלושה חודשים מתאריך יומן פטנטים זה, כפי שנקבע
92לחוק ובתקנה 61 בסעיף-לתקנות הפטנטים, תשכ"ח
1968
Any person may oppose the
said application within three
months from the date of this
Patents Journal, as
prescribed by section 61 of
the law and by regulation 92
of the Patent Regulations,
5728-1968
December 29, 2011 423-התשע"ב טבתב 'ג
ה לחוק 64לפי סעיף הודעה
1967-הפטנטים התשכ"ז
NOTICE under section 64E of the
Patents Law, 5727-1967
בכוונת רשם הפטנטים ליתן צו להארכת תקופת הגנה ע"פ פרק
לחוק הפטנטים, 1ד', סימן בלגבי הפטנט 1967-התשכ"ז
המפורט מטה:
It is the intention of the
Commissioner of Patents to grant an
order for the extension of the period
of protection of the following patent
in accordance with Chapter Four,
Article Two bis, of the Patents Law,
5727-1967
:No. of basic patent 103098 מס' פטנט בסיסי:
The order will be in effect until 14.04.2017 :הצו יעמוד בתוקפו עד ליום
Acceptance published in Journal 2/1996 קיבול פורסם ביומן מס':
No.:
:Title of invention שם האמצאה:
פירידין פיורו ופירולו אנאלוגים שלהןתהליכים -]C-3,2[-תולדות טטראהידרותיאנו להכנתן ותכשירי רוקחות המכילים אותם
TETRAHYDROTHIENO-[3,2-c]- PYRIDENE DERIVATIVES, FURO AND PYRROLO
ANALOGS THEREOF, PROCESSES FOR THE PREPARATION THEREOF AND
PHARMACEUT
:Proprietors בעלי הפטנט:
UBE INDUSTRIES LTD9 כל המעוניין להתנגד למתן צו
הארכה רשאי תוך שלושה ם מתאריך יומן זה, להגיש חודשי
לרשם הפטנטים הודעה התנגדות ו לחוק, בדרך 64לפי סעיף
לתקנות 3הקבועה בתקנה –הפטנטים )הארכת תקופה הגנה
סדרי דין בבקשה לצו, בהתנגדות -לצו, ובבקשה לביטול(, התשנ"ח
1998
Any person desiring to oppose the
said grant of an order may, within
three months from the date of this
journal, serve to the Commissioner
of Patents a notice of opposition
under Section 64F of the Law, as
prescribed by Rule 3 of the Patent
Regulations (extension of period of
protection – procedure of
application for order, opposition to
order, application to annul) 5758-
1998.
December 29, 2011 424-התשע"ב טבתב 'ג
שינויים בפרטים רשומים בפנקס
CHANGES IN PARTICULARS ENTERED IN REGISTER
December 29, 2011 425-התשע"ב טבתב 'ג
DESIGNS מדגמים
מדגמים שנרשמוDESIGNS REGISTERED
49052 Class 3(01) סוג פרסום 21.02.2010
MERCK SERONO SA
Tablet dispenser מנפק לגלולות
Convention date (WIPO) 08.09.2009 תאריך האמנה )וויפו(
49168 ,49169 Class 9(03) סוג פרסום 22.03.2010
CAESAREA LANDSCAPE DESIGN קיסריה עיצוב בנוף בע"מ
LTD.
Dustbin אשפתון
49261 Class 26(01) סוג פרסום 11.04.2010
.GISHAY HOLDING LTD גישאי אחזקות בע"מ
Memorial candle נר זיכרון
49066 Class 9(03) סוג פרסום 23.02.2010
CAESAREA LANDSCAPE DESIGN קיסריה עיצוב בנוף בע"מ
LTD.
December 29, 2011 426-התשע"ב טבתב 'ג
Dustbin אשפתון
49213 Class 3(01) סוג פרסום 25.03.2010 ALPLAST-PLASTIV SHEETS עיבוד לוחות פלסטיים בע"מ-עלפלסט
CONVERTING LTD.
Case מארז
49214 Class 19(02) סוג פרסום 25.03.2010 ALPLAST-PLASTIV SHEETS עיבוד לוחות פלסטיים בע"מ-עלפלסט
CONVERTING LTD.
Clip case אוגדנית עם תפס לדפים
50110 Class 7(02) סוג פרסום 21.09.2010
.STRAUSS COFFEE B.V
Cooking container כלי בישול
49262 ,49263 Class 24(04) סוג פרסום 11.04.2010
VECTURA DELIVERY DEVICES LIMITED
Inhaler משאף
Convention date (OHIM) 09.10.2009 תאריך האמנה )איחוד אירופי(
49263 Class 24(04) סוג פרסום
December 29, 2011 427-התשע"ב טבתב 'ג
11.04.2010
VECTURA DELIVERY DEVICES LIMITED
Inhaler משאף
Convention date (OHIM) 09.10.2009 תאריך האמנה )איחוד אירופי(
December 29, 2011 428-התשע"ב טבתב 'ג
49597 ,49598 Class 12(16) סוג פרסום 15.06.2010
.T.C. AVISAREI RECHEV B.M ט.ק. אביזרי רכב בע"מ
Vehicle seat cover כיסוי מושב לרכב
49609 ,51395 Class 24(02) סוג פרסום 16.06.2010
.ROCHE DIAGNOSTICS S.L
Portable medical equipment for clinical אבחון קליני מכשיר רפואי נייד לביצוע
analysis
Convention date (U.S.A.) 19.03.2010 תאריך האמנה )ארצות הברית(
49657 Class 3(01) סוג פרסום 21.06.2010
& SHUGON BAGS שוגון תיקים ומוצרי עור בע"מ
LEATHERGOODS LTD.
Backpack תיק גב
49922 Class 7(05) סוג פרסום 03.08.2010
K. VISION SYSTEM SOLUTIONS קיי ויז'ן סיסטם סולושנס בע"מ
LTD.
Dish dryer מייבש כלים
50085 Class 9(01) סוג פרסום 16.09.2010
December 29, 2011 429-התשע"ב טבתב 'ג
.GUERLAIN S.A
Bottle בקבוק
Convention date (OHIM) 17.03.2010 ירופי(תאריך האמנה )איחוד א
December 29, 2011 430-התשע"ב טבתב 'ג
50177 Class 6(09) סוג פרסום 09.12.2010
DGANIT BODEK LEVI דגנית בודק לוי
AHUVA ZAIRI SHITRIT אהובה זעירי שטרית
Nursing pillow כרית הנקה
50273 Class 21(01) סוג פרסום 11.11.2010
YERACHMEL BERENSHTEIN ירחמיאל ברנשטיין
BINYAMIN HUTA בנימין חוטה
Construction toy צעצוע הרכבה
50410 Class 23(01) סוג פרסום 13.12.2010 ETI SEGEV אתי שגב
A water spraying device מכשיר להתזת מים
50442 Class 7(02) סוג פרסום 21.12.2010
ARGO DEVELOPMENT AND ארגו פיתוח וייצור בע"מ
MANUFACTURING LTD.
Coffee maker מכשיר להכנת קפה
50141 Class 11(02) סוג פרסום 11.10.2010
JOSEFF ZAKARIYA יוסף זקריה
Ornament קישוט
December 29, 2011 431-התשע"ב טבתב 'ג
50506 Class 9(01) סוג פרסום 11.01.2011
.SOURCE VAGABOND SYSTEM LTD
Bottle בקבוק
Convention date (U.S.A.) 13.07.2010 תאריך האמנה )ארצות הברית(
50607 Class 25(01) סוג פרסום 07.02.2011
.SHOKET ALUMINIUM LTD שוקת אלומיניום בע"מ
Profile פרופיל
50704 ,50706 ,50707 Class 2(04) סוג פרסום 21.02.2011
.ANTELOPE SHIVUK (1994) LTD ( בע"מ1994אנטילופ שיווק )
Sole סוליה
50738 Class 24(04) סוג פרסום 24.02.2011
SHLOMO NORMATOV שלמה נורמטוב
Apparatus for weakening and/or cessation of התקן להחלשת ו/או הפסקת נחירות
snoring
50770 Class 6(06) סוג פרסום 06.03.2011
.SHOKET ALUMINIUM LTD שוקת אלומיניום בע"מ
December 29, 2011 433-התשע"ב טבתב 'ג
50812 Class 6(06) סוג פרסום 17.03.2011
.SHOKET ALUMINIUM LTD שוקת אלומיניום בע"מ
Profile for cabinet פרופיל לארון
50857 Class 8(03) סוג פרסום 27.03.2011
KOMET GROUP HOLDING GMBH
Cutting tools כלי חיתוך
Convention date (OHIM) 27.10.2010 תאריך האמנה )איחוד אירופי(
50867 ,50868 Class 11(01) פרסום סוג 28.03.2011
H. STERN COMERCIO E INDUSTRIA S.A.
Jewel תכשיט
50911 Class 25(01) סוג פרסום 07.04.2011
.SHOKET ALUMINIUM LTD שוקת אלומיניום בע"מ
Profile פרופיל
50878 Class 8(05) סוג פרסום 29.03.2011 AMIT LEVI עמית לוי
Bottles compressor דוחס בקבוקים
December 29, 2011 434-התשע"ב טבתב 'ג
50888 Class 12(16) סוג פרסום 30.03.2011
SAFECAR THEFT PREVANTION סייף קאר מערכות מניעת גניבה בע"מ
SYSTEMS LTD.
Defensive equipment for igniting computer מתקן הגנה למחשב הצתה
49756 Class 25(02) סוג פרסום 06.07.2010
JOSEPH ROKACH AND SONS רוקח יוסף ובניו יבוא ושיווק בע"מ
IMPORT AND DISTRIBUTION
LTD.
Manhole cover כיסוי לתא בקרה
50737 Class 25(01) סוג פרסום 24.02.2011 ARNON BARAK ארנון ברק
Profile פרופיל
50901 Class 2(01) סוג פרסום 05.04.2011 SARAH COHEN שרה כהן
Under garment לבוש תחתון
49899 Class 26(03) סוג פרסום 29.07.2010
KONINKLIJKE PHILIPS ELECTRONICS N.V
December 29, 2011 435-התשע"ב טבתב 'ג
Luminaire for road lighting אמצעי תאורה לדרך
Convention date (OHIM) 18.02.2010 תאריך האמנה )איחוד אירופי(
December 29, 2011 436-התשע"ב טבתב 'ג
50454 Class 25(03) סוג פרסום 27.12.2010
JOSEFF ZAKARIYA יוסף זקריה
Mobile structure מבנה נייד
50814 Class 25(03) סוג פרסום 21.03.2011 .Z. ROTH INDUSTRIES LTD שיות בע"מצ. רוט תע
Passenger shelter סככה לנוסעים
50314 Class 21(01) סוג פרסום 21.11.2010
.KETER PLASTIC LTD כתר פלסטיק בע"מ
Play house בית משחק
50484 Class 21(01) סוג פרסום 04.01.2011
KAMAL HASAN קמאל חסן
ISMAIL TURK אסמעיל טורק
Cube of languages & mathmatics קוביית שפות ומתמטיקה
49982 Class 23(03) סוג פרסום 19.08.2010 TAL KAMIL טל קמיל
Solar collector קולט סולארי
December 29, 2011 437-התשע"ב טבתב 'ג
50024 Class 21(01) סוג פרסום 26.08.2010
SOPHIE NESIHA BERMAN נסיכה ברמן סופי
Game משחק
50025 Class 21(01) סוג פרסום 26.08.2010
SOPHIE NESIHA BERMAN סופי נסיכה ברמן
Cube game קוביית משחק
December 29, 2011 438-התשע"ב טבתב 'ג
מדגמים שבוטלוDESIGNS VOID
35213 35200 35170 35168 35166 35157 27126 27054
27026 27004 35225 35223 35222 35217 35216 35215
35101 35097 35085 35084 35083 35082 27044 27043
35131 35121 35104
שחודשומדגמים DESIGN RENEWED
43632 43596 43594 43537 43424 43423 35948 35911
43848 43847 43846 43845 43837 43836 43835 43703
43902 43901 43893 43892 43852 43851 43850 43849
44745 44452 44097 44048 43945 43906 43905 43904
35995 35864 44743 45941 45939 49538 49537 44746
43213 43210 40807 36155 36119 36118 36084 36053
43644 43518 43409 43389 43318 43317 43316 43314
43686 43770 43762 43645
Asa Kling אסא קלינג
,Commissioner of Patents רשם הפטנטים, המדגמים
Designs and Trade Marks חר וסימני מס
December 29, 2011 439-התשע"ב טבתב 'ג
מפתחות לבקשות שקובלו
INDICES OF APPLICATIONS ACCEPTED
NAME INDEX מפתח שמי
185534 -א.פ.מ. פתרונות אוטומציה בע"מ
193003 -אביב עמירב
אוניברסיטת בן גוריון בנגב הרשות למחקר 172944 -ופיתוח
, 171722 -אי. סי. איי. טלקום בע"מ 189342
איי.בי.איי ישראל ביומדיקל אינוביישנס 188582 -בע"מ
194909 -אילן רוזן
177414 -אלונים אחזקות אגש"ח בע"מ
193059 -אלי הוגו בודמן
183398 -אלתא מערכות בע"מ
167142 -אמנון מאור
167142 -אמנון שילוני
145210 -אפוסנס בע"מ
189284 , 188649 -גאורגי נאומוב
174148 -גדעון אלון
167782 -גיוון אימג'ינג בע"מ
161938 -גל זילכה
184362 -גמסוניק בע"מ
193502 -דויד זילברברג
192011 -דוקול בע"מ
894139 -דקסל בע"מ
172326 -הוק מדיקל טכנולוג'יס בע"מ
-התעשייה האוירית לישראל בע"מ 163609 , 193866
181562 -חניתה מפעלי מתכת בע"מ
168332 -ות בע"מ חסין אש תעשי
168298 -יוסי סלע
179893 -יעקב צרור
174670 -ישקר בע"מ
174670 -ישקר בע"מ
161938 -לייט בוק בע"מ
188067 -ליתוטק מדיקל בע"מ
-מארוול ישראל )אמ.איי.אס.אל( בע"מ 189514
187667 -מדיגייד בע"מ
193848 , 186786 -מדינול בע"מ
181639 -יקל ברוגמן מי
188649 -מיכאל נאומוב
189284 -מיכאל נאומוב
193059 -מרסלו אדריאן אדטו
192005 -סויטרון בע"מ
168686 -סנו מפעלי ברונוס בע"מ
201461 -עידן נחמני
168399 -פואמיקס בע"מ
188645 -פיטרקס בע"מ
177323 -קורנית דיגיטל בע"מ
177323 -קורנית דיגיטל טכנולוגיות בע"מ
170726 -טק בע"מ -קמרו
161938 -רונן כרמונה
-רמות ליד אוניברסיטת תל אביב בע"מ 167400
192005 -טוב -רן סימן
-רפא"ל מערכות לחימה מתקדמות בע"מ 183320
193502 -ש"ח שנאי חולדה
164577 -תדיראן טלקום בע"מ
מחקרים ,תשתית ושירותים -תל השומר
December 29, 2011 440-התשע"ב טבתב 'ג
194299 -רפואיים בע"מ
3M INNOVATIVE PROPERTIES
COMPANY - 26212/
A.P.M. AUTOMATION SOLUTIONS
LTD. - 185534
ABBOTT LABORATORIES - 172457
ABGENOMICS COOPERATIEF U.A. -
174172
ABGENOMICS CORPORATION - 174172
ADIR SEGAL, LTD - 192011
AGENSYS, INC. - 197988
AIMSCO LIMITED - 180487
ALBERT EINSTEIN COLLEGE OF
MEDICINE OF YESHIVA UNIVERSITY
- 155791
ALBIS SPA - 196716
ALCATEL LUCENT - 180440
ALCHEMIA ONCOLOGY PTY LIMITED
- 189972
ALCON, INC. - 183323 , 183368
ALLENVEE HOLDINGS PTY LTD. -
194464
ALLERGAN, INC. - 167410
ALONIM HOLDINGS AGRICULTURAL
COOPERATIVE SOCIETY LTD. - 177414
ALPHAMED MEDIZINTECHNIK
FISCHER GMBH - 183030
ALZA CORPORATION - 156090
AMNON MAOR - 167142
AMNON SHILONI - 167142
AMPHENOL CORPORATION - 184200
ANTHROGENESIS CORPORATION -
190731
ANTIBIOTICOS S.P.A. - 200172
APOSENSE LTD. - 145210
APPLIED DESIGN AND ENGINEERING
LIMITED - 173997
AQUARIUS TECHNOLOGIES INC. -
183881
ARES TRADING S.A. - 161309
ARM LIMITED - 189206
ASTELLAS PHARMA INC. - 168121
ASTION PHARMA A/S - 186491
ASTRAZENECA AB - 193071
AVANTOR PERFORMANCE
MATERIALS, INC. - 190088
AVENTIS PHARMA S.A. - 193310
AVENTIS PHARMACEUTICALS INC. -
159506 , 190673
AVIV AMIRAV - 193003
BAE SYSTEMS BOFORS AB - 191614
BASF SE - 186680
BAYER ANIMAL HEALTH GMBH -
183200
BAYER PHARMA
AKTIENGESELLSCHAFT - 183200 ,
201694 , 205242
BAYER S.A.S. - 169527
BEN-GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY - 172944
BETH ISRAEL DEACONESS MEDICAL
CENTER - 178002
BIOAVAILABILITY, INC - 183157
BIOGEN IDEC MA INC. - 170178
BIONICHE LIFE SCIENCES INC. -
164664
BIOSENSE WEBSTER INC. - 156377
BIOSENSE WEBSTER INC. - 181119
BIOSENSE WEBSTER, INC. - 180516
BIO-TEC BIOLOGISCHE
NATURVERPACKUNGEN GMBH & CO.
KG - 194687
BIOTEMPT, B.V. - 178515
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM -
174374
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH - 166584 ,
175017 , 197377
BOEHRINGER INGELHEIM PHARMA
December 29, 2011 441-התשע"ב טבתב 'ג
GMBH & CO. KG - 157326
BOTULINUM TOXIN RESEARCH
ASSOCIATES, INC. - 168745
BRAVILOR HOLDING B.V. - 195661
BRISTOL-MYERS SQUIBB COMPANY -
157443
BRISTOL-MYERS SQUIBB COMPANY -
203533
BURLE TECHNOLOGIES, INC. - 160873
CABOT MICROELECTRONICS
CORPORATION - 182170 , 196221
CAMERO-TECH LTD. - 170726
CARDIOROBOTICS, INC. - 197032
CARLO CHIAVES - 170438
CARNEGIE INSTITUTION OF
WASHINGTON - 207054
CHEN CHUANO-CHUAN - 187048
CHEN MING-TE - 187048
CHOUDHARY CHARAN SINGH
HARYANA AGRICULTURAL
UNIVERSITY, - 179254
CHUGAI SEIYAKU KABUSHIKI
KAISHA - 187604
CLARIANT FINANCE (BVI) LIMITED -
186384
COLGATE-PALMOLIVE COMPANY -
177761
COLUMBIA LABORATORIES
(BERMUDA) LIMITED - 161513
COMBUSTION SCIENCE &
ENGINEERING INC. - 183500
COMMISSARIAT A L'ENERGIE
ATOMIQUE - 175936
COMPOUND PHOTONICS - 193789
CORDIS CORPORATION - 168361
COUNCIL OF SCIENTIFIC AND
INDUSTRIAL RESEARCH - 171177 ,
171178
CRUCELL HOLLAND B.V. - 146479 ,
198861
CSL BEHRING GMBH - 157360
CVTRON LTD. - 192005
CYTOS BIOTECHNOLOGY AG - 194656
DAS AJEE KAMATH - 171444
DAVID JACOB SCHWARTZ - 197165
DAVID ZILBERBERG - 193502
DENDERAH PHARMA SA - 182747
DEUTSCHE POST AG - 166911
DEXCEL LTD. - 139894
DONG WHA PHARMACEUTICAL CO.,
LTD. - 180524
DUCOOL LTD. - 192011
DURECT CORPORATION - 176649
DYNTEK PTE LTD. - 190071
EATON CORPORATION - 194135
ECI TELECOM LTD. - 171722 , 189342
ECODUNA OG - 206869
EGIS GYOGYSZERGYAR NYRT -
183739
EISAI R&D MANAGEMENT CO., LTD. -
180486 , 184983 , 188670
ELAN PHARMA INTERNATIONAL
LTD. - 163626
ELECTRONIC NAVIGATION
RESEARCH INSTITUTE - 158325
ELEMENT SIX LIMITED - 166905
ELI HUGO BUDMAN - 193059
ELTA SYSTEMS LTD. - 183398
ENZON PHARMACEUTICALS, INC. -
183054
ERNEST FRIEDEN - 192087
ESPERION THERAPEUTICS, INC. -
155213
EURO-CELTIQUE S.A. - 187813 , 207067
F. HOFFMANN-LA ROCHE AG - 154008
, 163563 , 170829 , 174075 , 174513 ,
179370 , 179737 , 181317 , 183594 ,
185631 , 189664 , 196327
FABIO PERINI S.P.A. - 177886
FITRACKS INC. - 188645
FITRACKS LTD. - 188645
FN HERSTAL S.A. - 183891
FOAMIX LTD. - 168399
FRED ZACOUTO - 186988
FUJIKIN INCORPORATED - 191738
FUJIMOTO CO., LTD. - 183028
FUNCTIONAL GENETICS, INC. - 167774
GABA INTERNATIONAL AG - 188246
Gal Zilkha - 161938
December 29, 2011 442-התשע"ב טבתב 'ג
GALLAHER SNUS AB - 185874
GAMASONIC LTD. - 184362
GE MEDICAL SYSTEMS GLOBAL
TECHNOLOGY COMPANY, LLC -
165619
GEBR. SCHMID GMBH & CO. - 189168
GENENTECH, INC. - 157378 , 170076 ,
174786 , 191077 , 191078 , 191824
GENERAL ELECTRIC COMPANY -
187519
GENSTRUCT, INC. - 167629
GEORGE NAUMOV - 188649 , 189284
GERON CORPORATION - 177324 ,
188264
GIDEON ALON - 174148
GILEAD SCIENCES, INC. - 180758 ,
180781
GIVEN IMAGING LTD. - 167782
GLAXO GROUP LIMITED - 184438
GLAXOSmithKLINE ISTRAZIVACKI
CENTAR ZAGREB D.O.O. - 184438
GLIDE PHARMACEUTICAL
TECHNOLOGIES LIMITED - 166508
GLIDE PHARMACEUTICAL
TECHNOLOGIES LIMITED - 185100
GRACEWAY PHARMACEUTICALS,
LLC - 184310
H. LUNDBECK A/S - 200959
H.T. HULDA TRANSFORMERS - 193502
HANITA METAL WORKS LTD. - 181562
HANMI HOLDINGS CO., LTD. - 188600
HANMI PHARM. CO., LTD. - 188600
HARTMUT ENGELMANN - 161309
HASSIN ESH INDUSTRIES LTD. -
168332
HAWK MEDICAL TECHNOLOGIES
LTD - 172326
HERAEUS QUARZGLAS GMBH & CO.
KG - 180213
HUTCHISON WHAMPOA THREE G IP
(BAHAMAS) LIMITED - 184887
I.B.I. ISRAEL BIOMEDICAL
INNOVATIONS LTD. - 188582
IBM CORPORATION - 173422 , 188757 ,
191952 , 194297
IDAN NACHMANI - 201461
ILAN ROSEN - 194909
INDENA S.P.A. - 165436 , 181024 ,
182396
INSERM (INSTITUT NATIONALE DE
LA SANTE ET DE LA RECHERCHE
MEDICALE) - 193310
INSTITUT NATIONAL DE LA SANTE
ET DE LA RECHERCHE MEDICALE -
I.N.S.E.R.M. - 198076
INSTITUT PASTEUR - 198076
INTARCIA THERAPEUTICS, INC. -
156090
INTERDIGITAL TECHNOLOGY
CORPORATION - 180004 , 184083 ,
189716
INTERNATIONAL STEM CELL
CORPORATION - 190869
INTEVAC, INC. - 174681
ISCAR LTD. - 174670
ISCAR LTD. - 174670
ISRAEL AEROSPACE INDUSTRIES
LTD. - 163609 , 193866
JACKOB TSROR - 179893
JACOBUS PHARMACEUTICAL
COMPANY, INC. - 168718
JAN BASTIAAN CILLIERS - 153456
JANSSEN PHARMACEUTICA, N.V. -
164003 , 180411
JOHN N. RASSIAS - 163231
JOMA INTERNATIONAL AS - 171363
KAKUICHI SHIOMI - 158325
KISSEI PHARMACEUTICAL CO., LTD. -
171713
KORNIT DIGITAL LTD. - 177323
KORNIT DIGITAL TECHNOLOGIES
LTD. - 177323
KYOCERA AMERICA, INC. - 168429
LABORATOIRES BESINS
INTERNATIONAL - 177778
LAM RESEARCH CORPORATION -
190454 , 209736 , 209737
LAURENTIU DUMITRU BREAZ -
189909
December 29, 2011 443-התשע"ב טבתב 'ג
LEHIGH TECHNOLOGIES, LLC - 175722
LG LIFE SCIENCES LTD. - 173638
LIGHT BOOK LTD. - 161938
LITHOTECH MEDICAL LTD. - 188067
LONZA LTD. - 177561
LTS LOHMANN THERAPIE-SYSTEME
AG - 168606
LTS LOHMANN THERAPIE-SYSTEME
AG - 184145
LUMEX AS - 193223
LUMIDIGM, INC. - 179699
MALAFON ELECTRONIC (SUZHOU)
CO. LTD. - 190011
MARCELO ADRIAN ADATTO - 193059
MARTHA SOPHIA CILLIERS - 153456
MARVELL ISRAEL (M.I.S.L) LTD. -
189514
MAX-PLANCK-GESELLSCHAFT ZUR
FOERDERUNG DER
WISSENSCHAFTEN E.V. - 185147
MEDA AB - 184310
MEDA AB - 184310
MEDELA HOLDING AG - 168355
MEDESIS PHARMA SA - 182747
MEDIGUIDE LTD. - 187667
MEDINOL LTD. - 186786 , 193848
MEDION DIAGNOSTICS AG - 172998
MEDION DIAGNOSTICS GMBH -
172998
MERCK PATENT GMBH - 159426
MERCK SERONO S.A. - 172354
MERCK SERONO S.A. - 172354
MICHAEL BRUGGEMAN - 181639
MICHAEL NAUMOV - 188649
MICHAEL NAUMOV - 189284
MICROSOFT CORPORATION - 178202 ,
199658
MILLISECOND TECHNOLOGIES
CORPORATION - 184161
MITSUBISHI SPACE SOFTWARE CO.,
LTD. - 158325
MORPHOSYS AG - 163563
MOSHE ATTIAS - 201461
MOSHE MAOR - 197165
MOWAG GMBH - 193387
NATIONAL RESEARCH
DEVELOPMENT CORPORATION -
179254
NATIONAL UNIVERSITY
CORPORATION KYUSHU UNIVERSITY
- 183028
NDS LIMITED - 178041
NDS LIMITED - 186288
NEURALAB LIMITED - 163626
NEXTER SYSTEMS - 191606
NIKKEN SOHONSHA CORPORATION -
189030
NORBROOK LABORATORIES LIMITED
- 194244
NOVARTIS VACCINES AND
DIAGNOSTICS, INC. - 175225
NUTRINOVA NUTRITION
SPECIALTIES & FOOD INGREDIENTS
GMBH - 175521
OBSCHESTVO S OGRANICHENNOI
OTVETSTVENNOSTIYU
"PHARMENTERPRISES" - 163763
ONO PHARMACEUTICAL CO., LTD. -
187840
OOO MILLISEKUNDNIYE
TEKHNOLOGII - 184161
OPED AG - 189804
OPTIMAIR HOLDING B.V.I.O. - 191720
ORTHO-HELIX SURGICAL DESIGNS,
INC. - 196257
OTO MELARA S.P.A. - 187093 , 210701 ,
210702
OXXIUS SA - 174764
PARATEK PHARMACEUTICALS, INC. -
173022
PFIZER PRODUCTS, INC. - 174299 ,
189666
PHARMACIA & UPJOHN COMPANY
LLC - 174414
PROMETHEUS LABORATORIES INC. -
191679
PROTEKTORWERK FLORENZ MAISCH
GMBH & CO. KG - 193932
QUALCOMM INCORPORATED - 173982
December 29, 2011 444-התשע"ב טבתב 'ג
QUALCOMM INCORPORATED - 178446
, 179802 , 180338
RAFAEL ADVANCED DEFENSE
SYSTEMS LTD. - 183320
RAMOT AT TEL AVIV UNIVERSITY
LTD. - 167400
RAN SIMAN-TOV - 192005
RAYTHEON BBN TECHNOLOGIES
CORP. - 181510
RAYTHEON COMPANY - 152185
RAYTHEON COMPANY - 181274
RAYTHEON COMPANY - 182473
RECCONN AG - 192087
RECON OIL INDUSTRIES PRIVATE
LIMITED - 185888
REGENERON PHARMACEUTICALS,
INC. - 172404 , 204984
REIFENHAUSER GMBH & CO. KG
MASCHINENFABRIK - 189823
RESOURCE BALLAST TECHNOLOGIES
(PROPRIETARY) LIMITED - 191066
RIGEL PHARMACEUTICALS, INC. -
166241
ROHDE & SCHWARZ GMBH & CO. KG
- 182301 , 185228
Ronen Carmona - 161938
SAFEAWAKE, LLC - 183500
SANO BRUNO'S ENTERPRISES LTD. -
168686
SANOFI - 174941
SANOFI AVENTIS - 190585
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 166494
SANOFI-AVENTIS DEUTSCHLAND
GMBH - 172008
SANTARIS PHARMA A/S - 183054
SANTARIS PHARMA A/S - 183054
SAVIO S.P.A. - 183773 , 183776 , 183777 ,
191839
SCHERING CORPORATION - 191417
SHANGHAI INSTITUTE OF MATERIA
MEDICA, CHINESE ACADEMY OF
SCIENCES - 188199
SHELL INTERNATIONALE RESEARCH
MAATSCHAPPIJ B.V. - 186203 , 186206 ,
186207 , 186211 , 186214
SHIONOGI & CO., LTD. - 180331
SNECMA - 173067 , 193030
SNECMA SERVICES - 173067
SOLVAY PHARMACEUTICALS GMBH
- 174373
SONY CORPORATION - 152589
SOURCE PRECISION MEDICINE, INC. -
147349
SRU BIOSYSTEMS, INC. - 187808
STOKKE AS - 172928
STOREWIZ INC. - 178694
STRAKAN INTERNATIONAL LIMITED
- 169881
STRAKAN LIMITED - 169881
SYNGENTA PARTICIPATIONS AG -
169307 , 177563
TADIRAN TELECOM LTD. - 164577
TAKEDA PHARMACEUTICAL
COMPANY LIMITED - 181462
TECRES S.P.A. - 188469
TEIJIN ARAMID GMBH - 188228
TEL HASHOMER MEDICAL
RESEARCH INFRASTRUCTURE AND
SERVICES LTD. - 194299
TELECOM ITALIA S.P.A. - 182824
TELEFONAKTIEBOLAGET L M
ERICSSON (PUBL) - 179003 , 183492 ,
186577
THE BRIGHAM AND WOMEN'S
HOSPITAL, INC. - 178002
THE GERD BORCHERS FAMILY
TRUST - 153456
THE JOHNS HOPKINS UNIVERSITY
SCHOOL OF MEDICINE - 163312
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA - 180219
THE UNIVERSITY OF MIAMI - 180995
THERAVANCE, INC. - 201639
TRUEPOSITION, INC. - 171217
UCB PHARMA GMBH - 173062
UNILEVER PLC - 194287
UNITED STATES GYPSUM COMPANY
- 179810
UNIVERSITE DE LAUSANNE - 172783
December 29, 2011 445-התשע"ב טבתב 'ג
UNIVERSITY OF NORTH CAROLINA
AT CHAPEL HILL - 155249
UT-BATTELLE, LLC - 191897
VARLEY AND GULLIVER LIMITED -
186517
VIPERGEN APS - 183013
VLAAMSE INSTELLING VOOR
TECHNOLOGISCH ONDERZOEK
(VITO) - 184877
VLADIMIR EVGENIEVICH NEBOLSIN -
163763
WARNER CHILCOTT (IRELAND)
LIMITED - 172620
WARNER-LAMBERT COMPANY LLC. -
178433
WEBER AIRCRAFT LP - 188641
WERLATONE, INC. - 185696
WESTERN UNIVERSITY OF HEALTH
SCIENCES - 183490
WILLEM MEIJER - 191720
WYETH LLC - 163626 , 176147
YALE UNIVERSITY - 177591
YAMIT NACHMANY - 201461
YM BIOSCIENCES AUSTRALIA PTY
LTD. - 175572
YOSSY SELA - 168298
ZAMBON GROUP S.P.A. - 175765
December 29, 2011 446-התשע"ב טבתב 'ג
SUBJECT MATTER INDEX מפתח ענייני
A01N - 153456, 177563
A23L - 184161, 193059, 194287
A43D - 188645
A44C - 179893
A45D - 197165
A46B - 188246
A47B - 173997
A47C - 172928
A47J - 195661
A61B - 156377, 158325, 165619,
167400, 167782, 172326,
183323, 187667, 188067,
188582, 196257, 197032
A61F - 183030, 186786, 188469
A61G - 189804
A61J - 168355
A61K - 154008, 155213, 155791,
157326, 157360, 157443,
161513, 163312, 164664,
166241, 168399, 168606,
168745, 169881, 171713,
172620, 172783, 173062,
174172, 174374, 176649,
177778, 178002, 178515,
179254, 180487, 182747,
183157, 183200, 183490,
184145, 186491, 187604,
187813, 189030, 189972,
193848, 194244, 194656,
200959
A61M - 156090, 166508, 175017,
180995, 185100, 201694
B21D - 193932
B23B - 174148, 174670, 193030
B23C - 181562
B23P - 187519
B24B - 182170, 196221
B29D - 187048
B32B - 188228, 194687
B41J - 177323
B60K - 187093, 210701, 210702
B60N - 188641, 193387
B60R - 201461
B64G - 182473
B65D - 168361, 185874
B65G - 194464
B65H - 177886
C01G - 171363
C02F - 183881, 191066
C03B - 180213
C04B - 168332
C07C - 168718, 170829, 175765,
177561, 181024, 181317,
186680, 188199, 193071,
196327, 201639
C07D - 139894, 159426, 159506,
164003, 165436, 166494,
166584, 168121, 169307,
169527, 172457, 173022,
173638, 174075, 174299,
174373, 174414, 174513,
174941, 175572, 176147,
178433, 179370, 179737,
180331, 180411, 180486,
180524, 181462, 182396,
183028, 183594, 183739,
184310, 184983, 187840,
188600, 188670, 189664,
189666, 190673, 191417,
203533, 205242, 207067
C07F - 180758, 180781
C07H - 183054, 184438
C07K - 163626, 163763, 167774,
170076, 175225, 185147,
191077, 191078, 191824,
193310, 197988
C08J - 175722
C11B - 185888
C11D - 168686, 177761
C12M - 206869
C12N - 146479, 155249, 157378,
170178, 172404, 174786,
177324, 183013, 186988,
188264, 190088, 190731,
December 29, 2011 447-התשע"ב טבתב 'ג
190869, 197377, 198076,
198861, 204984
C12P - 175521, 200172
C12Q - 145210, 167410, 172008,
177591, 190585, 191897,
194299
C22C - 173067
C25D - 177414, 189168
C30B - 166905, 207054
D01F - 196716
D04H - 189823
D21H - 186384
E01F - 186517
E02D - 170438
E04B - 190071
E04C - 189909
E05B - 190011, 191839
E05C - 183773
E05D - 183776, 183777
E21B - 186203, 186206, 186207,
186211, 186214
F01C - 171444
F16H - 192005
F16K - 191738
F21V - 184362
F24F - 191720
F25D - 179810, 192011
F41A - 183891, 191606
F41B - 167142
F41C - 163231
F41G - 152185, 163609
F42B - 191614, 192087
G01C - 188649, 189284
G01F - 185534
G01N - 147349, 161309, 163563,
171177, 171178, 172354,
172998, 175936, 180219,
181119, 185631, 187808,
191679, 193003, 194297
G01S - 170726, 171217, 181510,
193866
G02C - 183368
G02F - 193789
G06F - 161938, 167629, 178202,
178694, 189206, 191952
G06K - 179699, 181639, 193223
G06T - 183320
G07F - 166911
G08B - 194909
G11B - 152589
H01G - 209736, 209737
H01H - 194135
H01J - 160873, 180440
H01J - 174681
H01L - 168429, 173422, 181274,
190454
H01M - 172944
H01P - 185696
H01R - 184200
H01S - 174764
H02J - 193502
H04B - 182301, 183500, 186577
H04L - 178041, 179003, 179802,
180338, 182824, 184887,
185228, 189514, 199658
H04M - 164577, 183492
H04N - 186288, 188757
H04Q - 171722, 189342
H04R - 180516
H04W - 168298, 173982, 178446,
180004, 184083, 189716
H05H - 184877
H05K - 183398
December 29, 2011 448-התשע"ב טבתב 'ג
קודים למדינת המופיעים ביומן
COUNTRY CODES APPEARING IN THIS JOURNAL
Code Country or Organization Code Country or Organization AR Argentina MX Mexico AT Austria MY Malaysia AU Australia NL The Netherlands BA Herzegovina NO Norway BE Belgium NZ New Zealand BR Brazil PL Poland CA Canada PT Portugal CH Switzerland RU Russian Federation CN China SE Sweden CU Cuba SG Singapore CZ Czech Republic SI Slovenia DE Germany SK Slovakia DK Denmark TH Thailand EC Ecuador TR Turkey EP European Patent Office TW Taiwan ES Spain UA Ukraine FI Finland US United States of America FR France UY Uruguay GB United Kingdom UZ Uzbekistan GE Georgia WO World Intellectual Property GR Greece Organization (W.I.P.O.) GT Guatemala ZA South Africa HR Croatia HU Hungary IE Ireland IL Israel IN India IT Italy JP Japan KR Republic of Korea LK Sri Lanka LU Luxembourg LV Latvia